Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,Melanoma in situ,A1BG,Alpha-1B-glycoprotein,35692,141,1.33 [0.52-3.44],0.553241842295366
Chapter II Neoplasms,Melanoma in situ,AAMDC,Mth938 domain-containing protein,34695,137,1.07 [0.79-1.46],0.6584567738876008
Chapter II Neoplasms,Melanoma in situ,AARSD1,Alanyl-tRNA editing protein Aarsd1,40789,160,1.04 [0.81-1.34],0.7570237175562706
Chapter II Neoplasms,Melanoma in situ,ABCA2,ATP-binding cassette sub-family A member 2,34518,137,0.55 [0.34-0.90],0.0180266106675603
Chapter II Neoplasms,Melanoma in situ,ABHD14B,Protein ABHD14B,40546,158,1.06 [0.83-1.35],0.6498754382377929
Chapter II Neoplasms,Melanoma in situ,ABL1,Tyrosine-protein kinase ABL1,40789,160,1.10 [0.90-1.35],0.3669508803342782
Chapter II Neoplasms,Melanoma in situ,ABO,Histo-blood group ABO system transferase,35663,141,0.97 [0.86-1.08],0.5371886803298833
Chapter II Neoplasms,Melanoma in situ,ABRAXAS2,BRISC complex subunit Abraxas 2,34518,137,0.98 [0.76-1.26],0.8910255694311835
Chapter II Neoplasms,Melanoma in situ,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",40055,159,1.03 [0.87-1.23],0.7087578910328085
Chapter II Neoplasms,Melanoma in situ,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",34984,139,1.06 [0.86-1.32],0.568360803265306
Chapter II Neoplasms,Melanoma in situ,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",35640,141,1.05 [0.88-1.26],0.5840541582939138
Chapter II Neoplasms,Melanoma in situ,ACAN,Aggrecan core protein,40582,157,0.84 [0.50-1.40],0.497847686614594
Chapter II Neoplasms,Melanoma in situ,ACE,Angiotensin-converting enzyme,35663,141,1.08 [0.60-1.96],0.796019369147428
Chapter II Neoplasms,Melanoma in situ,ACE2,Angiotensin-converting enzyme 2,40258,158,0.85 [0.63-1.15],0.289678809440537
Chapter II Neoplasms,Melanoma in situ,ACHE,Acetylcholinesterase,34878,138,1.00 [0.61-1.64],0.994352984252624
Chapter II Neoplasms,Melanoma in situ,ACOT13,Acyl-coenzyme A thioesterase 13,35486,140,1.08 [0.93-1.24],0.306679898438662
Chapter II Neoplasms,Melanoma in situ,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,40984,163,1.22 [0.94-1.58],0.1354044463143571
Chapter II Neoplasms,Melanoma in situ,ACP1,Low molecular weight phosphotyrosine protein phosphatase,34608,134,1.14 [0.81-1.62],0.4532406827612039
Chapter II Neoplasms,Melanoma in situ,ACP5,Tartrate-resistant acid phosphatase type 5,41171,163,0.61 [0.40-0.94],0.0253330961290521
Chapter II Neoplasms,Melanoma in situ,ACP6,Lysophosphatidic acid phosphatase type 6,41296,164,1.22 [0.98-1.53],0.0782831679510444
Chapter II Neoplasms,Melanoma in situ,ACRBP,Acrosin-binding protein,35477,140,1.10 [0.74-1.63],0.6519724680859964
Chapter II Neoplasms,Melanoma in situ,ACRV1,Acrosomal protein SP-10,34608,134,1.10 [0.89-1.36],0.3644718652652778
Chapter II Neoplasms,Melanoma in situ,ACSL1,Long-chain-fatty-acid--CoA ligase 1,34518,137,0.86 [0.53-1.39],0.5351014441058211
Chapter II Neoplasms,Melanoma in situ,ACTA2,"Actin, aortic smooth muscle",40258,158,0.81 [0.57-1.17],0.2614617033777636
Chapter II Neoplasms,Melanoma in situ,ACTN2,Alpha-actinin-2,34518,137,1.11 [0.85-1.46],0.4493326011489109
Chapter II Neoplasms,Melanoma in situ,ACTN4,Alpha-actinin-4,40249,159,0.91 [0.57-1.44],0.6783039793576664
Chapter II Neoplasms,Melanoma in situ,ACVRL1,Serine/threonine-protein kinase receptor R3,40613,157,0.84 [0.46-1.54],0.5782233971897861
Chapter II Neoplasms,Melanoma in situ,ACY1,Aminoacylase-1,40984,163,1.13 [0.90-1.42],0.2761324144304833
Chapter II Neoplasms,Melanoma in situ,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,34518,137,1.07 [0.80-1.45],0.6470646683056508
Chapter II Neoplasms,Melanoma in situ,ACYP1,Acylphosphatase-1,34747,138,1.05 [0.82-1.35],0.6816445897194157
Chapter II Neoplasms,Melanoma in situ,ADA,Adenosine deaminase,41452,164,0.86 [0.57-1.29],0.4610118941193118
Chapter II Neoplasms,Melanoma in situ,ADA2,Adenosine deaminase 2,40746,163,0.90 [0.64-1.25],0.5300223648359764
Chapter II Neoplasms,Melanoma in situ,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,34608,134,1.15 [0.71-1.88],0.5672844773685499
Chapter II Neoplasms,Melanoma in situ,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40258,158,0.85 [0.54-1.36],0.5051458186240623
Chapter II Neoplasms,Melanoma in situ,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,40682,158,0.88 [0.59-1.33],0.551074175973929
Chapter II Neoplasms,Melanoma in situ,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,41452,164,0.88 [0.60-1.28],0.4955342055745444
Chapter II Neoplasms,Melanoma in situ,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,41279,165,0.92 [0.57-1.49],0.7367718001610982
Chapter II Neoplasms,Melanoma in situ,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,35486,140,0.80 [0.46-1.39],0.4307872632141777
Chapter II Neoplasms,Melanoma in situ,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,34608,134,0.94 [0.55-1.61],0.8197593624427326
Chapter II Neoplasms,Melanoma in situ,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,41485,164,0.95 [0.53-1.73],0.8780714589795909
Chapter II Neoplasms,Melanoma in situ,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,40789,160,0.94 [0.68-1.31],0.721276771966141
Chapter II Neoplasms,Melanoma in situ,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,40258,158,0.77 [0.46-1.28],0.3067294828977158
Chapter II Neoplasms,Melanoma in situ,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,34608,134,0.84 [0.52-1.36],0.4714690659863443
Chapter II Neoplasms,Melanoma in situ,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,41097,164,1.04 [0.76-1.41],0.8220345459766838
Chapter II Neoplasms,Melanoma in situ,ADAMTSL2,ADAMTS-like protein 2,35644,141,0.81 [0.48-1.36],0.4284512076450208
Chapter II Neoplasms,Melanoma in situ,ADAMTSL4,ADAMTS-like protein 4,34695,137,1.62 [0.81-3.22],0.1709010728405549
Chapter II Neoplasms,Melanoma in situ,ADAMTSL5,ADAMTS-like protein 5,35640,141,0.66 [0.44-0.99],0.0424251598259457
Chapter II Neoplasms,Melanoma in situ,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,40055,159,0.92 [0.59-1.42],0.6992655206287619
Chapter II Neoplasms,Melanoma in situ,ADD1,Alpha-adducin,34878,138,1.02 [0.81-1.28],0.8745663524095686
Chapter II Neoplasms,Melanoma in situ,ADGRB3,Adhesion G protein-coupled receptor B3,40613,157,0.71 [0.46-1.10],0.1265230040397764
Chapter II Neoplasms,Melanoma in situ,ADGRD1,Adhesion G-protein coupled receptor D1,34878,138,1.16 [0.75-1.78],0.5023355067115485
Chapter II Neoplasms,Melanoma in situ,ADGRE1,Adhesion G protein-coupled receptor E1,35486,140,1.12 [0.83-1.51],0.4530391236585488
Chapter II Neoplasms,Melanoma in situ,ADGRE2,Adhesion G protein-coupled receptor E2,41147,164,0.77 [0.46-1.27],0.3026818399469315
Chapter II Neoplasms,Melanoma in situ,ADGRE5,Adhesion G protein-coupled receptor E5,41287,162,0.83 [0.52-1.34],0.4526412521581312
Chapter II Neoplasms,Melanoma in situ,ADGRF5,Adhesion G protein-coupled receptor F5,35640,141,0.80 [0.45-1.40],0.4291127093288391
Chapter II Neoplasms,Melanoma in situ,ADGRG1,Adhesion G-protein coupled receptor G1,40789,160,1.08 [0.90-1.30],0.4175797264106839
Chapter II Neoplasms,Melanoma in situ,ADGRG2,Adhesion G-protein coupled receptor G2,40984,163,1.03 [0.61-1.73],0.9183631911769404
Chapter II Neoplasms,Melanoma in situ,ADGRV1,Adhesion G-protein coupled receptor V1,34549,138,1.00 [0.80-1.26],0.983431597961512
Chapter II Neoplasms,Melanoma in situ,ADH1B,All-trans-retinol dehydrogenase,34878,138,0.91 [0.72-1.14],0.4019452981320978
Chapter II Neoplasms,Melanoma in situ,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,40258,158,0.92 [0.77-1.09],0.3377045333416518
Chapter II Neoplasms,Melanoma in situ,ADIPOQ,Adiponectin,35692,141,1.12 [0.88-1.42],0.3459364993680541
Chapter II Neoplasms,Melanoma in situ,ADM,Pro-adrenomedullin,41358,164,1.08 [0.63-1.86],0.7742373155498569
Chapter II Neoplasms,Melanoma in situ,ADRA2A,Alpha-2A adrenergic receptor,34518,137,1.09 [0.88-1.34],0.4378780139692592
Chapter II Neoplasms,Melanoma in situ,AFAP1,Actin filament-associated protein 1,34878,138,0.91 [0.75-1.12],0.3847972441666784
Chapter II Neoplasms,Melanoma in situ,AFM,Afamin,35692,141,0.76 [0.33-1.72],0.5038119545783806
Chapter II Neoplasms,Melanoma in situ,AFP,Alpha-fetoprotein,40552,156,0.96 [0.78-1.19],0.7365512542522887
Chapter II Neoplasms,Melanoma in situ,AGBL2,Cytosolic carboxypeptidase 2,34549,138,0.92 [0.77-1.09],0.3138389864563059
Chapter II Neoplasms,Melanoma in situ,AGER,Advanced glycosylation end product-specific receptor,40875,162,1.02 [0.72-1.45],0.8901515097049624
Chapter II Neoplasms,Melanoma in situ,AGR2,Anterior gradient protein 2 homolog,39703,159,0.96 [0.83-1.10],0.5287750276130151
Chapter II Neoplasms,Melanoma in situ,AGR3,Anterior gradient protein 3,39989,159,1.10 [0.87-1.39],0.4130896563122711
Chapter II Neoplasms,Melanoma in situ,AGRN,Agrin,41147,164,1.28 [0.85-1.92],0.2401549194887328
Chapter II Neoplasms,Melanoma in situ,AGRP,Agouti-related protein,41452,164,1.03 [0.79-1.35],0.831127382005191
Chapter II Neoplasms,Melanoma in situ,AGT,Angiotensinogen,35663,141,0.79 [0.41-1.53],0.4900082773434288
Chapter II Neoplasms,Melanoma in situ,AGXT,Serine--pyruvate aminotransferase,40984,163,0.90 [0.75-1.09],0.2915106005227472
Chapter II Neoplasms,Melanoma in situ,AHCY,Adenosylhomocysteinase,40984,163,1.06 [0.87-1.31],0.5457580990257176
Chapter II Neoplasms,Melanoma in situ,AHNAK,Neuroblast differentiation-associated protein AHNAK,34695,137,0.76 [0.44-1.32],0.3258887813849532
Chapter II Neoplasms,Melanoma in situ,AHNAK2,Protein AHNAK2,34695,137,0.75 [0.41-1.36],0.3447058108488038
Chapter II Neoplasms,Melanoma in situ,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,35477,140,1.13 [0.91-1.40],0.2702920758848485
Chapter II Neoplasms,Melanoma in situ,AHSG,Alpha-2-HS-glycoprotein,35663,141,1.56 [0.86-2.81],0.1423928080019742
Chapter II Neoplasms,Melanoma in situ,AHSP,Alpha-hemoglobin-stabilizing protein,40920,164,0.97 [0.83-1.15],0.7554765924597038
Chapter II Neoplasms,Melanoma in situ,AIDA,"Axin interactor, dorsalization-associated protein",34686,135,0.93 [0.76-1.14],0.4935739513705223
Chapter II Neoplasms,Melanoma in situ,AIF1,Allograft inflammatory factor 1,40055,159,0.94 [0.72-1.23],0.6661847936212608
Chapter II Neoplasms,Melanoma in situ,AIF1L,Allograft inflammatory factor 1-like,34695,137,0.93 [0.68-1.27],0.6381878475254534
Chapter II Neoplasms,Melanoma in situ,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40721,159,1.03 [0.90-1.18],0.6237993496568313
Chapter II Neoplasms,Melanoma in situ,AK1,Adenylate kinase isoenzyme 1,40984,163,1.04 [0.84-1.29],0.7089022272328461
Chapter II Neoplasms,Melanoma in situ,AK2,"Adenylate kinase 2, mitochondrial",35570,140,1.09 [0.94-1.27],0.2711728076476223
Chapter II Neoplasms,Melanoma in situ,AKAP12,A-kinase anchor protein 12,34878,138,0.94 [0.43-2.06],0.8804315522011362
Chapter II Neoplasms,Melanoma in situ,AKR1B1,Aldo-keto reductase family 1 member B1,40055,159,1.19 [0.99-1.42],0.0654338574937119
Chapter II Neoplasms,Melanoma in situ,AKR1B10,Aldo-keto reductase family 1 member B10,34686,135,1.13 [0.88-1.45],0.3486429325523895
Chapter II Neoplasms,Melanoma in situ,AKR1C4,Aldo-keto reductase family 1 member C4,40258,158,1.06 [0.83-1.37],0.6276677418938621
Chapter II Neoplasms,Melanoma in situ,AKR7L,Aflatoxin B1 aldehyde reductase member 4,34608,134,1.06 [0.84-1.35],0.6019784750737134
Chapter II Neoplasms,Melanoma in situ,AKT1S1,Proline-rich AKT1 substrate 1,40031,160,1.02 [0.83-1.26],0.8428867479649981
Chapter II Neoplasms,Melanoma in situ,AKT2,RAC-beta serine/threonine-protein kinase,35587,140,1.08 [0.95-1.23],0.2238495858829594
Chapter II Neoplasms,Melanoma in situ,AKT3,RAC-gamma serine/threonine-protein kinase,39861,159,1.10 [0.86-1.41],0.4375140018571307
Chapter II Neoplasms,Melanoma in situ,ALCAM,CD166 antigen,41485,164,0.76 [0.37-1.58],0.4687320170351777
Chapter II Neoplasms,Melanoma in situ,ALDH1A1,Retinal dehydrogenase 1,40993,164,0.93 [0.72-1.21],0.6070112975045403
Chapter II Neoplasms,Melanoma in situ,ALDH2,"Aldehyde dehydrogenase, mitochondrial",35477,140,0.99 [0.72-1.35],0.9299458457750636
Chapter II Neoplasms,Melanoma in situ,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",40875,163,1.05 [0.86-1.28],0.6610615177901641
Chapter II Neoplasms,Melanoma in situ,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",35587,140,0.85 [0.59-1.22],0.3805599321850706
Chapter II Neoplasms,Melanoma in situ,ALMS1,Alstrom syndrome protein 1,34984,139,0.61 [0.39-0.95],0.0283562268930033
Chapter II Neoplasms,Melanoma in situ,ALPI,Intestinal-type alkaline phosphatase,34608,134,1.12 [0.99-1.28],0.08009270776463
Chapter II Neoplasms,Melanoma in situ,ALPP,"Alkaline phosphatase, placental type",40789,160,1.09 [0.95-1.26],0.2047232684496426
Chapter II Neoplasms,Melanoma in situ,AMBN,Ameloblastin,40249,159,0.92 [0.54-1.58],0.7662747264893226
Chapter II Neoplasms,Melanoma in situ,AMBP,Protein AMBP,41299,164,1.40 [0.70-2.81],0.3372628542939355
Chapter II Neoplasms,Melanoma in situ,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,35644,141,0.54 [0.30-0.98],0.0419109594683735
Chapter II Neoplasms,Melanoma in situ,AMFR,E3 ubiquitin-protein ligase AMFR,40031,160,0.81 [0.63-1.03],0.0816069005307194
Chapter II Neoplasms,Melanoma in situ,AMIGO1,Amphoterin-induced protein 1,34686,135,0.71 [0.48-1.06],0.0972079075579242
Chapter II Neoplasms,Melanoma in situ,AMIGO2,Amphoterin-induced protein 2,40789,160,1.31 [0.71-2.41],0.3806599685663737
Chapter II Neoplasms,Melanoma in situ,AMN,Protein amnionless,40249,159,1.19 [0.89-1.60],0.2346621363795578
Chapter II Neoplasms,Melanoma in situ,AMOT,Angiomotin,34878,138,1.10 [0.72-1.68],0.6505518807960247
Chapter II Neoplasms,Melanoma in situ,AMOTL2,Angiomotin-like protein 2,35352,139,1.16 [0.86-1.56],0.3412400494424724
Chapter II Neoplasms,Melanoma in situ,AMPD3,AMP deaminase 3,35570,140,1.04 [0.83-1.29],0.7588226172017098
Chapter II Neoplasms,Melanoma in situ,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,33372,130,1.06 [0.76-1.48],0.7306971539337588
Chapter II Neoplasms,Melanoma in situ,AMY2A,Pancreatic alpha-amylase,39420,155,1.06 [0.78-1.43],0.7057145756182732
Chapter II Neoplasms,Melanoma in situ,AMY2B,Alpha-amylase 2B,38211,149,1.06 [0.78-1.44],0.6986486626975767
Chapter II Neoplasms,Melanoma in situ,ANG,Angiogenin,40877,163,0.87 [0.57-1.32],0.5147073546108076
Chapter II Neoplasms,Melanoma in situ,ANGPT1,Angiopoietin-1,40828,161,0.99 [0.84-1.17],0.9315255115805569
Chapter II Neoplasms,Melanoma in situ,ANGPT2,Angiopoietin-2,41358,164,1.11 [0.77-1.60],0.5844206065687816
Chapter II Neoplasms,Melanoma in situ,ANGPTL1,Angiopoietin-related protein 1,40402,161,1.30 [0.80-2.10],0.2914468305575922
Chapter II Neoplasms,Melanoma in situ,ANGPTL2,Angiopoietin-related protein 2,41012,164,0.89 [0.63-1.26],0.5209447898512833
Chapter II Neoplasms,Melanoma in situ,ANGPTL3,Angiopoietin-related protein 3,41004,163,0.89 [0.60-1.32],0.5534517229441316
Chapter II Neoplasms,Melanoma in situ,ANGPTL4,Angiopoietin-related protein 4,41087,164,1.03 [0.76-1.41],0.839664343252633
Chapter II Neoplasms,Melanoma in situ,ANGPTL7,Angiopoietin-related protein 7,41358,164,0.86 [0.59-1.26],0.4379271885562267
Chapter II Neoplasms,Melanoma in situ,ANK2,Ankyrin-2,34518,137,1.03 [0.82-1.28],0.8100619750364847
Chapter II Neoplasms,Melanoma in situ,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,34608,134,1.22 [0.99-1.50],0.0574181865330571
Chapter II Neoplasms,Melanoma in situ,ANKRA2,Ankyrin repeat family A protein 2,34394,136,1.22 [0.94-1.57],0.1319837893097862
Chapter II Neoplasms,Melanoma in situ,ANKRD54,Ankyrin repeat domain-containing protein 54,40055,159,1.00 [0.79-1.27],0.9929220922785678
Chapter II Neoplasms,Melanoma in situ,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,34695,137,0.83 [0.52-1.31],0.4184467645434134
Chapter II Neoplasms,Melanoma in situ,ANPEP,Aminopeptidase N,41069,163,0.88 [0.53-1.46],0.6130742007501795
Chapter II Neoplasms,Melanoma in situ,ANXA1,Annexin A1,34674,137,0.60 [0.39-0.93],0.0213802849892252
Chapter II Neoplasms,Melanoma in situ,ANXA10,Annexin A10,40031,160,1.03 [0.87-1.22],0.7483119088936834
Chapter II Neoplasms,Melanoma in situ,ANXA11,Annexin A11,40872,163,1.06 [0.86-1.30],0.6003014411371761
Chapter II Neoplasms,Melanoma in situ,ANXA2,Annexin A2,34181,137,1.01 [0.80-1.28],0.9286291902474426
Chapter II Neoplasms,Melanoma in situ,ANXA3,Annexin A3,41279,165,1.04 [0.86-1.26],0.7030629006158249
Chapter II Neoplasms,Melanoma in situ,ANXA4,Annexin A4,40788,161,1.05 [0.86-1.27],0.629763583416707
Chapter II Neoplasms,Melanoma in situ,ANXA5,Annexin A5,39908,160,1.05 [0.66-1.68],0.8302529387421406
Chapter II Neoplasms,Melanoma in situ,AOC1,Amiloride-sensitive amine oxidase [copper-containing],40249,159,1.02 [0.80-1.31],0.8442250206142882
Chapter II Neoplasms,Melanoma in situ,AOC3,Membrane primary amine oxidase,41135,163,0.89 [0.56-1.42],0.627291750560552
Chapter II Neoplasms,Melanoma in situ,AP1G2,AP-1 complex subunit gamma-like 2,35477,140,1.17 [0.96-1.43],0.1190832785699756
Chapter II Neoplasms,Melanoma in situ,AP2B1,AP-2 complex subunit beta,34686,135,0.91 [0.64-1.30],0.5974840922935603
Chapter II Neoplasms,Melanoma in situ,AP3B1,AP-3 complex subunit beta-1,35486,140,1.05 [0.85-1.30],0.6421514194107952
Chapter II Neoplasms,Melanoma in situ,AP3S2,AP-3 complex subunit sigma-2,35570,140,1.01 [0.72-1.43],0.9509011527707648
Chapter II Neoplasms,Melanoma in situ,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40789,160,1.01 [0.74-1.37],0.9436888648824092
Chapter II Neoplasms,Melanoma in situ,APCS,Serum amyloid P-component,35367,141,0.76 [0.48-1.21],0.2455157847831173
Chapter II Neoplasms,Melanoma in situ,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,41234,163,1.02 [0.81-1.28],0.8766843720630275
Chapter II Neoplasms,Melanoma in situ,APLP1,Amyloid-like protein 1,40984,163,0.96 [0.73-1.26],0.7741283424978985
Chapter II Neoplasms,Melanoma in situ,APOA1,Apolipoprotein A-I,35692,141,0.68 [0.36-1.31],0.2525257661824682
Chapter II Neoplasms,Melanoma in situ,APOA2,Apolipoprotein A-II,35663,141,0.92 [0.66-1.28],0.6194812966806957
Chapter II Neoplasms,Melanoma in situ,APOA4,Apolipoprotein A-IV,35692,141,0.71 [0.43-1.17],0.1821423652537112
Chapter II Neoplasms,Melanoma in situ,APOB,Apolipoprotein B-100,35663,141,0.69 [0.35-1.35],0.2754126817813447
Chapter II Neoplasms,Melanoma in situ,APOBR,Apolipoprotein B receptor,34695,137,0.92 [0.63-1.34],0.653796554039352
Chapter II Neoplasms,Melanoma in situ,APOC1,Apolipoprotein C-I,35623,141,0.89 [0.57-1.40],0.6109282235386599
Chapter II Neoplasms,Melanoma in situ,APOD,Apolipoprotein D,34067,134,1.00 [0.68-1.49],0.9907737181336872
Chapter II Neoplasms,Melanoma in situ,APOE,Apolipoprotein E,35692,141,1.05 [0.85-1.29],0.6619941320556038
Chapter II Neoplasms,Melanoma in situ,APOF,Apolipoprotein F,35663,141,1.04 [0.49-2.21],0.9166998802127712
Chapter II Neoplasms,Melanoma in situ,APOH,Beta-2-glycoprotein 1,40993,164,0.96 [0.66-1.42],0.8504873129268975
Chapter II Neoplasms,Melanoma in situ,APOL1,Apolipoprotein L1,35663,141,0.87 [0.65-1.17],0.3585478923598769
Chapter II Neoplasms,Melanoma in situ,APOM,Apolipoprotein M,41076,163,0.86 [0.52-1.41],0.5464109624122462
Chapter II Neoplasms,Melanoma in situ,APP,Amyloid-beta precursor protein,40935,164,1.01 [0.83-1.25],0.8895405984586822
Chapter II Neoplasms,Melanoma in situ,APPL2,DCC-interacting protein 13-beta,34878,138,1.12 [0.96-1.30],0.151218342764646
Chapter II Neoplasms,Melanoma in situ,APRT,Adenine phosphoribosyltransferase,40621,157,1.17 [0.87-1.59],0.3003753938775085
Chapter II Neoplasms,Melanoma in situ,ARAF,Serine/threonine-protein kinase A-Raf,34984,139,1.23 [1.00-1.51],0.045304992875724
Chapter II Neoplasms,Melanoma in situ,AREG,Amphiregulin,40789,160,1.14 [0.82-1.57],0.4356660772414762
Chapter II Neoplasms,Melanoma in situ,ARF6,ADP-ribosylation factor 6,35486,140,1.13 [0.96-1.31],0.133877293383302
Chapter II Neoplasms,Melanoma in situ,ARFIP1,Arfaptin-1,35587,140,1.05 [0.83-1.33],0.7055550717394732
Chapter II Neoplasms,Melanoma in situ,ARG1,Arginase-1,40787,161,0.90 [0.69-1.17],0.436496953372625
Chapter II Neoplasms,Melanoma in situ,ARG2,"Arginase-2, mitochondrial",35477,140,1.02 [0.71-1.48],0.900052444643897
Chapter II Neoplasms,Melanoma in situ,ARHGAP1,Rho GTPase-activating protein 1,40055,159,1.05 [0.77-1.43],0.7404948409855676
Chapter II Neoplasms,Melanoma in situ,ARHGAP25,Rho GTPase-activating protein 25,40055,159,1.10 [0.87-1.38],0.4167480793279197
Chapter II Neoplasms,Melanoma in situ,ARHGAP30,Rho GTPase-activating protein 30,34984,139,0.80 [0.50-1.28],0.344681884129124
Chapter II Neoplasms,Melanoma in situ,ARHGAP45,Rho GTPase-activating protein 45,34878,138,1.14 [0.93-1.40],0.1939764611482465
Chapter II Neoplasms,Melanoma in situ,ARHGAP5,Rho GTPase-activating protein 5,34394,136,0.97 [0.78-1.20],0.7709540538085169
Chapter II Neoplasms,Melanoma in situ,ARHGEF1,Rho guanine nucleotide exchange factor 1,35570,140,1.14 [0.95-1.37],0.1536942261820444
Chapter II Neoplasms,Melanoma in situ,ARHGEF10,Rho guanine nucleotide exchange factor 10,35587,140,1.16 [0.98-1.37],0.0886498299856041
Chapter II Neoplasms,Melanoma in situ,ARHGEF12,Rho guanine nucleotide exchange factor 12,40939,163,1.11 [0.97-1.27],0.1133360914260733
Chapter II Neoplasms,Melanoma in situ,ARHGEF5,Rho guanine nucleotide exchange factor 5,34549,138,1.10 [0.89-1.35],0.391025033671476
Chapter II Neoplasms,Melanoma in situ,ARID3A,AT-rich interactive domain-containing protein 3A,34549,138,0.87 [0.57-1.33],0.5241644946079268
Chapter II Neoplasms,Melanoma in situ,ARID4B,AT-rich interactive domain-containing protein 4B,40031,160,0.74 [0.50-1.11],0.1466518130560753
Chapter II Neoplasms,Melanoma in situ,ARL13B,ADP-ribosylation factor-like protein 13B,34518,137,1.10 [0.88-1.39],0.4015743716875144
Chapter II Neoplasms,Melanoma in situ,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,34518,137,0.98 [0.65-1.48],0.9276661262119148
Chapter II Neoplasms,Melanoma in situ,ARMCX2,Armadillo repeat-containing X-linked protein 2,34549,138,0.94 [0.71-1.24],0.6746183008369523
Chapter II Neoplasms,Melanoma in situ,ARNT,Aryl hydrocarbon receptor nuclear translocator,40249,159,0.79 [0.52-1.19],0.2557288313188634
Chapter II Neoplasms,Melanoma in situ,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,34518,137,1.02 [0.75-1.38],0.9235532822612704
Chapter II Neoplasms,Melanoma in situ,ARSA,Arylsulfatase A,40993,164,0.85 [0.62-1.18],0.3374980152446251
Chapter II Neoplasms,Melanoma in situ,ARSB,Arylsulfatase B,40789,160,1.00 [0.77-1.29],0.9953451262371078
Chapter II Neoplasms,Melanoma in situ,ART3,Ecto-ADP-ribosyltransferase 3,41135,163,0.73 [0.49-1.10],0.1354597620697509
Chapter II Neoplasms,Melanoma in situ,ART5,Ecto-ADP-ribosyltransferase 5,34549,138,1.11 [0.89-1.38],0.3458541177936672
Chapter II Neoplasms,Melanoma in situ,ARTN,Artemin,40249,159,0.81 [0.56-1.18],0.2729224409609326
Chapter II Neoplasms,Melanoma in situ,ASAH1,Acid ceramidase,35320,141,1.14 [0.82-1.59],0.4259689606686978
Chapter II Neoplasms,Melanoma in situ,ASAH2,Neutral ceramidase,40682,158,0.98 [0.75-1.27],0.8734862667912956
Chapter II Neoplasms,Melanoma in situ,ASGR1,Asialoglycoprotein receptor 1,40682,158,1.49 [0.93-2.38],0.0988460470661998
Chapter II Neoplasms,Melanoma in situ,ASGR2,Asialoglycoprotein receptor 2,35663,141,1.17 [0.63-2.16],0.6226854218011949
Chapter II Neoplasms,Melanoma in situ,ASPN,Asporin,35640,141,0.63 [0.34-1.17],0.1398564651672263
Chapter II Neoplasms,Melanoma in situ,ASPSCR1,Tether containing UBX domain for GLUT4,35587,140,1.13 [0.89-1.43],0.3319896002548006
Chapter II Neoplasms,Melanoma in situ,ASRGL1,Isoaspartyl peptidase/L-asparaginase,34695,137,1.08 [0.92-1.27],0.3373664049763833
Chapter II Neoplasms,Melanoma in situ,ASS1,Argininosuccinate synthase,34518,137,0.89 [0.71-1.10],0.2863029072266642
Chapter II Neoplasms,Melanoma in situ,ATF2,Cyclic AMP-dependent transcription factor ATF-2,40031,160,0.87 [0.68-1.12],0.2845013265276183
Chapter II Neoplasms,Melanoma in situ,ATF4,Cyclic AMP-dependent transcription factor ATF-4,34394,136,0.70 [0.41-1.18],0.1830627053707174
Chapter II Neoplasms,Melanoma in situ,ATG16L1,Autophagy-related protein 16-1,35486,140,1.15 [0.95-1.39],0.1582318524436581
Chapter II Neoplasms,Melanoma in situ,ATG4A,Cysteine protease ATG4A,40055,159,0.98 [0.77-1.24],0.8729584418008688
Chapter II Neoplasms,Melanoma in situ,ATOX1,Copper transport protein ATOX1,41097,164,1.10 [0.91-1.34],0.3183963806029583
Chapter II Neoplasms,Melanoma in situ,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,34518,137,0.72 [0.47-1.10],0.1269587309832023
Chapter II Neoplasms,Melanoma in situ,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,34518,137,0.53 [0.30-0.95],0.0315724351037415
Chapter II Neoplasms,Melanoma in situ,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,34518,137,0.60 [0.36-1.00],0.0504142383170317
Chapter II Neoplasms,Melanoma in situ,ATP1B4,Protein ATP1B4,34394,136,0.88 [0.58-1.33],0.5467578059311525
Chapter II Neoplasms,Melanoma in situ,ATP2B4,Plasma membrane calcium-transporting ATPase 4,34518,137,0.92 [0.69-1.21],0.5439403011974249
Chapter II Neoplasms,Melanoma in situ,ATP5F1D,"ATP synthase subunit delta, mitochondrial",34518,137,0.79 [0.54-1.15],0.2141656124398866
Chapter II Neoplasms,Melanoma in situ,ATP5IF1,"ATPase inhibitor, mitochondrial",41147,164,1.06 [0.93-1.20],0.3981196238357573
Chapter II Neoplasms,Melanoma in situ,ATP5PO,"ATP synthase subunit O, mitochondrial",40031,160,0.96 [0.68-1.35],0.8115719261913503
Chapter II Neoplasms,Melanoma in situ,ATP6AP2,Renin receptor,40055,159,1.12 [0.81-1.54],0.4995980216082399
Chapter II Neoplasms,Melanoma in situ,ATP6V1D,V-type proton ATPase subunit D,40789,160,0.79 [0.44-1.39],0.4084595882230304
Chapter II Neoplasms,Melanoma in situ,ATP6V1F,V-type proton ATPase subunit F,39955,160,0.97 [0.78-1.20],0.7493723041249343
Chapter II Neoplasms,Melanoma in situ,ATP6V1G1,V-type proton ATPase subunit G 1,34695,137,1.21 [0.97-1.51],0.0924087264006182
Chapter II Neoplasms,Melanoma in situ,ATP6V1G2,V-type proton ATPase subunit G 2,34518,137,1.05 [0.89-1.23],0.5909451322789065
Chapter II Neoplasms,Melanoma in situ,ATRAID,All-trans retinoic acid-induced differentiation factor,35486,140,0.70 [0.38-1.30],0.2636663156842245
Chapter II Neoplasms,Melanoma in situ,ATRN,"Attractin, Isoform 2",35692,141,0.47 [0.18-1.23],0.1238312687408189
Chapter II Neoplasms,Melanoma in situ,ATXN10,Ataxin-10,40031,160,1.17 [0.96-1.42],0.1264945562302285
Chapter II Neoplasms,Melanoma in situ,ATXN2,Ataxin-2,34549,138,1.00 [0.86-1.16],0.9703770269232505
Chapter II Neoplasms,Melanoma in situ,ATXN2L,Ataxin-2-like protein,35587,140,1.16 [0.84-1.59],0.3604416830441388
Chapter II Neoplasms,Melanoma in situ,ATXN3,Ataxin-3,35570,140,1.09 [0.85-1.41],0.4984638637054972
Chapter II Neoplasms,Melanoma in situ,AXIN1,Axin-1,40939,163,1.14 [0.99-1.32],0.0710375185013626
Chapter II Neoplasms,Melanoma in situ,AXL,Tyrosine-protein kinase receptor UFO,41135,163,1.36 [0.82-2.25],0.229377328538024
Chapter II Neoplasms,Melanoma in situ,AZI2,5-azacytidine-induced protein 2,35587,140,1.29 [0.98-1.70],0.0670405767512346
Chapter II Neoplasms,Melanoma in situ,AZU1,Azurocidin,39728,156,0.87 [0.71-1.06],0.1687523269277499
Chapter II Neoplasms,Melanoma in situ,B2M,Beta-2-microglobulin,35692,141,1.11 [0.70-1.76],0.6600600154939316
Chapter II Neoplasms,Melanoma in situ,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,34518,137,0.48 [0.21-1.14],0.0958139237106291
Chapter II Neoplasms,Melanoma in situ,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",34695,137,0.80 [0.51-1.25],0.3290697780993499
Chapter II Neoplasms,Melanoma in situ,B4GALT1,"Beta-1,4-galactosyltransferase 1",41147,164,0.75 [0.45-1.26],0.2824022341736482
Chapter II Neoplasms,Melanoma in situ,B4GAT1,"Beta-1,4-glucuronyltransferase 1",40993,164,0.77 [0.44-1.37],0.3789411436105413
Chapter II Neoplasms,Melanoma in situ,BABAM1,BRISC and BRCA1-A complex member 1,34608,134,1.09 [0.63-1.87],0.7679856524785573
Chapter II Neoplasms,Melanoma in situ,BACH1,Transcription regulator protein BACH1,40939,163,1.19 [0.99-1.43],0.0652516263736367
Chapter II Neoplasms,Melanoma in situ,BAG3,BAG family molecular chaperone regulator 3,40613,157,0.96 [0.68-1.37],0.832506573680754
Chapter II Neoplasms,Melanoma in situ,BAG4,BAG family molecular chaperone regulator 4,34608,134,1.19 [0.86-1.63],0.2900563336098201
Chapter II Neoplasms,Melanoma in situ,BAG6,Large proline-rich protein BAG6,40258,158,1.12 [0.76-1.66],0.5640833498074616
Chapter II Neoplasms,Melanoma in situ,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,40055,159,1.03 [0.83-1.29],0.7940289011720356
Chapter II Neoplasms,Melanoma in situ,BAMBI,BMP and activin membrane-bound inhibitor homolog,40055,159,0.63 [0.38-1.05],0.077873703206357
Chapter II Neoplasms,Melanoma in situ,BANK1,B-cell scaffold protein with ankyrin repeats,40939,163,1.11 [0.97-1.27],0.1214298821214977
Chapter II Neoplasms,Melanoma in situ,BAP18,Chromatin complexes subunit BAP18,35570,140,1.00 [0.79-1.26],0.9836249137774736
Chapter II Neoplasms,Melanoma in situ,BATF,Basic leucine zipper transcriptional factor ATF-like,34686,135,1.05 [0.88-1.26],0.5949069509050076
Chapter II Neoplasms,Melanoma in situ,BAX,Apoptosis regulator BAX,39971,160,1.06 [0.91-1.25],0.4407335832221013
Chapter II Neoplasms,Melanoma in situ,BCAM,Basal cell adhesion molecule,40993,164,0.55 [0.30-0.99],0.0472218681200822
Chapter II Neoplasms,Melanoma in situ,BCAN,Brevican core protein,40682,158,0.90 [0.59-1.36],0.6121355360331568
Chapter II Neoplasms,Melanoma in situ,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",35640,141,1.07 [0.63-1.80],0.8097710948167273
Chapter II Neoplasms,Melanoma in situ,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",34549,138,0.94 [0.68-1.29],0.6900738572929692
Chapter II Neoplasms,Melanoma in situ,BCHE,Cholinesterase,34994,138,1.39 [0.76-2.56],0.2832469101219693
Chapter II Neoplasms,Melanoma in situ,BCL2,Apoptosis regulator Bcl-2,35486,140,0.91 [0.66-1.26],0.5750215192491138
Chapter II Neoplasms,Melanoma in situ,BCL2L1,Bcl-2-like protein 1,35570,140,1.16 [0.98-1.36],0.0815342721317396
Chapter II Neoplasms,Melanoma in situ,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",40939,163,1.13 [0.81-1.57],0.4843916952462443
Chapter II Neoplasms,Melanoma in situ,BCL2L15,Bcl-2-like protein 15,34608,134,1.02 [0.77-1.35],0.8971159497055926
Chapter II Neoplasms,Melanoma in situ,BCL7A,B-cell CLL/lymphoma 7 protein family member A,34394,136,0.98 [0.75-1.27],0.8640680907709145
Chapter II Neoplasms,Melanoma in situ,BCL7B,B-cell CLL/lymphoma 7 protein family member B,35477,140,0.77 [0.51-1.15],0.2004501462345179
Chapter II Neoplasms,Melanoma in situ,BCR,Breakpoint cluster region protein,40939,163,1.10 [0.95-1.28],0.2006618902297189
Chapter II Neoplasms,Melanoma in situ,BDNF,Brain-derived neurotrophic factor,35644,141,1.03 [0.85-1.25],0.7781607567359526
Chapter II Neoplasms,Melanoma in situ,BECN1,Beclin-1,34695,137,1.11 [0.85-1.46],0.4299240995509953
Chapter II Neoplasms,Melanoma in situ,BEX3,Protein BEX3,34394,136,0.63 [0.40-0.97],0.0354033437915809
Chapter II Neoplasms,Melanoma in situ,BGLAP,Osteocalcin,35644,141,1.03 [0.85-1.24],0.7596451127180835
Chapter II Neoplasms,Melanoma in situ,BGN,Biglycan,39990,159,0.98 [0.87-1.10],0.7470355399477764
Chapter II Neoplasms,Melanoma in situ,BHLHE40,Class E basic helix-loop-helix protein 40,34549,138,0.83 [0.64-1.07],0.157512463495731
Chapter II Neoplasms,Melanoma in situ,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,34518,137,0.56 [0.30-1.05],0.070356697444887
Chapter II Neoplasms,Melanoma in situ,BID,BH3-interacting domain death agonist,40939,163,1.07 [0.87-1.30],0.5366111303140226
Chapter II Neoplasms,Melanoma in situ,BIN2,Bridging integrator 2,40993,164,1.09 [0.94-1.27],0.2635072095718147
Chapter II Neoplasms,Melanoma in situ,BIRC2,Baculoviral IAP repeat-containing protein 2,40055,159,1.14 [0.91-1.41],0.2583693224866985
Chapter II Neoplasms,Melanoma in situ,BLMH,Bleomycin hydrolase,41485,164,0.89 [0.57-1.38],0.5899036490236338
Chapter II Neoplasms,Melanoma in situ,BLNK,B-cell linker protein,34608,134,1.13 [0.74-1.73],0.5728930482102249
Chapter II Neoplasms,Melanoma in situ,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,34549,138,1.10 [0.90-1.34],0.3491723656928505
Chapter II Neoplasms,Melanoma in situ,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,35570,140,1.27 [0.86-1.86],0.2310869983354603
Chapter II Neoplasms,Melanoma in situ,BLVRB,Flavin reductase,40993,164,0.93 [0.75-1.15],0.4988176652883006
Chapter II Neoplasms,Melanoma in situ,BMP10,Bone morphogenetic protein 10,34878,138,0.79 [0.45-1.39],0.4139895088197955
Chapter II Neoplasms,Melanoma in situ,BMP4,Bone morphogenetic protein 4,40613,157,0.95 [0.69-1.31],0.7768205591861417
Chapter II Neoplasms,Melanoma in situ,BMP6,Bone morphogenetic protein 6,40192,158,0.91 [0.64-1.29],0.6085949712435877
Chapter II Neoplasms,Melanoma in situ,BMPER,BMP-binding endothelial regulator protein,34878,138,0.77 [0.37-1.63],0.4994729738698333
Chapter II Neoplasms,Melanoma in situ,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,35640,141,1.07 [0.67-1.71],0.7738500764193971
Chapter II Neoplasms,Melanoma in situ,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,34608,134,1.40 [1.00-1.98],0.0531245450833692
Chapter II Neoplasms,Melanoma in situ,BOC,Brother of CDO,40258,158,0.66 [0.36-1.22],0.1846436312450294
Chapter II Neoplasms,Melanoma in situ,BOLA1,BolA-like protein 1,34549,138,1.07 [0.80-1.44],0.635290996987343
Chapter II Neoplasms,Melanoma in situ,BOLA2_BOLA2B,BolA-like protein 2,34695,137,1.01 [0.75-1.37],0.9435370087371622
Chapter II Neoplasms,Melanoma in situ,BPIFA2,BPI fold-containing family A member 2,33472,129,0.99 [0.85-1.16],0.9361213039733908
Chapter II Neoplasms,Melanoma in situ,BPIFB1,BPI fold-containing family B member 1,40900,162,1.00 [0.80-1.25],0.993657885886116
Chapter II Neoplasms,Melanoma in situ,BPIFB2,BPI fold-containing family B member 2,35578,140,1.11 [0.88-1.41],0.380506580967506
Chapter II Neoplasms,Melanoma in situ,BRAP,BRCA1-associated protein,35153,139,1.14 [0.98-1.33],0.0965462237248958
Chapter II Neoplasms,Melanoma in situ,BRD1,Bromodomain-containing protein 1,34984,139,0.92 [0.53-1.60],0.7767620987117254
Chapter II Neoplasms,Melanoma in situ,BRD2,Bromodomain-containing protein 2,34549,138,1.15 [0.75-1.75],0.5330204292375954
Chapter II Neoplasms,Melanoma in situ,BRD3,Bromodomain-containing protein 3,34518,137,1.19 [0.92-1.55],0.1931043012065939
Chapter II Neoplasms,Melanoma in situ,BRDT,Bromodomain testis-specific protein,34518,137,1.09 [0.70-1.70],0.6941874694499306
Chapter II Neoplasms,Melanoma in situ,BRK1,Protein BRICK1,40031,160,1.19 [0.87-1.62],0.2889944474328142
Chapter II Neoplasms,Melanoma in situ,BRME1,Break repair meiotic recombinase recruitment factor 1,34549,138,1.03 [0.70-1.52],0.878825819270219
Chapter II Neoplasms,Melanoma in situ,BRSK2,Serine/threonine-protein kinase BRSK2,35587,140,1.11 [0.74-1.68],0.6078309530569815
Chapter II Neoplasms,Melanoma in situ,BSG,Basigin,41379,164,0.84 [0.43-1.63],0.6022231746506732
Chapter II Neoplasms,Melanoma in situ,BSND,Barttin,34394,136,1.07 [0.67-1.71],0.7684990575717195
Chapter II Neoplasms,Melanoma in situ,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,41349,165,1.09 [0.80-1.49],0.5794762745729651
Chapter II Neoplasms,Melanoma in situ,BST2,Bone marrow stromal antigen 2,41349,165,0.94 [0.71-1.25],0.6588304343984601
Chapter II Neoplasms,Melanoma in situ,BTC,Probetacellulin,40055,159,1.07 [0.89-1.28],0.4623619119287162
Chapter II Neoplasms,Melanoma in situ,BTD,Biotinidase,35692,141,1.06 [0.49-2.31],0.8784689435032604
Chapter II Neoplasms,Melanoma in situ,BTLA,B- and T-lymphocyte attenuator,34394,136,1.01 [0.84-1.22],0.8813111026506207
Chapter II Neoplasms,Melanoma in situ,BTN1A1,Butyrophilin subfamily 1 member A1,35408,138,0.65 [0.39-1.08],0.0934464564668581
Chapter II Neoplasms,Melanoma in situ,BTN2A1,Butyrophilin subfamily 2 member A1,41147,164,1.06 [0.62-1.83],0.8218099163465229
Chapter II Neoplasms,Melanoma in situ,BTN3A2,Butyrophilin subfamily 3 member A2,40939,163,0.94 [0.64-1.36],0.7257045591868604
Chapter II Neoplasms,Melanoma in situ,BTNL10,Butyrophilin-like protein 10,34394,136,0.75 [0.46-1.22],0.2408463105056516
Chapter II Neoplasms,Melanoma in situ,C19orf12,Protein C19orf12,40031,160,0.75 [0.57-0.97],0.0295420965898363
Chapter II Neoplasms,Melanoma in situ,C1GALT1C1,C1GALT1-specific chaperone 1,34518,137,0.72 [0.41-1.25],0.2384596230422163
Chapter II Neoplasms,Melanoma in situ,C1QA,Complement C1q subcomponent subunit A,41243,162,0.83 [0.45-1.56],0.5647950144810059
Chapter II Neoplasms,Melanoma in situ,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",35587,140,0.99 [0.79-1.24],0.9071286730110886
Chapter II Neoplasms,Melanoma in situ,C1QL2,Complement C1q-like protein 2,34608,134,1.22 [0.86-1.74],0.2666180685637165
Chapter II Neoplasms,Melanoma in situ,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,41135,163,0.90 [0.65-1.25],0.5288941941195429
Chapter II Neoplasms,Melanoma in situ,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,34878,138,0.81 [0.52-1.24],0.328300111712011
Chapter II Neoplasms,Melanoma in situ,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,35587,140,0.55 [0.31-0.99],0.0459037944791602
Chapter II Neoplasms,Melanoma in situ,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,34812,138,1.02 [0.72-1.43],0.9167048148292168
Chapter II Neoplasms,Melanoma in situ,C1R,Complement C1r subcomponent,35692,141,0.84 [0.34-2.11],0.7156465597494694
Chapter II Neoplasms,Melanoma in situ,C1RL,Complement C1r subcomponent-like protein,35625,141,2.31 [0.98-5.45],0.0556677736280072
Chapter II Neoplasms,Melanoma in situ,C1S,Complement C1s subcomponent,35692,141,0.66 [0.30-1.42],0.2842388097636191
Chapter II Neoplasms,Melanoma in situ,C2,Complement C2,41076,163,0.82 [0.48-1.39],0.4525768975722236
Chapter II Neoplasms,Melanoma in situ,C2CD2L,Phospholipid transfer protein C2CD2L,39955,160,1.07 [0.78-1.48],0.6686305458651596
Chapter II Neoplasms,Melanoma in situ,C2orf69,UPF0565 protein C2orf69,34686,135,1.19 [0.95-1.49],0.1271770777654022
Chapter II Neoplasms,Melanoma in situ,C3,Complement C3,33876,133,1.06 [0.74-1.52],0.75166220024491
Chapter II Neoplasms,Melanoma in situ,C4BPB,C4b-binding protein beta chain,41097,164,1.01 [0.72-1.44],0.9355700836140052
Chapter II Neoplasms,Melanoma in situ,C5,Complement C5,35692,141,0.62 [0.21-1.89],0.4043337476060847
Chapter II Neoplasms,Melanoma in situ,C7,Complement component C7,34836,138,0.85 [0.51-1.43],0.536849235503184
Chapter II Neoplasms,Melanoma in situ,C7orf50,Uncharacterized protein C7orf50,35570,140,1.00 [0.50-2.01],0.994351005942296
Chapter II Neoplasms,Melanoma in situ,C8B,Complement component C8 beta chain,35692,141,0.73 [0.43-1.23],0.2396173949059391
Chapter II Neoplasms,Melanoma in situ,C9,Complement component C9,35663,141,1.15 [0.84-1.56],0.3847590723930213
Chapter II Neoplasms,Melanoma in situ,C9orf40,Uncharacterized protein C9orf40,35486,140,0.92 [0.75-1.12],0.4179992485872101
Chapter II Neoplasms,Melanoma in situ,CA1,Carbonic anhydrase 1,40092,161,0.88 [0.70-1.12],0.3022091367398014
Chapter II Neoplasms,Melanoma in situ,CA11,Carbonic anhydrase-related protein 11,40055,159,0.72 [0.42-1.24],0.2325231172653088
Chapter II Neoplasms,Melanoma in situ,CA12,Carbonic anhydrase 12,40789,160,0.99 [0.63-1.54],0.9618719263821324
Chapter II Neoplasms,Melanoma in situ,CA13,Carbonic anhydrase 13,40523,161,1.08 [0.95-1.24],0.2463655148801432
Chapter II Neoplasms,Melanoma in situ,CA14,Carbonic anhydrase 14,41358,164,0.97 [0.65-1.44],0.8831967924820676
Chapter II Neoplasms,Melanoma in situ,CA2,Carbonic anhydrase 2,40859,164,0.98 [0.80-1.19],0.8054732746743773
Chapter II Neoplasms,Melanoma in situ,CA3,Carbonic anhydrase 3,41421,164,0.84 [0.66-1.06],0.149255610103252
Chapter II Neoplasms,Melanoma in situ,CA4,Carbonic anhydrase 4,41485,164,0.70 [0.39-1.26],0.2389784109308665
Chapter II Neoplasms,Melanoma in situ,CA5A,"Carbonic anhydrase 5A, mitochondrial",40258,158,0.93 [0.79-1.09],0.3511981295226204
Chapter II Neoplasms,Melanoma in situ,CA6,Carbonic anhydrase 6,40863,164,0.86 [0.69-1.07],0.1670701969746392
Chapter II Neoplasms,Melanoma in situ,CA7,Carbonic anhydrase 7,34984,139,0.77 [0.46-1.28],0.3083207350335257
Chapter II Neoplasms,Melanoma in situ,CA8,Carbonic anhydrase-related protein,34608,134,0.65 [0.30-1.42],0.2851620740921117
Chapter II Neoplasms,Melanoma in situ,CA9,Carbonic anhydrase 9,41358,164,0.93 [0.69-1.26],0.6510724720422827
Chapter II Neoplasms,Melanoma in situ,CABP2,Calcium-binding protein 2,34686,135,1.05 [0.83-1.34],0.6790244081828511
Chapter II Neoplasms,Melanoma in situ,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,34549,138,0.74 [0.42-1.29],0.2884118782060403
Chapter II Neoplasms,Melanoma in situ,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,34518,137,0.70 [0.47-1.02],0.0663122384790369
Chapter II Neoplasms,Melanoma in situ,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,34549,138,1.28 [1.02-1.61],0.0353461148374706
Chapter II Neoplasms,Melanoma in situ,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,35587,140,1.09 [0.90-1.32],0.3759644480543146
Chapter II Neoplasms,Melanoma in situ,CACYBP,Calcyclin-binding protein,34808,138,1.14 [0.97-1.34],0.1095640467834726
Chapter II Neoplasms,Melanoma in situ,CADPS,Calcium-dependent secretion activator 1,34686,135,1.00 [0.67-1.48],0.9855674791780256
Chapter II Neoplasms,Melanoma in situ,CALB1,Calbindin,40789,160,1.15 [0.82-1.60],0.4163626045726891
Chapter II Neoplasms,Melanoma in situ,CALB2,Calretinin,40031,160,0.91 [0.56-1.49],0.718223727906827
Chapter II Neoplasms,Melanoma in situ,CALCA,Calcitonin,40606,158,0.82 [0.64-1.05],0.1227281890716789
Chapter II Neoplasms,Melanoma in situ,CALCB,Calcitonin gene-related peptide 2,35570,140,0.70 [0.44-1.13],0.1458962556525842
Chapter II Neoplasms,Melanoma in situ,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,41231,163,1.14 [1.00-1.31],0.0474586650972861
Chapter II Neoplasms,Melanoma in situ,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,34695,137,1.13 [0.91-1.40],0.2654080593886083
Chapter II Neoplasms,Melanoma in situ,CALY,Neuron-specific vesicular protein calcyon,34518,137,0.81 [0.50-1.32],0.3993970491938616
Chapter II Neoplasms,Melanoma in situ,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,40055,159,1.00 [0.72-1.38],0.9842152043469988
Chapter II Neoplasms,Melanoma in situ,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,34686,135,1.30 [1.01-1.69],0.0422504263125623
Chapter II Neoplasms,Melanoma in situ,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,35587,140,1.14 [0.98-1.32],0.0808368967892333
Chapter II Neoplasms,Melanoma in situ,CANT1,Soluble calcium-activated nucleotidase 1,40855,160,1.80 [0.90-3.61],0.0982488333596918
Chapter II Neoplasms,Melanoma in situ,CAPG,Macrophage-capping protein,40718,161,0.98 [0.77-1.25],0.88730342003045
Chapter II Neoplasms,Melanoma in situ,CAPN3,Calpain-3,35477,140,0.73 [0.44-1.19],0.2091716953138379
Chapter II Neoplasms,Melanoma in situ,CAPS,Calcyphosin,35570,140,1.13 [0.99-1.28],0.0648187795923158
Chapter II Neoplasms,Melanoma in situ,CARHSP1,Calcium-regulated heat-stable protein 1,40031,160,0.97 [0.74-1.27],0.8077014910350415
Chapter II Neoplasms,Melanoma in situ,CASC3,Protein CASC3,34686,135,0.98 [0.66-1.47],0.9247462912351287
Chapter II Neoplasms,Melanoma in situ,CASP1,Caspase-1,40031,160,1.04 [0.85-1.27],0.7167956710629928
Chapter II Neoplasms,Melanoma in situ,CASP10,Caspase-10,40031,160,0.93 [0.76-1.13],0.4446969487892406
Chapter II Neoplasms,Melanoma in situ,CASP2,Caspase-2,40939,163,1.12 [0.92-1.37],0.2564087006207177
Chapter II Neoplasms,Melanoma in situ,CASP3,Caspase-3,41485,164,1.09 [0.93-1.28],0.2712324022812973
Chapter II Neoplasms,Melanoma in situ,CASP4,Caspase-4,34984,139,1.09 [1.00-1.18],0.0613047768602907
Chapter II Neoplasms,Melanoma in situ,CASP7,Caspase-7,35570,140,1.20 [0.99-1.46],0.0621052381428306
Chapter II Neoplasms,Melanoma in situ,CASP8,Caspase-8,41237,164,1.14 [0.93-1.41],0.210611952719002
Chapter II Neoplasms,Melanoma in situ,CASP9,Caspase-9,34608,134,1.18 [0.92-1.52],0.1793714661994179
Chapter II Neoplasms,Melanoma in situ,CASQ2,Calsequestrin-2,34518,137,0.57 [0.36-0.92],0.0208091245032952
Chapter II Neoplasms,Melanoma in situ,CAT,Catalase,35128,140,0.89 [0.65-1.20],0.4340951716192928
Chapter II Neoplasms,Melanoma in situ,CBLIF,Cobalamin binding intrinsic factor,40930,163,0.96 [0.80-1.15],0.6656830173801764
Chapter II Neoplasms,Melanoma in situ,CBLN1,Cerebellin-1,34549,138,0.91 [0.74-1.10],0.32722407516709
Chapter II Neoplasms,Melanoma in situ,CBLN4,Cerebellin-4,41358,164,0.57 [0.37-0.89],0.0121131020714961
Chapter II Neoplasms,Melanoma in situ,CBS,Cystathionine beta-synthase,34695,137,0.82 [0.57-1.16],0.2609355991976635
Chapter II Neoplasms,Melanoma in situ,CBX2,Chromobox protein homolog 2,34518,137,0.86 [0.54-1.35],0.5025101836338474
Chapter II Neoplasms,Melanoma in situ,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,40682,158,1.10 [0.91-1.33],0.3012396525887617
Chapter II Neoplasms,Melanoma in situ,CCAR2,Cell cycle and apoptosis regulator protein 2,35570,140,0.95 [0.70-1.30],0.7493050293548124
Chapter II Neoplasms,Melanoma in situ,CCDC134,Coiled-coil domain-containing protein 134,35477,140,1.18 [0.87-1.62],0.2903827441263467
Chapter II Neoplasms,Melanoma in situ,CCDC28A,Coiled-coil domain-containing protein 28A,34686,135,0.75 [0.43-1.32],0.3206736208181162
Chapter II Neoplasms,Melanoma in situ,CCDC50,Coiled-coil domain-containing protein 50,35587,140,0.95 [0.76-1.18],0.6150399946187337
Chapter II Neoplasms,Melanoma in situ,CCDC80,Coiled-coil domain-containing protein 80,40984,163,0.89 [0.60-1.33],0.5687601347008249
Chapter II Neoplasms,Melanoma in situ,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,34695,137,1.04 [0.79-1.35],0.7953178087015316
Chapter II Neoplasms,Melanoma in situ,CCL11,Eotaxin,41452,164,0.91 [0.63-1.31],0.6125060488031029
Chapter II Neoplasms,Melanoma in situ,CCL13,C-C motif chemokine 13,41384,163,0.98 [0.80-1.19],0.8222940771342422
Chapter II Neoplasms,Melanoma in situ,CCL14,C-C motif chemokine 14,40877,163,1.14 [0.81-1.60],0.4521541695589252
Chapter II Neoplasms,Melanoma in situ,CCL15,C-C motif chemokine 15,41485,164,0.94 [0.68-1.31],0.7218432050782921
Chapter II Neoplasms,Melanoma in situ,CCL16,C-C motif chemokine 16,41485,164,0.86 [0.66-1.11],0.2543253756428869
Chapter II Neoplasms,Melanoma in situ,CCL17,C-C motif chemokine 17,40894,164,0.98 [0.84-1.14],0.7452671534356806
Chapter II Neoplasms,Melanoma in situ,CCL18,C-C motif chemokine 18,40413,162,0.98 [0.80-1.20],0.8332249043160088
Chapter II Neoplasms,Melanoma in situ,CCL19,C-C motif chemokine 19,41349,165,1.00 [0.90-1.12],0.9511872255325832
Chapter II Neoplasms,Melanoma in situ,CCL2,C-C motif chemokine 2,40613,157,1.03 [0.79-1.35],0.8103958893257583
Chapter II Neoplasms,Melanoma in situ,CCL20,C-C motif chemokine 20,41452,164,0.93 [0.78-1.09],0.3588404079254146
Chapter II Neoplasms,Melanoma in situ,CCL21,C-C motif chemokine 21,41147,164,0.75 [0.52-1.09],0.1317047040735673
Chapter II Neoplasms,Melanoma in situ,CCL22,C-C motif chemokine 22,40544,163,0.93 [0.71-1.22],0.6089341197087532
Chapter II Neoplasms,Melanoma in situ,CCL23,C-C motif chemokine 23,41147,164,1.20 [0.85-1.67],0.2981550126020663
Chapter II Neoplasms,Melanoma in situ,CCL24,C-C motif chemokine 24,41087,164,1.01 [0.86-1.19],0.91206999077215
Chapter II Neoplasms,Melanoma in situ,CCL25,C-C motif chemokine 25,41452,164,1.41 [1.07-1.87],0.0155987695808856
Chapter II Neoplasms,Melanoma in situ,CCL26,C-C motif chemokine 26,40939,163,0.97 [0.83-1.14],0.7315292343146356
Chapter II Neoplasms,Melanoma in situ,CCL27,C-C motif chemokine 27,40984,163,1.00 [0.79-1.26],0.9871117675402356
Chapter II Neoplasms,Melanoma in situ,CCL28,C-C motif chemokine 28,40801,163,1.08 [0.85-1.37],0.5216460711680599
Chapter II Neoplasms,Melanoma in situ,CCL3,C-C motif chemokine 3,40939,163,1.16 [0.93-1.45],0.1902019363274982
Chapter II Neoplasms,Melanoma in situ,CCL4,C-C motif chemokine 4,41021,164,1.06 [0.88-1.29],0.5298001036882225
Chapter II Neoplasms,Melanoma in situ,CCL5,C-C motif chemokine 5,41135,163,1.00 [0.87-1.14],0.9595863059648776
Chapter II Neoplasms,Melanoma in situ,CCL7,C-C motif chemokine 7,40939,163,1.05 [0.84-1.33],0.663671816205148
Chapter II Neoplasms,Melanoma in situ,CCL8,C-C motif chemokine 8,41299,164,1.13 [0.90-1.42],0.2961122012961413
Chapter II Neoplasms,Melanoma in situ,CCN1,CCN family member 1,40723,160,0.89 [0.74-1.07],0.2031980070820919
Chapter II Neoplasms,Melanoma in situ,CCN2,CCN family member 2,40961,164,1.06 [0.84-1.36],0.6103837866624412
Chapter II Neoplasms,Melanoma in situ,CCN3,CCN family member 3,41415,164,1.03 [0.67-1.57],0.901614824388621
Chapter II Neoplasms,Melanoma in situ,CCN4,CCN family member 4,41358,164,1.22 [0.87-1.71],0.2384095747136228
Chapter II Neoplasms,Melanoma in situ,CCN5,CCN family member 5,40993,164,0.86 [0.60-1.24],0.4151673485541037
Chapter II Neoplasms,Melanoma in situ,CCND2,G1/S-specific cyclin-D2,34984,139,0.73 [0.49-1.07],0.1083086765633693
Chapter II Neoplasms,Melanoma in situ,CCNE1,G1/S-specific cyclin-E1,34608,134,1.02 [0.86-1.21],0.7828523800561988
Chapter II Neoplasms,Melanoma in situ,CCS,Copper chaperone for superoxide dismutase,40682,158,1.07 [0.80-1.43],0.6654035208356965
Chapter II Neoplasms,Melanoma in situ,CCT5,T-complex protein 1 subunit epsilon,40055,159,1.00 [0.72-1.37],0.984751333826024
Chapter II Neoplasms,Melanoma in situ,CD101,Immunoglobulin superfamily member 2,35486,140,0.85 [0.59-1.22],0.3786931037612697
Chapter II Neoplasms,Melanoma in situ,CD109,CD109 antigen,40993,164,0.85 [0.56-1.28],0.4307470199592861
Chapter II Neoplasms,Melanoma in situ,CD14,Monocyte differentiation antigen CD14,40148,161,1.21 [0.86-1.70],0.2817618029453895
Chapter II Neoplasms,Melanoma in situ,CD160,CD160 antigen,41452,164,1.20 [0.89-1.61],0.2264840547705218
Chapter II Neoplasms,Melanoma in situ,CD163,Scavenger receptor cysteine-rich type 1 protein M130,41135,163,0.96 [0.69-1.33],0.7878868927794702
Chapter II Neoplasms,Melanoma in situ,CD164,Sialomucin core protein 24,40993,164,0.88 [0.50-1.55],0.6629562430226222
Chapter II Neoplasms,Melanoma in situ,CD164L2,CD164 sialomucin-like 2 protein,34686,135,1.44 [0.97-2.13],0.0713975942261169
Chapter II Neoplasms,Melanoma in situ,CD177,CD177 antigen,40932,164,0.99 [0.89-1.10],0.8575948386300585
Chapter II Neoplasms,Melanoma in situ,CD1C,T-cell surface glycoprotein CD1c,41097,164,0.85 [0.48-1.51],0.5750708573408174
Chapter II Neoplasms,Melanoma in situ,CD2,T-cell surface antigen CD2,34518,137,1.12 [0.76-1.63],0.5709278781782758
Chapter II Neoplasms,Melanoma in situ,CD200,OX-2 membrane glycoprotein,40939,163,1.15 [0.67-1.97],0.6075148521576618
Chapter II Neoplasms,Melanoma in situ,CD200R1,Cell surface glycoprotein CD200 receptor 1,40804,162,1.18 [0.79-1.75],0.4154706489904662
Chapter II Neoplasms,Melanoma in situ,CD207,C-type lectin domain family 4 member K,40059,158,0.83 [0.57-1.21],0.3301696048228019
Chapter II Neoplasms,Melanoma in situ,CD209,CD209 antigen,41081,163,0.86 [0.60-1.24],0.427024576051711
Chapter II Neoplasms,Melanoma in situ,CD22,B-cell receptor CD22,41452,164,0.81 [0.58-1.15],0.2405360913838212
Chapter II Neoplasms,Melanoma in situ,CD226,CD226 antigen,34608,134,1.45 [0.99-2.14],0.058140366883393
Chapter II Neoplasms,Melanoma in situ,CD244,Natural killer cell receptor 2B4,41452,164,1.16 [0.70-1.94],0.5593582846040712
Chapter II Neoplasms,Melanoma in situ,CD248,Endosialin,35644,141,0.90 [0.60-1.34],0.6005519029752093
Chapter II Neoplasms,Melanoma in situ,CD27,CD27 antigen,41097,164,0.95 [0.67-1.34],0.7593494924635456
Chapter II Neoplasms,Melanoma in situ,CD274,Programmed cell death 1 ligand 1,40682,158,1.04 [0.68-1.58],0.8682963550478089
Chapter II Neoplasms,Melanoma in situ,CD276,CD276 antigen,40948,164,0.97 [0.66-1.44],0.8965017771083975
Chapter II Neoplasms,Melanoma in situ,CD28,T-cell-specific surface glycoprotein CD28,40055,159,0.78 [0.52-1.17],0.2370450941775407
Chapter II Neoplasms,Melanoma in situ,CD2AP,CD2-associated protein,40984,163,1.22 [0.98-1.50],0.069321089813425
Chapter II Neoplasms,Melanoma in situ,CD300A,CMRF35-like molecule 8,34878,138,1.05 [0.61-1.82],0.8574430702139858
Chapter II Neoplasms,Melanoma in situ,CD300C,CMRF35-like molecule 6,41349,165,1.07 [0.71-1.60],0.7421062280912993
Chapter II Neoplasms,Melanoma in situ,CD300E,CMRF35-like molecule 2,41225,164,1.01 [0.71-1.43],0.9473968729851742
Chapter II Neoplasms,Melanoma in situ,CD300LF,CMRF35-like molecule 1,41358,164,1.03 [0.81-1.30],0.8203971762898477
Chapter II Neoplasms,Melanoma in situ,CD300LG,CMRF35-like molecule 9,40993,164,0.76 [0.53-1.11],0.1554089151994277
Chapter II Neoplasms,Melanoma in situ,CD302,CD302 antigen,40789,160,1.31 [0.82-2.08],0.2558270140153543
Chapter II Neoplasms,Melanoma in situ,CD33,Myeloid cell surface antigen CD33,41097,164,0.85 [0.73-1.00],0.0544744643935638
Chapter II Neoplasms,Melanoma in situ,CD34,Hematopoietic progenitor cell antigen CD34,41207,165,0.79 [0.45-1.41],0.425096920124355
Chapter II Neoplasms,Melanoma in situ,CD36,Platelet glycoprotein 4,34608,134,1.15 [0.80-1.67],0.4514764181781735
Chapter II Neoplasms,Melanoma in situ,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,40789,160,0.86 [0.55-1.35],0.5110367148372706
Chapter II Neoplasms,Melanoma in situ,CD3D,T-cell surface glycoprotein CD3 delta chain,34549,138,0.64 [0.36-1.15],0.1347924650667985
Chapter II Neoplasms,Melanoma in situ,CD3E,T-cell surface glycoprotein CD3 epsilon chain,34984,139,0.98 [0.62-1.53],0.917188620099807
Chapter II Neoplasms,Melanoma in situ,CD3G,T-cell surface glycoprotein CD3 gamma chain,34608,134,1.01 [0.84-1.21],0.9474958411386784
Chapter II Neoplasms,Melanoma in situ,CD4,T-cell surface glycoprotein CD4,40865,163,1.09 [0.69-1.71],0.7214992111838505
Chapter II Neoplasms,Melanoma in situ,CD40,Tumor necrosis factor receptor superfamily member 5,40961,164,1.10 [0.84-1.46],0.4895033709996625
Chapter II Neoplasms,Melanoma in situ,CD40LG,CD40 ligand,41452,164,1.05 [0.88-1.25],0.5844140061519763
Chapter II Neoplasms,Melanoma in situ,CD46,Membrane cofactor protein,40742,163,1.11 [0.68-1.83],0.6657605468799245
Chapter II Neoplasms,Melanoma in situ,CD48,CD48 antigen,41087,164,0.95 [0.59-1.52],0.8177163173585885
Chapter II Neoplasms,Melanoma in situ,CD5,T-cell surface glycoprotein CD5,41299,164,1.09 [0.72-1.66],0.6754601104062045
Chapter II Neoplasms,Melanoma in situ,CD55,Complement decay-accelerating factor,39553,157,0.71 [0.40-1.26],0.2417326601490058
Chapter II Neoplasms,Melanoma in situ,CD58,Lymphocyte function-associated antigen 3,40880,163,0.59 [0.27-1.27],0.17725348515804
Chapter II Neoplasms,Melanoma in situ,CD59,CD59 glycoprotein,39510,155,0.71 [0.36-1.41],0.3257033097123589
Chapter II Neoplasms,Melanoma in situ,CD5L,CD5 antigen-like,35507,141,1.36 [0.97-1.91],0.0769438870853522
Chapter II Neoplasms,Melanoma in situ,CD6,T-cell differentiation antigen CD6,41379,164,1.03 [0.79-1.34],0.8152621723742942
Chapter II Neoplasms,Melanoma in situ,CD63,CD63 antigen,40613,157,1.13 [0.86-1.49],0.3908213030269307
Chapter II Neoplasms,Melanoma in situ,CD69,Early activation antigen CD69,40795,163,1.09 [0.93-1.28],0.2914278086837698
Chapter II Neoplasms,Melanoma in situ,CD7,T-cell antigen CD7,34542,134,1.51 [1.08-2.11],0.0170344841763027
Chapter II Neoplasms,Melanoma in situ,CD70,CD70 antigen,40939,163,1.09 [0.78-1.51],0.6162650027463478
Chapter II Neoplasms,Melanoma in situ,CD72,B-cell differentiation antigen CD72,34878,138,1.06 [0.71-1.59],0.7600857804090311
Chapter II Neoplasms,Melanoma in situ,CD74,HLA class II histocompatibility antigen gamma chain,41349,165,1.20 [0.80-1.79],0.3828386313993476
Chapter II Neoplasms,Melanoma in situ,CD79B,B-cell antigen receptor complex-associated protein beta chain,41452,164,0.78 [0.56-1.10],0.1536473880750526
Chapter II Neoplasms,Melanoma in situ,CD80,T-lymphocyte activation antigen CD80,35640,141,0.91 [0.55-1.50],0.7186031248523961
Chapter II Neoplasms,Melanoma in situ,CD82,CD82 antigen,34984,139,0.79 [0.50-1.24],0.3028319910131939
Chapter II Neoplasms,Melanoma in situ,CD83,CD83 antigen,40939,163,0.96 [0.63-1.48],0.8657181337816203
Chapter II Neoplasms,Melanoma in situ,CD84,SLAM family member 5,40939,163,1.30 [0.83-2.02],0.2542959970308608
Chapter II Neoplasms,Melanoma in situ,CD86,T-lymphocyte activation antigen CD86,35486,140,0.93 [0.53-1.62],0.79415069944248
Chapter II Neoplasms,Melanoma in situ,CD8A,T-cell surface glycoprotein CD8 alpha chain,41349,165,1.15 [0.87-1.50],0.3241649039227144
Chapter II Neoplasms,Melanoma in situ,CD93,Complement component C1q receptor,39431,159,0.79 [0.49-1.26],0.3187019396409317
Chapter II Neoplasms,Melanoma in situ,CD99,CD99 antigen,40993,164,1.07 [0.52-2.19],0.855043783004861
Chapter II Neoplasms,Melanoma in situ,CD99L2,CD99 antigen-like protein 2,40993,164,1.36 [0.76-2.42],0.299752434302884
Chapter II Neoplasms,Melanoma in situ,CDA,Cytidine deaminase,35578,141,1.12 [0.81-1.55],0.5074778757382681
Chapter II Neoplasms,Melanoma in situ,CDAN1,Codanin-1,35570,140,0.76 [0.35-1.62],0.4741473225875621
Chapter II Neoplasms,Melanoma in situ,CDC123,Cell division cycle protein 123 homolog,34394,136,0.99 [0.77-1.29],0.9581030892182006
Chapter II Neoplasms,Melanoma in situ,CDC25A,M-phase inducer phosphatase 1,34394,136,1.02 [0.68-1.54],0.915248723783035
Chapter II Neoplasms,Melanoma in situ,CDC26,Anaphase-promoting complex subunit CDC26,35419,139,1.29 [1.03-1.61],0.0281161428264076
Chapter II Neoplasms,Melanoma in situ,CDC27,Cell division cycle protein 27 homolog,40055,159,1.13 [0.90-1.42],0.2742800434646045
Chapter II Neoplasms,Melanoma in situ,CDC37,Hsp90 co-chaperone Cdc37,41097,164,1.09 [0.92-1.28],0.3047610179804974
Chapter II Neoplasms,Melanoma in situ,CDC42BPB,Serine/threonine-protein kinase MRCK beta,35486,140,1.11 [0.95-1.30],0.1929481515685782
Chapter II Neoplasms,Melanoma in situ,CDCP1,CUB domain-containing protein 1,40682,158,0.97 [0.73-1.28],0.8235353849799264
Chapter II Neoplasms,Melanoma in situ,CDH1,Cadherin-1,39601,156,1.12 [0.79-1.59],0.510808548521585
Chapter II Neoplasms,Melanoma in situ,CDH15,Cadherin-15,41273,165,0.92 [0.72-1.18],0.5211479261604681
Chapter II Neoplasms,Melanoma in situ,CDH17,Cadherin-17,40984,163,1.15 [0.95-1.41],0.1529135433074055
Chapter II Neoplasms,Melanoma in situ,CDH2,Cadherin-2,40984,163,1.19 [0.80-1.77],0.3989795290577236
Chapter II Neoplasms,Melanoma in situ,CDH22,Cadherin-22,34984,139,0.60 [0.32-1.13],0.1125020946112728
Chapter II Neoplasms,Melanoma in situ,CDH23,Cadherin-23,35570,140,0.62 [0.33-1.18],0.1447681830679976
Chapter II Neoplasms,Melanoma in situ,CDH3,Cadherin-3,41349,165,1.03 [0.70-1.52],0.8716291844404818
Chapter II Neoplasms,Melanoma in situ,CDH4,Cadherin-4,34549,138,0.88 [0.61-1.27],0.4975187933800571
Chapter II Neoplasms,Melanoma in situ,CDH5,Cadherin-5,41485,164,0.77 [0.48-1.24],0.2807800572127741
Chapter II Neoplasms,Melanoma in situ,CDH6,Cadherin-6,40984,163,0.98 [0.68-1.42],0.930836355995128
Chapter II Neoplasms,Melanoma in situ,CDHR1,Cadherin-related family member 1,40031,160,0.82 [0.57-1.17],0.2730655649260569
Chapter II Neoplasms,Melanoma in situ,CDHR2,Cadherin-related family member 2,40789,160,0.85 [0.70-1.03],0.1006773816756743
Chapter II Neoplasms,Melanoma in situ,CDHR5,Cadherin-related family member 5,40984,163,1.09 [0.76-1.56],0.6550137197817237
Chapter II Neoplasms,Melanoma in situ,CDK1,Cyclin-dependent kinase 1,34394,136,0.86 [0.55-1.35],0.5153933546037133
Chapter II Neoplasms,Melanoma in situ,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,35587,140,0.94 [0.71-1.25],0.6612359727863161
Chapter II Neoplasms,Melanoma in situ,CDKL5,Cyclin-dependent kinase-like 5,34549,138,1.02 [0.75-1.38],0.8992500141296347
Chapter II Neoplasms,Melanoma in situ,CDKN1A,Cyclin-dependent kinase inhibitor 1,40789,160,1.10 [0.96-1.25],0.1693290834006157
Chapter II Neoplasms,Melanoma in situ,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,40789,160,1.08 [0.93-1.26],0.3141042899778324
Chapter II Neoplasms,Melanoma in situ,CDNF,Cerebral dopamine neurotrophic factor,40789,160,1.03 [0.66-1.59],0.9072044643962156
Chapter II Neoplasms,Melanoma in situ,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,41020,164,0.74 [0.44-1.25],0.259296875040216
Chapter II Neoplasms,Melanoma in situ,CDSN,Corneodesmosin,41321,164,1.15 [0.84-1.59],0.3894332058164285
Chapter II Neoplasms,Melanoma in situ,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,41032,164,0.78 [0.39-1.54],0.4678013300924066
Chapter II Neoplasms,Melanoma in situ,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,35486,140,1.08 [0.88-1.33],0.4464616590735284
Chapter II Neoplasms,Melanoma in situ,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,34984,139,1.10 [0.90-1.36],0.3495260007002579
Chapter II Neoplasms,Melanoma in situ,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,35486,140,0.97 [0.65-1.46],0.8930059562961081
Chapter II Neoplasms,Melanoma in situ,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,34984,139,0.85 [0.57-1.27],0.4316685249500165
Chapter II Neoplasms,Melanoma in situ,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,40939,163,0.93 [0.79-1.10],0.4133172825899002
Chapter II Neoplasms,Melanoma in situ,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,40055,159,0.83 [0.60-1.14],0.241921824145267
Chapter II Neoplasms,Melanoma in situ,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39518,159,1.28 [1.03-1.58],0.0239484880537161
Chapter II Neoplasms,Melanoma in situ,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,35644,141,1.11 [0.73-1.68],0.6204271277335545
Chapter II Neoplasms,Melanoma in situ,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,40258,158,0.94 [0.70-1.26],0.6882450855495025
Chapter II Neoplasms,Melanoma in situ,CEBPA,CCAAT/enhancer-binding protein alpha,34608,134,0.98 [0.62-1.54],0.922545771896834
Chapter II Neoplasms,Melanoma in situ,CEBPB,CCAAT/enhancer-binding protein beta,40258,158,0.90 [0.61-1.33],0.5960320844932496
Chapter II Neoplasms,Melanoma in situ,CELA2A,Chymotrypsin-like elastase family member 2A,35644,141,0.91 [0.70-1.19],0.4908168088286284
Chapter II Neoplasms,Melanoma in situ,CELA3A,Chymotrypsin-like elastase family member 3A,41416,164,0.99 [0.78-1.26],0.9520396648213332
Chapter II Neoplasms,Melanoma in situ,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,34878,138,0.61 [0.34-1.09],0.0949393756322242
Chapter II Neoplasms,Melanoma in situ,CEMIP2,Cell surface hyaluronidase,34608,134,1.14 [0.72-1.81],0.5796223345757978
Chapter II Neoplasms,Melanoma in situ,CEND1,Cell cycle exit and neuronal differentiation protein 1,34549,138,0.89 [0.65-1.22],0.4777823894803447
Chapter II Neoplasms,Melanoma in situ,CENPF,Centromere protein F,34984,139,0.99 [0.74-1.33],0.95347557780872
Chapter II Neoplasms,Melanoma in situ,CENPJ,Centromere protein J,34984,139,1.02 [0.81-1.27],0.8876653134871845
Chapter II Neoplasms,Melanoma in situ,CEP112,Centrosomal protein of 112 kDa,34518,137,1.12 [0.81-1.55],0.5042661539246083
Chapter II Neoplasms,Melanoma in situ,CEP152,Centrosomal protein of 152 kDa,34394,136,1.04 [0.71-1.52],0.8367961082763629
Chapter II Neoplasms,Melanoma in situ,CEP164,Centrosomal protein of 164 kDa,40249,159,1.12 [0.92-1.35],0.2562098572265131
Chapter II Neoplasms,Melanoma in situ,CEP170,Centrosomal protein of 170 kDa,34695,137,1.14 [0.92-1.40],0.2256359702741313
Chapter II Neoplasms,Melanoma in situ,CEP20,Centrosomal protein 20,40055,159,1.04 [0.86-1.25],0.7161472926151167
Chapter II Neoplasms,Melanoma in situ,CEP290,Centrosomal protein of 290 kDa,34984,139,0.87 [0.63-1.22],0.4235316138995061
Chapter II Neoplasms,Melanoma in situ,CEP350,Centrosome-associated protein 350,34394,136,1.02 [0.66-1.58],0.9277790003219047
Chapter II Neoplasms,Melanoma in situ,CEP43,Centrosomal protein 43,39940,155,0.95 [0.77-1.17],0.6436064408350632
Chapter II Neoplasms,Melanoma in situ,CEP85,Centrosomal protein of 85 kDa,40055,159,1.16 [0.93-1.44],0.1860466069381404
Chapter II Neoplasms,Melanoma in situ,CERT,Ceramide transfer protein,40031,160,1.08 [0.86-1.36],0.4877866648232806
Chapter II Neoplasms,Melanoma in situ,CES1,Liver carboxylesterase 1,41074,162,1.02 [0.86-1.21],0.796988343347208
Chapter II Neoplasms,Melanoma in situ,CES2,Cocaine esterase,40789,160,0.96 [0.74-1.24],0.7391419808455835
Chapter II Neoplasms,Melanoma in situ,CES3,Carboxylesterase 3,40789,160,1.09 [0.90-1.32],0.3976719042459146
Chapter II Neoplasms,Melanoma in situ,CETN2,Centrin-2,40031,160,1.08 [0.88-1.33],0.4555362899977702
Chapter II Neoplasms,Melanoma in situ,CETN3,Centrin-3,35486,140,1.22 [1.00-1.51],0.0547300163060169
Chapter II Neoplasms,Melanoma in situ,CFB,Complement factor B,35045,137,1.06 [0.63-1.76],0.8339535401755369
Chapter II Neoplasms,Melanoma in situ,CFC1,Cryptic protein,40055,159,0.86 [0.62-1.19],0.3490028923881269
Chapter II Neoplasms,Melanoma in situ,CFD,Complement factor D,35692,141,0.53 [0.23-1.24],0.144326127375528
Chapter II Neoplasms,Melanoma in situ,CFH,Complement factor H,33623,129,0.81 [0.39-1.70],0.5791856639339541
Chapter II Neoplasms,Melanoma in situ,CFHR2,Complement factor H-related protein 2,35435,140,1.21 [0.89-1.63],0.2226448881326032
Chapter II Neoplasms,Melanoma in situ,CFHR4,Complement factor H-related protein 4,35627,141,0.98 [0.78-1.22],0.833594026712777
Chapter II Neoplasms,Melanoma in situ,CFHR5,Complement factor H-related protein 5,35197,138,1.41 [0.94-2.13],0.1000059996439978
Chapter II Neoplasms,Melanoma in situ,CFI,Complement factor I,35692,141,0.89 [0.39-2.02],0.7801023935001932
Chapter II Neoplasms,Melanoma in situ,CFP,Properdin,35692,141,0.68 [0.31-1.49],0.3413339783601569
Chapter II Neoplasms,Melanoma in situ,CGA,Glycoprotein hormones alpha chain,40993,164,0.93 [0.77-1.13],0.4795497367207411
Chapter II Neoplasms,Melanoma in situ,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,35663,141,1.03 [0.68-1.56],0.8929008878675968
Chapter II Neoplasms,Melanoma in situ,CGN,Cingulin,34686,135,0.95 [0.63-1.45],0.8301296285455588
Chapter II Neoplasms,Melanoma in situ,CGREF1,Cell growth regulator with EF hand domain protein 1,40984,163,1.14 [0.82-1.59],0.4225903165508576
Chapter II Neoplasms,Melanoma in situ,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,40055,159,0.97 [0.77-1.23],0.794777455791514
Chapter II Neoplasms,Melanoma in situ,CHAD,Chondroadherin,34878,138,0.79 [0.58-1.09],0.1516217159455974
Chapter II Neoplasms,Melanoma in situ,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",35570,140,1.06 [0.70-1.59],0.7817562308359818
Chapter II Neoplasms,Melanoma in situ,CHCHD6,MICOS complex subunit MIC25,35477,140,0.61 [0.31-1.18],0.1386768773914164
Chapter II Neoplasms,Melanoma in situ,CHEK2,Serine/threonine-protein kinase Chk2,40258,158,0.95 [0.62-1.45],0.7996783286638971
Chapter II Neoplasms,Melanoma in situ,CHGA,Chromogranin-A,35644,141,1.03 [0.86-1.23],0.7480301616856444
Chapter II Neoplasms,Melanoma in situ,CHGB,Secretogranin-1,41208,165,0.80 [0.56-1.13],0.2024194007931243
Chapter II Neoplasms,Melanoma in situ,CHI3L1,Chitinase-3-like protein 1,40084,159,0.97 [0.81-1.17],0.7699995481046364
Chapter II Neoplasms,Melanoma in situ,CHIT1,Chitotriosidase-1,41163,162,1.07 [0.96-1.19],0.2143342821715665
Chapter II Neoplasms,Melanoma in situ,CHL1,Neural cell adhesion molecule L1-like protein,41071,163,0.61 [0.38-0.98],0.0420449180276503
Chapter II Neoplasms,Melanoma in situ,CHM,Rab proteins geranylgeranyltransferase component A 1,34686,135,1.03 [0.78-1.35],0.8430438999117236
Chapter II Neoplasms,Melanoma in situ,CHMP1A,Charged multivesicular body protein 1a,40682,158,1.09 [0.91-1.30],0.3490273228217375
Chapter II Neoplasms,Melanoma in situ,CHMP6,Charged multivesicular body protein 6,35640,141,1.17 [0.88-1.56],0.2793109784417543
Chapter II Neoplasms,Melanoma in situ,CHP1,Calcineurin B homologous protein 1,34549,138,0.96 [0.76-1.20],0.6942936322911969
Chapter II Neoplasms,Melanoma in situ,CHRDL1,Chordin-like protein 1,41087,164,0.80 [0.51-1.26],0.3361987391203231
Chapter II Neoplasms,Melanoma in situ,CHRDL2,Chordin-like protein 2,40984,163,0.84 [0.64-1.11],0.2315664242997639
Chapter II Neoplasms,Melanoma in situ,CHRM1,Muscarinic acetylcholine receptor M1,34686,135,0.76 [0.46-1.27],0.2952534799549875
Chapter II Neoplasms,Melanoma in situ,CIAPIN1,Anamorsin,41097,164,1.15 [0.92-1.43],0.2264545520939209
Chapter II Neoplasms,Melanoma in situ,CILP,Cartilage intermediate layer protein 1,35644,141,0.89 [0.67-1.19],0.4268142385335106
Chapter II Neoplasms,Melanoma in situ,CINP,Cyclin-dependent kinase 2-interacting protein,34984,139,1.00 [0.69-1.45],0.9916764525840294
Chapter II Neoplasms,Melanoma in situ,CIRBP,Cold-inducible RNA-binding protein,35486,140,1.16 [0.98-1.38],0.0878029451358879
Chapter II Neoplasms,Melanoma in situ,CIT,Citron Rho-interacting kinase,34686,135,1.21 [0.87-1.68],0.263250291153638
Chapter II Neoplasms,Melanoma in situ,CKAP4,Cytoskeleton-associated protein 4,41253,164,0.72 [0.42-1.25],0.2462652441988252
Chapter II Neoplasms,Melanoma in situ,CKB,Creatine kinase B-type,35644,141,0.89 [0.67-1.17],0.3962653421214618
Chapter II Neoplasms,Melanoma in situ,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40821,163,1.00 [0.82-1.22],0.9939166693610828
Chapter II Neoplasms,Melanoma in situ,CLASP1,CLIP-associating protein 1,34394,136,0.86 [0.67-1.10],0.2210649920865767
Chapter II Neoplasms,Melanoma in situ,CLC,Galectin-10,40920,163,1.03 [0.83-1.27],0.7981134680894882
Chapter II Neoplasms,Melanoma in situ,CLEC10A,C-type lectin domain family 10 member A,40682,158,0.76 [0.51-1.13],0.16937023900795
Chapter II Neoplasms,Melanoma in situ,CLEC11A,C-type lectin domain family 11 member A,40917,164,1.14 [0.85-1.52],0.3874262413095509
Chapter II Neoplasms,Melanoma in situ,CLEC12A,C-type lectin domain family 12 member A,34608,134,1.84 [0.94-3.61],0.0747940509331608
Chapter II Neoplasms,Melanoma in situ,CLEC14A,C-type lectin domain family 14 member A,40993,164,0.80 [0.51-1.25],0.3225509138403069
Chapter II Neoplasms,Melanoma in situ,CLEC1A,C-type lectin domain family 1 member A,40258,158,0.93 [0.60-1.44],0.7505188150164589
Chapter II Neoplasms,Melanoma in situ,CLEC1B,C-type lectin domain family 1 member B,41349,165,1.06 [0.92-1.23],0.4015289034609695
Chapter II Neoplasms,Melanoma in situ,CLEC2L,C-type lectin domain family 2 member L,34686,135,0.95 [0.68-1.32],0.7486567619146656
Chapter II Neoplasms,Melanoma in situ,CLEC3B,Tetranectin,34859,137,0.69 [0.31-1.54],0.3689681552437495
Chapter II Neoplasms,Melanoma in situ,CLEC4A,C-type lectin domain family 4 member A,40939,163,1.07 [0.71-1.60],0.7544178551200118
Chapter II Neoplasms,Melanoma in situ,CLEC4C,C-type lectin domain family 4 member C,40939,163,1.41 [1.06-1.88],0.0193981515690873
Chapter II Neoplasms,Melanoma in situ,CLEC4D,C-type lectin domain family 4 member D,40939,163,1.06 [0.84-1.33],0.6073465747814593
Chapter II Neoplasms,Melanoma in situ,CLEC4G,C-type lectin domain family 4 member G,40939,163,1.38 [0.91-2.09],0.1317028770112316
Chapter II Neoplasms,Melanoma in situ,CLEC4M,C-type lectin domain family 4 member M,35583,141,0.83 [0.59-1.16],0.2681759789235237
Chapter II Neoplasms,Melanoma in situ,CLEC5A,C-type lectin domain family 5 member A,40857,163,0.88 [0.54-1.43],0.6057430318684769
Chapter II Neoplasms,Melanoma in situ,CLEC6A,C-type lectin domain family 6 member A,40055,159,1.09 [0.81-1.48],0.5655726044729823
Chapter II Neoplasms,Melanoma in situ,CLEC7A,C-type lectin domain family 7 member A,41452,164,0.84 [0.70-1.01],0.062452771740969
Chapter II Neoplasms,Melanoma in situ,CLGN,Calmegin,34686,135,1.06 [0.73-1.52],0.7625930370050538
Chapter II Neoplasms,Melanoma in situ,CLIC5,Chloride intracellular channel protein 5,34686,135,0.66 [0.36-1.19],0.1662296973516603
Chapter II Neoplasms,Melanoma in situ,CLINT1,Clathrin interactor 1,34394,136,1.05 [0.75-1.47],0.7774479494771452
Chapter II Neoplasms,Melanoma in situ,CLIP2,CAP-Gly domain-containing linker protein 2,40939,163,1.10 [0.97-1.25],0.1320686971351924
Chapter II Neoplasms,Melanoma in situ,CLMP,CXADR-like membrane protein,41358,164,0.65 [0.33-1.27],0.2082463271125992
Chapter II Neoplasms,Melanoma in situ,CLNS1A,Methylosome subunit pICln,34686,135,0.88 [0.53-1.46],0.6191026653664589
Chapter II Neoplasms,Melanoma in situ,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",40606,158,1.09 [0.94-1.27],0.2385137985295972
Chapter II Neoplasms,Melanoma in situ,CLPS,Colipase,40920,164,0.94 [0.77-1.14],0.5055596620636611
Chapter II Neoplasms,Melanoma in situ,CLSPN,Claspin,39955,160,1.03 [0.70-1.53],0.8821533986956147
Chapter II Neoplasms,Melanoma in situ,CLSTN1,Calsyntenin-1,40031,160,0.87 [0.65-1.16],0.3530822423233032
Chapter II Neoplasms,Melanoma in situ,CLSTN2,Calsyntenin-2,41452,164,0.81 [0.56-1.18],0.2779596083798216
Chapter II Neoplasms,Melanoma in situ,CLSTN3,Calsyntenin-3,35570,140,0.92 [0.54-1.59],0.7766704195030073
Chapter II Neoplasms,Melanoma in situ,CLTA,Clathrin light chain A,40258,158,0.91 [0.66-1.24],0.5309654193105018
Chapter II Neoplasms,Melanoma in situ,CLU,Clusterin,35692,141,1.03 [0.61-1.71],0.9193381838248554
Chapter II Neoplasms,Melanoma in situ,CLUL1,Clusterin-like protein 1,40919,162,1.04 [0.76-1.42],0.789375258150951
Chapter II Neoplasms,Melanoma in situ,CMC1,COX assembly mitochondrial protein homolog,35640,141,1.08 [0.91-1.29],0.3870918697497801
Chapter II Neoplasms,Melanoma in situ,CMIP,C-Maf-inducing protein,35477,140,1.10 [0.91-1.34],0.3170472876924788
Chapter II Neoplasms,Melanoma in situ,CNDP1,Beta-Ala-His dipeptidase,41135,163,1.07 [0.78-1.46],0.6785084876903996
Chapter II Neoplasms,Melanoma in situ,CNGB3,Cyclic nucleotide-gated cation channel beta-3,34549,138,0.68 [0.46-1.02],0.0617424615442199
Chapter II Neoplasms,Melanoma in situ,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",34630,137,1.12 [0.91-1.38],0.2715752606560386
Chapter II Neoplasms,Melanoma in situ,CNPY2,Protein canopy homolog 2,40258,158,0.98 [0.78-1.24],0.86724473406423
Chapter II Neoplasms,Melanoma in situ,CNPY4,Protein canopy homolog 4,40789,160,1.08 [0.90-1.30],0.4206931785415696
Chapter II Neoplasms,Melanoma in situ,CNST,Consortin,40984,163,1.10 [0.97-1.25],0.1519985455220888
Chapter II Neoplasms,Melanoma in situ,CNTF,Ciliary neurotrophic factor,34549,138,0.73 [0.45-1.18],0.2037635712567467
Chapter II Neoplasms,Melanoma in situ,CNTN1,Contactin-1,41485,164,0.91 [0.55-1.51],0.7163600856824355
Chapter II Neoplasms,Melanoma in situ,CNTN2,Contactin-2,41358,164,0.91 [0.66-1.24],0.5296809048489494
Chapter II Neoplasms,Melanoma in situ,CNTN3,Contactin-3,40993,164,1.15 [0.74-1.80],0.5351051098326518
Chapter II Neoplasms,Melanoma in situ,CNTN4,Contactin-4,40993,164,0.72 [0.40-1.29],0.2677619425934913
Chapter II Neoplasms,Melanoma in situ,CNTN5,Contactin-5,41086,165,0.93 [0.64-1.35],0.6927591982105723
Chapter II Neoplasms,Melanoma in situ,CNTNAP2,Contactin-associated protein-like 2,40939,163,1.09 [0.78-1.53],0.6245077026268364
Chapter II Neoplasms,Melanoma in situ,CNTNAP4,Contactin-associated protein-like 4,34686,135,0.97 [0.83-1.15],0.743400073790468
Chapter II Neoplasms,Melanoma in situ,COCH,Cochlin,35640,141,0.98 [0.69-1.39],0.904478123809266
Chapter II Neoplasms,Melanoma in situ,COL15A1,Collagen alpha-1(XV) chain,35644,141,0.82 [0.44-1.52],0.5197152669601619
Chapter II Neoplasms,Melanoma in situ,COL18A1,Collagen alpha-1(XVIII) chain,41152,161,1.07 [0.58-1.96],0.8264420980209339
Chapter II Neoplasms,Melanoma in situ,COL1A1,Collagen alpha-1(I) chain,41485,164,0.89 [0.52-1.55],0.6879481078682887
Chapter II Neoplasms,Melanoma in situ,COL24A1,Collagen alpha-1(XXIV) chain,35486,140,0.95 [0.71-1.27],0.7195943485625472
Chapter II Neoplasms,Melanoma in situ,COL28A1,Collagen alpha-1(XXVIII) chain,34686,135,0.77 [0.61-0.98],0.0313528049027054
Chapter II Neoplasms,Melanoma in situ,COL2A1,Collagen alpha-1(II) chain,34695,137,0.97 [0.79-1.19],0.7586331440691396
Chapter II Neoplasms,Melanoma in situ,COL3A1,Collagen alpha-1(III) chain,35644,141,0.78 [0.39-1.56],0.4785753365781711
Chapter II Neoplasms,Melanoma in situ,COL4A1,Collagen alpha-1(IV) chain,40984,163,1.24 [0.88-1.77],0.2237799572523202
Chapter II Neoplasms,Melanoma in situ,COL4A4,Collagen alpha-4(IV) chain,34924,139,1.18 [0.86-1.63],0.3061726171207823
Chapter II Neoplasms,Melanoma in situ,COL5A1,Collagen alpha-1(V) chain,34878,138,0.99 [0.65-1.50],0.9545519652751872
Chapter II Neoplasms,Melanoma in situ,COL6A3,Collagen alpha-3(VI) chain,41485,164,0.96 [0.64-1.46],0.865088997254533
Chapter II Neoplasms,Melanoma in situ,COL9A1,Collagen alpha-1(IX) chain,40939,163,1.15 [0.87-1.52],0.3320007783582546
Chapter II Neoplasms,Melanoma in situ,COL9A2,Collagen alpha-2(IX) chain,34984,139,1.07 [0.76-1.49],0.7100372737972587
Chapter II Neoplasms,Melanoma in situ,COLEC12,Collectin-12,40948,164,0.95 [0.55-1.64],0.8581892085065485
Chapter II Neoplasms,Melanoma in situ,COMMD1,COMM domain-containing protein 1,34695,137,1.17 [0.90-1.53],0.244964803745614
Chapter II Neoplasms,Melanoma in situ,COMMD9,COMM domain-containing protein 9,35477,140,1.08 [0.73-1.60],0.7007238838534379
Chapter II Neoplasms,Melanoma in situ,COMP,Cartilage oligomeric matrix protein,40546,161,1.01 [0.66-1.55],0.9588756714860452
Chapter II Neoplasms,Melanoma in situ,COMT,Catechol O-methyltransferase,39826,158,1.02 [0.86-1.20],0.8516676179947883
Chapter II Neoplasms,Melanoma in situ,COPB2,Coatomer subunit beta',34518,137,0.93 [0.63-1.37],0.7110517677813082
Chapter II Neoplasms,Melanoma in situ,COPE,Coatomer subunit epsilon,40031,160,0.85 [0.61-1.19],0.3360191378424292
Chapter II Neoplasms,Melanoma in situ,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",34695,137,0.66 [0.43-1.03],0.0645977412442132
Chapter II Neoplasms,Melanoma in situ,CORO1A,Coronin-1A,40137,159,1.02 [0.87-1.19],0.8148943376016984
Chapter II Neoplasms,Melanoma in situ,CORO6,Coronin-6,34549,138,0.72 [0.44-1.17],0.1851841405753199
Chapter II Neoplasms,Melanoma in situ,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",40789,160,0.97 [0.79-1.19],0.7889973554952449
Chapter II Neoplasms,Melanoma in situ,COX6B1,Cytochrome c oxidase subunit 6B1,35640,141,1.00 [0.61-1.65],0.9948726527001815
Chapter II Neoplasms,Melanoma in situ,CPA1,Carboxypeptidase A1,41485,164,1.02 [0.81-1.28],0.8434131000836711
Chapter II Neoplasms,Melanoma in situ,CPA2,Carboxypeptidase A2,41209,164,0.98 [0.80-1.22],0.8858558940238644
Chapter II Neoplasms,Melanoma in situ,CPA4,Carboxypeptidase A4,34188,138,0.97 [0.66-1.43],0.892871276442201
Chapter II Neoplasms,Melanoma in situ,CPB1,Carboxypeptidase B,41485,164,1.09 [0.86-1.37],0.4895467230087809
Chapter II Neoplasms,Melanoma in situ,CPB2,Carboxypeptidase B2,35623,141,0.75 [0.36-1.53],0.4251418790438119
Chapter II Neoplasms,Melanoma in situ,CPE,Carboxypeptidase E,41036,164,0.75 [0.55-1.04],0.0875387862391746
Chapter II Neoplasms,Melanoma in situ,CPLX2,Complexin-2,34394,136,0.97 [0.57-1.65],0.9055857867256928
Chapter II Neoplasms,Melanoma in situ,CPM,Carboxypeptidase M,41155,164,0.78 [0.51-1.17],0.228559225458932
Chapter II Neoplasms,Melanoma in situ,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",34608,134,1.39 [0.80-2.42],0.2465208386687954
Chapter II Neoplasms,Melanoma in situ,CPPED1,Serine/threonine-protein phosphatase CPPED1,41349,165,1.07 [0.87-1.31],0.5306035716794729
Chapter II Neoplasms,Melanoma in situ,CPQ,Carboxypeptidase Q,35575,141,0.72 [0.46-1.13],0.1512406514230728
Chapter II Neoplasms,Melanoma in situ,CPTP,Ceramide-1-phosphate transfer protein,34518,137,0.71 [0.44-1.15],0.1629788809563089
Chapter II Neoplasms,Melanoma in situ,CPVL,Probable serine carboxypeptidase CPVL,41294,163,0.63 [0.47-0.86],0.0029283554808396
Chapter II Neoplasms,Melanoma in situ,CPXM1,Probable carboxypeptidase X1,41097,164,1.14 [0.94-1.39],0.1836643972938816
Chapter II Neoplasms,Melanoma in situ,CPXM2,Inactive carboxypeptidase-like protein X2,35640,141,0.66 [0.35-1.28],0.2209687496585125
Chapter II Neoplasms,Melanoma in situ,CR1,Complement receptor type 1,35526,141,0.79 [0.50-1.25],0.3079572221579194
Chapter II Neoplasms,Melanoma in situ,CR2,Complement receptor type 2,41135,163,0.92 [0.68-1.24],0.577133970928053
Chapter II Neoplasms,Melanoma in situ,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,40055,159,1.08 [0.92-1.26],0.3596198359440871
Chapter II Neoplasms,Melanoma in situ,CRADD,Death domain-containing protein CRADD,40606,158,1.07 [0.89-1.30],0.4527399363549842
Chapter II Neoplasms,Melanoma in situ,CREB3,Cyclic AMP-responsive element-binding protein 3,34394,136,1.11 [0.84-1.46],0.4638634209171133
Chapter II Neoplasms,Melanoma in situ,CREBZF,CREB/ATF bZIP transcription factor,34394,136,1.12 [0.60-2.08],0.7204112388209085
Chapter II Neoplasms,Melanoma in situ,CREG1,Protein CREG1,40443,160,0.82 [0.56-1.20],0.317210337929443
Chapter II Neoplasms,Melanoma in situ,CRELD1,Protein disulfide isomerase CRELD1,34878,138,1.02 [0.66-1.60],0.916673493304366
Chapter II Neoplasms,Melanoma in situ,CRELD2,Protein disulfide isomerase CRELD2,41087,164,1.12 [0.86-1.46],0.4075430599994732
Chapter II Neoplasms,Melanoma in situ,CRH,Corticoliberin,39988,159,0.97 [0.82-1.14],0.7067389025623124
Chapter II Neoplasms,Melanoma in situ,CRHBP,Corticotropin-releasing factor-binding protein,40948,164,0.81 [0.49-1.34],0.4180271194617714
Chapter II Neoplasms,Melanoma in situ,CRHR1,Corticotropin-releasing factor receptor 1,40258,158,0.91 [0.72-1.17],0.4678922288658719
Chapter II Neoplasms,Melanoma in situ,CRIM1,Cysteine-rich motor neuron 1 protein,41147,164,0.74 [0.36-1.49],0.3947385139630655
Chapter II Neoplasms,Melanoma in situ,CRIP2,Cysteine-rich protein 2,40682,158,0.74 [0.49-1.11],0.1445209548687193
Chapter II Neoplasms,Melanoma in situ,CRISP2,Cysteine-rich secretory protein 2,41358,164,1.13 [0.88-1.43],0.3363878255982587
Chapter II Neoplasms,Melanoma in situ,CRISP3,Cysteine-rich secretory protein 3,35328,140,1.27 [0.69-2.32],0.4415128690511624
Chapter II Neoplasms,Melanoma in situ,CRKL,Crk-like protein,41019,163,1.10 [0.96-1.25],0.1693622353922604
Chapter II Neoplasms,Melanoma in situ,CRLF1,Cytokine receptor-like factor 1,41147,164,1.92 [1.10-3.34],0.0217982402206335
Chapter II Neoplasms,Melanoma in situ,CRNN,Cornulin,39821,157,0.90 [0.73-1.11],0.3235277148451796
Chapter II Neoplasms,Melanoma in situ,CRTAC1,Cartilage acidic protein 1,41485,164,0.77 [0.49-1.21],0.2646516301303795
Chapter II Neoplasms,Melanoma in situ,CRTAM,Cytotoxic and regulatory T-cell molecule,40682,158,1.03 [0.78-1.37],0.8207693299392319
Chapter II Neoplasms,Melanoma in situ,CRTAP,Cartilage-associated protein,34686,135,0.76 [0.52-1.13],0.1796645608584479
Chapter II Neoplasms,Melanoma in situ,CRX,Cone-rod homeobox protein,40258,158,0.90 [0.77-1.05],0.1653661384913961
Chapter II Neoplasms,Melanoma in situ,CRYBB1,Beta-crystallin B1,35640,141,1.23 [0.96-1.58],0.0942624798959065
Chapter II Neoplasms,Melanoma in situ,CRYBB2,Beta-crystallin B2,35570,140,1.09 [0.90-1.32],0.3533820003066914
Chapter II Neoplasms,Melanoma in situ,CRYGD,Gamma-crystallin D,35570,140,1.09 [0.93-1.29],0.2931210949316547
Chapter II Neoplasms,Melanoma in situ,CRYM,Ketimine reductase mu-crystallin,34549,138,1.04 [0.84-1.29],0.7130477105150181
Chapter II Neoplasms,Melanoma in situ,CRYZL1,Quinone oxidoreductase-like protein 1,34695,137,1.10 [0.92-1.32],0.2990117884829705
Chapter II Neoplasms,Melanoma in situ,CSDE1,Cold shock domain-containing protein E1,34518,137,1.03 [0.91-1.18],0.6284247004996273
Chapter II Neoplasms,Melanoma in situ,CSF1,Macrophage colony-stimulating factor 1,41147,164,1.26 [0.75-2.11],0.3867057209600424
Chapter II Neoplasms,Melanoma in situ,CSF1R,Macrophage colony-stimulating factor 1 receptor,35663,141,0.89 [0.59-1.35],0.5922861634223544
Chapter II Neoplasms,Melanoma in situ,CSF2,Granulocyte-macrophage colony-stimulating factor,34518,137,0.59 [0.36-0.96],0.0350440440405193
Chapter II Neoplasms,Melanoma in situ,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,40682,158,1.12 [0.90-1.40],0.2914854595770126
Chapter II Neoplasms,Melanoma in situ,CSF2RB,Cytokine receptor common subunit beta,34608,134,0.56 [0.39-0.81],0.002386447693723
Chapter II Neoplasms,Melanoma in situ,CSF3,Granulocyte colony-stimulating factor,40249,159,0.87 [0.64-1.17],0.3504604771620649
Chapter II Neoplasms,Melanoma in situ,CSF3R,Granulocyte colony-stimulating factor receptor,34608,134,1.43 [0.86-2.39],0.1692492424163331
Chapter II Neoplasms,Melanoma in situ,CSH1,Chorionic somatomammotropin hormone 1,35663,141,0.94 [0.54-1.65],0.8358264426321091
Chapter II Neoplasms,Melanoma in situ,CSNK1D,Casein kinase I isoform delta,34608,134,0.96 [0.74-1.26],0.7850754894266204
Chapter II Neoplasms,Melanoma in situ,CSNK2A1,Casein kinase II subunit alpha,35587,140,1.03 [0.72-1.47],0.8897437092829926
Chapter II Neoplasms,Melanoma in situ,CSPG4,Chondroitin sulfate proteoglycan 4,35644,141,0.84 [0.51-1.38],0.4892364786124876
Chapter II Neoplasms,Melanoma in situ,CSPG5,Chondroitin sulfate proteoglycan 5,34549,138,1.02 [0.74-1.41],0.8923905127504517
Chapter II Neoplasms,Melanoma in situ,CSRP3,Cysteine and glycine-rich protein 3,34518,137,0.92 [0.77-1.10],0.3608237635013518
Chapter II Neoplasms,Melanoma in situ,CST1,Cystatin-SN,30936,123,1.03 [0.87-1.23],0.7408511013875259
Chapter II Neoplasms,Melanoma in situ,CST3,Cystatin-C,41067,163,0.84 [0.51-1.40],0.5143321157588183
Chapter II Neoplasms,Melanoma in situ,CST5,Cystatin-D,40221,156,0.74 [0.57-0.97],0.0274119797806777
Chapter II Neoplasms,Melanoma in situ,CST6,Cystatin-M,39935,156,0.90 [0.67-1.21],0.4967280545906339
Chapter II Neoplasms,Melanoma in situ,CST7,Cystatin-F,41021,164,1.00 [0.86-1.16],0.9925728763418792
Chapter II Neoplasms,Melanoma in situ,CSTB,Cystatin-B,40422,158,1.08 [0.77-1.51],0.6490862526681309
Chapter II Neoplasms,Melanoma in situ,CTAG1A_CTAG1B,Cancer/testis antigen 1,34913,138,0.81 [0.58-1.14],0.2275755785930999
Chapter II Neoplasms,Melanoma in situ,CTBS,Di-N-acetylchitobiase,35148,140,1.03 [0.56-1.92],0.9144373872552533
Chapter II Neoplasms,Melanoma in situ,CTF1,Cardiotrophin-1,40258,158,0.97 [0.82-1.14],0.6833435022372683
Chapter II Neoplasms,Melanoma in situ,CTHRC1,Collagen triple helix repeat-containing protein 1,35644,141,1.21 [0.68-2.13],0.5201741879300317
Chapter II Neoplasms,Melanoma in situ,CTLA4,Cytotoxic T-lymphocyte protein 4,35644,141,0.57 [0.33-0.99],0.0467735831442729
Chapter II Neoplasms,Melanoma in situ,CTNNA1,Catenin alpha-1,34549,138,1.15 [0.76-1.74],0.5170205126305891
Chapter II Neoplasms,Melanoma in situ,CTRB1,Chymotrypsinogen B,40993,164,0.86 [0.67-1.11],0.2410907781126328
Chapter II Neoplasms,Melanoma in situ,CTRC,Chymotrypsin-C,40957,164,0.95 [0.76-1.18],0.635867470332312
Chapter II Neoplasms,Melanoma in situ,CTRL,Chymotrypsin-like protease CTRL-1,35570,140,0.98 [0.77-1.25],0.8794456407741486
Chapter II Neoplasms,Melanoma in situ,CTSB,Cathepsin B,41008,161,0.88 [0.67-1.15],0.3360041649754648
Chapter II Neoplasms,Melanoma in situ,CTSC,Dipeptidyl peptidase 1,40879,163,0.97 [0.70-1.33],0.8331299694463604
Chapter II Neoplasms,Melanoma in situ,CTSD,Cathepsin D,38280,151,0.71 [0.47-1.07],0.098430722941549
Chapter II Neoplasms,Melanoma in situ,CTSE,Cathepsin E,34878,138,0.97 [0.71-1.33],0.8474465699474942
Chapter II Neoplasms,Melanoma in situ,CTSF,Cathepsin F,41097,164,0.73 [0.52-1.04],0.0845793008840236
Chapter II Neoplasms,Melanoma in situ,CTSH,Pro-cathepsin H,40133,157,0.81 [0.67-0.98],0.0308078244820992
Chapter II Neoplasms,Melanoma in situ,CTSL,Cathepsin L1,40984,163,1.55 [0.88-2.72],0.1256954140419124
Chapter II Neoplasms,Melanoma in situ,CTSO,Cathepsin O,41452,164,0.96 [0.61-1.53],0.8749007380702157
Chapter II Neoplasms,Melanoma in situ,CTSS,Cathepsin S,32256,135,1.28 [0.64-2.56],0.493641243306557
Chapter II Neoplasms,Melanoma in situ,CTSV,Cathepsin L2,41229,163,0.87 [0.61-1.23],0.419390981129204
Chapter II Neoplasms,Melanoma in situ,CTSZ,Cathepsin Z,40997,162,0.79 [0.50-1.23],0.2923856281327477
Chapter II Neoplasms,Melanoma in situ,CUZD1,CUB and zona pellucida-like domain-containing protein 1,34686,135,0.72 [0.43-1.21],0.2164647753165054
Chapter II Neoplasms,Melanoma in situ,CWC15,Spliceosome-associated protein CWC15 homolog,35277,140,0.94 [0.71-1.23],0.6324747041142157
Chapter II Neoplasms,Melanoma in situ,CX3CL1,Fractalkine,40682,158,0.74 [0.48-1.14],0.1698867033130386
Chapter II Neoplasms,Melanoma in situ,CXADR,Coxsackievirus and adenovirus receptor,40939,163,1.18 [0.90-1.53],0.2254781486642368
Chapter II Neoplasms,Melanoma in situ,CXCL1,Growth-regulated alpha protein,40894,164,1.05 [0.91-1.20],0.5272022901531344
Chapter II Neoplasms,Melanoma in situ,CXCL10,C-X-C motif chemokine 10,41147,164,1.02 [0.83-1.25],0.8751662688337193
Chapter II Neoplasms,Melanoma in situ,CXCL11,C-X-C motif chemokine 11,41349,165,1.23 [1.06-1.43],0.0065165008964435
Chapter II Neoplasms,Melanoma in situ,CXCL12,Stromal cell-derived factor 1,40249,159,0.82 [0.58-1.18],0.2935427430558101
Chapter II Neoplasms,Melanoma in situ,CXCL13,C-X-C motif chemokine 13,41349,165,1.01 [0.80-1.27],0.9560439003674216
Chapter II Neoplasms,Melanoma in situ,CXCL14,C-X-C motif chemokine 14,40249,159,1.11 [0.89-1.38],0.3633790999577392
Chapter II Neoplasms,Melanoma in situ,CXCL16,C-X-C motif chemokine 16,41415,164,0.83 [0.45-1.51],0.5395038669662572
Chapter II Neoplasms,Melanoma in situ,CXCL17,C-X-C motif chemokine 17,41452,164,0.97 [0.69-1.37],0.8672658671170652
Chapter II Neoplasms,Melanoma in situ,CXCL3,C-X-C motif chemokine 3,40961,164,1.03 [0.89-1.19],0.7126492910173445
Chapter II Neoplasms,Melanoma in situ,CXCL5,C-X-C motif chemokine 5,40849,163,0.99 [0.87-1.11],0.8099969351013474
Chapter II Neoplasms,Melanoma in situ,CXCL6,C-X-C motif chemokine 6,41452,164,1.08 [0.91-1.30],0.3769657214091907
Chapter II Neoplasms,Melanoma in situ,CXCL8,Interleukin-8,40700,159,0.98 [0.80-1.21],0.8659719759172569
Chapter II Neoplasms,Melanoma in situ,CXCL9,C-X-C motif chemokine 9,41147,164,1.10 [0.90-1.35],0.3419976322213888
Chapter II Neoplasms,Melanoma in situ,CYB5A,Cytochrome b5,34394,136,1.13 [0.92-1.37],0.2412914176430956
Chapter II Neoplasms,Melanoma in situ,CYB5R2,NADH-cytochrome b5 reductase 2,35077,136,1.29 [0.97-1.71],0.0794052324208414
Chapter II Neoplasms,Melanoma in situ,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",34518,137,1.01 [0.84-1.22],0.8950249540047087
Chapter II Neoplasms,Melanoma in situ,CYTH3,Cytohesin-3,34394,136,0.95 [0.75-1.20],0.6504039658249616
Chapter II Neoplasms,Melanoma in situ,CYTL1,Cytokine-like protein 1,35644,141,0.63 [0.32-1.22],0.1715967813062384
Chapter II Neoplasms,Melanoma in situ,DAAM1,Disheveled-associated activator of morphogenesis 1,34878,138,1.12 [0.92-1.37],0.2420633206006163
Chapter II Neoplasms,Melanoma in situ,DAB2,Disabled homolog 2,41358,164,1.09 [0.96-1.24],0.1663162097090877
Chapter II Neoplasms,Melanoma in situ,DAG1,Dystroglycan,41147,164,1.18 [0.88-1.58],0.261678903855119
Chapter II Neoplasms,Melanoma in situ,DAND5,DAN domain family member 5,34608,134,0.81 [0.60-1.10],0.1782848520408771
Chapter II Neoplasms,Melanoma in situ,DAPK2,Death-associated protein kinase 2,34608,134,1.02 [0.77-1.37],0.8706356528014385
Chapter II Neoplasms,Melanoma in situ,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,40939,163,1.04 [0.92-1.17],0.5324041054039229
Chapter II Neoplasms,Melanoma in situ,DARS1,"Aspartate--tRNA ligase, cytoplasmic",40606,158,1.11 [0.92-1.35],0.2769452026134578
Chapter II Neoplasms,Melanoma in situ,DBH,Dopamine beta-hydroxylase,35601,141,1.03 [0.89-1.20],0.6749605899337158
Chapter II Neoplasms,Melanoma in situ,DBI,Acyl-CoA-binding protein,40807,164,1.08 [0.90-1.29],0.4110529979161936
Chapter II Neoplasms,Melanoma in situ,DBN1,Drebrin,34608,134,1.44 [1.07-1.93],0.0148070997991338
Chapter II Neoplasms,Melanoma in situ,DBNL,Drebrin-like protein,41147,164,1.10 [0.94-1.27],0.2283301203895811
Chapter II Neoplasms,Melanoma in situ,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",41097,164,1.00 [0.67-1.49],0.990459532528732
Chapter II Neoplasms,Melanoma in situ,DCC,Netrin receptor DCC,34686,135,0.82 [0.37-1.79],0.6124687940911756
Chapter II Neoplasms,Melanoma in situ,DCDC2C,Doublecortin domain-containing protein 2C,34394,136,1.06 [0.82-1.36],0.6720719788753089
Chapter II Neoplasms,Melanoma in situ,DCLRE1C,Protein artemis,34394,136,0.83 [0.48-1.43],0.507802641129959
Chapter II Neoplasms,Melanoma in situ,DCN,Decorin,40258,158,0.87 [0.47-1.64],0.6730544501660773
Chapter II Neoplasms,Melanoma in situ,DCTD,Deoxycytidylate deaminase,34878,138,1.14 [0.96-1.36],0.1355302004607199
Chapter II Neoplasms,Melanoma in situ,DCTN1,Dynactin subunit 1,41358,164,1.12 [0.91-1.38],0.2857907784901013
Chapter II Neoplasms,Melanoma in situ,DCTN2,Dynactin subunit 2,40789,160,1.06 [0.91-1.23],0.4317541052928553
Chapter II Neoplasms,Melanoma in situ,DCTN6,Dynactin subunit 6,40031,160,0.96 [0.78-1.18],0.6996867277263195
Chapter II Neoplasms,Melanoma in situ,DCTPP1,dCTP pyrophosphatase 1,40984,163,1.43 [0.91-2.23],0.117196490860094
Chapter II Neoplasms,Melanoma in situ,DCUN1D1,DCN1-like protein 1,34549,138,1.01 [0.82-1.25],0.8903866133172662
Chapter II Neoplasms,Melanoma in situ,DCUN1D2,DCN1-like protein 2,34394,136,1.16 [0.98-1.38],0.0909917638113324
Chapter II Neoplasms,Melanoma in situ,DCXR,L-xylulose reductase,41097,164,0.90 [0.69-1.17],0.4240623033746835
Chapter II Neoplasms,Melanoma in situ,DDA1,DET1- and DDB1-associated protein 1,34518,137,0.64 [0.39-1.04],0.073376695614054
Chapter II Neoplasms,Melanoma in situ,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40789,160,1.12 [0.82-1.53],0.4617455353325994
Chapter II Neoplasms,Melanoma in situ,DDC,Aromatic-L-amino-acid decarboxylase,40930,163,1.23 [0.93-1.64],0.1512366011887212
Chapter II Neoplasms,Melanoma in situ,DDHD2,Phospholipase DDHD2,35587,140,1.08 [0.84-1.38],0.5597697467539162
Chapter II Neoplasms,Melanoma in situ,DDI2,Protein DDI1 homolog 2,34878,138,0.92 [0.75-1.14],0.4464226323011601
Chapter II Neoplasms,Melanoma in situ,DDR1,Epithelial discoidin domain-containing receptor 1,41349,165,0.78 [0.42-1.45],0.4244398097764799
Chapter II Neoplasms,Melanoma in situ,DDT,D-dopachrome decarboxylase,35644,141,0.89 [0.60-1.33],0.5793770907697591
Chapter II Neoplasms,Melanoma in situ,DDX1,ATP-dependent RNA helicase DDX1,35486,140,0.79 [0.55-1.15],0.218184123217327
Chapter II Neoplasms,Melanoma in situ,DDX25,ATP-dependent RNA helicase DDX25,34686,135,0.95 [0.60-1.50],0.8122629075009024
Chapter II Neoplasms,Melanoma in situ,DDX39A,ATP-dependent RNA helicase DDX39A,34608,134,1.41 [0.76-2.62],0.2752281964185862
Chapter II Neoplasms,Melanoma in situ,DDX4,Probable ATP-dependent RNA helicase DDX4,34608,134,0.79 [0.55-1.13],0.1891659939534652
Chapter II Neoplasms,Melanoma in situ,DDX53,Probable ATP-dependent RNA helicase DDX53,34686,135,1.16 [0.75-1.79],0.5000651665977942
Chapter II Neoplasms,Melanoma in situ,DDX58,Antiviral innate immune response receptor RIG-I,40055,159,1.03 [0.81-1.31],0.7995107128127651
Chapter II Neoplasms,Melanoma in situ,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",40939,163,1.03 [0.89-1.19],0.6545472468179867
Chapter II Neoplasms,Melanoma in situ,DEFA1_DEFA1B,Neutrophil defensin 1,40159,158,0.89 [0.67-1.18],0.4223253465901331
Chapter II Neoplasms,Melanoma in situ,DEFB103A_DEFB103B,Beta-defensin 103,34349,134,1.13 [0.79-1.62],0.501195488375041
Chapter II Neoplasms,Melanoma in situ,DEFB104A_DEFB104B,Beta-defensin 104,34549,138,1.04 [0.78-1.39],0.7887668516581926
Chapter II Neoplasms,Melanoma in situ,DEFB116,Beta-defensin 116,34549,138,1.24 [1.05-1.47],0.0129895178328889
Chapter II Neoplasms,Melanoma in situ,DEFB118,Beta-defensin 118,34549,138,0.91 [0.67-1.25],0.5681943494499145
Chapter II Neoplasms,Melanoma in situ,DEFB4A_DEFB4B,Beta-defensin 4A,40387,156,1.02 [0.93-1.13],0.6388243602820839
Chapter II Neoplasms,Melanoma in situ,DENND2B,DENN domain-containing protein 2B,34518,137,1.07 [0.79-1.44],0.6727457823859883
Chapter II Neoplasms,Melanoma in situ,DENR,Density-regulated protein,34608,134,1.11 [0.84-1.46],0.4667037542744774
Chapter II Neoplasms,Melanoma in situ,DFFA,DNA fragmentation factor subunit alpha,41452,164,1.16 [0.95-1.42],0.1375947689772413
Chapter II Neoplasms,Melanoma in situ,DGCR6,Protein DGCR6,34549,138,0.93 [0.63-1.38],0.7260748486073785
Chapter II Neoplasms,Melanoma in situ,DGKA,Diacylglycerol kinase alpha,34608,134,1.07 [0.79-1.45],0.6826781583803055
Chapter II Neoplasms,Melanoma in situ,DGKZ,Diacylglycerol kinase zeta,40249,159,1.02 [0.68-1.52],0.9273068033601876
Chapter II Neoplasms,Melanoma in situ,DHODH,Dihydroorotate dehydrogenase,34518,137,1.20 [0.89-1.61],0.2292413785004338
Chapter II Neoplasms,Melanoma in situ,DHPS,Deoxyhypusine synthase,35477,140,1.08 [0.74-1.58],0.6951649472614136
Chapter II Neoplasms,Melanoma in situ,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,35570,140,1.12 [0.80-1.55],0.5124532802859003
Chapter II Neoplasms,Melanoma in situ,DIABLO,"Diablo homolog, mitochondrial",40857,163,1.08 [0.95-1.22],0.2572134142673694
Chapter II Neoplasms,Melanoma in situ,DIPK1C,Divergent protein kinase domain 1C,34686,135,0.82 [0.53-1.26],0.3662364044387802
Chapter II Neoplasms,Melanoma in situ,DIPK2B,Divergent protein kinase domain 2B,34878,138,0.92 [0.50-1.68],0.7784816945986914
Chapter II Neoplasms,Melanoma in situ,DKK1,Dickkopf-related protein 1,41349,165,1.04 [0.82-1.31],0.7633503975864322
Chapter II Neoplasms,Melanoma in situ,DKK3,Dickkopf-related protein 3,41485,164,0.89 [0.55-1.42],0.6190972231396243
Chapter II Neoplasms,Melanoma in situ,DKK4,Dickkopf-related protein 4,40618,157,1.10 [0.81-1.50],0.5282421706481581
Chapter II Neoplasms,Melanoma in situ,DKKL1,Dickkopf-like protein 1,40789,160,1.03 [0.87-1.21],0.744853058713778
Chapter II Neoplasms,Melanoma in situ,DLG4,Disks large homolog 4,35570,140,1.15 [0.93-1.43],0.1963919970227885
Chapter II Neoplasms,Melanoma in situ,DLGAP5,Disks large-associated protein 5,35587,140,0.93 [0.66-1.30],0.670215416295241
Chapter II Neoplasms,Melanoma in situ,DLK1,Protein delta homolog 1,41485,164,0.84 [0.66-1.08],0.1788609473563751
Chapter II Neoplasms,Melanoma in situ,DLL1,Delta-like protein 1,41097,164,0.99 [0.61-1.59],0.9600505644805416
Chapter II Neoplasms,Melanoma in situ,DLL4,Delta-like protein 4,34695,137,0.81 [0.61-1.08],0.1566221621120508
Chapter II Neoplasms,Melanoma in situ,DMD,Dystrophin,34695,137,1.09 [0.79-1.51],0.5866221395708664
Chapter II Neoplasms,Melanoma in situ,DMP1,Dentin matrix acidic phosphoprotein 1,34695,137,0.91 [0.70-1.19],0.5022959715322363
Chapter II Neoplasms,Melanoma in situ,DNAJA1,DnaJ homolog subfamily A member 1,34394,136,0.91 [0.62-1.34],0.6339115386019295
Chapter II Neoplasms,Melanoma in situ,DNAJA2,DnaJ homolog subfamily A member 2,41326,164,1.08 [0.91-1.28],0.3674947379166161
Chapter II Neoplasms,Melanoma in situ,DNAJA4,DnaJ homolog subfamily A member 4,35570,140,0.93 [0.74-1.16],0.5015018747493389
Chapter II Neoplasms,Melanoma in situ,DNAJB1,DnaJ homolog subfamily B member 1,40789,160,1.06 [0.90-1.24],0.4790104375929247
Chapter II Neoplasms,Melanoma in situ,DNAJB14,DnaJ homolog subfamily B member 14,35486,140,1.18 [0.92-1.50],0.1901853034358591
Chapter II Neoplasms,Melanoma in situ,DNAJB2,DnaJ homolog subfamily B member 2,34878,138,1.02 [0.75-1.38],0.9106652516264536
Chapter II Neoplasms,Melanoma in situ,DNAJB6,DnaJ homolog subfamily B member 6,34545,138,1.12 [0.92-1.36],0.2581050836727315
Chapter II Neoplasms,Melanoma in situ,DNAJB8,DnaJ homolog subfamily B member 8,40258,158,1.01 [0.79-1.29],0.9307196847382412
Chapter II Neoplasms,Melanoma in situ,DNAJC21,DnaJ homolog subfamily C member 21,35570,140,1.16 [0.78-1.73],0.4632706705373256
Chapter II Neoplasms,Melanoma in situ,DNAJC6,Putative tyrosine-protein phosphatase auxilin,34695,137,1.18 [0.97-1.43],0.0947446805419734
Chapter II Neoplasms,Melanoma in situ,DNAJC9,DnaJ homolog subfamily C member 9,35486,140,1.05 [0.85-1.29],0.6553037726428995
Chapter II Neoplasms,Melanoma in situ,DNER,Delta and Notch-like epidermal growth factor-related receptor,40887,164,0.69 [0.40-1.19],0.182914902684917
Chapter II Neoplasms,Melanoma in situ,DNLZ,DNL-type zinc finger protein,34549,138,0.94 [0.77-1.14],0.5283220804289471
Chapter II Neoplasms,Melanoma in situ,DNM1,Dynamin-1,35486,140,1.07 [0.93-1.24],0.3278896286492897
Chapter II Neoplasms,Melanoma in situ,DNM3,Dynamin-3,35587,140,1.09 [0.81-1.45],0.5726172736886533
Chapter II Neoplasms,Melanoma in situ,DNMBP,Dynamin-binding protein,40682,158,1.13 [0.90-1.41],0.2865725595216287
Chapter II Neoplasms,Melanoma in situ,DNPEP,Aspartyl aminopeptidase,35570,140,1.09 [0.82-1.45],0.5568821000945037
Chapter II Neoplasms,Melanoma in situ,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,41079,163,0.98 [0.75-1.28],0.885118932374682
Chapter II Neoplasms,Melanoma in situ,DOC2B,Double C2-like domain-containing protein beta,34686,135,0.90 [0.55-1.47],0.6785682608360437
Chapter II Neoplasms,Melanoma in situ,DOCK9,Dedicator of cytokinesis protein 9,34549,138,0.95 [0.82-1.10],0.522168561398241
Chapter II Neoplasms,Melanoma in situ,DOK1,Docking protein 1,35570,140,1.10 [0.97-1.25],0.1208027278131244
Chapter II Neoplasms,Melanoma in situ,DOK2,Docking protein 2,40984,163,1.09 [0.97-1.22],0.1330050868687351
Chapter II Neoplasms,Melanoma in situ,DPEP1,Dipeptidase 1,40606,158,0.79 [0.60-1.05],0.1015222310539998
Chapter II Neoplasms,Melanoma in situ,DPEP2,Dipeptidase 2,40789,160,0.76 [0.47-1.24],0.270536875970907
Chapter II Neoplasms,Melanoma in situ,DPP10,Inactive dipeptidyl peptidase 10,40939,163,0.85 [0.56-1.29],0.4423472179476284
Chapter II Neoplasms,Melanoma in situ,DPP4,Dipeptidyl peptidase 4,40218,160,0.67 [0.41-1.10],0.1127736869279082
Chapter II Neoplasms,Melanoma in situ,DPP6,Dipeptidyl aminopeptidase-like protein 6,40789,160,0.81 [0.53-1.24],0.339205441729398
Chapter II Neoplasms,Melanoma in situ,DPP7,Dipeptidyl peptidase 2,40656,161,1.00 [0.79-1.26],0.9959720278689924
Chapter II Neoplasms,Melanoma in situ,DPT,Dermatopontin,41485,164,0.89 [0.52-1.51],0.6610708441390157
Chapter II Neoplasms,Melanoma in situ,DPY30,Protein dpy-30 homolog,41234,163,1.11 [0.89-1.39],0.3585464855272773
Chapter II Neoplasms,Melanoma in situ,DRAXIN,Draxin,40682,158,1.00 [0.72-1.40],0.9983627561807952
Chapter II Neoplasms,Melanoma in situ,DRG2,Developmentally-regulated GTP-binding protein 2,40789,160,1.17 [0.92-1.49],0.2085732424009373
Chapter II Neoplasms,Melanoma in situ,DSC2,Desmocollin-2,40518,163,0.91 [0.59-1.38],0.6471073441430772
Chapter II Neoplasms,Melanoma in situ,DSCAM,Down syndrome cell adhesion molecule,35587,140,1.07 [0.68-1.70],0.7627713766853145
Chapter II Neoplasms,Melanoma in situ,DSG2,Desmoglein-2,40993,164,0.86 [0.51-1.44],0.5581891224967792
Chapter II Neoplasms,Melanoma in situ,DSG3,Desmoglein-3,41231,162,0.86 [0.57-1.30],0.4737121019990415
Chapter II Neoplasms,Melanoma in situ,DSG4,Desmoglein-4,40644,160,0.73 [0.55-0.97],0.0291722022613423
Chapter II Neoplasms,Melanoma in situ,DTD1,D-aminoacyl-tRNA deacylase 1,34878,138,1.09 [0.90-1.31],0.3849835034781855
Chapter II Neoplasms,Melanoma in situ,DTNB,Dystrobrevin beta,35410,139,1.39 [0.97-1.99],0.0704761483456873
Chapter II Neoplasms,Melanoma in situ,DTX2,Probable E3 ubiquitin-protein ligase DTX2,34686,135,0.91 [0.68-1.21],0.5050104191977123
Chapter II Neoplasms,Melanoma in situ,DTX3,Probable E3 ubiquitin-protein ligase DTX3,40789,160,0.55 [0.30-1.03],0.0620223820171509
Chapter II Neoplasms,Melanoma in situ,DTYMK,Thymidylate kinase,35640,141,1.12 [0.89-1.42],0.3296852196143298
Chapter II Neoplasms,Melanoma in situ,DUOX2,Dual oxidase 2,40258,158,0.82 [0.65-1.04],0.1047724771339878
Chapter II Neoplasms,Melanoma in situ,DUSP13,Dual specificity protein phosphatase 13 isoform A,35477,140,0.91 [0.61-1.35],0.627749025915405
Chapter II Neoplasms,Melanoma in situ,DUSP29,Dual specificity phosphatase 29,34686,135,0.92 [0.70-1.20],0.5487470630209244
Chapter II Neoplasms,Melanoma in situ,DUSP3,Dual specificity protein phosphatase 3,40031,160,1.22 [1.07-1.38],0.0023299632078218
Chapter II Neoplasms,Melanoma in situ,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",35486,140,1.09 [0.93-1.27],0.3014855730329751
Chapter II Neoplasms,Melanoma in situ,DXO,Decapping and exoribonuclease protein,35570,140,1.54 [1.10-2.15],0.0119330254923236
Chapter II Neoplasms,Melanoma in situ,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,35477,140,0.88 [0.60-1.28],0.4948014380603177
Chapter II Neoplasms,Melanoma in situ,DYNLT1,Dynein light chain Tctex-type 1,34686,135,1.10 [0.91-1.34],0.3236325580454705
Chapter II Neoplasms,Melanoma in situ,DYNLT3,Dynein light chain Tctex-type 3,35477,140,1.43 [1.01-2.03],0.0456761757467614
Chapter II Neoplasms,Melanoma in situ,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,40682,158,1.11 [0.96-1.29],0.1750153430470559
Chapter II Neoplasms,Melanoma in situ,EBI3_IL27,Interleukin-27,41296,164,0.94 [0.59-1.50],0.8096230952522112
Chapter II Neoplasms,Melanoma in situ,ECE1,Endothelin-converting enzyme 1,40031,160,1.21 [0.82-1.79],0.3405268340650009
Chapter II Neoplasms,Melanoma in situ,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",35640,141,0.88 [0.70-1.11],0.2664261153089924
Chapter II Neoplasms,Melanoma in situ,ECHS1,"Enoyl-CoA hydratase, mitochondrial",34695,137,1.01 [0.85-1.20],0.9335535291641092
Chapter II Neoplasms,Melanoma in situ,ECI2,Enoyl-CoA delta isomerase 2,34518,137,1.05 [0.81-1.36],0.7191784769259837
Chapter II Neoplasms,Melanoma in situ,ECM1,Extracellular matrix protein 1,34706,138,0.78 [0.51-1.17],0.2295777970410983
Chapter II Neoplasms,Melanoma in situ,ECSCR,Endothelial cell-specific chemotaxis regulator,34549,138,0.76 [0.52-1.12],0.163981597602487
Chapter II Neoplasms,Melanoma in situ,EDA2R,Tumor necrosis factor receptor superfamily member 27,41358,164,0.72 [0.50-1.02],0.0651507194262863
Chapter II Neoplasms,Melanoma in situ,EDAR,Tumor necrosis factor receptor superfamily member EDAR,40939,163,1.06 [0.91-1.23],0.470749050135421
Chapter II Neoplasms,Melanoma in situ,EDDM3B,Epididymal secretory protein E3-beta,35477,140,1.14 [0.84-1.55],0.3863037249133263
Chapter II Neoplasms,Melanoma in situ,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,34518,137,0.71 [0.43-1.20],0.2043895689175116
Chapter II Neoplasms,Melanoma in situ,EDF1,Endothelial differentiation-related factor 1,35587,140,1.04 [0.83-1.30],0.7503264251379244
Chapter II Neoplasms,Melanoma in situ,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,40258,158,0.60 [0.39-0.93],0.0210332232227272
Chapter II Neoplasms,Melanoma in situ,EDN1,Endothelin-1,34695,137,0.99 [0.56-1.75],0.9622699622420484
Chapter II Neoplasms,Melanoma in situ,EDNRB,Endothelin receptor type B,34608,134,0.80 [0.52-1.23],0.3093161681019711
Chapter II Neoplasms,Melanoma in situ,EEF1D,Elongation factor 1-delta,35640,141,1.17 [0.99-1.39],0.0638919723203628
Chapter II Neoplasms,Melanoma in situ,EFCAB14,EF-hand calcium-binding domain-containing protein 14,35486,140,1.00 [0.55-1.81],0.9971913599183516
Chapter II Neoplasms,Melanoma in situ,EFCAB2,Dynein regulatory complex protein 8,34984,139,1.16 [0.74-1.82],0.5173547641348129
Chapter II Neoplasms,Melanoma in situ,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,41066,163,0.97 [0.61-1.52],0.8782394546524763
Chapter II Neoplasms,Melanoma in situ,EFHD1,EF-hand domain-containing protein D1,35587,140,0.61 [0.37-1.01],0.0563092553611892
Chapter II Neoplasms,Melanoma in situ,EFNA1,Ephrin-A1,40928,164,1.14 [0.69-1.88],0.6168443203996505
Chapter II Neoplasms,Melanoma in situ,EFNA4,Ephrin-A4,40613,157,0.90 [0.54-1.48],0.6748124209194437
Chapter II Neoplasms,Melanoma in situ,EFNB2,Ephrin-B2,34686,135,0.95 [0.70-1.29],0.7548666494864157
Chapter II Neoplasms,Melanoma in situ,EGF,Pro-epidermal growth factor,40898,162,1.05 [0.92-1.20],0.4727321003062674
Chapter II Neoplasms,Melanoma in situ,EGFL7,Epidermal growth factor-like protein 7,40055,159,1.03 [0.72-1.47],0.8558334214958173
Chapter II Neoplasms,Melanoma in situ,EGFLAM,Pikachurin,35486,140,1.21 [0.73-2.02],0.4527865116928486
Chapter II Neoplasms,Melanoma in situ,EGFR,Epidermal growth factor receptor,41485,164,1.17 [0.50-2.73],0.723571836105623
Chapter II Neoplasms,Melanoma in situ,EGLN1,Egl nine homolog 1,40939,163,0.98 [0.76-1.27],0.8807145404178529
Chapter II Neoplasms,Melanoma in situ,EHBP1,EH domain-binding protein 1,35640,141,1.12 [0.90-1.39],0.3060959809043623
Chapter II Neoplasms,Melanoma in situ,EHD3,EH domain-containing protein 3,34695,137,1.08 [0.94-1.25],0.2710646346717114
Chapter II Neoplasms,Melanoma in situ,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",35570,140,1.00 [0.75-1.34],0.9751531723019562
Chapter II Neoplasms,Melanoma in situ,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",35362,140,1.12 [0.97-1.30],0.1177300922251462
Chapter II Neoplasms,Melanoma in situ,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,34518,137,1.01 [0.79-1.31],0.9121519546837704
Chapter II Neoplasms,Melanoma in situ,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,34695,137,0.81 [0.53-1.22],0.3113735859531384
Chapter II Neoplasms,Melanoma in situ,EIF4B,Eukaryotic translation initiation factor 4B,40682,158,1.17 [0.91-1.50],0.2188777949092166
Chapter II Neoplasms,Melanoma in situ,EIF4E,Eukaryotic translation initiation factor 4E,34608,134,1.12 [0.93-1.34],0.233506970117294
Chapter II Neoplasms,Melanoma in situ,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,40984,163,1.04 [0.84-1.29],0.7028829928208656
Chapter II Neoplasms,Melanoma in situ,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,41452,164,1.12 [0.97-1.29],0.1105281774262192
Chapter II Neoplasms,Melanoma in situ,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,35587,140,1.06 [0.83-1.35],0.6616041567191088
Chapter II Neoplasms,Melanoma in situ,EIF5,Eukaryotic translation initiation factor 5,34518,137,0.89 [0.60-1.32],0.549403207650998
Chapter II Neoplasms,Melanoma in situ,EIF5A,Eukaryotic translation initiation factor 5A-1,40249,159,0.71 [0.43-1.18],0.1845860520934986
Chapter II Neoplasms,Melanoma in situ,ELAC1,Zinc phosphodiesterase ELAC protein 1,35587,140,1.16 [0.96-1.41],0.1247670753266486
Chapter II Neoplasms,Melanoma in situ,ELAVL4,ELAV-like protein 4,34549,138,0.90 [0.73-1.11],0.31639921652115
Chapter II Neoplasms,Melanoma in situ,ELN,Elastin,35640,141,1.25 [0.78-1.98],0.3522846334102857
Chapter II Neoplasms,Melanoma in situ,ELOA,Elongin-A,40789,160,0.89 [0.67-1.17],0.404241366668397
Chapter II Neoplasms,Melanoma in situ,ELOB,Elongin-B,34518,137,0.85 [0.53-1.34],0.4742305075287509
Chapter II Neoplasms,Melanoma in situ,ENAH,Protein enabled homolog,40249,159,1.12 [0.83-1.49],0.45833900548381
Chapter II Neoplasms,Melanoma in situ,ENDOU,Poly(U)-specific endoribonuclease,32897,128,1.09 [0.79-1.51],0.585502392037972
Chapter II Neoplasms,Melanoma in situ,ENG,Endoglin,41485,164,0.90 [0.40-2.02],0.7976747262633431
Chapter II Neoplasms,Melanoma in situ,ENO1,Alpha-enolase,40937,164,1.13 [0.94-1.34],0.1838920973221916
Chapter II Neoplasms,Melanoma in situ,ENO2,Gamma-enolase,41349,165,1.08 [0.87-1.33],0.4972033620552624
Chapter II Neoplasms,Melanoma in situ,ENO3,Beta-enolase,34695,137,1.04 [0.79-1.38],0.7572343096138363
Chapter II Neoplasms,Melanoma in situ,ENOPH1,Enolase-phosphatase E1,35477,140,0.76 [0.55-1.05],0.0999953545060221
Chapter II Neoplasms,Melanoma in situ,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,34518,137,0.99 [0.54-1.79],0.9642167473921466
Chapter II Neoplasms,Melanoma in situ,ENPEP,Glutamyl aminopeptidase,34518,137,0.84 [0.55-1.29],0.4253237514205045
Chapter II Neoplasms,Melanoma in situ,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,41485,164,0.85 [0.50-1.43],0.5385622498070382
Chapter II Neoplasms,Melanoma in situ,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,41147,164,0.73 [0.57-0.94],0.0140539113527518
Chapter II Neoplasms,Melanoma in situ,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,34695,137,0.80 [0.51-1.26],0.3352546695768025
Chapter II Neoplasms,Melanoma in situ,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39706,157,0.97 [0.82-1.14],0.6927803113978912
Chapter II Neoplasms,Melanoma in situ,ENSA,Alpha-endosulfine,35477,140,1.12 [0.84-1.51],0.4315974595116651
Chapter II Neoplasms,Melanoma in situ,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,40055,159,0.94 [0.68-1.30],0.7129985739826721
Chapter II Neoplasms,Melanoma in situ,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,40258,158,1.16 [0.59-2.27],0.6609862697326077
Chapter II Neoplasms,Melanoma in situ,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,40258,158,0.73 [0.46-1.17],0.190256371223291
Chapter II Neoplasms,Melanoma in situ,ENTR1,Endosome-associated-trafficking regulator 1,34695,137,0.97 [0.73-1.30],0.8411588766420541
Chapter II Neoplasms,Melanoma in situ,EP300,Histone acetyltransferase p300,34608,134,1.10 [0.66-1.84],0.7171382065589951
Chapter II Neoplasms,Melanoma in situ,EPB41L5,Band 4.1-like protein 5,34686,135,0.92 [0.70-1.22],0.5677580194805292
Chapter II Neoplasms,Melanoma in situ,EPCAM,Epithelial cell adhesion molecule,40947,164,1.10 [0.96-1.26],0.1808982510154978
Chapter II Neoplasms,Melanoma in situ,EPGN,Epigen,35477,140,1.18 [0.89-1.57],0.2527651155313146
Chapter II Neoplasms,Melanoma in situ,EPHA1,Ephrin type-A receptor 1,41079,163,0.71 [0.47-1.08],0.1128142559547307
Chapter II Neoplasms,Melanoma in situ,EPHA10,Ephrin type-A receptor 10,40031,160,1.08 [0.89-1.31],0.4467844747777937
Chapter II Neoplasms,Melanoma in situ,EPHA2,Ephrin type-A receptor 2,39533,153,0.84 [0.51-1.38],0.4998269287667444
Chapter II Neoplasms,Melanoma in situ,EPHA4,Ephrin type-A receptor 4,34878,138,0.92 [0.52-1.63],0.764641254933158
Chapter II Neoplasms,Melanoma in situ,EPHB4,Ephrin type-B receptor 4,41485,164,0.89 [0.50-1.57],0.6829965130621372
Chapter II Neoplasms,Melanoma in situ,EPHB6,Ephrin type-B receptor 6,40606,158,0.74 [0.47-1.17],0.1975060268793378
Chapter II Neoplasms,Melanoma in situ,EPHX2,Bifunctional epoxide hydrolase 2,40258,158,0.90 [0.70-1.15],0.3898550287277093
Chapter II Neoplasms,Melanoma in situ,EPN1,Epsin-1,34984,139,0.88 [0.59-1.32],0.5366779603102128
Chapter II Neoplasms,Melanoma in situ,EPO,Erythropoietin,40939,163,1.09 [0.91-1.31],0.3559983009420755
Chapter II Neoplasms,Melanoma in situ,EPPK1,Epiplakin,34695,137,1.10 [0.88-1.38],0.3962476998999259
Chapter II Neoplasms,Melanoma in situ,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,41296,163,1.05 [0.66-1.67],0.8526428549002996
Chapter II Neoplasms,Melanoma in situ,ERBB2,Receptor tyrosine-protein kinase erbB-2,41097,164,0.52 [0.30-0.90],0.0188901024341748
Chapter II Neoplasms,Melanoma in situ,ERBB3,Receptor tyrosine-protein kinase erbB-3,40826,163,1.72 [0.86-3.42],0.1239868262883629
Chapter II Neoplasms,Melanoma in situ,ERBB4,Receptor tyrosine-protein kinase erbB-4,41097,164,0.70 [0.39-1.26],0.2334684648654047
Chapter II Neoplasms,Melanoma in situ,ERBIN,Erbin,40789,160,1.06 [0.93-1.22],0.3762031454606752
Chapter II Neoplasms,Melanoma in situ,ERC2,ERC protein 2,34686,135,0.98 [0.78-1.22],0.8266317986178625
Chapter II Neoplasms,Melanoma in situ,ERCC1,DNA excision repair protein ERCC-1,34394,136,0.87 [0.52-1.47],0.6051758332134497
Chapter II Neoplasms,Melanoma in situ,EREG,Proepiregulin,40606,158,1.03 [0.87-1.23],0.7206346690138961
Chapter II Neoplasms,Melanoma in situ,ERI1,3'-5' exoribonuclease 1,34984,139,1.09 [0.68-1.75],0.7099856434404701
Chapter II Neoplasms,Melanoma in situ,ERMAP,Erythroid membrane-associated protein,34608,134,1.27 [0.88-1.84],0.2010305651129585
Chapter II Neoplasms,Melanoma in situ,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,35477,140,0.86 [0.55-1.33],0.4917008065648091
Chapter II Neoplasms,Melanoma in situ,ERP29,Endoplasmic reticulum resident protein 29,34878,138,1.10 [0.95-1.26],0.1912388671621717
Chapter II Neoplasms,Melanoma in situ,ERP44,Endoplasmic reticulum resident protein 44,40723,160,1.42 [0.83-2.44],0.1992063946217108
Chapter II Neoplasms,Melanoma in situ,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,34518,137,0.97 [0.66-1.42],0.8689355187034306
Chapter II Neoplasms,Melanoma in situ,ESAM,Endothelial cell-selective adhesion molecule,41485,164,1.02 [0.66-1.58],0.9366341007324496
Chapter II Neoplasms,Melanoma in situ,ESM1,Endothelial cell-specific molecule 1,40948,164,1.08 [0.72-1.63],0.7080081883105629
Chapter II Neoplasms,Melanoma in situ,ESPL1,Separin,34394,136,1.07 [0.81-1.40],0.6344231636419941
Chapter II Neoplasms,Melanoma in situ,ESR1,Estrogen receptor,34608,134,0.96 [0.71-1.29],0.7930671731031784
Chapter II Neoplasms,Melanoma in situ,ESYT2,Extended synaptotagmin-2,35570,140,1.10 [0.91-1.34],0.3326388985940776
Chapter II Neoplasms,Melanoma in situ,EVI2B,Protein EVI2B,34394,136,1.22 [0.87-1.70],0.2525725642336142
Chapter II Neoplasms,Melanoma in situ,EVI5,Ecotropic viral integration site 5 protein homolog,34608,134,1.07 [0.89-1.29],0.4571456364463615
Chapter II Neoplasms,Melanoma in situ,EVPL,Envoplakin,34984,139,0.77 [0.45-1.32],0.3440240079265092
Chapter II Neoplasms,Melanoma in situ,EXOSC10,Exosome component 10,34518,137,1.09 [0.84-1.41],0.52571848002063
Chapter II Neoplasms,Melanoma in situ,EXTL1,Exostosin-like 1,34518,137,0.69 [0.46-1.05],0.0847818676725636
Chapter II Neoplasms,Melanoma in situ,EZR,Ezrin,41349,165,0.99 [0.55-1.78],0.9760276525027388
Chapter II Neoplasms,Melanoma in situ,F10,Coagulation factor X,35663,141,1.45 [0.90-2.35],0.1291494808362552
Chapter II Neoplasms,Melanoma in situ,F11,Coagulation factor XI,35177,138,0.87 [0.50-1.53],0.6335956552415865
Chapter II Neoplasms,Melanoma in situ,F11R,Junctional adhesion molecule A,40993,164,1.12 [0.88-1.43],0.3719248232679316
Chapter II Neoplasms,Melanoma in situ,F12,Coagulation factor XII,35692,141,0.89 [0.61-1.30],0.5509384693615902
Chapter II Neoplasms,Melanoma in situ,F13B,Coagulation factor XIII B chain,35507,141,0.70 [0.38-1.30],0.2582760209060758
Chapter II Neoplasms,Melanoma in situ,F2,Prothrombin,35692,141,1.19 [0.41-3.47],0.7486239362650762
Chapter II Neoplasms,Melanoma in situ,F2R,Proteinase-activated receptor 1,41087,164,1.18 [0.92-1.50],0.1886935918535422
Chapter II Neoplasms,Melanoma in situ,F3,Tissue factor,41103,164,0.90 [0.53-1.51],0.6842564218974388
Chapter II Neoplasms,Melanoma in situ,F7,Coagulation factor VII,41077,163,1.18 [0.74-1.88],0.4878827334624757
Chapter II Neoplasms,Melanoma in situ,F9,Coagulation factor IX,41076,163,1.73 [0.81-3.73],0.1588033332710505
Chapter II Neoplasms,Melanoma in situ,FABP1,"Fatty acid-binding protein, liver",40948,164,1.04 [0.90-1.21],0.5861252256689884
Chapter II Neoplasms,Melanoma in situ,FABP2,"Fatty acid-binding protein, intestinal",40984,163,1.06 [0.89-1.26],0.519888063617094
Chapter II Neoplasms,Melanoma in situ,FABP3,"Fatty acid-binding protein, heart",35640,141,0.86 [0.62-1.21],0.3874011396846271
Chapter II Neoplasms,Melanoma in situ,FABP4,"Fatty acid-binding protein, adipocyte",41485,164,0.95 [0.72-1.27],0.7494035723542809
Chapter II Neoplasms,Melanoma in situ,FABP5,Fatty acid-binding protein 5,41221,164,1.10 [0.90-1.34],0.3569332261583877
Chapter II Neoplasms,Melanoma in situ,FABP6,Gastrotropin,40194,157,1.06 [0.82-1.36],0.657492040133488
Chapter II Neoplasms,Melanoma in situ,FABP9,Fatty acid-binding protein 9,40939,163,0.88 [0.68-1.13],0.312173827178438
Chapter II Neoplasms,Melanoma in situ,FADD,FAS-associated death domain protein,40984,163,1.07 [0.90-1.29],0.436896474552666
Chapter II Neoplasms,Melanoma in situ,FAM13A,Protein FAM13A,35486,140,1.14 [0.90-1.44],0.2843726831738906
Chapter II Neoplasms,Melanoma in situ,FAM171A2,Protein FAM171A2,35587,140,1.00 [0.91-1.11],0.9273048579436316
Chapter II Neoplasms,Melanoma in situ,FAM171B,Protein FAM171B,35477,140,1.12 [0.65-1.95],0.6830122557646934
Chapter II Neoplasms,Melanoma in situ,FAM172A,Cotranscriptional regulator FAM172A,34695,137,1.19 [0.91-1.55],0.2037607655764607
Chapter II Neoplasms,Melanoma in situ,FAM20A,Pseudokinase FAM20A,35640,141,0.61 [0.34-1.10],0.1014844693596036
Chapter II Neoplasms,Melanoma in situ,FAM3B,Protein FAM3B,40789,160,0.76 [0.51-1.13],0.1752520001467288
Chapter II Neoplasms,Melanoma in situ,FAM3C,Protein FAM3C,40930,163,1.35 [0.84-2.16],0.2089874134985152
Chapter II Neoplasms,Melanoma in situ,FAM3D,Protein FAM3D,35486,140,0.97 [0.80-1.17],0.724665859542418
Chapter II Neoplasms,Melanoma in situ,FAP,Prolyl endopeptidase FAP,41485,164,0.57 [0.34-0.95],0.0303771849431713
Chapter II Neoplasms,Melanoma in situ,FARSA,Phenylalanine--tRNA ligase alpha subunit,34686,135,1.09 [0.87-1.36],0.4774010015421385
Chapter II Neoplasms,Melanoma in situ,FAS,Tumor necrosis factor receptor superfamily member 6,41357,164,0.68 [0.41-1.12],0.1322075939836944
Chapter II Neoplasms,Melanoma in situ,FASLG,Tumor necrosis factor ligand superfamily member 6,41452,164,0.83 [0.57-1.21],0.3317363409902454
Chapter II Neoplasms,Melanoma in situ,FBLN2,Fibulin-2,35644,141,0.88 [0.51-1.50],0.6268695206289991
Chapter II Neoplasms,Melanoma in situ,FBN2,Fibrillin-2,34686,135,0.93 [0.70-1.23],0.6061281319169587
Chapter II Neoplasms,Melanoma in situ,FBP1,"Fructose-1,6-bisphosphatase 1",40984,163,1.01 [0.83-1.22],0.9361032288236952
Chapter II Neoplasms,Melanoma in situ,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,35640,141,1.03 [0.83-1.30],0.766493347473651
Chapter II Neoplasms,Melanoma in situ,FCAR,Immunoglobulin alpha Fc receptor,40939,163,1.04 [0.78-1.39],0.8033420879265246
Chapter II Neoplasms,Melanoma in situ,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,35587,140,0.58 [0.37-0.90],0.0151539324646441
Chapter II Neoplasms,Melanoma in situ,FCER2,Low affinity immunoglobulin epsilon Fc receptor,40993,164,0.87 [0.65-1.17],0.3659904382954687
Chapter II Neoplasms,Melanoma in situ,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,40813,162,0.98 [0.78-1.22],0.8433042775890587
Chapter II Neoplasms,Melanoma in situ,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,40055,159,1.03 [0.81-1.32],0.8176669718055739
Chapter II Neoplasms,Melanoma in situ,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,41011,163,1.04 [0.79-1.38],0.775721897463156
Chapter II Neoplasms,Melanoma in situ,FCN1,Ficolin-1,35601,141,1.13 [0.83-1.53],0.4306442502359819
Chapter II Neoplasms,Melanoma in situ,FCN2,Ficolin-2,40798,163,1.35 [0.94-1.94],0.109250075797908
Chapter II Neoplasms,Melanoma in situ,FCRL1,Fc receptor-like protein 1,40984,163,0.77 [0.56-1.05],0.1014347697630887
Chapter II Neoplasms,Melanoma in situ,FCRL2,Fc receptor-like protein 2,41260,163,0.91 [0.67-1.22],0.522993541277033
Chapter II Neoplasms,Melanoma in situ,FCRL3,Fc receptor-like protein 3,40249,159,1.02 [0.79-1.32],0.8766196510851181
Chapter II Neoplasms,Melanoma in situ,FCRL5,Fc receptor-like protein 5,40993,164,0.86 [0.67-1.10],0.2330828558840603
Chapter II Neoplasms,Melanoma in situ,FCRL6,Fc receptor-like protein 6,40939,163,1.19 [0.97-1.46],0.096468154628789
Chapter II Neoplasms,Melanoma in situ,FCRLB,Fc receptor-like B,40055,159,0.91 [0.71-1.18],0.4864524103153348
Chapter II Neoplasms,Melanoma in situ,FDX1,"Adrenodoxin, mitochondrial",34518,137,0.94 [0.71-1.23],0.640007911208826
Chapter II Neoplasms,Melanoma in situ,FDX2,"Ferredoxin-2, mitochondrial",34518,137,0.86 [0.62-1.17],0.3313289557317324
Chapter II Neoplasms,Melanoma in situ,FEN1,Flap endonuclease 1,40055,159,0.95 [0.76-1.19],0.6632205699418383
Chapter II Neoplasms,Melanoma in situ,FES,Tyrosine-protein kinase Fes/Fps,40055,159,0.90 [0.66-1.23],0.5109131033201602
Chapter II Neoplasms,Melanoma in situ,FETUB,Fetuin-B,41076,163,1.22 [0.79-1.89],0.3702726621693323
Chapter II Neoplasms,Melanoma in situ,FGA,Fibrinogen alpha chain,34858,136,1.01 [0.59-1.73],0.9800739671383984
Chapter II Neoplasms,Melanoma in situ,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",35587,140,1.03 [0.84-1.26],0.7755135728900215
Chapter II Neoplasms,Melanoma in situ,FGF12,Fibroblast growth factor 12,34608,134,1.15 [0.86-1.53],0.3621582622263043
Chapter II Neoplasms,Melanoma in situ,FGF16,Fibroblast growth factor 16,34608,134,1.34 [1.02-1.75],0.0329654177569316
Chapter II Neoplasms,Melanoma in situ,FGF19,Fibroblast growth factor 19,41147,164,0.97 [0.81-1.16],0.7254686959296757
Chapter II Neoplasms,Melanoma in situ,FGF2,Fibroblast growth factor 2,40939,163,1.09 [0.89-1.34],0.3927775383128533
Chapter II Neoplasms,Melanoma in situ,FGF20,Fibroblast growth factor 20,34608,134,1.12 [0.80-1.56],0.5181953722864084
Chapter II Neoplasms,Melanoma in situ,FGF21,Fibroblast growth factor 21,41296,164,1.00 [0.88-1.12],0.9474697121029636
Chapter II Neoplasms,Melanoma in situ,FGF23,Fibroblast growth factor 23,41296,164,1.17 [0.92-1.48],0.1987871028440653
Chapter II Neoplasms,Melanoma in situ,FGF3,Fibroblast growth factor 3,34608,134,1.05 [0.62-1.77],0.8659688814495631
Chapter II Neoplasms,Melanoma in situ,FGF5,Fibroblast growth factor 5,40249,159,0.66 [0.43-1.03],0.0675277099454301
Chapter II Neoplasms,Melanoma in situ,FGF6,Fibroblast growth factor 6,34608,134,0.96 [0.63-1.46],0.845192589968917
Chapter II Neoplasms,Melanoma in situ,FGF7,Fibroblast growth factor 7,34394,136,1.13 [0.94-1.35],0.1925777075365582
Chapter II Neoplasms,Melanoma in situ,FGF9,Fibroblast growth factor 9,34328,135,0.84 [0.57-1.25],0.3891525344100084
Chapter II Neoplasms,Melanoma in situ,FGFBP1,Fibroblast growth factor-binding protein 1,41097,164,1.01 [0.65-1.55],0.9775468429056682
Chapter II Neoplasms,Melanoma in situ,FGFBP2,Fibroblast growth factor-binding protein 2,35644,141,0.90 [0.65-1.24],0.5158736987799903
Chapter II Neoplasms,Melanoma in situ,FGFBP3,Fibroblast growth factor-binding protein 3,35570,140,1.18 [0.76-1.82],0.4670637002224783
Chapter II Neoplasms,Melanoma in situ,FGFR2,Fibroblast growth factor receptor 2,41097,164,0.72 [0.38-1.39],0.3329718164748858
Chapter II Neoplasms,Melanoma in situ,FGFR4,Fibroblast growth factor receptor 4,34878,138,1.04 [0.76-1.42],0.8154171381270413
Chapter II Neoplasms,Melanoma in situ,FGL1,Fibrinogen-like protein 1,35663,141,1.15 [0.90-1.49],0.2663321188858556
Chapter II Neoplasms,Melanoma in situ,FGR,Tyrosine-protein kinase Fgr,40031,160,1.03 [0.82-1.29],0.7927328355985794
Chapter II Neoplasms,Melanoma in situ,FH,"Fumarate hydratase, mitochondrial",34549,138,0.97 [0.79-1.18],0.7314498736706431
Chapter II Neoplasms,Melanoma in situ,FHIP2A,FHF complex subunit HOOK interacting protein 2A,34518,137,0.69 [0.47-1.03],0.0669623782654442
Chapter II Neoplasms,Melanoma in situ,FHIT,Bis(5'-adenosyl)-triphosphatase,40031,160,1.04 [0.86-1.26],0.6937035140087227
Chapter II Neoplasms,Melanoma in situ,FIS1,Mitochondrial fission 1 protein,40953,163,1.07 [0.90-1.28],0.4489023236417139
Chapter II Neoplasms,Melanoma in situ,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,35587,140,1.18 [1.00-1.39],0.046551724923847
Chapter II Neoplasms,Melanoma in situ,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,41118,161,1.09 [0.97-1.24],0.1574229712636796
Chapter II Neoplasms,Melanoma in situ,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,40682,158,1.11 [0.81-1.54],0.50987003558858
Chapter II Neoplasms,Melanoma in situ,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,40682,158,1.10 [0.95-1.28],0.1964985188945358
Chapter II Neoplasms,Melanoma in situ,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39955,160,1.09 [0.83-1.45],0.5281007772434829
Chapter II Neoplasms,Melanoma in situ,FKBPL,FK506-binding protein-like,35486,140,1.19 [0.91-1.56],0.2006444630589514
Chapter II Neoplasms,Melanoma in situ,FLI1,Friend leukemia integration 1 transcription factor,40055,159,1.06 [0.93-1.20],0.3820376324176466
Chapter II Neoplasms,Melanoma in situ,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,40682,158,0.69 [0.42-1.15],0.153375256869672
Chapter II Neoplasms,Melanoma in situ,FLT1,Vascular endothelial growth factor receptor 1,40712,160,0.54 [0.27-1.08],0.0832376376237793
Chapter II Neoplasms,Melanoma in situ,FLT3,Receptor-type tyrosine-protein kinase FLT3,40055,159,1.04 [0.66-1.63],0.8762117474659049
Chapter II Neoplasms,Melanoma in situ,FLT3LG,Fms-related tyrosine kinase 3 ligand,41452,164,0.62 [0.41-0.94],0.0230765966146986
Chapter II Neoplasms,Melanoma in situ,FLT4,Vascular endothelial growth factor receptor 3,41097,164,1.45 [0.95-2.21],0.0836468402868072
Chapter II Neoplasms,Melanoma in situ,FMNL1,Formin-like protein 1,40031,160,0.93 [0.74-1.17],0.5444300984418433
Chapter II Neoplasms,Melanoma in situ,FMR1,Synaptic functional regulator FMR1,40055,159,0.97 [0.65-1.45],0.8787746041716136
Chapter II Neoplasms,Melanoma in situ,FN1,Fibronectin,35692,141,0.36 [0.20-0.67],0.0012314164669782
Chapter II Neoplasms,Melanoma in situ,FNDC1,Fibronectin type III domain-containing protein 1,35570,140,0.86 [0.61-1.22],0.3969881835743095
Chapter II Neoplasms,Melanoma in situ,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,35477,140,1.46 [0.99-2.15],0.0562446286666952
Chapter II Neoplasms,Melanoma in situ,FOLH1,Glutamate carboxypeptidase 2,34608,134,0.97 [0.83-1.14],0.7397961164465596
Chapter II Neoplasms,Melanoma in situ,FOLR1,Folate receptor alpha,40908,161,0.77 [0.46-1.28],0.3133238634195967
Chapter II Neoplasms,Melanoma in situ,FOLR2,Folate receptor beta,41349,165,0.76 [0.47-1.23],0.2656486783110202
Chapter II Neoplasms,Melanoma in situ,FOLR3,Folate receptor gamma,40968,164,0.98 [0.91-1.06],0.6683236284776626
Chapter II Neoplasms,Melanoma in situ,FOS,Proto-oncogene c-Fos,34328,135,0.88 [0.56-1.41],0.6026344805281416
Chapter II Neoplasms,Melanoma in situ,FOSB,Protein fosB,40031,160,0.90 [0.62-1.33],0.6102092467516795
Chapter II Neoplasms,Melanoma in situ,FOXJ3,Forkhead box protein J3,34608,134,0.98 [0.68-1.44],0.9368699903597713
Chapter II Neoplasms,Melanoma in situ,FOXO1,Forkhead box protein O1,40939,163,1.12 [0.95-1.31],0.1860840357371839
Chapter II Neoplasms,Melanoma in situ,FOXO3,Forkhead box protein O3,40055,159,1.04 [0.90-1.20],0.5716945242253242
Chapter II Neoplasms,Melanoma in situ,FRMD4B,FERM domain-containing protein 4B,34518,137,1.19 [0.95-1.49],0.140792992595604
Chapter II Neoplasms,Melanoma in situ,FRMD7,FERM domain-containing protein 7,34686,135,1.07 [0.66-1.74],0.7872422910730522
Chapter II Neoplasms,Melanoma in situ,FRZB,Secreted frizzled-related protein 3,40551,157,0.82 [0.47-1.43],0.4779986380380662
Chapter II Neoplasms,Melanoma in situ,FSHB,Follitropin subunit beta,34695,137,0.99 [0.75-1.31],0.9495612616442608
Chapter II Neoplasms,Melanoma in situ,FST,Follistatin,41087,164,1.13 [0.86-1.49],0.365853566687298
Chapter II Neoplasms,Melanoma in situ,FSTL1,Follistatin-related protein 1,34695,137,1.17 [0.56-2.42],0.6796550500592022
Chapter II Neoplasms,Melanoma in situ,FSTL3,Follistatin-related protein 3,40884,161,1.15 [0.73-1.82],0.5343606085037944
Chapter II Neoplasms,Melanoma in situ,FTCD,Formimidoyltransferase-cyclodeaminase,35503,139,0.90 [0.74-1.10],0.3026155413894529
Chapter II Neoplasms,Melanoma in situ,FUCA1,Tissue alpha-L-fucosidase,41229,163,1.02 [0.86-1.20],0.8518595470366869
Chapter II Neoplasms,Melanoma in situ,FUOM,Fucose mutarotase,34878,138,0.98 [0.75-1.27],0.855920947141885
Chapter II Neoplasms,Melanoma in situ,FURIN,Furin,41097,164,1.11 [0.73-1.69],0.6216541151606341
Chapter II Neoplasms,Melanoma in situ,FUS,RNA-binding protein FUS,39994,159,1.00 [0.70-1.43],0.984601565886104
Chapter II Neoplasms,Melanoma in situ,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",34915,138,0.66 [0.47-0.91],0.0114436750429253
Chapter II Neoplasms,Melanoma in situ,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,41349,165,0.69 [0.51-0.93],0.0150791641518414
Chapter II Neoplasms,Melanoma in situ,FUT8,"Alpha-(1,6)-fucosyltransferase",40682,158,1.01 [0.79-1.28],0.9625970157889392
Chapter II Neoplasms,Melanoma in situ,FXN,"Frataxin, mitochondrial",41358,164,1.07 [0.89-1.30],0.4487439804124477
Chapter II Neoplasms,Melanoma in situ,FXYD5,FXYD domain-containing ion transport regulator 5,40249,159,1.14 [0.92-1.40],0.2329138076940466
Chapter II Neoplasms,Melanoma in situ,FYB1,FYN-binding protein 1,40920,164,1.07 [0.92-1.24],0.399142144479348
Chapter II Neoplasms,Melanoma in situ,FZD10,Frizzled-10,34686,135,0.94 [0.70-1.27],0.690409278979885
Chapter II Neoplasms,Melanoma in situ,FZD8,Frizzled-8,34549,138,1.09 [0.76-1.55],0.6487038711732069
Chapter II Neoplasms,Melanoma in situ,GABARAP,Gamma-aminobutyric acid receptor-associated protein,35477,140,1.15 [0.84-1.56],0.3769482785509479
Chapter II Neoplasms,Melanoma in situ,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,34984,139,0.89 [0.68-1.17],0.4057866650094068
Chapter II Neoplasms,Melanoma in situ,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,34549,138,0.98 [0.76-1.28],0.9001517107521877
Chapter II Neoplasms,Melanoma in situ,GAD1,Glutamate decarboxylase 1,34394,136,1.04 [0.55-1.96],0.903080445098036
Chapter II Neoplasms,Melanoma in situ,GAD2,Glutamate decarboxylase 2,34608,134,0.97 [0.67-1.41],0.89173318915246
Chapter II Neoplasms,Melanoma in situ,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,34984,139,0.88 [0.60-1.28],0.5021766140621609
Chapter II Neoplasms,Melanoma in situ,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,34695,137,1.10 [0.81-1.50],0.541427954115526
Chapter II Neoplasms,Melanoma in situ,GAGE2A,G antigen 2A,34394,136,0.70 [0.50-0.97],0.031777488475045
Chapter II Neoplasms,Melanoma in situ,GAL,Galanin peptides,41147,164,0.98 [0.79-1.21],0.8274449995554694
Chapter II Neoplasms,Melanoma in situ,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40789,160,0.86 [0.52-1.43],0.5631927880415559
Chapter II Neoplasms,Melanoma in situ,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,41358,164,0.81 [0.48-1.38],0.4400971983963092
Chapter II Neoplasms,Melanoma in situ,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,40249,159,0.76 [0.54-1.06],0.1068835214935079
Chapter II Neoplasms,Melanoma in situ,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,35640,141,0.83 [0.46-1.49],0.5309712254249439
Chapter II Neoplasms,Melanoma in situ,GALNT7,N-acetylgalactosaminyltransferase 7,40789,160,0.74 [0.38-1.44],0.375960328250588
Chapter II Neoplasms,Melanoma in situ,GAMT,Guanidinoacetate N-methyltransferase,34518,137,0.87 [0.54-1.42],0.584198938441072
Chapter II Neoplasms,Melanoma in situ,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,34115,137,1.19 [0.71-1.98],0.5123399077472235
Chapter II Neoplasms,Melanoma in situ,GART,Trifunctional purine biosynthetic protein adenosine-3,35587,140,0.82 [0.43-1.58],0.5612297131933737
Chapter II Neoplasms,Melanoma in situ,GAS2,Growth arrest-specific protein 2,34984,139,0.88 [0.62-1.25],0.479536331078697
Chapter II Neoplasms,Melanoma in situ,GAS6,Growth arrest-specific protein 6,41218,162,0.69 [0.40-1.21],0.1971533524576479
Chapter II Neoplasms,Melanoma in situ,GASK1A,Golgi-associated kinase 1A,34518,137,0.90 [0.61-1.32],0.5854898676000975
Chapter II Neoplasms,Melanoma in situ,GAST,Gastrin,35570,140,0.99 [0.87-1.11],0.8144542604118701
Chapter II Neoplasms,Melanoma in situ,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,34394,136,0.84 [0.45-1.57],0.5870283345818188
Chapter II Neoplasms,Melanoma in situ,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",34695,137,1.14 [0.92-1.40],0.2214788277985567
Chapter II Neoplasms,Melanoma in situ,GBA,Lysosomal acid glucosylceramidase,34686,135,1.15 [0.86-1.54],0.3538816504976108
Chapter II Neoplasms,Melanoma in situ,GBP1,Guanylate-binding protein 1,35505,140,1.07 [0.83-1.37],0.6146906696044818
Chapter II Neoplasms,Melanoma in situ,GBP2,Guanylate-binding protein 2,40249,159,0.96 [0.75-1.22],0.7322763592597719
Chapter II Neoplasms,Melanoma in situ,GBP4,Guanylate-binding protein 4,40031,160,0.93 [0.70-1.25],0.6498577272572499
Chapter II Neoplasms,Melanoma in situ,GBP6,Guanylate-binding protein 6,34518,137,0.88 [0.59-1.32],0.5457513679952914
Chapter II Neoplasms,Melanoma in situ,GC,Vitamin D-binding protein,35692,141,0.89 [0.48-1.65],0.7154569358415537
Chapter II Neoplasms,Melanoma in situ,GCC1,GRIP and coiled-coil domain-containing protein 1,35570,140,1.14 [0.98-1.32],0.1005308400228872
Chapter II Neoplasms,Melanoma in situ,GCG,Pro-glucagon,40055,159,0.92 [0.82-1.03],0.162344728985386
Chapter II Neoplasms,Melanoma in situ,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,34037,138,0.84 [0.59-1.21],0.3545416810076517
Chapter II Neoplasms,Melanoma in situ,GCLM,Glutamate--cysteine ligase regulatory subunit,34518,137,0.88 [0.60-1.29],0.5216320087916657
Chapter II Neoplasms,Melanoma in situ,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40789,160,1.33 [0.89-1.99],0.1622313251242536
Chapter II Neoplasms,Melanoma in situ,GDF15,Growth/differentiation factor 15,41485,164,1.12 [0.81-1.56],0.4900847709302729
Chapter II Neoplasms,Melanoma in situ,GDF2,Growth/differentiation factor 2,40984,163,0.79 [0.54-1.18],0.252211258726113
Chapter II Neoplasms,Melanoma in situ,GDNF,Glial cell line-derived neurotrophic factor,40031,160,1.08 [0.75-1.57],0.6647129443186146
Chapter II Neoplasms,Melanoma in situ,GET3,ATPase GET3,35640,141,0.89 [0.65-1.22],0.4534795125921741
Chapter II Neoplasms,Melanoma in situ,GFAP,Glial fibrillary acidic protein,39989,159,0.95 [0.71-1.28],0.7476377391258935
Chapter II Neoplasms,Melanoma in situ,GFER,FAD-linked sulfhydryl oxidase ALR,40055,159,1.11 [0.89-1.38],0.3689635324191475
Chapter II Neoplasms,Melanoma in situ,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,40055,159,0.95 [0.84-1.08],0.4495689269343
Chapter II Neoplasms,Melanoma in situ,GFRA1,GDNF family receptor alpha-1,41296,164,0.71 [0.43-1.19],0.1989487521967691
Chapter II Neoplasms,Melanoma in situ,GFRA2,GDNF family receptor alpha-2,40789,160,0.69 [0.36-1.33],0.2665021398870887
Chapter II Neoplasms,Melanoma in situ,GFRA3,GDNF family receptor alpha-3,40557,155,0.48 [0.29-0.81],0.0060374821170718
Chapter II Neoplasms,Melanoma in situ,GFRAL,GDNF family receptor alpha-like,34521,140,0.90 [0.68-1.18],0.4300549616130283
Chapter II Neoplasms,Melanoma in situ,GGA1,ADP-ribosylation factor-binding protein GGA1,40031,160,0.71 [0.55-0.93],0.0119403657407944
Chapter II Neoplasms,Melanoma in situ,GGACT,Gamma-glutamylaminecyclotransferase,35640,141,1.20 [0.96-1.50],0.1023377193187211
Chapter II Neoplasms,Melanoma in situ,GGCT,Gamma-glutamylcyclotransferase,35570,141,1.36 [0.99-1.86],0.0541589565829901
Chapter II Neoplasms,Melanoma in situ,GGH,Gamma-glutamyl hydrolase,40289,158,0.84 [0.55-1.28],0.4169533041744782
Chapter II Neoplasms,Melanoma in situ,GGT1,Glutathione hydrolase 1 proenzyme,40928,164,0.91 [0.68-1.22],0.523806026356777
Chapter II Neoplasms,Melanoma in situ,GGT5,Glutathione hydrolase 5 proenzyme,40682,158,0.88 [0.47-1.65],0.6845302398554947
Chapter II Neoplasms,Melanoma in situ,GH1,Somatotropin,40930,163,0.96 [0.88-1.04],0.2910239512137156
Chapter II Neoplasms,Melanoma in situ,GH2,Growth hormone variant,40055,159,0.98 [0.90-1.07],0.7023847155723324
Chapter II Neoplasms,Melanoma in situ,GHR,Growth hormone receptor,34878,138,1.00 [0.56-1.79],0.9881406066552528
Chapter II Neoplasms,Melanoma in situ,GHRHR,Growth hormone-releasing hormone receptor,40031,160,0.89 [0.68-1.18],0.4357443419164891
Chapter II Neoplasms,Melanoma in situ,GHRL,Appetite-regulating hormone,40984,163,0.96 [0.81-1.14],0.6294387083101792
Chapter II Neoplasms,Melanoma in situ,GID8,Glucose-induced degradation protein 8 homolog,35587,140,0.95 [0.58-1.57],0.8485458457459484
Chapter II Neoplasms,Melanoma in situ,GIGYF2,GRB10-interacting GYF protein 2,35587,140,1.05 [0.85-1.30],0.6473604359044517
Chapter II Neoplasms,Melanoma in situ,GIMAP7,GTPase IMAP family member 7,34878,138,0.80 [0.46-1.39],0.4292572178042527
Chapter II Neoplasms,Melanoma in situ,GIMAP8,GTPase IMAP family member 8,34394,136,1.13 [0.85-1.52],0.4048634346257656
Chapter II Neoplasms,Melanoma in situ,GIP,Gastric inhibitory polypeptide,34695,137,1.01 [0.75-1.36],0.9433915604118952
Chapter II Neoplasms,Melanoma in situ,GIPC2,PDZ domain-containing protein GIPC2,35570,140,0.79 [0.45-1.38],0.4033436698495793
Chapter II Neoplasms,Melanoma in situ,GIPC3,PDZ domain-containing protein GIPC3,35486,140,1.09 [0.92-1.29],0.3042630520121644
Chapter II Neoplasms,Melanoma in situ,GIPR,Gastric inhibitory polypeptide receptor,34608,134,0.82 [0.55-1.23],0.3390652804831857
Chapter II Neoplasms,Melanoma in situ,GIT1,ARF GTPase-activating protein GIT1,34608,134,1.14 [0.96-1.36],0.1248857710387994
Chapter II Neoplasms,Melanoma in situ,GJA8,Gap junction alpha-8 protein,34394,136,0.83 [0.62-1.12],0.223006309692276
Chapter II Neoplasms,Melanoma in situ,GKN1,Gastrokine-1,39264,156,0.78 [0.46-1.31],0.3497750092889146
Chapter II Neoplasms,Melanoma in situ,GLA,Alpha-galactosidase A,34808,138,0.98 [0.63-1.54],0.9408813738696348
Chapter II Neoplasms,Melanoma in situ,GLB1,Beta-galactosidase,40682,158,0.86 [0.61-1.22],0.4017271054380145
Chapter II Neoplasms,Melanoma in situ,GLI2,Zinc finger protein GLI2,34608,134,0.99 [0.60-1.63],0.9615005771425468
Chapter II Neoplasms,Melanoma in situ,GLO1,Lactoylglutathione lyase,40258,158,0.92 [0.72-1.17],0.4804596677723829
Chapter II Neoplasms,Melanoma in situ,GLOD4,Glyoxalase domain-containing protein 4,40893,163,1.20 [0.82-1.78],0.3500128017716785
Chapter II Neoplasms,Melanoma in situ,GLP1R,Glucagon-like peptide 1 receptor,34549,138,1.00 [0.65-1.55],0.993067399754868
Chapter II Neoplasms,Melanoma in situ,GLRX,Glutaredoxin-1,40714,162,0.99 [0.77-1.26],0.9110150770631172
Chapter II Neoplasms,Melanoma in situ,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",34878,138,1.10 [0.91-1.32],0.325031535695284
Chapter II Neoplasms,Melanoma in situ,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,40031,160,0.99 [0.73-1.34],0.9320806214994576
Chapter II Neoplasms,Melanoma in situ,GLYR1,Putative oxidoreductase GLYR1,35477,140,0.86 [0.63-1.17],0.3457196559069253
Chapter II Neoplasms,Melanoma in situ,GM2A,Ganglioside GM2 activator,34784,140,0.82 [0.52-1.30],0.3988190032291969
Chapter II Neoplasms,Melanoma in situ,GMFG,Glia maturation factor gamma,35640,141,1.17 [0.93-1.46],0.1818277659220469
Chapter II Neoplasms,Melanoma in situ,GMPR,GMP reductase 1,41452,164,1.02 [0.78-1.34],0.8847270108735448
Chapter II Neoplasms,Melanoma in situ,GMPR2,GMP reductase 2,34878,138,1.18 [0.93-1.51],0.1769731238738209
Chapter II Neoplasms,Melanoma in situ,GNAS,Neuroendocrine secretory protein 55,35587,140,0.85 [0.69-1.05],0.1313974062311331
Chapter II Neoplasms,Melanoma in situ,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,40055,159,1.09 [0.88-1.34],0.4434394566028788
Chapter II Neoplasms,Melanoma in situ,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,34686,135,0.87 [0.60-1.25],0.4471947408925028
Chapter II Neoplasms,Melanoma in situ,GNLY,Granulysin,40993,164,0.88 [0.68-1.15],0.3434184974954084
Chapter II Neoplasms,Melanoma in situ,GNPDA1,Glucosamine-6-phosphate isomerase 1,34695,137,1.09 [0.69-1.72],0.7209701978824633
Chapter II Neoplasms,Melanoma in situ,GNPDA2,Glucosamine-6-phosphate isomerase 2,34878,138,1.13 [0.72-1.78],0.5839661191579542
Chapter II Neoplasms,Melanoma in situ,GOLGA3,Golgin subfamily A member 3,35587,140,1.12 [0.92-1.37],0.2698428956864785
Chapter II Neoplasms,Melanoma in situ,GOLM2,Protein GOLM2,41349,165,1.22 [0.66-2.23],0.5291007507554457
Chapter II Neoplasms,Melanoma in situ,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,40939,163,1.11 [0.97-1.28],0.1320323276335616
Chapter II Neoplasms,Melanoma in situ,GORASP2,Golgi reassembly-stacking protein 2,35486,140,1.16 [0.83-1.62],0.3857734880777713
Chapter II Neoplasms,Melanoma in situ,GOT1,"Aspartate aminotransferase, cytoplasmic",35644,141,0.80 [0.53-1.20],0.2784936172701903
Chapter II Neoplasms,Melanoma in situ,GP1BA,Platelet glycoprotein Ib alpha chain,40806,163,1.22 [0.79-1.86],0.3672810970692172
Chapter II Neoplasms,Melanoma in situ,GP1BB,Platelet glycoprotein Ib beta chain,34518,137,1.11 [0.87-1.41],0.3958579909822637
Chapter II Neoplasms,Melanoma in situ,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39754,157,0.92 [0.77-1.10],0.3676661482819163
Chapter II Neoplasms,Melanoma in situ,GP5,Platelet glycoprotein V,34878,138,1.29 [0.80-2.07],0.2963684941172325
Chapter II Neoplasms,Melanoma in situ,GP6,Platelet glycoprotein VI,40920,164,1.10 [0.94-1.29],0.2183405863355
Chapter II Neoplasms,Melanoma in situ,GPA33,Cell surface A33 antigen,40789,160,1.06 [0.96-1.18],0.2418493534968545
Chapter II Neoplasms,Melanoma in situ,GPC1,Glypican-1,41358,164,0.80 [0.50-1.28],0.3542086400834449
Chapter II Neoplasms,Melanoma in situ,GPC5,Glypican-5,40682,158,0.88 [0.69-1.14],0.3350814510572318
Chapter II Neoplasms,Melanoma in situ,GPD1,Glycerol-3-phosphate dehydrogenase,35477,140,1.07 [0.78-1.46],0.6716551297092668
Chapter II Neoplasms,Melanoma in situ,GPHA2,Glycoprotein hormone alpha-2,35486,140,1.19 [0.88-1.61],0.269147941583981
Chapter II Neoplasms,Melanoma in situ,GPI,Glucose-6-phosphate isomerase,35663,141,1.22 [0.88-1.70],0.2307134653480729
Chapter II Neoplasms,Melanoma in situ,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,35486,140,1.00 [0.80-1.26],0.9758421401653112
Chapter II Neoplasms,Melanoma in situ,GPKOW,G-patch domain and KOW motifs-containing protein,40031,160,1.03 [0.64-1.65],0.8975982633427917
Chapter II Neoplasms,Melanoma in situ,GPNMB,Transmembrane glycoprotein NMB,39880,157,0.81 [0.49-1.34],0.4217076486189157
Chapter II Neoplasms,Melanoma in situ,GPR101,Probable G-protein coupled receptor 101,34549,138,1.00 [0.75-1.32],0.9792340678872862
Chapter II Neoplasms,Melanoma in situ,GPR158,Probable G-protein coupled receptor 158,35587,140,1.10 [0.71-1.71],0.6589740480272257
Chapter II Neoplasms,Melanoma in situ,GPR15L,Protein GPR15L,35486,140,0.92 [0.70-1.20],0.5293493834301379
Chapter II Neoplasms,Melanoma in situ,GPR37,Prosaposin receptor GPR37,40258,158,0.99 [0.79-1.23],0.911501414530232
Chapter II Neoplasms,Melanoma in situ,GPRC5C,G-protein coupled receptor family C group 5 member C,35477,140,0.80 [0.57-1.11],0.1745964999218749
Chapter II Neoplasms,Melanoma in situ,GRAP2,GRB2-related adapter protein 2,40984,163,1.08 [0.97-1.21],0.1480925702767835
Chapter II Neoplasms,Melanoma in situ,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,35640,141,1.17 [0.91-1.50],0.233372645880462
Chapter II Neoplasms,Melanoma in situ,GRIK2,"Glutamate receptor ionotropic, kainate 2",35587,140,0.77 [0.51-1.17],0.2148726446003877
Chapter II Neoplasms,Melanoma in situ,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",34549,138,1.18 [0.94-1.50],0.1593539670405178
Chapter II Neoplasms,Melanoma in situ,GRK5,G protein-coupled receptor kinase 5,40258,158,1.00 [0.76-1.32],0.9952111992227708
Chapter II Neoplasms,Melanoma in situ,GRN,Progranulin,40797,164,0.89 [0.50-1.61],0.706085374354765
Chapter II Neoplasms,Melanoma in situ,GRP,Gastrin-releasing peptide,34695,137,0.91 [0.67-1.23],0.54089592989442
Chapter II Neoplasms,Melanoma in situ,GRPEL1,"GrpE protein homolog 1, mitochondrial",40789,160,1.02 [0.80-1.29],0.8757857506297455
Chapter II Neoplasms,Melanoma in situ,GRSF1,G-rich sequence factor 1,34200,135,1.07 [0.88-1.31],0.4896598990871958
Chapter II Neoplasms,Melanoma in situ,GSAP,Gamma-secretase-activating protein,40055,159,1.01 [0.85-1.18],0.9430835063630264
Chapter II Neoplasms,Melanoma in situ,GSN,Gelsolin,35526,141,0.73 [0.34-1.61],0.4395365869960648
Chapter II Neoplasms,Melanoma in situ,GSR,"Glutathione reductase, mitochondrial",35460,141,1.31 [0.62-2.75],0.4776085217393225
Chapter II Neoplasms,Melanoma in situ,GSTA1,Glutathione S-transferase A1,40920,163,1.00 [0.85-1.18],0.9962177948003074
Chapter II Neoplasms,Melanoma in situ,GSTA3,Glutathione S-transferase A3,40055,159,0.91 [0.75-1.10],0.3299105087186882
Chapter II Neoplasms,Melanoma in situ,GSTM4,Glutathione S-transferase Mu 4,34518,137,1.02 [0.82-1.27],0.8692210891868052
Chapter II Neoplasms,Melanoma in situ,GSTP1,Glutathione S-transferase P,39782,160,1.16 [0.96-1.40],0.1298157371149678
Chapter II Neoplasms,Melanoma in situ,GSTT2B,Glutathione S-transferase theta-2B,35570,140,1.01 [0.94-1.08],0.8839255633465015
Chapter II Neoplasms,Melanoma in situ,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,34984,139,0.86 [0.66-1.13],0.2855665229754105
Chapter II Neoplasms,Melanoma in situ,GTPBP2,GTP-binding protein 2,34686,135,1.15 [0.94-1.41],0.1720880860706857
Chapter II Neoplasms,Melanoma in situ,GUCA2A,Guanylin,40783,163,0.97 [0.64-1.48],0.8828788698826909
Chapter II Neoplasms,Melanoma in situ,GUCY2C,Heat-stable enterotoxin receptor,34984,139,0.96 [0.78-1.19],0.7296800427573373
Chapter II Neoplasms,Melanoma in situ,GUK1,Guanylate kinase,34518,137,0.53 [0.31-0.90],0.0186042297808343
Chapter II Neoplasms,Melanoma in situ,GUSB,Beta-glucuronidase,41171,163,1.03 [0.82-1.30],0.7947813190773324
Chapter II Neoplasms,Melanoma in situ,GYS1,"Glycogen [starch] synthase, muscle",40258,158,1.03 [0.88-1.20],0.7331963251339753
Chapter II Neoplasms,Melanoma in situ,GZMA,Granzyme A,41452,164,1.16 [0.78-1.72],0.4557761418414604
Chapter II Neoplasms,Melanoma in situ,GZMB,Granzyme B,40939,163,0.89 [0.71-1.12],0.3148958403463331
Chapter II Neoplasms,Melanoma in situ,GZMH,Granzyme H,40258,158,1.03 [0.86-1.24],0.7300980703461096
Chapter II Neoplasms,Melanoma in situ,H2AP,Huntingtin-interacting protein M,34394,136,0.98 [0.70-1.37],0.901306765137617
Chapter II Neoplasms,Melanoma in situ,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",34518,137,0.80 [0.58-1.09],0.1581221094734787
Chapter II Neoplasms,Melanoma in situ,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",41237,164,0.92 [0.76-1.12],0.4087149446373443
Chapter II Neoplasms,Melanoma in situ,HAO1,Hydroxyacid oxidase 1,41358,164,0.90 [0.81-1.01],0.0803523483781702
Chapter II Neoplasms,Melanoma in situ,HARS1,"Histidine--tRNA ligase, cytoplasmic",40993,164,1.13 [0.95-1.36],0.17173334637242
Chapter II Neoplasms,Melanoma in situ,HAVCR1,Hepatitis A virus cellular receptor 1,41299,164,1.31 [1.06-1.63],0.0136759358758009
Chapter II Neoplasms,Melanoma in situ,HAVCR2,Hepatitis A virus cellular receptor 2,40993,164,0.92 [0.61-1.38],0.682643888465822
Chapter II Neoplasms,Melanoma in situ,HBEGF,Proheparin-binding EGF-like growth factor,41237,164,1.08 [0.89-1.30],0.4471359234397845
Chapter II Neoplasms,Melanoma in situ,HBQ1,Hemoglobin subunit theta-1,41358,164,0.89 [0.70-1.12],0.3059094726414316
Chapter II Neoplasms,Melanoma in situ,HBZ,Hemoglobin subunit zeta,35640,141,1.00 [0.86-1.17],0.9579023907200948
Chapter II Neoplasms,Melanoma in situ,HCG22,Protein PBMUCL2,34518,137,0.63 [0.40-1.00],0.0507534159592438
Chapter II Neoplasms,Melanoma in situ,HCLS1,Hematopoietic lineage cell-specific protein,41452,164,1.16 [0.90-1.49],0.2441891417214417
Chapter II Neoplasms,Melanoma in situ,HDAC8,Histone deacetylase 8,34608,134,0.88 [0.65-1.20],0.4287969342706285
Chapter II Neoplasms,Melanoma in situ,HDAC9,Histone deacetylase 9,34549,138,1.03 [0.81-1.30],0.8330132196259141
Chapter II Neoplasms,Melanoma in situ,HDDC2,5'-deoxynucleotidase HDDC2,35486,140,1.13 [0.79-1.62],0.5018297750275207
Chapter II Neoplasms,Melanoma in situ,HDGF,Hepatoma-derived growth factor,41294,164,1.16 [1.00-1.33],0.0506882136472901
Chapter II Neoplasms,Melanoma in situ,HDGFL2,Hepatoma-derived growth factor-related protein 2,35570,140,1.09 [0.85-1.39],0.4995433291188069
Chapter II Neoplasms,Melanoma in situ,HEBP1,Heme-binding protein 1,40258,158,1.09 [0.86-1.38],0.4959194498598726
Chapter II Neoplasms,Melanoma in situ,HEG1,Protein HEG homolog 1,34878,138,0.66 [0.35-1.22],0.185000639351139
Chapter II Neoplasms,Melanoma in situ,HEPACAM2,HEPACAM family member 2,35570,140,0.91 [0.62-1.34],0.6196706328821959
Chapter II Neoplasms,Melanoma in situ,HEPH,Hephaestin,35640,141,1.15 [0.62-2.13],0.6618936811023278
Chapter II Neoplasms,Melanoma in situ,HEXIM1,Protein HEXIM1,40939,163,1.16 [0.98-1.37],0.0904512755626674
Chapter II Neoplasms,Melanoma in situ,HGF,Hepatocyte growth factor,41452,164,0.98 [0.65-1.47],0.9076603709732872
Chapter II Neoplasms,Melanoma in situ,HGFAC,Hepatocyte growth factor activator,35328,138,0.87 [0.50-1.51],0.6185519661367518
Chapter II Neoplasms,Melanoma in situ,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,40055,159,1.09 [0.91-1.31],0.3280047707990795
Chapter II Neoplasms,Melanoma in situ,HHEX,Hematopoietically-expressed homeobox protein HHEX,35570,140,1.21 [0.98-1.49],0.0740882525284238
Chapter II Neoplasms,Melanoma in situ,HIF1A,Hypoxia-inducible factor 1-alpha,34608,134,0.90 [0.68-1.21],0.4911512113895125
Chapter II Neoplasms,Melanoma in situ,HIP1,Huntingtin-interacting protein 1,34518,137,0.78 [0.45-1.34],0.3623754057688757
Chapter II Neoplasms,Melanoma in situ,HIP1R,Huntingtin-interacting protein 1-related protein,35500,140,0.96 [0.66-1.40],0.8216787684163069
Chapter II Neoplasms,Melanoma in situ,HJV,Hemojuvelin,35587,140,0.90 [0.62-1.33],0.6094777966845883
Chapter II Neoplasms,Melanoma in situ,HK2,Hexokinase-2,40258,158,0.96 [0.58-1.59],0.8735827500890455
Chapter II Neoplasms,Melanoma in situ,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",35587,140,0.88 [0.54-1.44],0.6039368870487993
Chapter II Neoplasms,Melanoma in situ,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",40811,163,1.20 [0.82-1.75],0.3420572159760254
Chapter II Neoplasms,Melanoma in situ,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",40939,163,1.83 [1.18-2.84],0.0065816484680015
Chapter II Neoplasms,Melanoma in situ,HMBS,Porphobilinogen deaminase,41358,164,0.80 [0.58-1.09],0.1596735925218225
Chapter II Neoplasms,Melanoma in situ,HMCN2,Hemicentin-2,34811,137,0.93 [0.69-1.23],0.5950348954726242
Chapter II Neoplasms,Melanoma in situ,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",34695,137,1.20 [0.87-1.64],0.2668672572584634
Chapter II Neoplasms,Melanoma in situ,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",34518,137,0.92 [0.63-1.36],0.6908953978383359
Chapter II Neoplasms,Melanoma in situ,HMMR,Hyaluronan mediated motility receptor,34327,135,1.23 [0.93-1.63],0.1443022740800598
Chapter II Neoplasms,Melanoma in situ,HMOX1,Heme oxygenase 1,40537,161,1.00 [0.74-1.34],0.9905380582981456
Chapter II Neoplasms,Melanoma in situ,HMOX2,Heme oxygenase 2,40031,160,0.88 [0.64-1.22],0.4417660186696633
Chapter II Neoplasms,Melanoma in situ,HNF1A,Hepatocyte nuclear factor 1-alpha,34686,135,1.06 [0.85-1.31],0.6219099906125319
Chapter II Neoplasms,Melanoma in situ,HNMT,Histamine N-methyltransferase,40480,157,0.92 [0.68-1.24],0.5732264655445898
Chapter II Neoplasms,Melanoma in situ,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,40128,157,0.99 [0.82-1.19],0.8898302751643444
Chapter II Neoplasms,Melanoma in situ,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,35587,140,1.17 [0.86-1.58],0.3207454525430944
Chapter II Neoplasms,Melanoma in situ,HPCAL1,Hippocalcin-like protein 1,41452,164,1.11 [0.92-1.35],0.2676248720830108
Chapter II Neoplasms,Melanoma in situ,HPGDS,Hematopoietic prostaglandin D synthase,40055,159,0.88 [0.60-1.30],0.5326804118406443
Chapter II Neoplasms,Melanoma in situ,HPSE,Heparanase,35174,140,1.14 [0.95-1.36],0.1570289953035547
Chapter II Neoplasms,Melanoma in situ,HRAS,GTPase Hras,34919,139,0.94 [0.78-1.13],0.5086060707093827
Chapter II Neoplasms,Melanoma in situ,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,34695,137,0.85 [0.51-1.43],0.5470429904628045
Chapter II Neoplasms,Melanoma in situ,HRG,Histidine-rich glycoprotein,35507,141,0.66 [0.39-1.09],0.1049002922271629
Chapter II Neoplasms,Melanoma in situ,HS1BP3,HCLS1-binding protein 3,34695,137,1.17 [0.97-1.40],0.098712148827646
Chapter II Neoplasms,Melanoma in situ,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,40789,160,0.79 [0.54-1.15],0.2177701807348599
Chapter II Neoplasms,Melanoma in situ,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,41358,164,0.92 [0.61-1.38],0.6819351452605676
Chapter II Neoplasms,Melanoma in situ,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,34608,134,0.86 [0.51-1.43],0.5512309698778585
Chapter II Neoplasms,Melanoma in situ,HSBP1,Heat shock factor-binding protein 1,34695,137,1.14 [0.96-1.35],0.1308771216640607
Chapter II Neoplasms,Melanoma in situ,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,40939,163,0.87 [0.61-1.23],0.4270441235441063
Chapter II Neoplasms,Melanoma in situ,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,35570,140,1.09 [0.84-1.41],0.5142158928597911
Chapter II Neoplasms,Melanoma in situ,HSD17B3,Testosterone 17-beta-dehydrogenase 3,34518,137,1.03 [0.74-1.43],0.8777533297344228
Chapter II Neoplasms,Melanoma in situ,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,34695,137,0.88 [0.62-1.25],0.4770004956261129
Chapter II Neoplasms,Melanoma in situ,HSP90B1,Endoplasmin,39846,158,0.87 [0.68-1.11],0.2745495774269038
Chapter II Neoplasms,Melanoma in situ,HSPA1A,Heat shock 70 kDa protein 1A,41079,163,1.07 [0.88-1.29],0.5068951189433979
Chapter II Neoplasms,Melanoma in situ,HSPA2,Heat shock-related 70 kDa protein 2,35477,140,1.00 [0.62-1.63],0.9884369472646768
Chapter II Neoplasms,Melanoma in situ,HSPB1,Heat shock protein beta-1,40329,162,1.23 [0.99-1.52],0.0619063171322469
Chapter II Neoplasms,Melanoma in situ,HSPB6,Heat shock protein beta-6,41358,164,0.92 [0.63-1.33],0.6448131220275777
Chapter II Neoplasms,Melanoma in situ,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,40677,162,1.04 [0.60-1.81],0.8977727788685111
Chapter II Neoplasms,Melanoma in situ,HTR1A,5-hydroxytryptamine receptor 1A,34549,138,0.90 [0.71-1.14],0.3759766255564858
Chapter II Neoplasms,Melanoma in situ,HTR1B,5-hydroxytryptamine receptor 1B,34549,138,0.85 [0.57-1.28],0.4412664504712223
Chapter II Neoplasms,Melanoma in situ,HTRA2,"Serine protease HTRA2, mitochondrial",41097,164,1.13 [0.90-1.41],0.296330898217427
Chapter II Neoplasms,Melanoma in situ,HYAL1,Hyaluronidase-1,40745,162,0.74 [0.40-1.38],0.3448766635193382
Chapter II Neoplasms,Melanoma in situ,HYOU1,Hypoxia up-regulated protein 1,41485,164,1.12 [0.60-2.09],0.717724873689277
Chapter II Neoplasms,Melanoma in situ,ICA1,Islet cell autoantigen 1,40249,159,1.13 [0.94-1.34],0.1842441993347615
Chapter II Neoplasms,Melanoma in situ,ICAM1,Intercellular adhesion molecule 1,40812,163,1.16 [0.71-1.90],0.5550439290367291
Chapter II Neoplasms,Melanoma in situ,ICAM2,Intercellular adhesion molecule 2,41485,164,1.36 [0.88-2.11],0.1621236816647773
Chapter II Neoplasms,Melanoma in situ,ICAM3,Intercellular adhesion molecule 3,41485,164,0.94 [0.54-1.62],0.8231348964822225
Chapter II Neoplasms,Melanoma in situ,ICAM4,Intercellular adhesion molecule 4,40939,163,0.95 [0.73-1.23],0.7007301345990504
Chapter II Neoplasms,Melanoma in situ,ICAM5,Intercellular adhesion molecule 5,40984,163,0.62 [0.46-0.83],0.0016336603114411
Chapter II Neoplasms,Melanoma in situ,ICOSLG,ICOS ligand,40789,160,0.88 [0.42-1.85],0.7417229151551228
Chapter II Neoplasms,Melanoma in situ,ID4,DNA-binding protein inhibitor ID-4,34984,139,1.07 [0.76-1.51],0.7086233210371162
Chapter II Neoplasms,Melanoma in situ,IDI2,Isopentenyl-diphosphate delta-isomerase 2,40031,160,0.84 [0.62-1.15],0.2804343819027666
Chapter II Neoplasms,Melanoma in situ,IDO1,"Indoleamine 2,3-dioxygenase 1",34695,137,0.93 [0.71-1.22],0.6049510634369452
Chapter II Neoplasms,Melanoma in situ,IDS,Iduronate 2-sulfatase,41452,164,0.93 [0.19-4.51],0.9275719068744356
Chapter II Neoplasms,Melanoma in situ,IDUA,Alpha-L-iduronidase,41358,164,0.84 [0.62-1.12],0.2333426044867802
Chapter II Neoplasms,Melanoma in situ,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,34641,136,0.94 [0.60-1.45],0.772863045682332
Chapter II Neoplasms,Melanoma in situ,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,34984,139,0.72 [0.51-1.02],0.0634685234766066
Chapter II Neoplasms,Melanoma in situ,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,34984,139,1.07 [0.70-1.64],0.7389513352736845
Chapter II Neoplasms,Melanoma in situ,IFNAR1,Interferon alpha/beta receptor 1,35486,140,1.02 [0.55-1.89],0.9607292677344844
Chapter II Neoplasms,Melanoma in situ,IFNG,Interferon gamma,40249,159,1.08 [0.95-1.22],0.2519752093208866
Chapter II Neoplasms,Melanoma in situ,IFNGR1,Interferon gamma receptor 1,41147,164,0.69 [0.35-1.38],0.2964423331449305
Chapter II Neoplasms,Melanoma in situ,IFNGR2,Interferon gamma receptor 2,40682,158,1.20 [0.92-1.56],0.1843549919614738
Chapter II Neoplasms,Melanoma in situ,IFNL1,Interferon lambda-1,40031,160,1.08 [0.79-1.48],0.6111824397915107
Chapter II Neoplasms,Melanoma in situ,IFNL2,Interferon lambda-2,34549,138,1.01 [0.78-1.31],0.9247994491330036
Chapter II Neoplasms,Melanoma in situ,IFNLR1,Interferon lambda receptor 1,40939,163,1.04 [0.71-1.52],0.8511625817821465
Chapter II Neoplasms,Melanoma in situ,IFNW1,Interferon omega-1,34518,137,0.98 [0.62-1.55],0.9290386235347652
Chapter II Neoplasms,Melanoma in situ,IFT20,Intraflagellar transport protein 20 homolog,34686,135,1.09 [0.75-1.57],0.6599385760703337
Chapter II Neoplasms,Melanoma in situ,IGBP1,Immunoglobulin-binding protein 1,35587,140,1.06 [0.82-1.38],0.6589545543209889
Chapter II Neoplasms,Melanoma in situ,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,34549,138,0.97 [0.68-1.38],0.8482923083558696
Chapter II Neoplasms,Melanoma in situ,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,35644,141,0.69 [0.38-1.25],0.2209346511477887
Chapter II Neoplasms,Melanoma in situ,IGF1R,Insulin-like growth factor 1 receptor,40789,160,0.61 [0.31-1.20],0.1524016155293442
Chapter II Neoplasms,Melanoma in situ,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,34518,137,0.74 [0.49-1.12],0.1506624345963259
Chapter II Neoplasms,Melanoma in situ,IGF2R,Cation-independent mannose-6-phosphate receptor,40993,164,0.79 [0.44-1.44],0.4439548371966273
Chapter II Neoplasms,Melanoma in situ,IGFBP1,Insulin-like growth factor-binding protein 1,41421,164,1.00 [0.89-1.13],0.9499693219926724
Chapter II Neoplasms,Melanoma in situ,IGFBP2,Insulin-like growth factor-binding protein 2,41415,162,0.91 [0.73-1.15],0.4421121206851618
Chapter II Neoplasms,Melanoma in situ,IGFBP3,Insulin-like growth factor-binding protein 3,41135,163,1.00 [0.63-1.60],0.9986006785251702
Chapter II Neoplasms,Melanoma in situ,IGFBP4,Insulin-like growth factor-binding protein 4,40473,162,0.95 [0.68-1.34],0.7768087960780148
Chapter II Neoplasms,Melanoma in situ,IGFBP6,Insulin-like growth factor-binding protein 6,40805,163,0.90 [0.55-1.46],0.6637298602085488
Chapter II Neoplasms,Melanoma in situ,IGFBP7,Insulin-like growth factor-binding protein 7,41485,164,1.33 [0.87-2.04],0.1914860063809397
Chapter II Neoplasms,Melanoma in situ,IGFBPL1,Insulin-like growth factor-binding protein-like 1,40984,163,1.28 [0.85-1.93],0.2321019390644427
Chapter II Neoplasms,Melanoma in situ,IGFL4,Insulin growth factor-like family member 4,34608,134,1.22 [1.04-1.44],0.0140482066306101
Chapter II Neoplasms,Melanoma in situ,IGHMBP2,DNA-binding protein SMUBP-2,34518,137,0.79 [0.57-1.09],0.1449127940629156
Chapter II Neoplasms,Melanoma in situ,IGLC2,Immunoglobulin lambda constant 2,35631,141,0.97 [0.50-1.86],0.9220464197358148
Chapter II Neoplasms,Melanoma in situ,IGLON5,IgLON family member 5,34394,136,1.04 [0.88-1.23],0.6556185455251953
Chapter II Neoplasms,Melanoma in situ,IGSF21,Immunoglobulin superfamily member 21,34695,137,0.73 [0.46-1.16],0.1848091749811405
Chapter II Neoplasms,Melanoma in situ,IGSF3,Immunoglobulin superfamily member 3,40789,160,0.91 [0.59-1.41],0.6743543952120773
Chapter II Neoplasms,Melanoma in situ,IGSF8,Immunoglobulin superfamily member 8,40984,163,1.54 [1.00-2.38],0.0509442226308149
Chapter II Neoplasms,Melanoma in situ,IGSF9,Protein turtle homolog A,35640,141,0.90 [0.73-1.10],0.2965622510963432
Chapter II Neoplasms,Melanoma in situ,IKBKG,NF-kappa-B essential modulator,40939,163,1.16 [1.00-1.35],0.0531469589193624
Chapter II Neoplasms,Melanoma in situ,IKZF2,Zinc finger protein Helios,40055,159,0.95 [0.81-1.12],0.5607575739095363
Chapter II Neoplasms,Melanoma in situ,IL10,Interleukin-10,40249,159,1.08 [0.92-1.27],0.3487165949734314
Chapter II Neoplasms,Melanoma in situ,IL10RA,Interleukin-10 receptor subunit alpha,40249,159,0.91 [0.69-1.18],0.4669391366568156
Chapter II Neoplasms,Melanoma in situ,IL10RB,Interleukin-10 receptor subunit beta,41147,164,0.57 [0.35-0.95],0.0317360101592263
Chapter II Neoplasms,Melanoma in situ,IL11,Interleukin-11,40249,159,0.79 [0.61-1.03],0.0799747155147927
Chapter II Neoplasms,Melanoma in situ,IL12A_IL12B,Interleukin-12,40789,160,0.95 [0.79-1.14],0.5582388800927303
Chapter II Neoplasms,Melanoma in situ,IL12B,Interleukin-12 subunit beta,41452,164,0.94 [0.72-1.21],0.6199007457395544
Chapter II Neoplasms,Melanoma in situ,IL12RB1,Interleukin-12 receptor subunit beta-1,40249,159,1.32 [0.91-1.90],0.137854656414317
Chapter II Neoplasms,Melanoma in situ,IL12RB2,Interleukin-12 receptor subunit beta-2,34608,134,0.92 [0.61-1.39],0.6943628344661381
Chapter II Neoplasms,Melanoma in situ,IL13,Interleukin-13,40249,159,0.95 [0.70-1.29],0.7432679919731779
Chapter II Neoplasms,Melanoma in situ,IL13RA1,Interleukin-13 receptor subunit alpha-1,40459,162,0.63 [0.34-1.17],0.144909018805008
Chapter II Neoplasms,Melanoma in situ,IL13RA2,Interleukin-13 receptor subunit alpha-2,34549,138,0.69 [0.39-1.21],0.1943622244473317
Chapter II Neoplasms,Melanoma in situ,IL15,Interleukin-15,40939,163,1.23 [0.81-1.87],0.325244912236336
Chapter II Neoplasms,Melanoma in situ,IL15RA,Interleukin-15 receptor subunit alpha,40249,159,0.99 [0.66-1.49],0.955021038113205
Chapter II Neoplasms,Melanoma in situ,IL16,Pro-interleukin-16,41452,164,1.04 [0.75-1.43],0.8270750272208144
Chapter II Neoplasms,Melanoma in situ,IL17A,Interleukin-17A,40185,159,0.86 [0.60-1.22],0.3954568162921296
Chapter II Neoplasms,Melanoma in situ,IL17C,Interleukin-17C,40249,159,1.09 [0.90-1.32],0.3653075004359439
Chapter II Neoplasms,Melanoma in situ,IL17D,Interleukin-17D,40249,159,0.87 [0.55-1.38],0.5642811682951421
Chapter II Neoplasms,Melanoma in situ,IL17F,Interleukin-17F,40249,159,0.95 [0.78-1.15],0.5980536177841416
Chapter II Neoplasms,Melanoma in situ,IL17RA,Interleukin-17 receptor A,40993,164,0.99 [0.72-1.35],0.9441285958933848
Chapter II Neoplasms,Melanoma in situ,IL17RB,Interleukin-17 receptor B,40423,163,0.82 [0.63-1.07],0.1530163719144336
Chapter II Neoplasms,Melanoma in situ,IL18,Interleukin-18,40810,163,1.18 [0.88-1.58],0.2827988979116275
Chapter II Neoplasms,Melanoma in situ,IL18BP,Interleukin-18-binding protein,41135,163,1.21 [0.77-1.90],0.4064898815495081
Chapter II Neoplasms,Melanoma in situ,IL18R1,Interleukin-18 receptor 1,41452,164,1.19 [0.78-1.81],0.4215034842304477
Chapter II Neoplasms,Melanoma in situ,IL18RAP,Interleukin-18 receptor accessory protein,40423,157,0.97 [0.89-1.06],0.4825798083979433
Chapter II Neoplasms,Melanoma in situ,IL19,Interleukin-19,39957,156,1.09 [0.90-1.33],0.3752962336134705
Chapter II Neoplasms,Melanoma in situ,IL1A,Interleukin-1 alpha,40249,159,0.80 [0.60-1.07],0.1338054182795753
Chapter II Neoplasms,Melanoma in situ,IL1B,Interleukin-1 beta,40061,156,1.10 [0.86-1.40],0.4493941119312489
Chapter II Neoplasms,Melanoma in situ,IL1R1,Interleukin-1 receptor type 1,40928,164,0.61 [0.33-1.15],0.1269890464918469
Chapter II Neoplasms,Melanoma in situ,IL1R2,Interleukin-1 receptor type 2,40890,164,0.66 [0.33-1.32],0.2360964452194973
Chapter II Neoplasms,Melanoma in situ,IL1RAP,Interleukin-1 receptor accessory protein,40993,164,1.06 [0.78-1.44],0.7163453480869693
Chapter II Neoplasms,Melanoma in situ,IL1RL1,Interleukin-1 receptor-like 1,41357,164,0.97 [0.72-1.31],0.8509636049236529
Chapter II Neoplasms,Melanoma in situ,IL1RL2,Interleukin-1 receptor-like 2,40249,159,1.23 [0.85-1.79],0.2687390462820176
Chapter II Neoplasms,Melanoma in situ,IL1RN,Interleukin-1 receptor antagonist protein,40883,163,1.04 [0.81-1.34],0.7412355031686906
Chapter II Neoplasms,Melanoma in situ,IL2,Interleukin-2,40249,159,1.09 [0.69-1.70],0.7192217392922704
Chapter II Neoplasms,Melanoma in situ,IL20,Interleukin-20,40249,159,0.69 [0.48-0.97],0.0345754028404472
Chapter II Neoplasms,Melanoma in situ,IL20RA,Interleukin-20 receptor subunit alpha,40249,159,1.00 [0.73-1.37],0.9998736563293082
Chapter II Neoplasms,Melanoma in situ,IL20RB,Interleukin-20 receptor subunit beta,34608,134,0.85 [0.56-1.27],0.4221470788576477
Chapter II Neoplasms,Melanoma in situ,IL21R,Interleukin-21 receptor,34608,134,0.92 [0.66-1.27],0.6024984442013691
Chapter II Neoplasms,Melanoma in situ,IL22,Interleukin-22,35477,140,0.93 [0.73-1.19],0.576615051162787
Chapter II Neoplasms,Melanoma in situ,IL22RA1,Interleukin-22 receptor subunit alpha-1,40249,159,0.94 [0.67-1.32],0.7202353520191043
Chapter II Neoplasms,Melanoma in situ,IL24,Interleukin-24,40249,159,1.18 [0.92-1.51],0.1967685753790919
Chapter II Neoplasms,Melanoma in situ,IL25,Interleukin-25,34265,135,0.85 [0.53-1.38],0.5189571148269464
Chapter II Neoplasms,Melanoma in situ,IL2RA,Interleukin-2 receptor subunit alpha,40698,159,0.84 [0.58-1.20],0.3326787900820724
Chapter II Neoplasms,Melanoma in situ,IL2RB,Interleukin-2 receptor subunit beta,40249,159,1.06 [0.74-1.52],0.7307536979750433
Chapter II Neoplasms,Melanoma in situ,IL2RG,Cytokine receptor common subunit gamma,35477,140,0.78 [0.47-1.28],0.3239254241118343
Chapter II Neoplasms,Melanoma in situ,IL3,Interleukin-3,34394,136,0.73 [0.60-0.89],0.0018838714419915
Chapter II Neoplasms,Melanoma in situ,IL31,Interleukin-31,34608,134,1.11 [0.85-1.45],0.4363901350647432
Chapter II Neoplasms,Melanoma in situ,IL31RA,Interleukin-31 receptor subunit alpha,34476,132,0.58 [0.38-0.90],0.0150175624056054
Chapter II Neoplasms,Melanoma in situ,IL32,Interleukin-32,40939,163,0.73 [0.51-1.02],0.0681579893459766
Chapter II Neoplasms,Melanoma in situ,IL33,Interleukin-33,40249,159,0.83 [0.58-1.19],0.3047505741311833
Chapter II Neoplasms,Melanoma in situ,IL34,Interleukin-34,39971,160,0.73 [0.50-1.06],0.1003800814418464
Chapter II Neoplasms,Melanoma in situ,IL36A,Interleukin-36 alpha,34608,134,0.97 [0.72-1.31],0.8349142835301162
Chapter II Neoplasms,Melanoma in situ,IL36G,Interleukin-36 gamma,34481,134,1.05 [0.82-1.33],0.7101388689341397
Chapter II Neoplasms,Melanoma in situ,IL3RA,Interleukin-3 receptor subunit alpha,40249,159,1.03 [0.66-1.60],0.8953133259937209
Chapter II Neoplasms,Melanoma in situ,IL4,Interleukin-4,40249,159,0.98 [0.84-1.13],0.7442463468655316
Chapter II Neoplasms,Melanoma in situ,IL4R,Interleukin-4 receptor subunit alpha,40939,163,0.96 [0.64-1.42],0.8242191414331084
Chapter II Neoplasms,Melanoma in situ,IL5,Interleukin-5,40249,159,1.02 [0.92-1.12],0.7109984308456959
Chapter II Neoplasms,Melanoma in situ,IL5RA,Interleukin-5 receptor subunit alpha,40939,163,0.97 [0.75-1.25],0.802758354879213
Chapter II Neoplasms,Melanoma in situ,IL6,Interleukin-6,40789,160,1.01 [0.83-1.22],0.9336738796869186
Chapter II Neoplasms,Melanoma in situ,IL6R,Interleukin-6 receptor subunit alpha,40743,163,1.27 [0.85-1.90],0.2508330179177586
Chapter II Neoplasms,Melanoma in situ,IL6ST,Interleukin-6 receptor subunit beta,40984,163,0.71 [0.32-1.59],0.4034573607778507
Chapter II Neoplasms,Melanoma in situ,IL7,Interleukin-7,40939,163,0.98 [0.79-1.21],0.8294842457648499
Chapter II Neoplasms,Melanoma in situ,IL7R,Interleukin-7 receptor subunit alpha,40993,164,0.85 [0.66-1.10],0.2202653570634137
Chapter II Neoplasms,Melanoma in situ,IL9,Interleukin-9,34984,139,0.91 [0.66-1.25],0.5620640785341422
Chapter II Neoplasms,Melanoma in situ,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39974,159,1.09 [0.85-1.38],0.5027377239994661
Chapter II Neoplasms,Melanoma in situ,IMMT,MICOS complex subunit MIC60,35477,140,1.21 [0.87-1.69],0.2652136975324946
Chapter II Neoplasms,Melanoma in situ,IMPA1,Inositol monophosphatase 1,40682,158,1.18 [0.94-1.48],0.1467058208916751
Chapter II Neoplasms,Melanoma in situ,IMPACT,Protein IMPACT,35570,140,1.10 [0.83-1.47],0.5069171472635748
Chapter II Neoplasms,Melanoma in situ,IMPG1,Interphotoreceptor matrix proteoglycan 1,34549,138,0.57 [0.31-1.08],0.0837821413838362
Chapter II Neoplasms,Melanoma in situ,ING1,Inhibitor of growth protein 1,39955,160,1.10 [0.83-1.47],0.502523194940595
Chapter II Neoplasms,Melanoma in situ,INHBB,Inhibin beta B chain,34878,138,0.84 [0.60-1.16],0.284704284533299
Chapter II Neoplasms,Melanoma in situ,INHBC,Inhibin beta C chain,40993,164,1.13 [0.80-1.58],0.4872843153796028
Chapter II Neoplasms,Melanoma in situ,INPP1,Inositol polyphosphate 1-phosphatase,40789,160,1.24 [0.96-1.60],0.0927772091628115
Chapter II Neoplasms,Melanoma in situ,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",34695,137,1.26 [0.95-1.66],0.1133571306118992
Chapter II Neoplasms,Melanoma in situ,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",35587,140,0.98 [0.67-1.44],0.9147971926725332
Chapter II Neoplasms,Melanoma in situ,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",40789,160,1.10 [0.96-1.27],0.1804775341878192
Chapter II Neoplasms,Melanoma in situ,INSL3,Insulin-like 3,35570,140,1.01 [0.81-1.25],0.934127864932578
Chapter II Neoplasms,Melanoma in situ,INSL4,Early placenta insulin-like peptide,35477,140,1.29 [1.01-1.64],0.0434165931501645
Chapter II Neoplasms,Melanoma in situ,INSL5,Insulin-like peptide INSL5,35486,140,0.86 [0.72-1.02],0.0870809342057129
Chapter II Neoplasms,Melanoma in situ,INSR,Insulin receptor,34608,134,1.40 [0.52-3.77],0.5026193078961907
Chapter II Neoplasms,Melanoma in situ,IPCEF1,Interactor protein for cytohesin exchange factors 1,40613,157,1.09 [0.93-1.27],0.3077811417926323
Chapter II Neoplasms,Melanoma in situ,IQGAP2,Ras GTPase-activating-like protein IQGAP2,40789,160,1.00 [0.77-1.30],0.9959572145507362
Chapter II Neoplasms,Melanoma in situ,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",40258,158,1.05 [0.89-1.22],0.5825403340719304
Chapter II Neoplasms,Melanoma in situ,IRAK1,Interleukin-1 receptor-associated kinase 1,40249,159,1.14 [0.93-1.39],0.2104544013319573
Chapter II Neoplasms,Melanoma in situ,IRAK4,Interleukin-1 receptor-associated kinase 4,40939,163,1.11 [0.97-1.28],0.1182428751092212
Chapter II Neoplasms,Melanoma in situ,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39447,157,0.88 [0.60-1.29],0.5061038361480561
Chapter II Neoplasms,Melanoma in situ,ISM1,Isthmin-1,40939,163,0.88 [0.61-1.26],0.4868495356635197
Chapter II Neoplasms,Melanoma in situ,ISM2,Isthmin-2,35644,141,0.87 [0.59-1.29],0.4951844953343178
Chapter II Neoplasms,Melanoma in situ,IST1,IST1 homolog,35219,139,1.10 [0.93-1.30],0.2588960180758295
Chapter II Neoplasms,Melanoma in situ,ITGA11,Integrin alpha-11,40939,163,0.81 [0.54-1.22],0.3132241702595834
Chapter II Neoplasms,Melanoma in situ,ITGA2,Integrin alpha-2,34878,138,0.87 [0.54-1.41],0.5659397856227664
Chapter II Neoplasms,Melanoma in situ,ITGA5,Integrin alpha-5,40993,164,0.76 [0.43-1.34],0.3431946643842151
Chapter II Neoplasms,Melanoma in situ,ITGA6,Integrin alpha-6,40939,163,1.03 [0.79-1.34],0.832033510096078
Chapter II Neoplasms,Melanoma in situ,ITGAL,Integrin alpha-L,34608,134,1.14 [0.77-1.68],0.5193833569796995
Chapter II Neoplasms,Melanoma in situ,ITGAM,Integrin alpha-M,40993,164,0.68 [0.43-1.06],0.0856366348008417
Chapter II Neoplasms,Melanoma in situ,ITGAV,Integrin alpha-V,41358,164,0.73 [0.31-1.69],0.4595252363148696
Chapter II Neoplasms,Melanoma in situ,ITGAX,Integrin alpha-X,34984,139,1.01 [0.75-1.37],0.9348628079478916
Chapter II Neoplasms,Melanoma in situ,ITGB1,Integrin beta-1,40942,163,0.97 [0.50-1.86],0.9175908969140758
Chapter II Neoplasms,Melanoma in situ,ITGB1BP1,Integrin beta-1-binding protein 1,40055,159,0.78 [0.55-1.10],0.159703818892787
Chapter II Neoplasms,Melanoma in situ,ITGB1BP2,Integrin beta-1-binding protein 2,40258,158,1.05 [0.93-1.20],0.4344786747524698
Chapter II Neoplasms,Melanoma in situ,ITGB2,Integrin beta-2,40748,161,0.69 [0.42-1.15],0.1578006620239814
Chapter II Neoplasms,Melanoma in situ,ITGB5,Integrin beta-5,41097,164,1.08 [0.75-1.56],0.675992538898134
Chapter II Neoplasms,Melanoma in situ,ITGB6,Integrin beta-6,40249,159,0.82 [0.51-1.31],0.4080652093671879
Chapter II Neoplasms,Melanoma in situ,ITGB7,Integrin beta-7,41358,164,0.87 [0.64-1.18],0.3676143520369362
Chapter II Neoplasms,Melanoma in situ,ITGBL1,Integrin beta-like protein 1,35644,141,1.06 [0.68-1.66],0.7982605521382656
Chapter II Neoplasms,Melanoma in situ,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,35692,141,1.15 [0.50-2.69],0.7411256592955933
Chapter II Neoplasms,Melanoma in situ,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,41135,163,1.02 [0.70-1.47],0.9306203884111144
Chapter II Neoplasms,Melanoma in situ,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,35692,141,0.97 [0.51-1.82],0.9144686788241836
Chapter II Neoplasms,Melanoma in situ,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,35477,140,1.24 [0.91-1.70],0.179271430854347
Chapter II Neoplasms,Melanoma in situ,ITM2A,Integral membrane protein 2A,40939,163,1.00 [0.79-1.26],0.983994011533602
Chapter II Neoplasms,Melanoma in situ,ITPA,Inosine triphosphate pyrophosphatase,34518,137,1.13 [0.88-1.44],0.3404144265404866
Chapter II Neoplasms,Melanoma in situ,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",34695,137,1.31 [1.09-1.58],0.0035300281650704
Chapter II Neoplasms,Melanoma in situ,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",34549,138,0.86 [0.58-1.28],0.4525180431432655
Chapter II Neoplasms,Melanoma in situ,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",40031,160,0.97 [0.73-1.29],0.8388394468367086
Chapter II Neoplasms,Melanoma in situ,IZUMO1,Izumo sperm-egg fusion protein 1,34394,136,0.79 [0.53-1.19],0.2654290330643848
Chapter II Neoplasms,Melanoma in situ,JAM2,Junctional adhesion molecule B,41349,165,0.85 [0.49-1.47],0.5679779945580046
Chapter II Neoplasms,Melanoma in situ,JAM3,Junctional adhesion molecule C,34878,138,1.01 [0.73-1.41],0.93028376216172
Chapter II Neoplasms,Melanoma in situ,JCHAIN,Immunoglobulin J chain,40249,159,1.01 [0.80-1.27],0.9205900787749774
Chapter II Neoplasms,Melanoma in situ,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,34394,136,0.99 [0.74-1.33],0.961417700352881
Chapter II Neoplasms,Melanoma in situ,JPT2,Jupiter microtubule associated homolog 2,35486,140,1.20 [1.00-1.45],0.0556986261930267
Chapter II Neoplasms,Melanoma in situ,JUN,Transcription factor AP-1,40249,159,0.87 [0.63-1.19],0.3860059143959612
Chapter II Neoplasms,Melanoma in situ,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40789,160,1.21 [0.87-1.66],0.2566230920239493
Chapter II Neoplasms,Melanoma in situ,KAZN,Kazrin,35486,140,1.18 [1.00-1.37],0.0435306946658996
Chapter II Neoplasms,Melanoma in situ,KCNC4,Potassium voltage-gated channel subfamily C member 4,34549,138,1.47 [1.22-1.77],5.495190006852735e-05
Chapter II Neoplasms,Melanoma in situ,KCNH2,Potassium voltage-gated channel subfamily H member 2,34686,135,1.05 [0.85-1.28],0.6596692451906876
Chapter II Neoplasms,Melanoma in situ,KCNIP4,Kv channel-interacting protein 4,40031,160,1.12 [0.87-1.44],0.3895214401899289
Chapter II Neoplasms,Melanoma in situ,KCTD5,BTB/POZ domain-containing protein KCTD5,34893,139,0.97 [0.67-1.41],0.8835392315272991
Chapter II Neoplasms,Melanoma in situ,KDM3A,Lysine-specific demethylase 3A,34608,134,0.94 [0.77-1.15],0.5540054273043
Chapter II Neoplasms,Melanoma in situ,KDR,Vascular endothelial growth factor receptor 2,41097,164,1.30 [0.75-2.25],0.353096075005303
Chapter II Neoplasms,Melanoma in situ,KEL,Kell blood group glycoprotein,40031,160,0.76 [0.52-1.13],0.1784694692985232
Chapter II Neoplasms,Melanoma in situ,KHDC3L,KH domain-containing protein 3,34394,136,0.88 [0.67-1.16],0.3689543064944468
Chapter II Neoplasms,Melanoma in situ,KHK,Ketohexokinase,34695,137,1.12 [0.86-1.45],0.4132361370807471
Chapter II Neoplasms,Melanoma in situ,KIAA0319,Dyslexia-associated protein KIAA0319,35570,140,0.73 [0.42-1.28],0.273072376837522
Chapter II Neoplasms,Melanoma in situ,KIAA1549,UPF0606 protein KIAA1549,34984,139,1.07 [0.85-1.34],0.5708296757610665
Chapter II Neoplasms,Melanoma in situ,KIAA1549L,UPF0606 protein KIAA1549L,34984,139,0.60 [0.33-1.11],0.1059938052060812
Chapter II Neoplasms,Melanoma in situ,KIAA2013,Uncharacterized protein KIAA2013,35477,140,0.85 [0.61-1.19],0.3369143579304009
Chapter II Neoplasms,Melanoma in situ,KIF1C,Kinesin-like protein KIF1C,34518,137,0.74 [0.43-1.27],0.277222102999636
Chapter II Neoplasms,Melanoma in situ,KIF20B,Kinesin-like protein KIF20B,34549,138,0.90 [0.72-1.13],0.3597854833882282
Chapter II Neoplasms,Melanoma in situ,KIF22,Kinesin-like protein KIF22,34518,137,1.06 [0.93-1.22],0.3666694928687155
Chapter II Neoplasms,Melanoma in situ,KIFBP,KIF-binding protein,40789,160,1.08 [0.91-1.28],0.3952567661397422
Chapter II Neoplasms,Melanoma in situ,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,35477,140,1.08 [0.90-1.30],0.3944983883143035
Chapter II Neoplasms,Melanoma in situ,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,40055,159,1.02 [0.85-1.22],0.8518912635869118
Chapter II Neoplasms,Melanoma in situ,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,35486,140,0.97 [0.88-1.07],0.5352679085391937
Chapter II Neoplasms,Melanoma in situ,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,40055,159,0.87 [0.78-0.98],0.0206111734013394
Chapter II Neoplasms,Melanoma in situ,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,34394,136,1.14 [0.98-1.33],0.0977812122124232
Chapter II Neoplasms,Melanoma in situ,KIRREL1,Kin of IRRE-like protein 1,34549,138,0.88 [0.64-1.21],0.4231912678145251
Chapter II Neoplasms,Melanoma in situ,KIRREL2,Kin of IRRE-like protein 2,40031,160,0.76 [0.53-1.10],0.1447582541700699
Chapter II Neoplasms,Melanoma in situ,KIT,Mast/stem cell growth factor receptor Kit,41076,163,1.11 [0.69-1.77],0.6765029597315111
Chapter II Neoplasms,Melanoma in situ,KITLG,Kit ligand,40984,163,0.82 [0.56-1.20],0.3024038312263875
Chapter II Neoplasms,Melanoma in situ,KLB,Beta-klotho,40031,160,0.94 [0.78-1.14],0.5448410518489555
Chapter II Neoplasms,Melanoma in situ,KLF4,Krueppel-like factor 4,34549,138,1.02 [0.69-1.53],0.9049936946256532
Chapter II Neoplasms,Melanoma in situ,KLHL41,Kelch-like protein 41,35587,140,0.98 [0.69-1.37],0.8927792720083877
Chapter II Neoplasms,Melanoma in situ,KLK1,Kallikrein-1,40571,160,0.91 [0.81-1.02],0.0900860407383819
Chapter II Neoplasms,Melanoma in situ,KLK10,Kallikrein-10,40972,164,0.86 [0.61-1.22],0.4037147339913257
Chapter II Neoplasms,Melanoma in situ,KLK11,Kallikrein-11,40690,164,0.81 [0.50-1.29],0.3706799522837207
Chapter II Neoplasms,Melanoma in situ,KLK12,Kallikrein-12,40055,159,0.99 [0.89-1.09],0.8108673327232876
Chapter II Neoplasms,Melanoma in situ,KLK13,Kallikrein-13,40054,157,1.14 [0.83-1.57],0.4127425144746526
Chapter II Neoplasms,Melanoma in situ,KLK14,Kallikrein-14,41358,164,0.78 [0.58-1.05],0.106166224352472
Chapter II Neoplasms,Melanoma in situ,KLK15,Kallikrein-15,35421,140,0.80 [0.59-1.09],0.1594404316385822
Chapter II Neoplasms,Melanoma in situ,KLK3,Prostate-specific antigen,35644,141,1.03 [0.86-1.24],0.7474734294494676
Chapter II Neoplasms,Melanoma in situ,KLK4,Kallikrein-4,41358,164,1.19 [0.97-1.48],0.1002219740657148
Chapter II Neoplasms,Melanoma in situ,KLK6,Kallikrein-6,41033,164,1.15 [0.73-1.81],0.5594171412892217
Chapter II Neoplasms,Melanoma in situ,KLK7,Kallikrein-7,33978,138,0.68 [0.43-1.06],0.0849592002308635
Chapter II Neoplasms,Melanoma in situ,KLK8,Kallikrein-8,39603,160,1.05 [0.70-1.56],0.8167696856057114
Chapter II Neoplasms,Melanoma in situ,KLKB1,Plasma kallikrein,34979,140,1.14 [0.59-2.19],0.7057614180802207
Chapter II Neoplasms,Melanoma in situ,KLRB1,Killer cell lectin-like receptor subfamily B member 1,41452,164,1.04 [0.72-1.51],0.8224992054788878
Chapter II Neoplasms,Melanoma in situ,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,34549,138,0.91 [0.67-1.23],0.5242692986446207
Chapter II Neoplasms,Melanoma in situ,KLRD1,Natural killer cells antigen CD94,41452,164,1.30 [0.97-1.75],0.083315573996589
Chapter II Neoplasms,Melanoma in situ,KLRF1,Killer cell lectin-like receptor subfamily F member 1,34608,134,0.89 [0.58-1.35],0.5780552075076586
Chapter II Neoplasms,Melanoma in situ,KLRK1,NKG2-D type II integral membrane protein,35570,140,1.01 [0.72-1.43],0.9391484943256544
Chapter II Neoplasms,Melanoma in situ,KRT14,"Keratin, type I cytoskeletal 14",38752,150,1.07 [0.65-1.74],0.7965138626628019
Chapter II Neoplasms,Melanoma in situ,KRT17,"Keratin, type I cytoskeletal 17",34518,137,0.86 [0.55-1.35],0.5087981487077708
Chapter II Neoplasms,Melanoma in situ,KRT18,"Keratin, type I cytoskeletal 18",40789,160,0.91 [0.76-1.09],0.307758814060701
Chapter II Neoplasms,Melanoma in situ,KRT19,"Keratin, type I cytoskeletal 19",40875,163,0.90 [0.72-1.11],0.3229871699532197
Chapter II Neoplasms,Melanoma in situ,KRT5,"Keratin, type II cytoskeletal 5",40031,160,1.11 [0.84-1.46],0.4567458607384085
Chapter II Neoplasms,Melanoma in situ,KRT6C,"Keratin, type II cytoskeletal 6C",34518,137,0.93 [0.59-1.46],0.74977874582698
Chapter II Neoplasms,Melanoma in situ,KRT8,"Keratin, type II cytoskeletal 8",34549,138,0.79 [0.59-1.06],0.1215434431113367
Chapter II Neoplasms,Melanoma in situ,KYAT1,Kynurenine--oxoglutarate transaminase 1,40914,163,1.15 [0.90-1.46],0.2544005744150075
Chapter II Neoplasms,Melanoma in situ,KYNU,Kynureninase,41452,164,1.23 [0.91-1.66],0.1786295247680207
Chapter II Neoplasms,Melanoma in situ,L1CAM,Neural cell adhesion molecule L1,41097,164,0.69 [0.42-1.11],0.1242499232462504
Chapter II Neoplasms,Melanoma in situ,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,35640,141,1.03 [0.86-1.24],0.7225880362578665
Chapter II Neoplasms,Melanoma in situ,LACRT,Extracellular glycoprotein lacritin,35406,139,1.32 [1.02-1.71],0.0317432673616071
Chapter II Neoplasms,Melanoma in situ,LACTB2,Endoribonuclease LACTB2,40984,163,1.15 [0.93-1.42],0.1855045377149323
Chapter II Neoplasms,Melanoma in situ,LAG3,Lymphocyte activation gene 3 protein,40789,160,1.12 [0.79-1.59],0.5170585912485215
Chapter II Neoplasms,Melanoma in situ,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,40948,164,1.19 [0.81-1.75],0.3646779844072956
Chapter II Neoplasms,Melanoma in situ,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,40682,158,1.01 [0.88-1.16],0.8843071727672736
Chapter II Neoplasms,Melanoma in situ,LAMA1,Laminin subunit alpha-1,34518,137,0.92 [0.66-1.29],0.639322108927122
Chapter II Neoplasms,Melanoma in situ,LAMA4,Laminin subunit alpha-4,41147,164,0.99 [0.65-1.50],0.9496679724366636
Chapter II Neoplasms,Melanoma in situ,LAMB1,Laminin subunit beta-1,34695,137,0.87 [0.50-1.50],0.6144134105156442
Chapter II Neoplasms,Melanoma in situ,LAMP1,Lysosome-associated membrane glycoprotein 1,34664,139,1.05 [0.60-1.82],0.8689169235899464
Chapter II Neoplasms,Melanoma in situ,LAMP2,Lysosome-associated membrane glycoprotein 2,39742,159,1.34 [0.65-2.79],0.4289144416995747
Chapter II Neoplasms,Melanoma in situ,LAMP3,Lysosome-associated membrane glycoprotein 3,41379,164,1.09 [0.83-1.43],0.5165983481305776
Chapter II Neoplasms,Melanoma in situ,LAMTOR5,Ragulator complex protein LAMTOR5,35477,140,1.09 [0.75-1.60],0.6421679578393478
Chapter II Neoplasms,Melanoma in situ,LAP3,Cytosol aminopeptidase,40249,159,1.13 [0.85-1.50],0.3939268170476738
Chapter II Neoplasms,Melanoma in situ,LARP1,La-related protein 1,35477,140,1.00 [0.78-1.29],0.99032039623069
Chapter II Neoplasms,Melanoma in situ,LAT,Linker for activation of T-cells family member 1,41452,164,1.11 [0.92-1.34],0.2613887424956457
Chapter II Neoplasms,Melanoma in situ,LAT2,Linker for activation of T-cells family member 2,40789,160,1.03 [0.92-1.15],0.6451554261962507
Chapter II Neoplasms,Melanoma in situ,LATS1,Serine/threonine-protein kinase LATS1,34608,134,1.20 [0.99-1.46],0.0665301537890094
Chapter II Neoplasms,Melanoma in situ,LAYN,Layilin,40606,158,0.88 [0.57-1.35],0.5573906234727326
Chapter II Neoplasms,Melanoma in situ,LBP,Lipopolysaccharide-binding protein,41135,163,0.91 [0.72-1.15],0.4202397148364513
Chapter II Neoplasms,Melanoma in situ,LBR,Delta(14)-sterol reductase LBR,41349,165,1.06 [0.88-1.28],0.5550273338881254
Chapter II Neoplasms,Melanoma in situ,LCAT,Phosphatidylcholine-sterol acyltransferase,35663,141,1.45 [0.69-3.08],0.3289636441625551
Chapter II Neoplasms,Melanoma in situ,LCN15,Lipocalin-15,35587,140,0.72 [0.52-0.99],0.0405651357734654
Chapter II Neoplasms,Melanoma in situ,LCN2,Neutrophil gelatinase-associated lipocalin,39752,155,1.03 [0.71-1.50],0.8829914512004624
Chapter II Neoplasms,Melanoma in situ,LCP1,Plastin-2,35644,141,0.89 [0.63-1.27],0.5289065820422709
Chapter II Neoplasms,Melanoma in situ,LDLR,Low-density lipoprotein receptor,41092,160,0.98 [0.75-1.28],0.8845895696297148
Chapter II Neoplasms,Melanoma in situ,LDLRAP1,Low density lipoprotein receptor adapter protein 1,35587,140,1.13 [0.96-1.34],0.1367720008610028
Chapter II Neoplasms,Melanoma in situ,LECT2,Leukocyte cell-derived chemotaxin-2,35640,141,1.07 [0.84-1.36],0.603585214686581
Chapter II Neoplasms,Melanoma in situ,LEFTY2,Left-right determination factor 2,41296,164,0.75 [0.57-0.99],0.0394389056095289
Chapter II Neoplasms,Melanoma in situ,LEG1,Protein LEG1 homolog,33677,131,1.16 [0.91-1.49],0.2197789909565323
Chapter II Neoplasms,Melanoma in situ,LELP1,Late cornified envelope-like proline-rich protein 1,34549,138,1.01 [0.80-1.27],0.9333964125765808
Chapter II Neoplasms,Melanoma in situ,LEO1,RNA polymerase-associated protein LEO1,35587,140,0.76 [0.42-1.38],0.3703942262323538
Chapter II Neoplasms,Melanoma in situ,LEP,Leptin,40984,163,1.05 [0.85-1.29],0.6716504224031512
Chapter II Neoplasms,Melanoma in situ,LEPR,Leptin receptor,40984,163,0.95 [0.60-1.49],0.8211211584591224
Chapter II Neoplasms,Melanoma in situ,LETM1,Mitochondrial proton/calcium exchanger protein,35587,140,0.96 [0.70-1.31],0.7832017648038437
Chapter II Neoplasms,Melanoma in situ,LGALS1,Galectin-1,40984,163,0.90 [0.59-1.36],0.6063138022129118
Chapter II Neoplasms,Melanoma in situ,LGALS3,Galectin-3,41093,161,0.90 [0.56-1.43],0.6555791328807005
Chapter II Neoplasms,Melanoma in situ,LGALS3BP,Galectin-3-binding protein,35692,141,0.62 [0.35-1.11],0.1086028066302539
Chapter II Neoplasms,Melanoma in situ,LGALS4,Galectin-4,40948,164,1.16 [0.90-1.49],0.2509487236524134
Chapter II Neoplasms,Melanoma in situ,LGALS7_LGALS7B,Galectin-7,40917,162,1.04 [0.74-1.45],0.8362671255692481
Chapter II Neoplasms,Melanoma in situ,LGALS8,Galectin-8,41349,165,1.17 [0.93-1.46],0.1715616590951755
Chapter II Neoplasms,Melanoma in situ,LGALS9,Galectin-9,40961,164,1.05 [0.67-1.64],0.8268257105693795
Chapter II Neoplasms,Melanoma in situ,LGMN,Legumain,41147,164,1.05 [0.71-1.54],0.8204942035276945
Chapter II Neoplasms,Melanoma in situ,LHB,Lutropin subunit beta,40055,159,0.90 [0.75-1.08],0.2482286503279738
Chapter II Neoplasms,Melanoma in situ,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,41009,163,0.90 [0.71-1.14],0.3896195588847168
Chapter II Neoplasms,Melanoma in situ,LIF,Leukemia inhibitory factor,40031,160,0.84 [0.62-1.14],0.2568542867844315
Chapter II Neoplasms,Melanoma in situ,LIFR,Leukemia inhibitory factor receptor,40939,163,1.22 [0.69-2.17],0.496208182855634
Chapter II Neoplasms,Melanoma in situ,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,40993,164,1.04 [0.70-1.55],0.8359448090245194
Chapter II Neoplasms,Melanoma in situ,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,35644,141,1.00 [0.90-1.13],0.9495691741355524
Chapter II Neoplasms,Melanoma in situ,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,34518,137,0.79 [0.54-1.14],0.2050052592905552
Chapter II Neoplasms,Melanoma in situ,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,40930,163,0.95 [0.62-1.48],0.8342835087797907
Chapter II Neoplasms,Melanoma in situ,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,35640,141,0.99 [0.80-1.23],0.921900118561437
Chapter II Neoplasms,Melanoma in situ,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,41485,164,0.83 [0.50-1.37],0.456753982454813
Chapter II Neoplasms,Melanoma in situ,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,41287,162,0.96 [0.65-1.44],0.8585832608956092
Chapter II Neoplasms,Melanoma in situ,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,40249,159,0.95 [0.68-1.32],0.7599897309254233
Chapter II Neoplasms,Melanoma in situ,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,41485,164,0.87 [0.73-1.05],0.1544798360294247
Chapter II Neoplasms,Melanoma in situ,LIPF,Gastric triacylglycerol lipase,34695,137,0.86 [0.66-1.13],0.2845583554134854
Chapter II Neoplasms,Melanoma in situ,LMNB1,Lamin-B1,35415,139,0.87 [0.66-1.14],0.3086126790866355
Chapter II Neoplasms,Melanoma in situ,LMNB2,Lamin-B2,35570,140,0.92 [0.51-1.68],0.7945758499752944
Chapter II Neoplasms,Melanoma in situ,LMOD1,Leiomodin-1,35587,140,0.85 [0.52-1.39],0.5180955857336895
Chapter II Neoplasms,Melanoma in situ,LMOD2,Leiomodin-2,34549,138,0.71 [0.52-0.97],0.0288979727626639
Chapter II Neoplasms,Melanoma in situ,LONP1,"Lon protease homolog, mitochondrial",34695,137,1.09 [0.90-1.31],0.388043686702633
Chapter II Neoplasms,Melanoma in situ,LPA,Apolipoprotein(a),34847,138,0.97 [0.89-1.06],0.5492749356965401
Chapter II Neoplasms,Melanoma in situ,LPCAT2,Lysophosphatidylcholine acyltransferase 2,40789,160,1.02 [0.74-1.41],0.8924525215575877
Chapter II Neoplasms,Melanoma in situ,LPL,Lipoprotein lipase,40984,163,0.91 [0.68-1.21],0.5082472442052173
Chapter II Neoplasms,Melanoma in situ,LPO,Lactoperoxidase,39641,154,1.26 [0.99-1.60],0.0591313423945822
Chapter II Neoplasms,Melanoma in situ,LPP,Lipoma-preferred partner,34518,137,1.06 [0.83-1.37],0.6257147019388989
Chapter II Neoplasms,Melanoma in situ,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,34518,137,0.98 [0.77-1.26],0.9005235514034754
Chapter II Neoplasms,Melanoma in situ,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,34686,135,0.89 [0.60-1.31],0.5475208578037757
Chapter II Neoplasms,Melanoma in situ,LRG1,Leucine-rich alpha-2-glycoprotein,35692,141,1.20 [0.65-2.21],0.5580947205023346
Chapter II Neoplasms,Melanoma in situ,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,41237,164,1.41 [0.95-2.10],0.0891694026377453
Chapter II Neoplasms,Melanoma in situ,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,34485,134,0.54 [0.27-1.08],0.0820841418522772
Chapter II Neoplasms,Melanoma in situ,LRP1,Prolow-density lipoprotein receptor-related protein 1,40789,160,0.73 [0.43-1.27],0.2664024989098945
Chapter II Neoplasms,Melanoma in situ,LRP11,Low-density lipoprotein receptor-related protein 11,40984,163,0.93 [0.63-1.38],0.73004589132149
Chapter II Neoplasms,Melanoma in situ,LRP2,Low-density lipoprotein receptor-related protein 2,34686,135,0.80 [0.49-1.31],0.3782719328429547
Chapter II Neoplasms,Melanoma in situ,LRP2BP,LRP2-binding protein,34686,135,0.87 [0.69-1.10],0.24468309422423
Chapter II Neoplasms,Melanoma in situ,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,41349,165,0.93 [0.73-1.20],0.5956903247870934
Chapter II Neoplasms,Melanoma in situ,LRRC25,Leucine-rich repeat-containing protein 25,40789,160,0.98 [0.68-1.42],0.9192083064910148
Chapter II Neoplasms,Melanoma in situ,LRRC37A2,Leucine-rich repeat-containing protein 37A2,35486,140,1.15 [0.79-1.68],0.4630759053299789
Chapter II Neoplasms,Melanoma in situ,LRRC38,Leucine-rich repeat-containing protein 38,34686,135,0.89 [0.62-1.26],0.5034226576362477
Chapter II Neoplasms,Melanoma in situ,LRRC59,Leucine-rich repeat-containing protein 59,35640,141,1.19 [0.87-1.65],0.2774761197349031
Chapter II Neoplasms,Melanoma in situ,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,35477,140,1.20 [0.87-1.66],0.2612370723196007
Chapter II Neoplasms,Melanoma in situ,LRRN1,Leucine-rich repeat neuronal protein 1,40249,159,0.64 [0.45-0.92],0.0153347471617455
Chapter II Neoplasms,Melanoma in situ,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,34686,135,1.08 [0.73-1.58],0.7083424945598249
Chapter II Neoplasms,Melanoma in situ,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,35587,140,0.82 [0.44-1.56],0.5539531761236008
Chapter II Neoplasms,Melanoma in situ,LSM1,U6 snRNA-associated Sm-like protein LSm1,40055,159,1.05 [0.82-1.35],0.693761423007025
Chapter II Neoplasms,Melanoma in situ,LSM8,U6 snRNA-associated Sm-like protein LSm8,34984,139,0.98 [0.81-1.19],0.852909291679628
Chapter II Neoplasms,Melanoma in situ,LSP1,Lymphocyte-specific protein 1,40939,163,0.98 [0.69-1.38],0.9033176346951648
Chapter II Neoplasms,Melanoma in situ,LTA,Lymphotoxin-alpha,40939,163,0.84 [0.59-1.20],0.3412599224317386
Chapter II Neoplasms,Melanoma in situ,LTA4H,Leukotriene A-4 hydrolase,41358,164,1.02 [0.80-1.28],0.8991033650359442
Chapter II Neoplasms,Melanoma in situ,LTB,Lymphotoxin-beta,35477,140,1.09 [0.70-1.69],0.7001409246911519
Chapter II Neoplasms,Melanoma in situ,LTBP2,Latent-transforming growth factor beta-binding protein 2,41485,164,0.96 [0.61-1.51],0.8620094035209591
Chapter II Neoplasms,Melanoma in situ,LTBP3,Latent-transforming growth factor beta-binding protein 3,40055,159,0.89 [0.67-1.18],0.411928993134435
Chapter II Neoplasms,Melanoma in situ,LTBR,Tumor necrosis factor receptor superfamily member 3,40754,163,0.83 [0.49-1.38],0.4672744429611
Chapter II Neoplasms,Melanoma in situ,LTO1,Protein LTO1 homolog,40249,159,1.06 [0.76-1.48],0.739198844632889
Chapter II Neoplasms,Melanoma in situ,LUZP2,Leucine zipper protein 2,35477,140,1.02 [0.71-1.46],0.9266936036641452
Chapter II Neoplasms,Melanoma in situ,LXN,Latexin,40496,158,0.96 [0.78-1.18],0.6862831947257511
Chapter II Neoplasms,Melanoma in situ,LY6D,Lymphocyte antigen 6D,40761,162,0.98 [0.67-1.43],0.91777496586343
Chapter II Neoplasms,Melanoma in situ,LY75,Lymphocyte antigen 75,40939,163,1.44 [0.99-2.09],0.0554492571535771
Chapter II Neoplasms,Melanoma in situ,LY9,T-lymphocyte surface antigen Ly-9,40536,160,1.46 [0.89-2.37],0.131218475077476
Chapter II Neoplasms,Melanoma in situ,LY96,Lymphocyte antigen 96,40682,158,0.73 [0.48-1.11],0.1399481222539724
Chapter II Neoplasms,Melanoma in situ,LYAR,Cell growth-regulating nucleolar protein,40055,159,0.99 [0.76-1.29],0.946999201896776
Chapter II Neoplasms,Melanoma in situ,LYN,Tyrosine-protein kinase Lyn,40789,160,1.06 [0.90-1.25],0.46882468761817
Chapter II Neoplasms,Melanoma in situ,LYPD1,Ly6/PLAUR domain-containing protein 1,40031,160,0.89 [0.69-1.14],0.3471157930203091
Chapter II Neoplasms,Melanoma in situ,LYPD3,Ly6/PLAUR domain-containing protein 3,40770,164,0.70 [0.46-1.07],0.1022839486494776
Chapter II Neoplasms,Melanoma in situ,LYPD8,Ly6/PLAUR domain-containing protein 8,40055,159,0.84 [0.62-1.14],0.2630055573996515
Chapter II Neoplasms,Melanoma in situ,LYPLA2,Acyl-protein thioesterase 2,34549,138,0.85 [0.70-1.02],0.0802229150843313
Chapter II Neoplasms,Melanoma in situ,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,34686,135,1.19 [1.04-1.35],0.0088184953499696
Chapter II Neoplasms,Melanoma in situ,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,35692,141,0.62 [0.27-1.42],0.2616393167737029
Chapter II Neoplasms,Melanoma in situ,LYZL2,Lysozyme-like protein 2,34394,136,1.08 [0.69-1.69],0.737283145658615
Chapter II Neoplasms,Melanoma in situ,LZTFL1,Leucine zipper transcription factor-like protein 1,34878,138,1.19 [0.95-1.49],0.1371079345738641
Chapter II Neoplasms,Melanoma in situ,M6PR,Cation-dependent mannose-6-phosphate receptor,34695,137,1.38 [1.01-1.89],0.0423888015758283
Chapter II Neoplasms,Melanoma in situ,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40541,158,0.99 [0.74-1.32],0.9601070758428476
Chapter II Neoplasms,Melanoma in situ,MAEA,E3 ubiquitin-protein transferase MAEA,40055,159,0.82 [0.56-1.20],0.3095606862639182
Chapter II Neoplasms,Melanoma in situ,MAG,Myelin-associated glycoprotein,34686,135,0.89 [0.63-1.26],0.5137399303323376
Chapter II Neoplasms,Melanoma in situ,MAGEA3,Melanoma-associated antigen 3,34984,139,1.01 [0.83-1.23],0.9059765058450232
Chapter II Neoplasms,Melanoma in situ,MAGED1,Melanoma-associated antigen D1,40055,159,1.18 [0.89-1.56],0.2396268328111277
Chapter II Neoplasms,Melanoma in situ,MAMDC2,MAM domain-containing protein 2,35640,141,1.18 [0.75-1.87],0.4737988519423733
Chapter II Neoplasms,Melanoma in situ,MAMDC4,Apical endosomal glycoprotein,35477,140,0.86 [0.64-1.17],0.3415893284482567
Chapter II Neoplasms,Melanoma in situ,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",34695,137,0.91 [0.47-1.74],0.7682788962445721
Chapter II Neoplasms,Melanoma in situ,MAN2B2,Epididymis-specific alpha-mannosidase,35640,141,0.84 [0.64-1.09],0.188619394045783
Chapter II Neoplasms,Melanoma in situ,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",34394,136,0.96 [0.69-1.33],0.7889234848190674
Chapter II Neoplasms,Melanoma in situ,MANF,Mesencephalic astrocyte-derived neurotrophic factor,41147,164,1.09 [0.96-1.22],0.1778586364376826
Chapter II Neoplasms,Melanoma in situ,MANSC1,MANSC domain-containing protein 1,41097,164,0.88 [0.53-1.47],0.6257645451038164
Chapter II Neoplasms,Melanoma in situ,MANSC4,MANSC domain-containing protein 4,34518,137,0.80 [0.62-1.04],0.0931710057652551
Chapter II Neoplasms,Melanoma in situ,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,34549,138,1.01 [0.60-1.69],0.9733600589246548
Chapter II Neoplasms,Melanoma in situ,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,34518,137,0.86 [0.63-1.16],0.3134008686556137
Chapter II Neoplasms,Melanoma in situ,MAP2,Microtubule-associated protein 2,35570,140,1.42 [1.04-1.93],0.0258939995637271
Chapter II Neoplasms,Melanoma in situ,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,35486,140,1.15 [0.89-1.47],0.2901315967256878
Chapter II Neoplasms,Melanoma in situ,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,40939,163,1.05 [0.91-1.21],0.4901781347580102
Chapter II Neoplasms,Melanoma in situ,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,40055,159,1.07 [0.93-1.23],0.3679116295657616
Chapter II Neoplasms,Melanoma in situ,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,40606,158,1.09 [0.96-1.23],0.1973078521976606
Chapter II Neoplasms,Melanoma in situ,MAPK13,Mitogen-activated protein kinase 13,34394,136,0.86 [0.57-1.28],0.4496680736396446
Chapter II Neoplasms,Melanoma in situ,MAPK9,Mitogen-activated protein kinase 9,40939,163,1.56 [1.14-2.14],0.0055051811239013
Chapter II Neoplasms,Melanoma in situ,MAPKAPK2,MAP kinase-activated protein kinase 2,34984,139,1.12 [0.90-1.40],0.3092848033446279
Chapter II Neoplasms,Melanoma in situ,MAPRE3,Microtubule-associated protein RP/EB family member 3,34394,136,0.96 [0.85-1.08],0.4894204836795374
Chapter II Neoplasms,Melanoma in situ,MAPT,Microtubule-associated protein tau,40031,160,0.79 [0.63-1.00],0.0463330636942311
Chapter II Neoplasms,Melanoma in situ,MARCO,Macrophage receptor MARCO,40984,163,0.85 [0.50-1.45],0.5529058992249959
Chapter II Neoplasms,Melanoma in situ,MARS1,"Methionine--tRNA ligase, cytoplasmic",34808,138,1.13 [0.93-1.37],0.2185212153313073
Chapter II Neoplasms,Melanoma in situ,MASP1,Mannan-binding lectin serine protease 1,40606,158,0.86 [0.47-1.57],0.6132858907891314
Chapter II Neoplasms,Melanoma in situ,MATN2,Matrilin-2,41020,164,0.80 [0.50-1.28],0.3527937821071504
Chapter II Neoplasms,Melanoma in situ,MATN3,Matrilin-3,40613,157,1.00 [0.64-1.55],0.9924271886280096
Chapter II Neoplasms,Melanoma in situ,MAVS,Mitochondrial antiviral-signaling protein,40055,159,1.09 [0.93-1.27],0.2763718475151546
Chapter II Neoplasms,Melanoma in situ,MAX,Protein max,40031,160,1.14 [0.99-1.30],0.062726930303567
Chapter II Neoplasms,Melanoma in situ,MB,Myoglobin,41485,164,0.91 [0.70-1.20],0.5135639612383993
Chapter II Neoplasms,Melanoma in situ,MBL2,Mannose-binding protein C,35189,139,0.94 [0.81-1.09],0.3853090120067226
Chapter II Neoplasms,Melanoma in situ,MCAM,Cell surface glycoprotein MUC18,41135,163,0.90 [0.59-1.38],0.6332852603762593
Chapter II Neoplasms,Melanoma in situ,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",35587,140,1.25 [0.90-1.75],0.1839598535842044
Chapter II Neoplasms,Melanoma in situ,MCEMP1,Mast cell-expressed membrane protein 1,34608,134,0.97 [0.81-1.17],0.7581203362902713
Chapter II Neoplasms,Melanoma in situ,MCFD2,Multiple coagulation factor deficiency protein 2,40790,159,1.43 [1.04-1.96],0.0262752651734818
Chapter II Neoplasms,Melanoma in situ,MCTS1,Malignant T-cell-amplified sequence 1,35486,140,0.96 [0.52-1.80],0.9081700952497552
Chapter II Neoplasms,Melanoma in situ,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,40682,158,1.04 [0.85-1.27],0.7159032591933443
Chapter II Neoplasms,Melanoma in situ,MDH1,"Malate dehydrogenase, cytoplasmic",35460,141,1.17 [0.79-1.72],0.4413848042235754
Chapter II Neoplasms,Melanoma in situ,MDK,Midkine,40975,163,1.07 [0.82-1.39],0.615122135748961
Chapter II Neoplasms,Melanoma in situ,MDM1,Nuclear protein MDM1,34686,135,0.73 [0.42-1.26],0.2587481435022488
Chapter II Neoplasms,Melanoma in situ,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",34695,137,1.11 [0.93-1.33],0.2582214991554785
Chapter II Neoplasms,Melanoma in situ,MED18,Mediator of RNA polymerase II transcription subunit 18,40055,159,1.13 [0.94-1.36],0.194664368669295
Chapter II Neoplasms,Melanoma in situ,MED21,Mediator of RNA polymerase II transcription subunit 21,34518,137,0.65 [0.42-1.01],0.0541630970635497
Chapter II Neoplasms,Melanoma in situ,MEGF10,Multiple epidermal growth factor-like domains protein 10,40948,164,0.90 [0.63-1.28],0.5451029602631605
Chapter II Neoplasms,Melanoma in situ,MEGF11,Multiple epidermal growth factor-like domains protein 11,34518,137,0.81 [0.47-1.39],0.4374641730717064
Chapter II Neoplasms,Melanoma in situ,MEGF9,Multiple epidermal growth factor-like domains protein 9,41357,164,0.96 [0.47-1.94],0.9082292081159578
Chapter II Neoplasms,Melanoma in situ,MELTF,Melanotransferrin,35640,141,1.38 [0.80-2.36],0.2442446207533009
Chapter II Neoplasms,Melanoma in situ,MENT,Protein MENT,34878,138,0.82 [0.40-1.70],0.5957468465638793
Chapter II Neoplasms,Melanoma in situ,MEP1A,Meprin A subunit alpha,35486,140,1.09 [0.87-1.37],0.4319811738280522
Chapter II Neoplasms,Melanoma in situ,MEP1B,Meprin A subunit beta,40984,163,1.01 [0.90-1.14],0.8392619894129266
Chapter II Neoplasms,Melanoma in situ,MEPE,Matrix extracellular phosphoglycoprotein,40948,164,1.05 [0.60-1.85],0.8524979650952151
Chapter II Neoplasms,Melanoma in situ,MERTK,Tyrosine-protein kinase Mer,41452,164,0.73 [0.42-1.27],0.2669664569777575
Chapter II Neoplasms,Melanoma in situ,MESD,LRP chaperone MESD,40993,164,1.07 [0.96-1.20],0.2238664143084845
Chapter II Neoplasms,Melanoma in situ,MET,Hepatocyte growth factor receptor,41087,161,0.95 [0.47-1.93],0.8948251225358127
Chapter II Neoplasms,Melanoma in situ,METAP1,Methionine aminopeptidase 1,40031,160,0.93 [0.57-1.51],0.768705696201941
Chapter II Neoplasms,Melanoma in situ,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",40939,163,1.06 [0.90-1.25],0.5051766191534632
Chapter II Neoplasms,Melanoma in situ,METAP2,Methionine aminopeptidase 2,41296,164,1.11 [0.87-1.41],0.4162482191509772
Chapter II Neoplasms,Melanoma in situ,MFAP3,Microfibril-associated glycoprotein 3,40258,158,1.02 [0.76-1.35],0.9055519620197612
Chapter II Neoplasms,Melanoma in situ,MFAP3L,Microfibrillar-associated protein 3-like,34686,135,0.97 [0.75-1.26],0.8425165082472735
Chapter II Neoplasms,Melanoma in situ,MFAP4,Microfibril-associated glycoprotein 4,34878,138,1.02 [0.61-1.71],0.9395070074767022
Chapter II Neoplasms,Melanoma in situ,MFAP5,Microfibrillar-associated protein 5,41485,164,1.05 [0.75-1.49],0.7635301284755852
Chapter II Neoplasms,Melanoma in situ,MFGE8,Lactadherin,40993,164,0.84 [0.60-1.16],0.2795946601936884
Chapter II Neoplasms,Melanoma in situ,MGLL,Monoglyceride lipase,41087,164,1.10 [0.94-1.29],0.2458102560635919
Chapter II Neoplasms,Melanoma in situ,MGMT,Methylated-DNA--protein-cysteine methyltransferase,40939,163,1.05 [0.93-1.17],0.4415534203383993
Chapter II Neoplasms,Melanoma in situ,MIA,Melanoma-derived growth regulatory protein,41097,164,0.87 [0.59-1.28],0.4670942761335908
Chapter II Neoplasms,Melanoma in situ,MICALL2,MICAL-like protein 2,34686,135,1.16 [0.93-1.45],0.1883420580941011
Chapter II Neoplasms,Melanoma in situ,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,40939,163,1.10 [0.99-1.23],0.0902737478041435
Chapter II Neoplasms,Melanoma in situ,MIF,Macrophage migration inhibitory factor,40927,163,1.08 [0.88-1.32],0.4651164872103084
Chapter II Neoplasms,Melanoma in situ,MILR1,Allergin-1,40249,159,0.69 [0.52-0.92],0.0118001222446773
Chapter II Neoplasms,Melanoma in situ,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,35477,140,1.09 [0.94-1.27],0.2659260945825581
Chapter II Neoplasms,Melanoma in situ,MINK1,Misshapen-like kinase 1,35570,140,1.17 [0.98-1.40],0.0863507869930503
Chapter II Neoplasms,Melanoma in situ,MITD1,MIT domain-containing protein 1,40682,158,1.09 [0.94-1.27],0.2384388877382132
Chapter II Neoplasms,Melanoma in situ,MKI67,Proliferation marker protein Ki-67,34608,134,0.94 [0.61-1.44],0.7656613389330758
Chapter II Neoplasms,Melanoma in situ,MLLT1,Protein ENL,34394,136,1.18 [0.95-1.46],0.1290643407425521
Chapter II Neoplasms,Melanoma in situ,MLN,Promotilin,40939,163,0.87 [0.74-1.01],0.0683790940156293
Chapter II Neoplasms,Melanoma in situ,MME,Neprilysin,40789,160,0.88 [0.73-1.06],0.1671280328130295
Chapter II Neoplasms,Melanoma in situ,MMP1,Interstitial collagenase,39502,155,1.10 [0.94-1.30],0.2223317658149567
Chapter II Neoplasms,Melanoma in situ,MMP10,Stromelysin-2,40894,164,0.90 [0.70-1.15],0.391514366015667
Chapter II Neoplasms,Melanoma in situ,MMP12,Macrophage metalloelastase,41048,162,0.90 [0.69-1.18],0.4368911742981264
Chapter II Neoplasms,Melanoma in situ,MMP13,Collagenase 3,40031,160,0.64 [0.42-0.99],0.0451789696680265
Chapter II Neoplasms,Melanoma in situ,MMP15,Matrix metalloproteinase-15,35640,141,0.76 [0.50-1.17],0.2119693211642712
Chapter II Neoplasms,Melanoma in situ,MMP3,Stromelysin-1,40993,164,0.99 [0.74-1.32],0.9325433183057816
Chapter II Neoplasms,Melanoma in situ,MMP7,Matrilysin,40193,158,1.06 [0.79-1.41],0.716322438283616
Chapter II Neoplasms,Melanoma in situ,MMP8,Neutrophil collagenase,41279,165,1.03 [0.85-1.24],0.7828567411494959
Chapter II Neoplasms,Melanoma in situ,MMP9,Matrix metalloproteinase-9,40932,164,0.95 [0.75-1.19],0.6521034961241192
Chapter II Neoplasms,Melanoma in situ,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",34518,137,0.80 [0.56-1.15],0.2279886639383443
Chapter II Neoplasms,Melanoma in situ,MN1,Transcriptional activator MN1,34686,135,0.83 [0.60-1.14],0.2405869233056423
Chapter II Neoplasms,Melanoma in situ,MNAT1,CDK-activating kinase assembly factor MAT1,34984,139,0.77 [0.51-1.16],0.2048257076981651
Chapter II Neoplasms,Melanoma in situ,MNDA,Myeloid cell nuclear differentiation antigen,40920,163,0.96 [0.83-1.10],0.5538192498311287
Chapter II Neoplasms,Melanoma in situ,MOCS2,Molybdopterin synthase catalytic subunit,34878,138,1.11 [0.86-1.42],0.4252985462162854
Chapter II Neoplasms,Melanoma in situ,MOG,Myelin-oligodendrocyte glycoprotein,41358,164,0.86 [0.56-1.32],0.4917325892847768
Chapter II Neoplasms,Melanoma in situ,MORC3,MORC family CW-type zinc finger protein 3,35570,140,0.80 [0.43-1.51],0.4933382552240044
Chapter II Neoplasms,Melanoma in situ,MORF4L1,Mortality factor 4-like protein 1,34984,139,0.82 [0.52-1.28],0.3832070572290484
Chapter II Neoplasms,Melanoma in situ,MORF4L2,Mortality factor 4-like protein 2,34394,136,0.87 [0.55-1.37],0.5409385019836369
Chapter II Neoplasms,Melanoma in situ,MORN4,MORN repeat-containing protein 4,34394,136,0.91 [0.72-1.15],0.4206662785647153
Chapter II Neoplasms,Melanoma in situ,MPHOSPH8,M-phase phosphoprotein 8,40258,158,0.98 [0.81-1.19],0.8690679762425829
Chapter II Neoplasms,Melanoma in situ,MPI,Mannose-6-phosphate isomerase,40789,160,1.06 [0.90-1.25],0.4928414706867724
Chapter II Neoplasms,Melanoma in situ,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,41087,164,1.11 [0.92-1.33],0.2860997690167549
Chapter II Neoplasms,Melanoma in situ,MPO,Myeloperoxidase,40993,164,0.96 [0.71-1.29],0.763718527075048
Chapter II Neoplasms,Melanoma in situ,MPRIP,Myosin phosphatase Rho-interacting protein,35408,139,1.05 [0.74-1.51],0.7737890999482103
Chapter II Neoplasms,Melanoma in situ,MRC1,Macrophage mannose receptor 1,35663,141,0.75 [0.42-1.33],0.3291402130498801
Chapter II Neoplasms,Melanoma in situ,MRI1,Methylthioribose-1-phosphate isomerase,34686,135,0.91 [0.72-1.16],0.4606641470291424
Chapter II Neoplasms,Melanoma in situ,MRPL24,"39S ribosomal protein L24, mitochondrial",34518,137,0.82 [0.51-1.31],0.4018945821180835
Chapter II Neoplasms,Melanoma in situ,MRPL28,"39S ribosomal protein L28, mitochondrial",35587,140,0.92 [0.58-1.48],0.7442111491785737
Chapter II Neoplasms,Melanoma in situ,MRPL46,"39S ribosomal protein L46, mitochondrial",40031,160,0.82 [0.48-1.40],0.4666230168509327
Chapter II Neoplasms,Melanoma in situ,MRPL52,"39S ribosomal protein L52, mitochondrial",34327,135,0.48 [0.25-0.95],0.0347937498995784
Chapter II Neoplasms,Melanoma in situ,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",35587,140,1.02 [0.82-1.28],0.8348735800863022
Chapter II Neoplasms,Melanoma in situ,MRPS16,"28S ribosomal protein S16, mitochondrial",34608,134,0.99 [0.56-1.75],0.974065448947064
Chapter II Neoplasms,Melanoma in situ,MSLN,Mesothelin,40728,160,1.14 [0.89-1.45],0.296540296000036
Chapter II Neoplasms,Melanoma in situ,MSLNL,Mesothelin-like protein,34686,135,1.29 [0.87-1.90],0.2067273017379673
Chapter II Neoplasms,Melanoma in situ,MSMB,Beta-microseminoprotein,40878,160,0.96 [0.78-1.17],0.668730801261874
Chapter II Neoplasms,Melanoma in situ,MSR1,Macrophage scavenger receptor types I and II,41349,165,0.99 [0.73-1.35],0.9508514863154484
Chapter II Neoplasms,Melanoma in situ,MSRA,Mitochondrial peptide methionine sulfoxide reductase,41097,164,1.13 [0.93-1.36],0.2161180690710703
Chapter II Neoplasms,Melanoma in situ,MST1,Hepatocyte growth factor-like protein,35122,138,0.92 [0.74-1.15],0.4692333026529615
Chapter II Neoplasms,Melanoma in situ,MSTN,Growth/differentiation factor 8,40258,158,0.80 [0.61-1.06],0.115439414254665
Chapter II Neoplasms,Melanoma in situ,MTDH,Protein LYRIC,34608,134,1.14 [0.96-1.36],0.1450762434677339
Chapter II Neoplasms,Melanoma in situ,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",35570,140,0.60 [0.29-1.22],0.1579124370272806
Chapter II Neoplasms,Melanoma in situ,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,34984,139,1.05 [0.91-1.22],0.4921480167672217
Chapter II Neoplasms,Melanoma in situ,MTIF3,"Translation initiation factor IF-3, mitochondrial",35486,140,1.11 [0.93-1.34],0.2493112021159206
Chapter II Neoplasms,Melanoma in situ,MTPN,Myotrophin,40258,158,1.18 [0.81-1.74],0.3902240503158706
Chapter II Neoplasms,Melanoma in situ,MTR,Methionine synthase,34518,137,0.82 [0.62-1.10],0.1915534657074325
Chapter II Neoplasms,Melanoma in situ,MTSS1,Protein MTSS 1,35486,140,1.14 [0.99-1.32],0.0724057969578583
Chapter II Neoplasms,Melanoma in situ,MTSS2,Protein MTSS 2,35477,140,1.12 [0.96-1.32],0.1581335424927193
Chapter II Neoplasms,Melanoma in situ,MTUS1,Microtubule-associated tumor suppressor 1,34984,139,1.07 [0.80-1.42],0.6443895817689282
Chapter II Neoplasms,Melanoma in situ,MUC13,Mucin-13,40031,160,1.12 [0.84-1.48],0.4324233742492798
Chapter II Neoplasms,Melanoma in situ,MUC16,Mucin-16,40789,160,1.00 [0.93-1.08],0.9553559553294996
Chapter II Neoplasms,Melanoma in situ,MUC2,Mucin-2,35644,141,0.79 [0.66-0.95],0.0114488881661487
Chapter II Neoplasms,Melanoma in situ,MUCL3,Mucin-like protein 3,34394,136,0.88 [0.58-1.34],0.5504385896813383
Chapter II Neoplasms,Melanoma in situ,MVK,Mevalonate kinase,40249,159,1.08 [0.91-1.29],0.3907371937391061
Chapter II Neoplasms,Melanoma in situ,MXRA8,Matrix remodeling-associated protein 8,34878,138,0.77 [0.45-1.31],0.3349637676899862
Chapter II Neoplasms,Melanoma in situ,MYBPC1,"Myosin-binding protein C, slow-type",35640,141,1.05 [0.84-1.32],0.681512863425751
Chapter II Neoplasms,Melanoma in situ,MYBPC2,"Myosin-binding protein C, fast-type",34695,137,0.95 [0.77-1.16],0.5973979755575248
Chapter II Neoplasms,Melanoma in situ,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,35587,140,0.90 [0.70-1.17],0.431028154463675
Chapter II Neoplasms,Melanoma in situ,MYDGF,Myeloid-derived growth factor,35640,141,1.13 [0.96-1.32],0.1515246628395826
Chapter II Neoplasms,Melanoma in situ,MYH4,Myosin-4,34518,137,0.92 [0.63-1.36],0.6845063182908853
Chapter II Neoplasms,Melanoma in situ,MYH7B,Myosin-7B,34394,136,1.04 [0.72-1.49],0.8485909662323612
Chapter II Neoplasms,Melanoma in situ,MYH9,Myosin-9,35644,141,1.16 [1.01-1.34],0.0394900243503667
Chapter II Neoplasms,Melanoma in situ,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",34518,137,0.91 [0.58-1.41],0.661835126718111
Chapter II Neoplasms,Melanoma in situ,MYL3,Myosin light chain 3,34695,137,0.91 [0.72-1.15],0.4298292630162972
Chapter II Neoplasms,Melanoma in situ,MYL4,Myosin light chain 4,34695,137,0.87 [0.62-1.21],0.3946125890848239
Chapter II Neoplasms,Melanoma in situ,MYL6B,Myosin light chain 6B,34686,135,0.95 [0.79-1.15],0.6255436831842185
Chapter II Neoplasms,Melanoma in situ,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",34686,135,1.27 [0.95-1.69],0.1014502876423221
Chapter II Neoplasms,Melanoma in situ,MYO6,Unconventional myosin-VI,35587,140,0.74 [0.45-1.22],0.2399486989628562
Chapter II Neoplasms,Melanoma in situ,MYO9B,Unconventional myosin-IXb,40249,159,1.03 [0.83-1.27],0.7849016018318853
Chapter II Neoplasms,Melanoma in situ,MYOC,Myocilin,40993,164,0.85 [0.63-1.15],0.2988527856137679
Chapter II Neoplasms,Melanoma in situ,MYOM1,Myomesin-1,34549,138,0.94 [0.66-1.35],0.7517411457124137
Chapter II Neoplasms,Melanoma in situ,MYOM2,Myomesin-2,34518,137,0.95 [0.68-1.34],0.7705457021460483
Chapter II Neoplasms,Melanoma in situ,MYOM3,Myomesin-3,34878,138,0.90 [0.75-1.08],0.2557005252781405
Chapter II Neoplasms,Melanoma in situ,MZB1,Marginal zone B- and B1-cell-specific protein,41080,164,0.84 [0.64-1.11],0.2282977060003011
Chapter II Neoplasms,Melanoma in situ,MZT1,Mitotic-spindle organizing protein 1,40055,159,1.07 [0.81-1.40],0.635018353508232
Chapter II Neoplasms,Melanoma in situ,NAA10,N-alpha-acetyltransferase 10,34518,137,1.07 [0.77-1.48],0.6848364264638951
Chapter II Neoplasms,Melanoma in situ,NAA80,N-alpha-acetyltransferase 80,34686,135,1.11 [0.97-1.28],0.1207792148320097
Chapter II Neoplasms,Melanoma in situ,NAAA,N-acylethanolamine-hydrolyzing acid amidase,40497,158,0.92 [0.72-1.18],0.5256346437903485
Chapter II Neoplasms,Melanoma in situ,NACC1,Nucleus accumbens-associated protein 1,35477,140,0.96 [0.72-1.30],0.810627370632022
Chapter II Neoplasms,Melanoma in situ,NADK,NAD kinase,40984,163,0.87 [0.67-1.13],0.2957892881479833
Chapter II Neoplasms,Melanoma in situ,NAGA,Alpha-N-acetylgalactosaminidase,34542,134,0.97 [0.73-1.30],0.8496202463816531
Chapter II Neoplasms,Melanoma in situ,NAGK,N-acetyl-D-glucosamine kinase,34630,137,1.17 [0.87-1.56],0.2960370496338287
Chapter II Neoplasms,Melanoma in situ,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,34878,138,1.27 [0.59-2.75],0.5448724832387374
Chapter II Neoplasms,Melanoma in situ,NAMPT,Nicotinamide phosphoribosyltransferase,40055,159,0.96 [0.73-1.25],0.7537586631281107
Chapter II Neoplasms,Melanoma in situ,NAP1L4,Nucleosome assembly protein 1-like 4,35419,139,1.17 [0.78-1.74],0.4429513633255738
Chapter II Neoplasms,Melanoma in situ,NAPRT,Nicotinate phosphoribosyltransferase,35570,140,0.82 [0.49-1.35],0.4355684465774893
Chapter II Neoplasms,Melanoma in situ,NARS1,"Asparagine--tRNA ligase, cytoplasmic",35587,140,1.28 [0.90-1.81],0.1670020201180331
Chapter II Neoplasms,Melanoma in situ,NBL1,Neuroblastoma suppressor of tumorigenicity 1,41097,164,0.98 [0.57-1.66],0.9275457815913902
Chapter II Neoplasms,Melanoma in situ,NBN,Nibrin,40249,159,0.88 [0.65-1.18],0.3952760231028375
Chapter II Neoplasms,Melanoma in situ,NCAM1,Neural cell adhesion molecule 1,41135,163,0.79 [0.50-1.26],0.3266970144323228
Chapter II Neoplasms,Melanoma in situ,NCAM2,Neural cell adhesion molecule 2,40993,164,0.81 [0.48-1.36],0.4235835341672491
Chapter II Neoplasms,Melanoma in situ,NCAN,Neurocan core protein,41349,165,0.82 [0.57-1.18],0.2755534922605048
Chapter II Neoplasms,Melanoma in situ,NCF2,Neutrophil cytosol factor 2,40872,163,0.95 [0.80-1.12],0.5223125710214662
Chapter II Neoplasms,Melanoma in situ,NCK2,Cytoplasmic protein NCK2,41147,164,1.07 [0.94-1.22],0.3200803170334139
Chapter II Neoplasms,Melanoma in situ,NCLN,Nicalin,40249,159,0.99 [0.76-1.30],0.966830986165901
Chapter II Neoplasms,Melanoma in situ,NCR1,Natural cytotoxicity triggering receptor 1,40881,163,1.02 [0.70-1.49],0.919352837653874
Chapter II Neoplasms,Melanoma in situ,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,35486,140,1.22 [0.76-1.98],0.4062133554900244
Chapter II Neoplasms,Melanoma in situ,NCS1,Neuronal calcium sensor 1,41358,164,0.87 [0.53-1.42],0.5814466180052044
Chapter II Neoplasms,Melanoma in situ,NDRG1,Protein NDRG1,40031,160,0.85 [0.67-1.09],0.1986266433312068
Chapter II Neoplasms,Melanoma in situ,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,35477,140,1.03 [0.81-1.32],0.7856195444725147
Chapter II Neoplasms,Melanoma in situ,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,34545,134,1.06 [0.66-1.69],0.8077084550046261
Chapter II Neoplasms,Melanoma in situ,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,35486,140,1.08 [0.90-1.29],0.4068537176005709
Chapter II Neoplasms,Melanoma in situ,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",40055,159,1.03 [0.87-1.23],0.7249740235613624
Chapter II Neoplasms,Melanoma in situ,NEB,Nebulin,34518,137,1.14 [0.76-1.70],0.5256354318224499
Chapter II Neoplasms,Melanoma in situ,NECAP2,Adaptin ear-binding coat-associated protein 2,34518,137,1.08 [0.85-1.36],0.542495388755754
Chapter II Neoplasms,Melanoma in situ,NECTIN1,Nectin-1,34608,134,0.82 [0.48-1.40],0.465012916293295
Chapter II Neoplasms,Melanoma in situ,NECTIN2,Nectin-2,40930,163,1.37 [0.86-2.19],0.1864827556390036
Chapter II Neoplasms,Melanoma in situ,NECTIN4,Nectin-4,41097,164,0.72 [0.45-1.16],0.1770642543023523
Chapter II Neoplasms,Melanoma in situ,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,34608,134,1.01 [0.72-1.43],0.9335203353831744
Chapter II Neoplasms,Melanoma in situ,NEDD9,Enhancer of filamentation 1,34608,134,1.05 [0.65-1.69],0.8319982795365971
Chapter II Neoplasms,Melanoma in situ,NEFL,Neurofilament light polypeptide,39900,159,0.94 [0.67-1.32],0.7302426707907057
Chapter II Neoplasms,Melanoma in situ,NEK7,Serine/threonine-protein kinase Nek7,34984,139,0.94 [0.75-1.19],0.6171639268309856
Chapter II Neoplasms,Melanoma in situ,NELL1,Protein kinase C-binding protein NELL1,41097,164,0.88 [0.63-1.22],0.4486608221118229
Chapter II Neoplasms,Melanoma in situ,NELL2,Protein kinase C-binding protein NELL2,41147,164,0.83 [0.51-1.36],0.4631568367367842
Chapter II Neoplasms,Melanoma in situ,NENF,Neudesin,35477,140,1.00 [0.87-1.15],0.9898787187902705
Chapter II Neoplasms,Melanoma in situ,NEO1,Neogenin,35587,140,0.57 [0.26-1.23],0.1499408337852738
Chapter II Neoplasms,Melanoma in situ,NEXN,Nexilin,35663,141,1.22 [0.98-1.53],0.0775456547017544
Chapter II Neoplasms,Melanoma in situ,NFASC,Neurofascin,41452,164,0.72 [0.44-1.20],0.2127690047842703
Chapter II Neoplasms,Melanoma in situ,NFAT5,Nuclear factor of activated T-cells 5,34608,134,1.12 [0.93-1.35],0.2157984594671492
Chapter II Neoplasms,Melanoma in situ,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",40939,163,1.12 [0.97-1.29],0.1308893052939418
Chapter II Neoplasms,Melanoma in situ,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",40249,159,1.07 [0.85-1.35],0.563713399084779
Chapter II Neoplasms,Melanoma in situ,NFE2,Transcription factor NF-E2 45 kDa subunit,34695,137,1.21 [0.97-1.50],0.0903364619344501
Chapter II Neoplasms,Melanoma in situ,NFIC,Nuclear factor 1 C-type,35587,140,0.97 [0.66-1.41],0.8557416357682156
Chapter II Neoplasms,Melanoma in situ,NFKB1,Nuclear factor NF-kappa-B p105 subunit,34518,137,1.14 [0.92-1.43],0.23489490094288
Chapter II Neoplasms,Melanoma in situ,NFKB2,Nuclear factor NF-kappa-B p100 subunit,34984,139,0.71 [0.47-1.07],0.1042204060711608
Chapter II Neoplasms,Melanoma in situ,NFKBIE,NF-kappa-B inhibitor epsilon,40055,159,1.03 [0.77-1.37],0.8450025769457699
Chapter II Neoplasms,Melanoma in situ,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",35486,140,1.08 [0.92-1.27],0.3208612591227947
Chapter II Neoplasms,Melanoma in situ,NFX1,Transcriptional repressor NF-X1,34518,137,1.11 [0.88-1.41],0.3752038854012806
Chapter II Neoplasms,Melanoma in situ,NFYA,Nuclear transcription factor Y subunit alpha,34518,137,0.89 [0.57-1.39],0.6004027906974305
Chapter II Neoplasms,Melanoma in situ,NGF,Beta-nerve growth factor,40682,158,0.75 [0.24-2.39],0.6272100509113625
Chapter II Neoplasms,Melanoma in situ,NGFR,Tumor necrosis factor receptor superfamily member 16,35640,141,1.08 [0.63-1.83],0.7870439751392726
Chapter II Neoplasms,Melanoma in situ,NGRN,Neugrin,35570,140,1.11 [0.55-2.24],0.7757693599719434
Chapter II Neoplasms,Melanoma in situ,NHLRC3,NHL repeat-containing protein 3,34033,137,1.26 [0.73-2.17],0.4027898630053079
Chapter II Neoplasms,Melanoma in situ,NID1,Nidogen-1,41004,163,0.82 [0.57-1.18],0.2854956101769313
Chapter II Neoplasms,Melanoma in situ,NID2,Nidogen-2,40993,164,1.07 [0.89-1.28],0.4745364217079115
Chapter II Neoplasms,Melanoma in situ,NINJ1,Ninjurin-1,40055,159,0.90 [0.68-1.19],0.4669241995361317
Chapter II Neoplasms,Melanoma in situ,NIT1,Deaminated glutathione amidase,34695,137,1.17 [0.82-1.67],0.3863093010489167
Chapter II Neoplasms,Melanoma in situ,NIT2,Omega-amidase NIT2,35511,141,1.17 [0.94-1.46],0.1624898268326962
Chapter II Neoplasms,Melanoma in situ,NLGN1,Neuroligin-1,34686,135,0.96 [0.75-1.24],0.774262283957274
Chapter II Neoplasms,Melanoma in situ,NLGN2,Neuroligin-2,34549,138,0.84 [0.57-1.23],0.371069441465335
Chapter II Neoplasms,Melanoma in situ,NME1,Nucleoside diphosphate kinase A,34608,134,0.76 [0.34-1.69],0.5023916237890053
Chapter II Neoplasms,Melanoma in situ,NME3,Nucleoside diphosphate kinase 3,41020,164,0.64 [0.34-1.21],0.1686438354678597
Chapter II Neoplasms,Melanoma in situ,NMI,N-myc-interactor,35339,139,1.05 [0.84-1.32],0.6431446679223307
Chapter II Neoplasms,Melanoma in situ,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,40682,158,0.88 [0.71-1.08],0.2081100012889448
Chapter II Neoplasms,Melanoma in situ,NMRK2,Nicotinamide riboside kinase 2,34394,136,0.92 [0.60-1.42],0.7047713504695607
Chapter II Neoplasms,Melanoma in situ,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,35587,140,1.12 [0.90-1.40],0.3201891857477529
Chapter II Neoplasms,Melanoma in situ,NOMO1,Nodal modulator 1,40993,164,1.02 [0.56-1.84],0.9594021876882786
Chapter II Neoplasms,Melanoma in situ,NOP56,Nucleolar protein 56,34518,137,0.98 [0.84-1.14],0.77807628071017
Chapter II Neoplasms,Melanoma in situ,NOS1,"Nitric oxide synthase, brain",40031,160,1.11 [0.86-1.45],0.42262152890003
Chapter II Neoplasms,Melanoma in situ,NOS2,"Nitric oxide synthase, inducible",34518,137,0.69 [0.44-1.09],0.1092071343539157
Chapter II Neoplasms,Melanoma in situ,NOS3,"Nitric oxide synthase, endothelial",40031,160,0.79 [0.59-1.07],0.1233879888552959
Chapter II Neoplasms,Melanoma in situ,NOTCH1,Neurogenic locus notch homolog protein 1,41485,164,0.71 [0.29-1.74],0.4545130896415676
Chapter II Neoplasms,Melanoma in situ,NOTCH2,Neurogenic locus notch homolog protein 2,35644,141,0.66 [0.30-1.48],0.3172833795389214
Chapter II Neoplasms,Melanoma in situ,NOTCH3,Neurogenic locus notch homolog protein 3,41485,164,1.04 [0.69-1.57],0.8548660412237012
Chapter II Neoplasms,Melanoma in situ,NPC2,NPC intracellular cholesterol transporter 2,35048,140,1.03 [0.61-1.72],0.9240929413322926
Chapter II Neoplasms,Melanoma in situ,NPDC1,Neural proliferation differentiation and control protein 1,40984,163,0.90 [0.57-1.44],0.6674626650529498
Chapter II Neoplasms,Melanoma in situ,NPHS1,Nephrin,34608,134,0.69 [0.41-1.16],0.1659427212737496
Chapter II Neoplasms,Melanoma in situ,NPHS2,Podocin,34608,134,0.91 [0.76-1.08],0.2854633874370474
Chapter II Neoplasms,Melanoma in situ,NPL,N-acetylneuraminate lyase,35640,141,0.92 [0.64-1.32],0.6334176150534537
Chapter II Neoplasms,Melanoma in situ,NPPB,Natriuretic peptides B,40258,158,1.09 [0.98-1.21],0.1217859865302433
Chapter II Neoplasms,Melanoma in situ,NPPC,C-type natriuretic peptide,40939,163,0.67 [0.49-0.93],0.014825976089124
Chapter II Neoplasms,Melanoma in situ,NPR1,Atrial natriuretic peptide receptor 1,34518,137,0.57 [0.34-0.95],0.0313104035249602
Chapter II Neoplasms,Melanoma in situ,NPTN,Neuroplastin,40055,159,1.08 [0.92-1.26],0.3586882724924322
Chapter II Neoplasms,Melanoma in situ,NPTX1,Neuronal pentraxin-1,40993,164,0.69 [0.48-0.98],0.0407889583496836
Chapter II Neoplasms,Melanoma in situ,NPTX2,Neuronal pentraxin-2,35644,141,0.79 [0.48-1.30],0.3587692097702335
Chapter II Neoplasms,Melanoma in situ,NPTXR,Neuronal pentraxin receptor,40984,163,1.08 [0.72-1.61],0.7180289375361097
Chapter II Neoplasms,Melanoma in situ,NPY,Pro-neuropeptide Y,41358,164,0.87 [0.71-1.08],0.2096997464822104
Chapter II Neoplasms,Melanoma in situ,NRCAM,Neuronal cell adhesion molecule,40984,163,0.72 [0.43-1.19],0.2025015410053912
Chapter II Neoplasms,Melanoma in situ,NRGN,Neurogranin,35663,141,1.16 [0.97-1.38],0.1012404161962977
Chapter II Neoplasms,Melanoma in situ,NRN1,Neuritin,35587,140,1.20 [0.83-1.74],0.3326976635153683
Chapter II Neoplasms,Melanoma in situ,NRP1,Neuropilin-1,41211,163,1.06 [0.64-1.76],0.8094606908162427
Chapter II Neoplasms,Melanoma in situ,NRP2,Neuropilin-2,40993,164,0.82 [0.50-1.35],0.4437456680998713
Chapter II Neoplasms,Melanoma in situ,NRTN,Neurturin,40249,159,1.08 [0.83-1.41],0.5643181364393624
Chapter II Neoplasms,Melanoma in situ,NRXN3,Neurexin-3,34686,135,0.83 [0.50-1.39],0.4861154464235253
Chapter II Neoplasms,Melanoma in situ,NSFL1C,NSFL1 cofactor p47,41349,165,1.05 [0.85-1.30],0.62897523230024
Chapter II Neoplasms,Melanoma in situ,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",35640,141,1.08 [0.87-1.35],0.4946980365760473
Chapter II Neoplasms,Melanoma in situ,NT5C1A,Cytosolic 5'-nucleotidase 1A,35570,140,1.10 [0.67-1.82],0.6973541401486043
Chapter II Neoplasms,Melanoma in situ,NT5C3A,Cytosolic 5'-nucleotidase 3A,40872,163,1.12 [0.95-1.32],0.1643114675524487
Chapter II Neoplasms,Melanoma in situ,NT5E,5'-nucleotidase,41097,164,0.86 [0.66-1.11],0.2476051787461282
Chapter II Neoplasms,Melanoma in situ,NTF3,Neurotrophin-3,40939,163,0.77 [0.52-1.16],0.2120968028935746
Chapter II Neoplasms,Melanoma in situ,NTF4,Neurotrophin-4,40055,159,0.92 [0.62-1.37],0.6875804789289128
Chapter II Neoplasms,Melanoma in situ,NTRK2,BDNF/NT-3 growth factors receptor,40984,163,0.82 [0.47-1.41],0.4742460583994549
Chapter II Neoplasms,Melanoma in situ,NTRK3,NT-3 growth factor receptor,41349,165,0.57 [0.30-1.08],0.0843833623223607
Chapter II Neoplasms,Melanoma in situ,NTproBNP,N-terminal prohormone of brain natriuretic peptide,40984,163,1.16 [1.03-1.31],0.0186389483495198
Chapter II Neoplasms,Melanoma in situ,NUB1,NEDD8 ultimate buster 1,40939,163,1.09 [0.93-1.28],0.2918133972164205
Chapter II Neoplasms,Melanoma in situ,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,35477,140,1.02 [0.87-1.19],0.8519644961310304
Chapter II Neoplasms,Melanoma in situ,NUCB2,Nucleobindin-2,41289,164,1.28 [0.89-1.85],0.1856771262330609
Chapter II Neoplasms,Melanoma in situ,NUDC,Nuclear migration protein nudC,41452,164,1.23 [0.98-1.53],0.0696039717080197
Chapter II Neoplasms,Melanoma in situ,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,34695,137,1.01 [0.54-1.91],0.9758169423779935
Chapter II Neoplasms,Melanoma in situ,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,34518,137,1.04 [0.77-1.41],0.7990347208856063
Chapter II Neoplasms,Melanoma in situ,NUDT16,U8 snoRNA-decapping enzyme,35425,140,1.13 [0.94-1.36],0.1837326328443619
Chapter II Neoplasms,Melanoma in situ,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],40789,160,1.19 [0.95-1.50],0.1278929707815945
Chapter II Neoplasms,Melanoma in situ,NUDT5,ADP-sugar pyrophosphatase,40993,164,1.08 [0.82-1.42],0.5828497647600382
Chapter II Neoplasms,Melanoma in situ,NUMB,Protein numb homolog,34608,134,1.20 [0.98-1.47],0.0803327064555636
Chapter II Neoplasms,Melanoma in situ,NUP50,Nuclear pore complex protein Nup50,34518,137,0.39 [0.20-0.77],0.0063462991327933
Chapter II Neoplasms,Melanoma in situ,NXPE4,NXPE family member 4,34518,137,0.72 [0.41-1.26],0.2468262646436858
Chapter II Neoplasms,Melanoma in situ,NXPH1,Neurexophilin-1,40031,160,1.21 [0.86-1.70],0.2823787535678798
Chapter II Neoplasms,Melanoma in situ,NXPH3,Neurexophilin-3,34608,134,0.94 [0.54-1.63],0.8272302707679462
Chapter II Neoplasms,Melanoma in situ,OBP2B,Odorant-binding protein 2b,40552,156,1.05 [0.83-1.33],0.6885325942311666
Chapter II Neoplasms,Melanoma in situ,OCLN,Occludin,35587,140,0.85 [0.57-1.26],0.4163003886433817
Chapter II Neoplasms,Melanoma in situ,ODAM,Odontogenic ameloblast-associated protein,39971,160,0.72 [0.54-0.97],0.0289967956965873
Chapter II Neoplasms,Melanoma in situ,OFD1,Oral-facial-digital syndrome 1 protein,34984,139,0.79 [0.59-1.07],0.1318179174196095
Chapter II Neoplasms,Melanoma in situ,OGA,Protein O-GlcNAcase,35486,140,1.17 [0.93-1.47],0.1749515914913563
Chapter II Neoplasms,Melanoma in situ,OGFR,Opioid growth factor receptor,40789,160,1.25 [0.81-1.91],0.3150777263578576
Chapter II Neoplasms,Melanoma in situ,OGN,Mimecan,40993,164,0.91 [0.64-1.28],0.5696944234159056
Chapter II Neoplasms,Melanoma in situ,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,34984,139,0.99 [0.77-1.28],0.9370691356897292
Chapter II Neoplasms,Melanoma in situ,OLFM4,Olfactomedin-4,33566,135,0.99 [0.87-1.14],0.9124495592016846
Chapter II Neoplasms,Melanoma in situ,OLR1,Oxidized low-density lipoprotein receptor 1,40583,161,0.95 [0.75-1.21],0.7028228425729889
Chapter II Neoplasms,Melanoma in situ,OMD,Osteomodulin,41147,164,0.81 [0.59-1.11],0.1960097507251529
Chapter II Neoplasms,Melanoma in situ,OMG,Oligodendrocyte-myelin glycoprotein,40789,160,1.05 [0.85-1.30],0.6360411245055076
Chapter II Neoplasms,Melanoma in situ,OMP,Olfactory marker protein,34549,138,0.94 [0.67-1.32],0.7172753349728578
Chapter II Neoplasms,Melanoma in situ,OPHN1,Oligophrenin-1,35570,140,1.15 [0.99-1.33],0.0771523964761638
Chapter II Neoplasms,Melanoma in situ,OPLAH,5-oxoprolinase,34695,137,1.09 [0.86-1.38],0.4745392721581606
Chapter II Neoplasms,Melanoma in situ,OPTC,Opticin,40789,160,1.00 [0.73-1.36],0.9781776731495534
Chapter II Neoplasms,Melanoma in situ,ORM1,Alpha-1-acid glycoprotein 1,35563,141,1.30 [0.58-2.89],0.5281983783607258
Chapter II Neoplasms,Melanoma in situ,OSBPL2,Oxysterol-binding protein-related protein 2,35570,140,1.29 [0.94-1.77],0.1186540513211631
Chapter II Neoplasms,Melanoma in situ,OSCAR,Osteoclast-associated immunoglobulin-like receptor,41020,164,1.16 [0.77-1.75],0.482123631419678
Chapter II Neoplasms,Melanoma in situ,OSM,Oncostatin-M,40743,163,0.97 [0.80-1.19],0.7929277509604391
Chapter II Neoplasms,Melanoma in situ,OSMR,Oncostatin-M-specific receptor subunit beta,41211,163,0.73 [0.37-1.46],0.375630219555378
Chapter II Neoplasms,Melanoma in situ,OSTN,Osteocrin,34686,135,0.65 [0.40-1.08],0.0947255328125611
Chapter II Neoplasms,Melanoma in situ,OTOA,Otoancorin,34549,138,1.08 [0.81-1.44],0.5887060171662615
Chapter II Neoplasms,Melanoma in situ,OTUD6B,Deubiquitinase OTUD6B,35486,140,1.19 [0.90-1.56],0.2160116158283294
Chapter II Neoplasms,Melanoma in situ,OTUD7B,OTU domain-containing protein 7B,35587,140,1.15 [0.89-1.48],0.2845942354079298
Chapter II Neoplasms,Melanoma in situ,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",34695,137,1.17 [0.93-1.49],0.1814834089825846
Chapter II Neoplasms,Melanoma in situ,OXT,Oxytocin-neurophysin 1,41349,165,1.05 [0.95-1.16],0.3273691764923703
Chapter II Neoplasms,Melanoma in situ,P4HB,Protein disulfide-isomerase,40771,162,1.15 [0.80-1.65],0.4449162966135257
Chapter II Neoplasms,Melanoma in situ,PACS2,Phosphofurin acidic cluster sorting protein 2,34518,137,1.12 [0.86-1.46],0.3902894760522715
Chapter II Neoplasms,Melanoma in situ,PADI2,Protein-arginine deiminase type-2,40249,159,0.95 [0.74-1.23],0.7149390319848451
Chapter II Neoplasms,Melanoma in situ,PADI4,Protein-arginine deiminase type-4,39971,160,0.93 [0.76-1.14],0.4843103150143525
Chapter II Neoplasms,Melanoma in situ,PAEP,Glycodelin,40682,158,1.02 [0.90-1.15],0.7464475801334411
Chapter II Neoplasms,Melanoma in situ,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,35587,140,0.96 [0.84-1.11],0.6205927746825872
Chapter II Neoplasms,Melanoma in situ,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",34984,139,1.03 [0.74-1.43],0.8514784206509245
Chapter II Neoplasms,Melanoma in situ,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,40258,158,1.00 [0.77-1.29],0.9747134825221652
Chapter II Neoplasms,Melanoma in situ,PAGR1,PAXIP1-associated glutamate-rich protein 1,34695,137,1.12 [0.78-1.60],0.5552767886164932
Chapter II Neoplasms,Melanoma in situ,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,34328,135,0.74 [0.53-1.05],0.0913765921085934
Chapter II Neoplasms,Melanoma in situ,PAK4,Serine/threonine-protein kinase PAK 4,40031,160,1.14 [0.92-1.42],0.2370368543584667
Chapter II Neoplasms,Melanoma in situ,PALLD,Palladin,34608,134,0.97 [0.63-1.49],0.9004332348316187
Chapter II Neoplasms,Melanoma in situ,PALM,Paralemmin-1,35284,138,0.71 [0.43-1.19],0.1947626776181358
Chapter II Neoplasms,Melanoma in situ,PALM2,Paralemmin-2,35570,140,0.76 [0.48-1.21],0.253030801182146
Chapter II Neoplasms,Melanoma in situ,PALM3,Paralemmin-3,34518,137,0.92 [0.72-1.17],0.4916051364750278
Chapter II Neoplasms,Melanoma in situ,PAM,Peptidyl-glycine alpha-amidating monooxygenase,41274,162,0.84 [0.52-1.36],0.4787393132099888
Chapter II Neoplasms,Melanoma in situ,PAMR1,Inactive serine protease PAMR1,40993,164,1.25 [0.75-2.09],0.3913221751610423
Chapter II Neoplasms,Melanoma in situ,PAPPA,Pappalysin-1,40249,159,0.89 [0.66-1.21],0.4662950287419117
Chapter II Neoplasms,Melanoma in situ,PARD3,Partitioning defective 3 homolog,34984,139,0.99 [0.79-1.23],0.9180237227925496
Chapter II Neoplasms,Melanoma in situ,PARK7,Parkinson disease protein 7,40993,164,1.05 [0.80-1.36],0.7320058897485345
Chapter II Neoplasms,Melanoma in situ,PARP1,Poly [ADP-ribose] polymerase 1,40939,163,0.89 [0.68-1.18],0.4235138233513581
Chapter II Neoplasms,Melanoma in situ,PAXX,Protein PAXX,34878,138,1.05 [0.74-1.51],0.7739061962468685
Chapter II Neoplasms,Melanoma in situ,PBK,Lymphokine-activated killer T-cell-originated protein kinase,34394,136,0.90 [0.53-1.54],0.6949624597768804
Chapter II Neoplasms,Melanoma in situ,PBLD,Phenazine biosynthesis-like domain-containing protein,40031,160,1.18 [0.90-1.55],0.235697262618643
Chapter II Neoplasms,Melanoma in situ,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,35486,140,0.84 [0.47-1.48],0.5407949100815121
Chapter II Neoplasms,Melanoma in situ,PCARE,Photoreceptor cilium actin regulator,34549,138,0.99 [0.82-1.20],0.9536456299385482
Chapter II Neoplasms,Melanoma in situ,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,34804,138,0.97 [0.68-1.39],0.8767455323257867
Chapter II Neoplasms,Melanoma in situ,PCBP2,Poly(rC)-binding protein 2,35587,140,1.08 [0.86-1.35],0.5040971211085901
Chapter II Neoplasms,Melanoma in situ,PCDH1,Protocadherin-1,41316,163,1.21 [0.65-2.24],0.5507788360462739
Chapter II Neoplasms,Melanoma in situ,PCDH12,Protocadherin-12,35587,140,0.50 [0.27-0.94],0.0313720973977294
Chapter II Neoplasms,Melanoma in situ,PCDH17,Protocadherin-17,40984,163,0.73 [0.49-1.09],0.1255389243315801
Chapter II Neoplasms,Melanoma in situ,PCDH7,Protocadherin-7,35486,140,1.00 [0.62-1.59],0.9882918945987088
Chapter II Neoplasms,Melanoma in situ,PCDH9,Protocadherin-9,35486,140,1.03 [0.64-1.67],0.8916459373694745
Chapter II Neoplasms,Melanoma in situ,PCDHB15,Protocadherin beta-15,35477,140,1.06 [0.71-1.58],0.7847874618691445
Chapter II Neoplasms,Melanoma in situ,PCNA,Proliferating cell nuclear antigen,34394,136,0.98 [0.75-1.28],0.8739832724870662
Chapter II Neoplasms,Melanoma in situ,PCSK7,Proprotein convertase subtilisin/kexin type 7,35477,140,0.78 [0.53-1.16],0.2231678457555799
Chapter II Neoplasms,Melanoma in situ,PCSK9,Proprotein convertase subtilisin/kexin type 9,41485,164,1.03 [0.72-1.46],0.8830569121714776
Chapter II Neoplasms,Melanoma in situ,PCYT2,Ethanolamine-phosphate cytidylyltransferase,35486,140,1.23 [0.99-1.52],0.0598742296495694
Chapter II Neoplasms,Melanoma in situ,PDAP1,28 kDa heat- and acid-stable phosphoprotein,35640,141,1.16 [0.98-1.37],0.0818811077949054
Chapter II Neoplasms,Melanoma in situ,PDCD1,Programmed cell death protein 1,41293,163,0.86 [0.61-1.21],0.3887992608937766
Chapter II Neoplasms,Melanoma in situ,PDCD1LG2,Programmed cell death 1 ligand 2,40789,160,1.06 [0.68-1.67],0.7908520988727762
Chapter II Neoplasms,Melanoma in situ,PDCD5,Programmed cell death protein 5,41349,165,1.12 [0.89-1.41],0.3507998764206086
Chapter II Neoplasms,Melanoma in situ,PDCD6,Programmed cell death protein 6,40984,163,1.19 [0.95-1.50],0.1360903597300805
Chapter II Neoplasms,Melanoma in situ,PDCL2,Phosducin-like protein 2,34394,136,0.97 [0.70-1.33],0.8375721393974338
Chapter II Neoplasms,Melanoma in situ,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",34394,136,0.76 [0.52-1.11],0.1503879942301199
Chapter II Neoplasms,Melanoma in situ,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",34518,137,1.05 [0.81-1.37],0.6930160619340162
Chapter II Neoplasms,Melanoma in situ,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",34878,138,1.13 [0.96-1.33],0.12727784607731
Chapter II Neoplasms,Melanoma in situ,PDGFA,Platelet-derived growth factor subunit A,41485,164,1.11 [0.92-1.34],0.289802970709062
Chapter II Neoplasms,Melanoma in situ,PDGFB,Platelet-derived growth factor subunit B,41147,164,1.01 [0.86-1.18],0.927639251922055
Chapter II Neoplasms,Melanoma in situ,PDGFC,Platelet-derived growth factor C,40055,159,1.00 [0.61-1.65],0.9870931982454196
Chapter II Neoplasms,Melanoma in situ,PDGFRA,Platelet-derived growth factor receptor alpha,40984,163,0.78 [0.47-1.28],0.3261959683236529
Chapter II Neoplasms,Melanoma in situ,PDGFRB,Platelet-derived growth factor receptor beta,41485,164,0.96 [0.65-1.42],0.8263321991630711
Chapter II Neoplasms,Melanoma in situ,PDIA2,Protein disulfide-isomerase A2,34394,136,0.69 [0.43-1.09],0.1136784287912632
Chapter II Neoplasms,Melanoma in situ,PDIA3,Protein disulfide-isomerase A3,34878,138,0.83 [0.42-1.65],0.6034720434001852
Chapter II Neoplasms,Melanoma in situ,PDIA4,Protein disulfide-isomerase A4,35644,141,1.17 [0.90-1.52],0.2324398029111169
Chapter II Neoplasms,Melanoma in situ,PDIA5,Protein disulfide-isomerase A5,34394,136,1.07 [0.83-1.40],0.5953468575957525
Chapter II Neoplasms,Melanoma in situ,PDLIM5,PDZ and LIM domain protein 5,35587,140,1.09 [0.95-1.25],0.2233148485259556
Chapter II Neoplasms,Melanoma in situ,PDLIM7,PDZ and LIM domain protein 7,41147,164,1.08 [0.97-1.21],0.1651632133436518
Chapter II Neoplasms,Melanoma in situ,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",40055,159,0.78 [0.56-1.08],0.1287116231136608
Chapter II Neoplasms,Melanoma in situ,PDRG1,p53 and DNA damage-regulated protein 1,34686,135,0.77 [0.53-1.10],0.1529880751373703
Chapter II Neoplasms,Melanoma in situ,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,34394,136,0.89 [0.63-1.26],0.5179593370440512
Chapter II Neoplasms,Melanoma in situ,PDZD2,PDZ domain-containing protein 2,34518,137,1.01 [0.77-1.34],0.920866651570313
Chapter II Neoplasms,Melanoma in situ,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,34608,134,0.92 [0.62-1.37],0.6795220022133869
Chapter II Neoplasms,Melanoma in situ,PEAR1,Platelet endothelial aggregation receptor 1,41485,164,1.22 [0.66-2.25],0.5172356086066157
Chapter II Neoplasms,Melanoma in situ,PEBP1,Phosphatidylethanolamine-binding protein 1,40993,164,1.04 [0.82-1.32],0.7306459658834576
Chapter II Neoplasms,Melanoma in situ,PECAM1,Platelet endothelial cell adhesion molecule,40993,164,1.17 [0.74-1.84],0.511109392544759
Chapter II Neoplasms,Melanoma in situ,PECR,Peroxisomal trans-2-enoyl-CoA reductase,34695,137,0.77 [0.41-1.44],0.4195872880622531
Chapter II Neoplasms,Melanoma in situ,PENK,Proenkephalin-A,34878,138,1.07 [0.63-1.82],0.7928108826742242
Chapter II Neoplasms,Melanoma in situ,PEPD,Xaa-Pro dipeptidase,35663,141,0.73 [0.39-1.35],0.3124224032794262
Chapter II Neoplasms,Melanoma in situ,PER3,Period circadian protein homolog 3,34608,134,1.11 [0.97-1.27],0.1147786694155219
Chapter II Neoplasms,Melanoma in situ,PF4,Platelet factor 4,35428,141,1.05 [0.89-1.24],0.541184308101524
Chapter II Neoplasms,Melanoma in situ,PFDN2,Prefoldin subunit 2,40031,160,1.04 [0.81-1.33],0.7723373122174966
Chapter II Neoplasms,Melanoma in situ,PFDN4,Prefoldin subunit 4,34394,136,0.82 [0.58-1.16],0.2551413657790393
Chapter II Neoplasms,Melanoma in situ,PFDN6,Prefoldin subunit 6,34686,135,0.99 [0.77-1.28],0.9441244697381798
Chapter II Neoplasms,Melanoma in situ,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40723,160,1.04 [0.87-1.24],0.6862681121681996
Chapter II Neoplasms,Melanoma in situ,PGA4,Pepsin A-4,35663,141,0.89 [0.73-1.10],0.2832912926007744
Chapter II Neoplasms,Melanoma in situ,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",35640,141,1.36 [1.02-1.81],0.0345584755430843
Chapter II Neoplasms,Melanoma in situ,PGF,Placenta growth factor,41452,164,0.89 [0.50-1.59],0.6967604804791795
Chapter II Neoplasms,Melanoma in situ,PGLYRP1,Peptidoglycan recognition protein 1,41287,162,1.00 [0.72-1.39],0.99102066636377
Chapter II Neoplasms,Melanoma in situ,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,35236,139,0.60 [0.35-1.00],0.0507654500530617
Chapter II Neoplasms,Melanoma in situ,PGLYRP4,Peptidoglycan recognition protein 4,34518,137,0.83 [0.61-1.14],0.2497397581685281
Chapter II Neoplasms,Melanoma in situ,PGM2,Phosphoglucomutase-2,34686,135,1.14 [0.90-1.44],0.2928327948156577
Chapter II Neoplasms,Melanoma in situ,PGR,Progesterone receptor,34608,134,1.04 [0.89-1.21],0.6258631785258842
Chapter II Neoplasms,Melanoma in situ,PHACTR2,Phosphatase and actin regulator 2,35587,140,1.11 [0.96-1.28],0.1546664164220825
Chapter II Neoplasms,Melanoma in situ,PHLDB1,Pleckstrin homology-like domain family B member 1,35486,140,1.27 [0.93-1.72],0.1277568553816326
Chapter II Neoplasms,Melanoma in situ,PHLDB2,Pleckstrin homology-like domain family B member 2,34394,136,0.97 [0.81-1.16],0.7359560526984731
Chapter II Neoplasms,Melanoma in situ,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,40682,158,0.92 [0.57-1.48],0.7236530553378155
Chapter II Neoplasms,Melanoma in situ,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,34878,138,1.18 [0.79-1.76],0.4248479099908088
Chapter II Neoplasms,Melanoma in situ,PI16,Peptidase inhibitor 16,35663,141,0.74 [0.39-1.42],0.3687290228736344
Chapter II Neoplasms,Melanoma in situ,PI3,Elafin,40448,157,1.31 [1.03-1.66],0.0273481403903686
Chapter II Neoplasms,Melanoma in situ,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",35587,140,1.14 [0.93-1.39],0.2223534528248207
Chapter II Neoplasms,Melanoma in situ,PIGR,Polymeric immunoglobulin receptor,40478,161,1.12 [0.75-1.68],0.5753532585777648
Chapter II Neoplasms,Melanoma in situ,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,40939,163,1.06 [0.85-1.33],0.6115373147479471
Chapter II Neoplasms,Melanoma in situ,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,40993,164,0.78 [0.45-1.33],0.3631336030722039
Chapter II Neoplasms,Melanoma in situ,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,34608,134,1.06 [0.79-1.42],0.6895828164871509
Chapter II Neoplasms,Melanoma in situ,PILRA,Paired immunoglobulin-like type 2 receptor alpha,40993,164,0.83 [0.60-1.15],0.2703892375825125
Chapter II Neoplasms,Melanoma in situ,PILRB,Paired immunoglobulin-like type 2 receptor beta,40984,163,0.91 [0.72-1.15],0.4293020663381476
Chapter II Neoplasms,Melanoma in situ,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,34878,138,0.73 [0.59-0.92],0.0061673541660447
Chapter II Neoplasms,Melanoma in situ,PITHD1,PITH domain-containing protein 1,34328,135,1.23 [1.05-1.44],0.0122514938648219
Chapter II Neoplasms,Melanoma in situ,PKD1,Polycystin-1,35640,141,0.83 [0.45-1.53],0.5507490395978558
Chapter II Neoplasms,Melanoma in situ,PKD2,Polycystin-2,34518,137,1.15 [0.88-1.50],0.3158507716745247
Chapter II Neoplasms,Melanoma in situ,PKLR,Pyruvate kinase PKLR,41019,163,0.93 [0.75-1.15],0.5038216784880487
Chapter II Neoplasms,Melanoma in situ,PKN3,Serine/threonine-protein kinase N3,34984,139,0.98 [0.78-1.22],0.8227579954035615
Chapter II Neoplasms,Melanoma in situ,PLA2G10,Group 10 secretory phospholipase A2,40682,158,0.97 [0.76-1.23],0.8027511815018991
Chapter II Neoplasms,Melanoma in situ,PLA2G15,Phospholipase A2 group XV,41097,164,0.67 [0.39-1.14],0.1414064553125077
Chapter II Neoplasms,Melanoma in situ,PLA2G1B,Phospholipase A2,41421,163,0.80 [0.58-1.10],0.1670243040555729
Chapter II Neoplasms,Melanoma in situ,PLA2G2A,"Phospholipase A2, membrane associated",40896,163,1.15 [0.92-1.45],0.219158252119505
Chapter II Neoplasms,Melanoma in situ,PLA2G4A,Cytosolic phospholipase A2,41147,164,1.13 [0.97-1.32],0.12823659098051
Chapter II Neoplasms,Melanoma in situ,PLA2G7,Platelet-activating factor acetylhydrolase,40993,164,1.05 [0.68-1.62],0.8340952930678058
Chapter II Neoplasms,Melanoma in situ,PLAT,Tissue-type plasminogen activator,41357,164,0.87 [0.66-1.15],0.3230915488794392
Chapter II Neoplasms,Melanoma in situ,PLAU,Urokinase-type plasminogen activator,40993,164,0.57 [0.34-0.94],0.028965130819241
Chapter II Neoplasms,Melanoma in situ,PLAUR,Urokinase plasminogen activator surface receptor,40693,163,0.94 [0.55-1.59],0.8047774605348402
Chapter II Neoplasms,Melanoma in situ,PLB1,"Phospholipase B1, membrane-associated",35570,140,1.05 [0.80-1.37],0.7429358245251906
Chapter II Neoplasms,Melanoma in situ,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",34608,134,0.93 [0.62-1.37],0.7006641267964798
Chapter II Neoplasms,Melanoma in situ,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",35570,140,1.12 [0.95-1.32],0.1905569690378504
Chapter II Neoplasms,Melanoma in situ,PLEKHO1,Pleckstrin homology domain-containing family O member 1,35570,140,1.21 [0.96-1.52],0.1059667038617171
Chapter II Neoplasms,Melanoma in situ,PLG,Plasminogen,34780,137,0.61 [0.29-1.29],0.1977077210487815
Chapter II Neoplasms,Melanoma in situ,PLIN1,Perilipin-1,40031,160,0.86 [0.56-1.31],0.4764116920954977
Chapter II Neoplasms,Melanoma in situ,PLIN3,Perilipin-3,40984,163,1.10 [0.80-1.52],0.5512767234594753
Chapter II Neoplasms,Melanoma in situ,PLPBP,Pyridoxal phosphate homeostasis protein,40984,163,1.08 [0.88-1.32],0.4835574866940578
Chapter II Neoplasms,Melanoma in situ,PLSCR3,Phospholipid scramblase 3,35512,140,1.05 [0.79-1.38],0.7515063934251776
Chapter II Neoplasms,Melanoma in situ,PLTP,Phospholipid transfer protein,41339,162,0.73 [0.50-1.07],0.1071671229897793
Chapter II Neoplasms,Melanoma in situ,PLXDC1,Plexin domain-containing protein 1,40055,159,0.92 [0.59-1.43],0.7191880609275023
Chapter II Neoplasms,Melanoma in situ,PLXDC2,Plexin domain-containing protein 2,35570,140,0.87 [0.47-1.60],0.6607572808660694
Chapter II Neoplasms,Melanoma in situ,PLXNA4,Plexin-A4,40939,163,1.07 [0.90-1.27],0.4294928346102754
Chapter II Neoplasms,Melanoma in situ,PLXNB2,Plexin-B2,41301,164,0.90 [0.50-1.63],0.7325662575079144
Chapter II Neoplasms,Melanoma in situ,PLXNB3,Plexin-B3,40856,161,1.35 [1.01-1.80],0.0414282955254838
Chapter II Neoplasms,Melanoma in situ,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,40803,163,1.02 [0.95-1.10],0.5917572841110792
Chapter II Neoplasms,Melanoma in situ,PMCH,Pro-MCH,34518,137,1.06 [0.89-1.27],0.4905740253374728
Chapter II Neoplasms,Melanoma in situ,PMM2,Phosphomannomutase 2,34518,137,0.96 [0.73-1.27],0.7941589168651307
Chapter II Neoplasms,Melanoma in situ,PMS1,PMS1 protein homolog 1,34686,135,0.78 [0.54-1.11],0.1689476221740355
Chapter II Neoplasms,Melanoma in situ,PMVK,Phosphomevalonate kinase,39964,160,1.09 [0.95-1.25],0.2112246339759826
Chapter II Neoplasms,Melanoma in situ,PNLIP,Pancreatic triacylglycerol lipase,35663,141,0.93 [0.72-1.21],0.598623483679196
Chapter II Neoplasms,Melanoma in situ,PNLIPRP1,Inactive pancreatic lipase-related protein 1,35570,140,1.15 [0.94-1.41],0.1760449577053519
Chapter II Neoplasms,Melanoma in situ,PNLIPRP2,Pancreatic lipase-related protein 2,40948,164,1.00 [0.95-1.04],0.8484472584900324
Chapter II Neoplasms,Melanoma in situ,PNMA1,Paraneoplastic antigen Ma1,34695,137,1.24 [0.94-1.63],0.1331863192569393
Chapter II Neoplasms,Melanoma in situ,PNMA2,Paraneoplastic antigen Ma2,34549,138,0.80 [0.54-1.19],0.2750907489814906
Chapter II Neoplasms,Melanoma in situ,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",40249,159,0.85 [0.74-0.98],0.0256439840595977
Chapter II Neoplasms,Melanoma in situ,PODXL,Podocalyxin,40789,160,0.51 [0.21-1.28],0.1520980884584484
Chapter II Neoplasms,Melanoma in situ,PODXL2,Podocalyxin-like protein 2,41097,164,0.89 [0.54-1.47],0.6453436400035417
Chapter II Neoplasms,Melanoma in situ,POF1B,Protein POF1B,34608,134,0.72 [0.48-1.09],0.1238615891534545
Chapter II Neoplasms,Melanoma in situ,POLR2A,DNA-directed RNA polymerase II subunit RPB1,34608,134,0.90 [0.51-1.60],0.7195725053328375
Chapter II Neoplasms,Melanoma in situ,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40789,160,0.94 [0.61-1.43],0.7567395103275164
Chapter II Neoplasms,Melanoma in situ,POMC,Pro-opiomelanocortin,34695,137,0.93 [0.73-1.18],0.5388248110763726
Chapter II Neoplasms,Melanoma in situ,PON1,Serum paraoxonase/arylesterase 1,35663,141,1.32 [0.70-2.49],0.3831870981643077
Chapter II Neoplasms,Melanoma in situ,PON2,Serum paraoxonase/arylesterase 2,40258,158,0.86 [0.57-1.30],0.473310124413994
Chapter II Neoplasms,Melanoma in situ,PON3,Serum paraoxonase/lactonase 3,41147,164,0.71 [0.45-1.12],0.1443605053172627
Chapter II Neoplasms,Melanoma in situ,POSTN,Periostin,35644,141,0.82 [0.53-1.28],0.38181875668701
Chapter II Neoplasms,Melanoma in situ,PPBP,Platelet basic protein,35423,141,1.13 [0.93-1.37],0.2098542095451327
Chapter II Neoplasms,Melanoma in situ,PPCDC,Phosphopantothenoylcysteine decarboxylase,41349,165,1.17 [0.88-1.56],0.2892811611887942
Chapter II Neoplasms,Melanoma in situ,PPIB,Peptidyl-prolyl cis-trans isomerase B,41005,161,1.14 [0.99-1.33],0.0771036938453001
Chapter II Neoplasms,Melanoma in situ,PPIE,Peptidyl-prolyl cis-trans isomerase E,34984,139,1.17 [0.95-1.46],0.1431895554103359
Chapter II Neoplasms,Melanoma in situ,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",35644,141,1.10 [0.87-1.40],0.4187554427584206
Chapter II Neoplasms,Melanoma in situ,PPL,Periplakin,34608,134,0.78 [0.46-1.34],0.3737696783351987
Chapter II Neoplasms,Melanoma in situ,PPM1A,Protein phosphatase 1A,40055,159,1.17 [0.77-1.78],0.4634166494781511
Chapter II Neoplasms,Melanoma in situ,PPM1B,Protein phosphatase 1B,34608,134,1.05 [0.82-1.35],0.6991060837356011
Chapter II Neoplasms,Melanoma in situ,PPM1F,Protein phosphatase 1F,35640,141,1.23 [0.90-1.66],0.1926000147151402
Chapter II Neoplasms,Melanoma in situ,PPME1,Protein phosphatase methylesterase 1,40789,160,1.08 [0.86-1.35],0.5274407254775251
Chapter II Neoplasms,Melanoma in situ,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,35477,140,1.12 [0.92-1.35],0.2655847692242895
Chapter II Neoplasms,Melanoma in situ,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,41097,164,1.08 [0.94-1.25],0.2738823930658036
Chapter II Neoplasms,Melanoma in situ,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,34984,139,0.95 [0.75-1.20],0.6739884766423954
Chapter II Neoplasms,Melanoma in situ,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,35587,140,1.13 [0.93-1.37],0.2199412680326559
Chapter II Neoplasms,Melanoma in situ,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,35587,140,0.99 [0.65-1.51],0.9614431842201788
Chapter II Neoplasms,Melanoma in situ,PPP1R2,Protein phosphatase inhibitor 2,40984,163,1.14 [0.96-1.36],0.130040527310583
Chapter II Neoplasms,Melanoma in situ,PPP1R9B,Neurabin-2,41452,164,1.16 [1.00-1.34],0.0505906945555528
Chapter II Neoplasms,Melanoma in situ,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,35486,140,1.03 [0.90-1.19],0.624726755546953
Chapter II Neoplasms,Melanoma in situ,PPP3R1,Calcineurin subunit B type 1,40682,158,0.96 [0.68-1.36],0.8284061100655504
Chapter II Neoplasms,Melanoma in situ,PPT1,Palmitoyl-protein thioesterase 1,34686,135,0.80 [0.60-1.05],0.1037127347905592
Chapter II Neoplasms,Melanoma in situ,PPY,Pancreatic prohormone,40906,164,1.05 [0.92-1.20],0.4669312676321047
Chapter II Neoplasms,Melanoma in situ,PQBP1,Polyglutamine-binding protein 1,40055,159,0.93 [0.71-1.21],0.5678191589061362
Chapter II Neoplasms,Melanoma in situ,PRAME,Melanoma antigen preferentially expressed in tumors,34394,136,0.68 [0.35-1.32],0.2586695364254198
Chapter II Neoplasms,Melanoma in situ,PRAP1,Proline-rich acidic protein 1,35644,141,1.31 [0.87-1.97],0.1903756991992226
Chapter II Neoplasms,Melanoma in situ,PRC1,Protein regulator of cytokinesis 1,35477,140,0.85 [0.55-1.30],0.4430804725457996
Chapter II Neoplasms,Melanoma in situ,PRCP,Lysosomal Pro-X carboxypeptidase,41235,162,0.65 [0.41-1.02],0.0628569544704241
Chapter II Neoplasms,Melanoma in situ,PRDX1,Peroxiredoxin-1,39843,156,1.11 [0.95-1.30],0.1789753442423852
Chapter II Neoplasms,Melanoma in situ,PRDX2,Peroxiredoxin-2,35063,139,0.84 [0.65-1.10],0.2125889606827418
Chapter II Neoplasms,Melanoma in situ,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",40249,159,0.93 [0.76-1.14],0.4764929773025397
Chapter II Neoplasms,Melanoma in situ,PRDX5,"Peroxiredoxin-5, mitochondrial",41452,164,1.10 [0.89-1.35],0.371440558524972
Chapter II Neoplasms,Melanoma in situ,PRDX6,Peroxiredoxin-6,41358,164,1.12 [0.90-1.41],0.3070223124406545
Chapter II Neoplasms,Melanoma in situ,PREB,Prolactin regulatory element-binding protein,40249,159,0.93 [0.57-1.51],0.7605496269377654
Chapter II Neoplasms,Melanoma in situ,PRELP,Prolargin,40948,164,0.94 [0.52-1.71],0.8482117212915982
Chapter II Neoplasms,Melanoma in situ,PRG2,Bone marrow proteoglycan,35644,141,1.31 [0.97-1.77],0.0821598799519552
Chapter II Neoplasms,Melanoma in situ,PRG3,Proteoglycan 3,35644,141,1.05 [0.75-1.46],0.7904634033181752
Chapter II Neoplasms,Melanoma in situ,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,40249,159,1.21 [0.94-1.54],0.1382641742775219
Chapter II Neoplasms,Melanoma in situ,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,34686,135,0.87 [0.51-1.48],0.6045552309184629
Chapter II Neoplasms,Melanoma in situ,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,40984,163,1.03 [0.88-1.22],0.6857686054450347
Chapter II Neoplasms,Melanoma in situ,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,35500,140,1.15 [0.94-1.40],0.1676479821304927
Chapter II Neoplasms,Melanoma in situ,PRKCQ,Protein kinase C theta type,40249,159,0.74 [0.51-1.06],0.10370523588393
Chapter II Neoplasms,Melanoma in situ,PRKD2,Serine/threonine-protein kinase D2,34518,137,0.84 [0.56-1.27],0.4126550734603177
Chapter II Neoplasms,Melanoma in situ,PRKG1,cGMP-dependent protein kinase 1,34878,138,1.09 [0.96-1.25],0.186377145784508
Chapter II Neoplasms,Melanoma in situ,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,40055,159,1.04 [0.85-1.28],0.6979076438524396
Chapter II Neoplasms,Melanoma in situ,PRL,Prolactin,41349,165,1.13 [0.94-1.35],0.1926175357726305
Chapter II Neoplasms,Melanoma in situ,PRND,Prion-like protein doppel,35570,140,0.94 [0.68-1.30],0.695941368525669
Chapter II Neoplasms,Melanoma in situ,PROC,Vitamin K-dependent protein C,41076,163,1.44 [0.83-2.51],0.1982832402753656
Chapter II Neoplasms,Melanoma in situ,PROCR,Endothelial protein C receptor,34518,137,0.84 [0.50-1.40],0.4975073945158813
Chapter II Neoplasms,Melanoma in situ,PROK1,Prokineticin-1,40939,163,1.09 [0.86-1.38],0.4848281676026837
Chapter II Neoplasms,Melanoma in situ,PROS1,Vitamin K-dependent protein S,35692,141,1.02 [0.54-1.93],0.96077190154816
Chapter II Neoplasms,Melanoma in situ,PRR4,Proline-rich protein 4,34629,136,1.26 [1.00-1.57],0.0465807756939416
Chapter II Neoplasms,Melanoma in situ,PRR5,Proline-rich protein 5,34608,134,1.24 [0.91-1.70],0.1711483632172644
Chapter II Neoplasms,Melanoma in situ,PRRT3,Proline-rich transmembrane protein 3,34695,137,0.85 [0.54-1.33],0.4716898254868267
Chapter II Neoplasms,Melanoma in situ,PRSS2,Trypsin-2,41135,163,0.99 [0.76-1.29],0.9514135912223992
Chapter II Neoplasms,Melanoma in situ,PRSS22,Brain-specific serine protease 4,34608,134,0.83 [0.49-1.38],0.4654917839403858
Chapter II Neoplasms,Melanoma in situ,PRSS27,Serine protease 27,40857,163,1.05 [0.74-1.49],0.7646033466180836
Chapter II Neoplasms,Melanoma in situ,PRSS53,Serine protease 53,35570,140,0.89 [0.57-1.38],0.6002674923462752
Chapter II Neoplasms,Melanoma in situ,PRSS8,Prostasin,40821,163,1.07 [0.76-1.50],0.7137874307063108
Chapter II Neoplasms,Melanoma in situ,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,40031,160,1.11 [0.98-1.26],0.1144322697943841
Chapter II Neoplasms,Melanoma in situ,PRTG,Protogenin,41358,164,0.66 [0.38-1.14],0.1342004133965657
Chapter II Neoplasms,Melanoma in situ,PRTN3,Myeloblastin,39944,158,0.91 [0.67-1.24],0.5515334845648536
Chapter II Neoplasms,Melanoma in situ,PRUNE2,Protein prune homolog 2,34984,139,0.74 [0.40-1.37],0.3348001964813824
Chapter II Neoplasms,Melanoma in situ,PSAP,Prosaposin,35316,140,1.06 [0.60-1.89],0.8313892207313851
Chapter II Neoplasms,Melanoma in situ,PSAPL1,Proactivator polypeptide-like 1,35486,140,1.06 [0.77-1.47],0.7277090007803495
Chapter II Neoplasms,Melanoma in situ,PSCA,Prostate stem cell antigen,35486,140,1.00 [0.94-1.06],0.9538781265696936
Chapter II Neoplasms,Melanoma in situ,PSG1,Pregnancy-specific beta-1-glycoprotein 1,40682,158,1.02 [0.91-1.16],0.7035026873679157
Chapter II Neoplasms,Melanoma in situ,PSIP1,PC4 and SFRS1-interacting protein,40939,163,1.09 [0.89-1.33],0.4238842580757598
Chapter II Neoplasms,Melanoma in situ,PSMA1,Proteasome subunit alpha type-1,40055,159,0.86 [0.62-1.20],0.3771126567704446
Chapter II Neoplasms,Melanoma in situ,PSMC3,26S proteasome regulatory subunit 6A,34394,136,0.64 [0.37-1.12],0.1183889110639757
Chapter II Neoplasms,Melanoma in situ,PSMD1,26S proteasome non-ATPase regulatory subunit 1,35587,140,0.99 [0.71-1.37],0.9509006062056198
Chapter II Neoplasms,Melanoma in situ,PSMD5,26S proteasome non-ATPase regulatory subunit 5,34686,135,1.22 [0.96-1.54],0.1094251938930742
Chapter II Neoplasms,Melanoma in situ,PSMD9,26S proteasome non-ATPase regulatory subunit 9,40789,160,0.93 [0.72-1.20],0.5734559078693846
Chapter II Neoplasms,Melanoma in situ,PSME1,Proteasome activator complex subunit 1,40621,157,1.00 [0.69-1.46],0.986454838412798
Chapter II Neoplasms,Melanoma in situ,PSME2,Proteasome activator complex subunit 2,40495,158,1.06 [0.73-1.56],0.7517080851178523
Chapter II Neoplasms,Melanoma in situ,PSMG3,Proteasome assembly chaperone 3,40939,163,0.90 [0.69-1.19],0.4702458754724903
Chapter II Neoplasms,Melanoma in situ,PSMG4,Proteasome assembly chaperone 4,34608,134,0.91 [0.68-1.23],0.5340129644935984
Chapter II Neoplasms,Melanoma in situ,PSPN,Persephin,40939,163,1.00 [0.87-1.16],0.966418716121253
Chapter II Neoplasms,Melanoma in situ,PSRC1,Proline/serine-rich coiled-coil protein 1,40055,159,1.02 [0.80-1.29],0.8839468880563988
Chapter II Neoplasms,Melanoma in situ,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,33634,133,1.17 [1.00-1.38],0.0571255626295004
Chapter II Neoplasms,Melanoma in situ,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",40031,160,0.89 [0.56-1.41],0.6112157783722129
Chapter II Neoplasms,Melanoma in situ,PTGDS,Prostaglandin-H2 D-isomerase,40680,163,0.90 [0.55-1.46],0.6658660865338508
Chapter II Neoplasms,Melanoma in situ,PTGES2,Prostaglandin E synthase 2,34344,131,1.32 [0.98-1.78],0.0669361475889886
Chapter II Neoplasms,Melanoma in situ,PTGR1,Prostaglandin reductase 1,35640,141,1.10 [0.91-1.34],0.3136333746664325
Chapter II Neoplasms,Melanoma in situ,PTH,Parathyroid hormone,34686,135,1.15 [0.94-1.41],0.1720227639522571
Chapter II Neoplasms,Melanoma in situ,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,40939,163,1.03 [0.73-1.47],0.857339728961857
Chapter II Neoplasms,Melanoma in situ,PTK7,Inactive tyrosine-protein kinase 7,40031,160,0.89 [0.62-1.30],0.5609361158260342
Chapter II Neoplasms,Melanoma in situ,PTN,Pleiotrophin,40258,158,1.11 [0.84-1.48],0.4663425276638514
Chapter II Neoplasms,Melanoma in situ,PTP4A3,Protein tyrosine phosphatase type IVA 3,34608,134,0.95 [0.69-1.32],0.7784655205088487
Chapter II Neoplasms,Melanoma in situ,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,40682,158,1.12 [0.94-1.34],0.2036984941077058
Chapter II Neoplasms,Melanoma in situ,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,41087,164,1.08 [0.92-1.27],0.3319498397457919
Chapter II Neoplasms,Melanoma in situ,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,34544,134,0.88 [0.55-1.39],0.5743462011012146
Chapter II Neoplasms,Melanoma in situ,PTPRB,Receptor-type tyrosine-protein phosphatase beta,35640,141,0.57 [0.32-0.99],0.0464618492231355
Chapter II Neoplasms,Melanoma in situ,PTPRC,Receptor-type tyrosine-protein phosphatase C,35644,141,0.60 [0.29-1.24],0.1691197054280261
Chapter II Neoplasms,Melanoma in situ,PTPRF,Receptor-type tyrosine-protein phosphatase F,41485,164,0.79 [0.49-1.28],0.3378035977627259
Chapter II Neoplasms,Melanoma in situ,PTPRH,Receptor-type tyrosine-protein phosphatase H,35486,140,1.02 [0.73-1.43],0.9070104058999782
Chapter II Neoplasms,Melanoma in situ,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,35486,140,0.65 [0.29-1.46],0.2963325460935387
Chapter II Neoplasms,Melanoma in situ,PTPRM,Receptor-type tyrosine-protein phosphatase mu,40870,163,1.67 [0.94-2.94],0.0790172318314071
Chapter II Neoplasms,Melanoma in situ,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,40542,157,1.08 [0.69-1.68],0.7342914669083136
Chapter II Neoplasms,Melanoma in situ,PTPRR,Receptor-type tyrosine-protein phosphatase R,35570,140,1.01 [0.65-1.58],0.964395628143904
Chapter II Neoplasms,Melanoma in situ,PTPRS,Receptor-type tyrosine-protein phosphatase S,41485,164,0.95 [0.54-1.66],0.8532949553861277
Chapter II Neoplasms,Melanoma in situ,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,35640,141,0.88 [0.53-1.45],0.6070325742316992
Chapter II Neoplasms,Melanoma in situ,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,34878,138,1.17 [0.89-1.54],0.2479248685436542
Chapter II Neoplasms,Melanoma in situ,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39846,158,0.97 [0.75-1.27],0.8303695889806395
Chapter II Neoplasms,Melanoma in situ,PTTG1,Securin,34984,139,1.11 [0.77-1.61],0.5785643381417209
Chapter II Neoplasms,Melanoma in situ,PTX3,Pentraxin-related protein PTX3,40939,163,0.95 [0.72-1.25],0.7145962389764852
Chapter II Neoplasms,Melanoma in situ,PVALB,Parvalbumin alpha,41171,164,1.11 [0.98-1.27],0.0956174162224506
Chapter II Neoplasms,Melanoma in situ,PVR,Poliovirus receptor,41349,165,0.79 [0.53-1.16],0.225233337721078
Chapter II Neoplasms,Melanoma in situ,PXDNL,Peroxidasin-like protein,35477,140,0.95 [0.70-1.29],0.7591558026775047
Chapter II Neoplasms,Melanoma in situ,PXN,Paxillin,40031,160,0.94 [0.71-1.23],0.6395551871341915
Chapter II Neoplasms,Melanoma in situ,PYDC1,Pyrin domain-containing protein 1,34695,137,1.09 [0.74-1.60],0.6643552437518123
Chapter II Neoplasms,Melanoma in situ,PYY,Peptide YY,34518,137,0.78 [0.65-0.93],0.0065139231543687
Chapter II Neoplasms,Melanoma in situ,PZP,Pregnancy zone protein,35692,141,1.08 [0.79-1.47],0.6339405743223663
Chapter II Neoplasms,Melanoma in situ,QDPR,Dihydropteridine reductase,40793,162,1.10 [0.80-1.52],0.5455104964327468
Chapter II Neoplasms,Melanoma in situ,QPCT,Glutaminyl-peptide cyclotransferase,41040,162,1.21 [0.71-2.06],0.4743492882155214
Chapter II Neoplasms,Melanoma in situ,QSOX1,Sulfhydryl oxidase 1,34967,138,1.00 [0.67-1.49],0.997980025788946
Chapter II Neoplasms,Melanoma in situ,RAB10,Ras-related protein Rab-10,35640,141,1.08 [0.80-1.46],0.5953262604058176
Chapter II Neoplasms,Melanoma in situ,RAB11FIP3,Rab11 family-interacting protein 3,35640,141,1.13 [0.97-1.32],0.1071960011509765
Chapter II Neoplasms,Melanoma in situ,RAB27B,Ras-related protein Rab-27B,35640,141,1.14 [0.93-1.40],0.2035317628004675
Chapter II Neoplasms,Melanoma in situ,RAB2B,Ras-related protein Rab-2B,35477,140,1.13 [0.87-1.47],0.366269108095607
Chapter II Neoplasms,Melanoma in situ,RAB33A,Ras-related protein Rab-33A,34518,137,1.08 [0.85-1.39],0.5256955925283939
Chapter II Neoplasms,Melanoma in situ,RAB37,Ras-related protein Rab-37,40249,159,0.88 [0.73-1.07],0.1908191043137013
Chapter II Neoplasms,Melanoma in situ,RAB39B,Ras-related protein Rab-39B,34518,137,1.17 [1.02-1.34],0.0275098548058058
Chapter II Neoplasms,Melanoma in situ,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,34549,138,1.11 [0.87-1.43],0.4018878990357463
Chapter II Neoplasms,Melanoma in situ,RAB44,Ras-related protein Rab-44,35477,140,0.91 [0.62-1.34],0.6296077187962619
Chapter II Neoplasms,Melanoma in situ,RAB6A,Ras-related protein Rab-6A,40939,163,0.85 [0.63-1.16],0.3096702866661698
Chapter II Neoplasms,Melanoma in situ,RAB6B,Ras-related protein Rab-6B,40031,160,0.95 [0.70-1.27],0.7156162360166418
Chapter II Neoplasms,Melanoma in situ,RABEP1,Rab GTPase-binding effector protein 1,34878,138,1.15 [0.93-1.42],0.1901633489493837
Chapter II Neoplasms,Melanoma in situ,RABEPK,Rab9 effector protein with kelch motifs,40055,159,0.80 [0.61-1.05],0.1091628150216287
Chapter II Neoplasms,Melanoma in situ,RABGAP1L,Rab GTPase-activating protein 1-like,40249,159,1.05 [0.83-1.32],0.7052897627945632
Chapter II Neoplasms,Melanoma in situ,RAC3,Ras-related C3 botulinum toxin substrate 3,34686,135,1.09 [0.88-1.35],0.4242643238215438
Chapter II Neoplasms,Melanoma in situ,RAD23B,UV excision repair protein RAD23 homolog B,40055,159,0.96 [0.71-1.30],0.7932529653743448
Chapter II Neoplasms,Melanoma in situ,RAD51,DNA repair protein RAD51 homolog 1,34984,139,1.05 [0.80-1.39],0.7117568189000689
Chapter II Neoplasms,Melanoma in situ,RALB,Ras-related protein Ral-B,34608,134,1.56 [0.97-2.52],0.0688884815246139
Chapter II Neoplasms,Melanoma in situ,RALY,RNA-binding protein Raly,35477,140,1.31 [1.01-1.69],0.0400199870027703
Chapter II Neoplasms,Melanoma in situ,RANBP1,Ran-specific GTPase-activating protein,34695,137,0.99 [0.73-1.35],0.9706436798241642
Chapter II Neoplasms,Melanoma in situ,RANBP2,E3 SUMO-protein ligase RanBP2,34549,138,1.14 [0.71-1.85],0.588039399219576
Chapter II Neoplasms,Melanoma in situ,RANGAP1,Ran GTPase-activating protein 1,40055,159,0.96 [0.71-1.30],0.7914355668857821
Chapter II Neoplasms,Melanoma in situ,RAP1A,Ras-related protein Rap-1A,34608,134,0.86 [0.65-1.14],0.3043245927288974
Chapter II Neoplasms,Melanoma in situ,RAPGEF2,Rap guanine nucleotide exchange factor 2,34984,139,1.38 [1.04-1.82],0.0243943077445655
Chapter II Neoplasms,Melanoma in situ,RARRES1,Retinoic acid receptor responder protein 1,40055,159,1.33 [0.95-1.84],0.0927170133775807
Chapter II Neoplasms,Melanoma in situ,RARRES2,Retinoic acid receptor responder protein 2,41211,163,1.07 [0.80-1.42],0.6680282166642058
Chapter II Neoplasms,Melanoma in situ,RASA1,Ras GTPase-activating protein 1,40031,160,0.96 [0.63-1.46],0.8400302522641778
Chapter II Neoplasms,Melanoma in situ,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,34394,136,1.10 [0.76-1.60],0.6021649998776584
Chapter II Neoplasms,Melanoma in situ,RASSF2,Ras association domain-containing protein 2,40055,159,0.83 [0.63-1.09],0.1770660975045906
Chapter II Neoplasms,Melanoma in situ,RBFOX3,RNA binding protein fox-1 homolog 3,35587,140,0.78 [0.49-1.24],0.2930753609453602
Chapter II Neoplasms,Melanoma in situ,RBKS,Ribokinase,40022,156,1.03 [0.77-1.36],0.8624952962344153
Chapter II Neoplasms,Melanoma in situ,RBM17,Splicing factor 45,35587,140,1.23 [1.00-1.51],0.0459374712775749
Chapter II Neoplasms,Melanoma in situ,RBM19,Probable RNA-binding protein 19,34518,137,0.71 [0.46-1.08],0.1077802986203951
Chapter II Neoplasms,Melanoma in situ,RBM25,RNA-binding protein 25,34394,136,1.13 [0.80-1.59],0.4964384486643066
Chapter II Neoplasms,Melanoma in situ,RBP1,Retinol-binding protein 1,34686,135,0.92 [0.71-1.19],0.5190758233665619
Chapter II Neoplasms,Melanoma in situ,RBP2,Retinol-binding protein 2,40789,160,1.09 [0.90-1.30],0.3809422667783749
Chapter II Neoplasms,Melanoma in situ,RBP5,Retinol-binding protein 5,40789,160,1.06 [0.82-1.36],0.6755992302998426
Chapter II Neoplasms,Melanoma in situ,RBP7,Retinoid-binding protein 7,35486,140,1.02 [0.78-1.32],0.901525381983061
Chapter II Neoplasms,Melanoma in situ,RBPMS,RNA-binding protein with multiple splicing,34608,134,0.97 [0.75-1.25],0.8201789797247668
Chapter II Neoplasms,Melanoma in situ,RBPMS2,RNA-binding protein with multiple splicing 2,34695,137,1.16 [0.99-1.36],0.0738561450837754
Chapter II Neoplasms,Melanoma in situ,RCC1,Regulator of chromosome condensation,35477,140,1.06 [0.79-1.43],0.7024178432384518
Chapter II Neoplasms,Melanoma in situ,RCOR1,REST corepressor 1,40258,158,0.83 [0.56-1.21],0.3266904509751679
Chapter II Neoplasms,Melanoma in situ,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,34695,137,0.39 [0.18-0.84],0.0169016233622223
Chapter II Neoplasms,Melanoma in situ,REEP4,Receptor expression-enhancing protein 4,35587,140,1.17 [0.91-1.50],0.2255830856442775
Chapter II Neoplasms,Melanoma in situ,REG1A,Lithostathine-1-alpha,40740,163,1.11 [0.84-1.47],0.4495142400530444
Chapter II Neoplasms,Melanoma in situ,REG1B,Lithostathine-1-beta,41485,164,1.11 [0.88-1.40],0.3944169381052752
Chapter II Neoplasms,Melanoma in situ,REG3A,Regenerating islet-derived protein 3-alpha,41485,164,1.05 [0.84-1.31],0.6749438697403347
Chapter II Neoplasms,Melanoma in situ,REG3G,Regenerating islet-derived protein 3-gamma,35477,140,0.81 [0.53-1.23],0.3200367911357554
Chapter II Neoplasms,Melanoma in situ,REG4,Regenerating islet-derived protein 4,41020,164,0.81 [0.61-1.09],0.1671262759541998
Chapter II Neoplasms,Melanoma in situ,RELB,Transcription factor RelB,34608,134,1.19 [0.88-1.59],0.2539656862693106
Chapter II Neoplasms,Melanoma in situ,RELT,Tumor necrosis factor receptor superfamily member 19L,40993,164,1.08 [0.66-1.77],0.7660309913296082
Chapter II Neoplasms,Melanoma in situ,REN,Renin,40984,163,0.96 [0.80-1.16],0.6989554024999165
Chapter II Neoplasms,Melanoma in situ,REPS1,RalBP1-associated Eps domain-containing protein 1,34608,134,1.39 [0.96-2.01],0.083869045836679
Chapter II Neoplasms,Melanoma in situ,REST,RE1-silencing transcription factor,34394,136,1.02 [0.64-1.63],0.9291361750115882
Chapter II Neoplasms,Melanoma in situ,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,40789,160,0.60 [0.42-0.86],0.0052115922468539
Chapter II Neoplasms,Melanoma in situ,RETN,Resistin,40883,159,1.01 [0.72-1.42],0.94813710670975
Chapter II Neoplasms,Melanoma in situ,REXO2,"Oligoribonuclease, mitochondrial",34518,137,0.71 [0.46-1.08],0.1057096414942821
Chapter II Neoplasms,Melanoma in situ,RFC4,Replication factor C subunit 4,35477,140,1.40 [0.68-2.86],0.3632404417024972
Chapter II Neoplasms,Melanoma in situ,RGCC,Regulator of cell cycle RGCC,35587,140,1.09 [0.88-1.35],0.4146235497829673
Chapter II Neoplasms,Melanoma in situ,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,34984,139,0.99 [0.76-1.28],0.9097277003416282
Chapter II Neoplasms,Melanoma in situ,RGMA,Repulsive guidance molecule A,41349,165,0.77 [0.49-1.20],0.2442876684293259
Chapter II Neoplasms,Melanoma in situ,RGMB,RGM domain family member B,41349,165,0.65 [0.38-1.11],0.1151842394763042
Chapter II Neoplasms,Melanoma in situ,RGS10,Regulator of G-protein signaling 10,35587,140,1.15 [0.88-1.49],0.3141860268383586
Chapter II Neoplasms,Melanoma in situ,RGS8,Regulator of G-protein signaling 8,40249,159,1.14 [0.94-1.37],0.1726258137537113
Chapter II Neoplasms,Melanoma in situ,RHOC,Rho-related GTP-binding protein RhoC,40431,158,1.09 [0.96-1.23],0.1762569004564335
Chapter II Neoplasms,Melanoma in situ,RICTOR,Rapamycin-insensitive companion of mTOR,34608,134,1.11 [0.82-1.51],0.4849512897304086
Chapter II Neoplasms,Melanoma in situ,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,34878,138,0.91 [0.64-1.28],0.5757117330269865
Chapter II Neoplasms,Melanoma in situ,RILP,Rab-interacting lysosomal protein,41237,164,1.05 [0.83-1.32],0.6893316982382294
Chapter II Neoplasms,Melanoma in situ,RILPL2,RILP-like protein 2,35640,141,1.15 [0.98-1.36],0.0942597471494304
Chapter II Neoplasms,Melanoma in situ,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,34518,137,0.72 [0.53-0.99],0.0423398932883176
Chapter II Neoplasms,Melanoma in situ,RLN1,Prorelaxin H1,35587,140,1.15 [0.91-1.45],0.2463444538484023
Chapter II Neoplasms,Melanoma in situ,RLN2,Prorelaxin H2,34818,138,1.09 [0.91-1.30],0.3634008052870631
Chapter II Neoplasms,Melanoma in situ,RNASE1,Ribonuclease pancreatic,35663,141,1.11 [0.59-2.11],0.7473970790487173
Chapter II Neoplasms,Melanoma in situ,RNASE10,Inactive ribonuclease-like protein 10,34695,137,1.09 [0.78-1.52],0.6193758931478197
Chapter II Neoplasms,Melanoma in situ,RNASE3,Eosinophil cationic protein,40793,163,1.00 [0.88-1.13],0.9977903735898273
Chapter II Neoplasms,Melanoma in situ,RNASE4,Ribonuclease 4,34486,132,0.70 [0.39-1.25],0.2278021117863835
Chapter II Neoplasms,Melanoma in situ,RNASE6,Ribonuclease K6,35401,141,0.68 [0.38-1.25],0.2141002131321752
Chapter II Neoplasms,Melanoma in situ,RNASEH2A,Ribonuclease H2 subunit A,35587,140,0.99 [0.71-1.36],0.93440876533931
Chapter II Neoplasms,Melanoma in situ,RNASET2,Ribonuclease T2,41299,162,1.05 [0.62-1.78],0.8439898525217322
Chapter II Neoplasms,Melanoma in situ,RNF149,E3 ubiquitin-protein ligase RNF149,34695,137,1.03 [0.60-1.76],0.9184258468756652
Chapter II Neoplasms,Melanoma in situ,RNF168,E3 ubiquitin-protein ligase RNF168,34608,134,0.91 [0.60-1.39],0.6702506741971651
Chapter II Neoplasms,Melanoma in situ,RNF31,E3 ubiquitin-protein ligase RNF31,34608,134,1.25 [0.86-1.83],0.23602691820641
Chapter II Neoplasms,Melanoma in situ,RNF4,E3 ubiquitin-protein ligase RNF4,34984,139,1.05 [0.83-1.32],0.680078456217313
Chapter II Neoplasms,Melanoma in situ,RNF41,E3 ubiquitin-protein ligase NRDP1,40055,159,1.12 [0.91-1.38],0.2764032180860911
Chapter II Neoplasms,Melanoma in situ,RNF43,E3 ubiquitin-protein ligase RNF43,34984,139,0.81 [0.57-1.14],0.229533786670937
Chapter II Neoplasms,Melanoma in situ,RNF5,E3 ubiquitin-protein ligase RNF5,34695,137,1.17 [0.93-1.48],0.1790071141585042
Chapter II Neoplasms,Melanoma in situ,ROBO1,Roundabout homolog 1,41020,164,0.77 [0.43-1.39],0.3843400606585579
Chapter II Neoplasms,Melanoma in situ,ROBO2,Roundabout homolog 2,41349,165,0.73 [0.39-1.33],0.3003581042718993
Chapter II Neoplasms,Melanoma in situ,ROBO4,Roundabout homolog 4,34695,137,0.78 [0.31-1.97],0.5966950912144309
Chapter II Neoplasms,Melanoma in situ,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,40984,163,0.97 [0.62-1.51],0.8996576799878923
Chapter II Neoplasms,Melanoma in situ,RP2,Protein XRP2,40789,160,0.95 [0.68-1.33],0.752214253848006
Chapter II Neoplasms,Melanoma in situ,RPA2,Replication protein A 32 kDa subunit,34608,134,0.92 [0.53-1.59],0.7579580307817264
Chapter II Neoplasms,Melanoma in situ,RPE,Ribulose-phosphate 3-epimerase,34984,139,1.06 [0.85-1.32],0.6276638790778161
Chapter II Neoplasms,Melanoma in situ,RPGR,X-linked retinitis pigmentosa GTPase regulator,34686,135,0.89 [0.58-1.36],0.5832046181514932
Chapter II Neoplasms,Melanoma in situ,RPL14,60S ribosomal protein L14,34695,137,1.05 [0.70-1.57],0.8258118308514448
Chapter II Neoplasms,Melanoma in situ,RPS10,40S ribosomal protein S10,34518,137,0.63 [0.39-1.03],0.064939057702922
Chapter II Neoplasms,Melanoma in situ,RRAS,Ras-related protein R-Ras,34686,135,1.07 [0.94-1.22],0.2817450987381176
Chapter II Neoplasms,Melanoma in situ,RRM2,Ribonucleoside-diphosphate reductase subunit M2,40055,159,0.97 [0.72-1.30],0.8335835722956321
Chapter II Neoplasms,Melanoma in situ,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,40055,159,1.05 [0.86-1.30],0.6155862272436594
Chapter II Neoplasms,Melanoma in situ,RRP15,RRP15-like protein,34549,138,1.08 [0.90-1.28],0.4082520844852405
Chapter II Neoplasms,Melanoma in situ,RSPO1,R-spondin-1,40682,158,1.13 [0.75-1.71],0.5625256596560011
Chapter II Neoplasms,Melanoma in situ,RSPO3,R-spondin-3,41358,164,0.66 [0.40-1.11],0.1146416722113978
Chapter II Neoplasms,Melanoma in situ,RTBDN,Retbindin,40789,160,1.11 [0.68-1.81],0.6876019306948483
Chapter II Neoplasms,Melanoma in situ,RTKN2,Rhotekin-2,34518,137,0.81 [0.56-1.18],0.273659990006974
Chapter II Neoplasms,Melanoma in situ,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",35587,140,1.10 [0.92-1.31],0.2992536412546331
Chapter II Neoplasms,Melanoma in situ,RTN4R,Reticulon-4 receptor,41358,164,0.93 [0.62-1.41],0.7439404914743293
Chapter II Neoplasms,Melanoma in situ,RUVBL1,RuvB-like 1,40055,159,1.03 [0.91-1.18],0.6346352763684999
Chapter II Neoplasms,Melanoma in situ,RWDD1,RWD domain-containing protein 1,41349,165,1.16 [0.93-1.44],0.1803616403167223
Chapter II Neoplasms,Melanoma in situ,RYR1,Ryanodine receptor 1,34518,137,0.67 [0.38-1.17],0.1605493389389526
Chapter II Neoplasms,Melanoma in situ,S100A11,Protein S100-A11,40668,162,0.95 [0.70-1.28],0.7255177496854879
Chapter II Neoplasms,Melanoma in situ,S100A12,Protein S100-A12,40409,156,1.03 [0.85-1.24],0.7532252102105188
Chapter II Neoplasms,Melanoma in situ,S100A13,Protein S100-A13,34608,134,0.80 [0.49-1.32],0.3885588335083895
Chapter II Neoplasms,Melanoma in situ,S100A14,Protein S100-A14,35587,140,1.01 [0.74-1.36],0.9650079970660158
Chapter II Neoplasms,Melanoma in situ,S100A16,Protein S100-A16,39971,160,1.15 [0.93-1.42],0.2023813942591865
Chapter II Neoplasms,Melanoma in situ,S100A3,Protein S100-A3,35477,140,1.09 [0.79-1.50],0.6164676075078104
Chapter II Neoplasms,Melanoma in situ,S100A4,Protein S100-A4,41097,164,1.00 [0.79-1.28],0.9791071783017952
Chapter II Neoplasms,Melanoma in situ,S100G,Protein S100-G,35587,140,0.95 [0.67-1.36],0.796705039224239
Chapter II Neoplasms,Melanoma in situ,S100P,Protein S100-P,40258,158,1.13 [0.89-1.43],0.3316977780083457
Chapter II Neoplasms,Melanoma in situ,SAA4,Serum amyloid A-4 protein,35692,141,0.99 [0.58-1.69],0.9629675624563282
Chapter II Neoplasms,Melanoma in situ,SAFB2,Scaffold attachment factor B2,35587,140,0.87 [0.48-1.58],0.6363942518037196
Chapter II Neoplasms,Melanoma in situ,SAG,S-arrestin,34549,138,0.92 [0.66-1.27],0.5958341752920164
Chapter II Neoplasms,Melanoma in situ,SAMD9L,Sterile alpha motif domain-containing protein 9-like,40939,163,1.10 [0.91-1.33],0.3009495112835487
Chapter II Neoplasms,Melanoma in situ,SAP18,Histone deacetylase complex subunit SAP18,34984,139,0.97 [0.78-1.22],0.8067074462544144
Chapter II Neoplasms,Melanoma in situ,SARG,Specifically androgen-regulated gene protein,35516,140,1.14 [0.98-1.33],0.0825146030382705
Chapter II Neoplasms,Melanoma in situ,SART1,U4/U6.U5 tri-snRNP-associated protein 1,34518,137,0.85 [0.52-1.40],0.5218985458944184
Chapter II Neoplasms,Melanoma in situ,SAT1,Diamine acetyltransferase 1,34518,137,0.92 [0.65-1.30],0.6229697105945844
Chapter II Neoplasms,Melanoma in situ,SAT2,Thialysine N-epsilon-acetyltransferase,34984,139,0.99 [0.77-1.26],0.91624666753336
Chapter II Neoplasms,Melanoma in situ,SATB1,DNA-binding protein SATB1,35587,140,0.84 [0.47-1.50],0.5484615649469793
Chapter II Neoplasms,Melanoma in situ,SBSN,Suprabasin,35576,141,0.72 [0.45-1.16],0.1815412819208617
Chapter II Neoplasms,Melanoma in situ,SCAMP3,Secretory carrier-associated membrane protein 3,40789,160,1.10 [0.93-1.29],0.2691210569018878
Chapter II Neoplasms,Melanoma in situ,SCARA5,Scavenger receptor class A member 5,41349,165,0.48 [0.30-0.76],0.0016894921947747
Chapter II Neoplasms,Melanoma in situ,SCARB1,Scavenger receptor class B member 1,40031,160,1.13 [0.91-1.39],0.2758352534029065
Chapter II Neoplasms,Melanoma in situ,SCARB2,Lysosome membrane protein 2,39909,157,1.13 [0.70-1.81],0.6126259088195075
Chapter II Neoplasms,Melanoma in situ,SCARF1,Scavenger receptor class F member 1,41485,164,1.14 [0.83-1.58],0.420080141547079
Chapter II Neoplasms,Melanoma in situ,SCARF2,Scavenger receptor class F member 2,41349,165,0.78 [0.48-1.27],0.3190104743189211
Chapter II Neoplasms,Melanoma in situ,SCG2,Secretogranin-2,41168,164,0.87 [0.56-1.35],0.5289782753827128
Chapter II Neoplasms,Melanoma in situ,SCG3,Secretogranin-3,41020,164,0.82 [0.54-1.24],0.3548845813945885
Chapter II Neoplasms,Melanoma in situ,SCGB1A1,Uteroglobin,41021,164,0.90 [0.70-1.15],0.3957983723426185
Chapter II Neoplasms,Melanoma in situ,SCGB2A2,Mammaglobin-A,34518,137,0.83 [0.47-1.47],0.5207927639752925
Chapter II Neoplasms,Melanoma in situ,SCGB3A1,Secretoglobin family 3A member 1,34878,138,1.70 [0.90-3.22],0.1040806462724501
Chapter II Neoplasms,Melanoma in situ,SCGB3A2,Secretoglobin family 3A member 2,41087,164,0.92 [0.77-1.10],0.3471141043636153
Chapter II Neoplasms,Melanoma in situ,SCGN,Secretagogin,40249,159,0.89 [0.64-1.24],0.4903278487726202
Chapter II Neoplasms,Melanoma in situ,SCIN,Adseverin,34549,138,0.97 [0.77-1.21],0.7664670046895596
Chapter II Neoplasms,Melanoma in situ,SCLY,Selenocysteine lyase,41237,164,1.05 [0.78-1.40],0.7602852533235658
Chapter II Neoplasms,Melanoma in situ,SCN2A,Sodium channel protein type 2 subunit alpha,34549,138,0.90 [0.62-1.29],0.5555290905216468
Chapter II Neoplasms,Melanoma in situ,SCN2B,Sodium channel subunit beta-2,34686,135,1.15 [0.66-2.02],0.6219004923098702
Chapter II Neoplasms,Melanoma in situ,SCN3A,Sodium channel protein type 3 subunit alpha,34686,135,1.11 [0.73-1.68],0.6357264190304905
Chapter II Neoplasms,Melanoma in situ,SCN3B,Sodium channel subunit beta-3,34549,138,0.95 [0.67-1.36],0.7948135182742314
Chapter II Neoplasms,Melanoma in situ,SCN4B,Sodium channel subunit beta-4,34695,137,0.94 [0.64-1.40],0.7718783658026307
Chapter II Neoplasms,Melanoma in situ,SCP2,Non-specific lipid-transfer protein,40055,159,0.81 [0.65-1.01],0.0602462211286707
Chapter II Neoplasms,Melanoma in situ,SCPEP1,Retinoid-inducible serine carboxypeptidase,34570,137,1.18 [0.85-1.64],0.3118935516530827
Chapter II Neoplasms,Melanoma in situ,SCRG1,Scrapie-responsive protein 1,35640,141,0.85 [0.46-1.57],0.6078276487833825
Chapter II Neoplasms,Melanoma in situ,SCRIB,Protein scribble homolog,34695,137,1.06 [0.89-1.25],0.5272457766032451
Chapter II Neoplasms,Melanoma in situ,SCRN1,Secernin-1,40939,163,1.29 [1.02-1.62],0.0321659661190708
Chapter II Neoplasms,Melanoma in situ,SCT,Secretin,34686,135,1.04 [0.73-1.47],0.8267025374662895
Chapter II Neoplasms,Melanoma in situ,SDC1,Syndecan-1,40984,163,1.15 [0.81-1.64],0.4318500088769541
Chapter II Neoplasms,Melanoma in situ,SDC4,Syndecan-4,40984,163,0.94 [0.70-1.27],0.6852788674161678
Chapter II Neoplasms,Melanoma in situ,SDCCAG8,Serologically defined colon cancer antigen 8,35477,140,1.12 [0.97-1.29],0.1109232051046476
Chapter II Neoplasms,Melanoma in situ,SDHB,Succinate dehydrogenase,35486,140,0.83 [0.64-1.09],0.1858885901871183
Chapter II Neoplasms,Melanoma in situ,SDK2,Protein sidekick-2,34878,138,0.77 [0.49-1.21],0.251871719576807
Chapter II Neoplasms,Melanoma in situ,SEC31A,Protein transport protein Sec31A,34695,137,1.16 [0.93-1.44],0.1890056062180224
Chapter II Neoplasms,Melanoma in situ,SEL1L,Protein sel-1 homolog 1,34695,137,1.30 [0.86-1.96],0.2131437776826344
Chapter II Neoplasms,Melanoma in situ,SELE,E-selectin,41485,164,1.11 [0.84-1.46],0.4665140916354799
Chapter II Neoplasms,Melanoma in situ,SELENOP,Selenoprotein P,35692,141,0.76 [0.37-1.56],0.448211625809638
Chapter II Neoplasms,Melanoma in situ,SELL,L-selectin,35692,141,0.87 [0.43-1.78],0.7086665300472572
Chapter II Neoplasms,Melanoma in situ,SELP,P-selectin,41135,163,1.11 [0.87-1.41],0.4043628964818615
Chapter II Neoplasms,Melanoma in situ,SELPLG,P-selectin glycoprotein ligand 1,40939,163,0.93 [0.54-1.58],0.7791845785947563
Chapter II Neoplasms,Melanoma in situ,SEMA3F,Semaphorin-3F,40984,163,1.19 [0.69-2.02],0.5331480263852835
Chapter II Neoplasms,Melanoma in situ,SEMA3G,Semaphorin-3G,34878,138,1.03 [0.71-1.50],0.863654293749636
Chapter II Neoplasms,Melanoma in situ,SEMA4C,Semaphorin-4C,40789,160,1.33 [0.87-2.04],0.1870983045732438
Chapter II Neoplasms,Melanoma in situ,SEMA4D,Semaphorin-4D,41349,165,1.38 [0.87-2.20],0.1677262592544411
Chapter II Neoplasms,Melanoma in situ,SEMA6C,Semaphorin-6C,34608,134,0.73 [0.37-1.44],0.3673847916333568
Chapter II Neoplasms,Melanoma in situ,SEMA7A,Semaphorin-7A,41357,164,0.88 [0.52-1.49],0.621300904501956
Chapter II Neoplasms,Melanoma in situ,SEPTIN3,Neuronal-specific septin-3,35587,140,0.83 [0.66-1.05],0.1164929277361446
Chapter II Neoplasms,Melanoma in situ,SEPTIN7,Septin-7,34984,139,1.06 [0.79-1.41],0.6930561127241113
Chapter II Neoplasms,Melanoma in situ,SEPTIN8,Septin-8,35497,140,0.70 [0.41-1.20],0.1955882349727105
Chapter II Neoplasms,Melanoma in situ,SEPTIN9,Septin-9,40789,160,0.86 [0.52-1.43],0.5711999701192371
Chapter II Neoplasms,Melanoma in situ,SERPINA1,Alpha-1-antitrypsin,35012,140,1.26 [0.17-9.24],0.819116908825012
Chapter II Neoplasms,Melanoma in situ,SERPINA11,Serpin A11,41485,164,1.01 [0.72-1.42],0.9387751735392942
Chapter II Neoplasms,Melanoma in situ,SERPINA12,Serpin A12,39823,156,0.99 [0.86-1.14],0.8688454512170382
Chapter II Neoplasms,Melanoma in situ,SERPINA3,Alpha-1-antichymotrypsin,35569,141,1.49 [0.54-4.11],0.4394908130964401
Chapter II Neoplasms,Melanoma in situ,SERPINA4,Kallistatin,35028,140,1.02 [0.51-2.01],0.9630481018584692
Chapter II Neoplasms,Melanoma in situ,SERPINA5,Plasma serine protease inhibitor,35153,141,0.56 [0.31-1.00],0.0494847100738222
Chapter II Neoplasms,Melanoma in situ,SERPINA6,Corticosteroid-binding globulin,35692,141,0.58 [0.21-1.58],0.2840650669373391
Chapter II Neoplasms,Melanoma in situ,SERPINA7,Thyroxine-binding globulin,35692,141,1.19 [0.50-2.85],0.6882452062104334
Chapter II Neoplasms,Melanoma in situ,SERPINA9,Serpin A9,40580,159,0.88 [0.71-1.08],0.2069246238150745
Chapter II Neoplasms,Melanoma in situ,SERPINB1,Leukocyte elastase inhibitor,40866,163,1.07 [0.92-1.24],0.4103377257207933
Chapter II Neoplasms,Melanoma in situ,SERPINB5,Serpin B5,40258,158,0.87 [0.65-1.15],0.3187093863603407
Chapter II Neoplasms,Melanoma in situ,SERPINB6,Serpin B6,41216,164,1.11 [0.88-1.40],0.3769866615064415
Chapter II Neoplasms,Melanoma in situ,SERPINB8,Serpin B8,41452,164,0.92 [0.72-1.18],0.5188724971881307
Chapter II Neoplasms,Melanoma in situ,SERPINB9,Serpin B9,40682,158,1.25 [0.83-1.89],0.2920413370239573
Chapter II Neoplasms,Melanoma in situ,SERPINC1,Antithrombin-III,35623,141,1.67 [0.56-4.96],0.3539642931959288
Chapter II Neoplasms,Melanoma in situ,SERPIND1,Heparin cofactor 2,35623,141,0.95 [0.53-1.69],0.8503165576594082
Chapter II Neoplasms,Melanoma in situ,SERPINE1,Plasminogen activator inhibitor 1,41485,164,1.08 [0.88-1.32],0.4829389921158333
Chapter II Neoplasms,Melanoma in situ,SERPINE2,Glia-derived nexin,35640,141,1.14 [0.89-1.46],0.2882282993194233
Chapter II Neoplasms,Melanoma in situ,SERPINF1,Pigment epithelium-derived factor,35154,140,0.73 [0.39-1.37],0.3247633950844131
Chapter II Neoplasms,Melanoma in situ,SERPINF2,Alpha-2-antiplasmin,35011,140,2.20 [0.68-7.08],0.1875591436880898
Chapter II Neoplasms,Melanoma in situ,SERPING1,Plasma protease C1 inhibitor,35623,141,0.56 [0.23-1.35],0.1957922028438982
Chapter II Neoplasms,Melanoma in situ,SERPINH1,Serpin H1,34984,139,1.05 [0.92-1.19],0.4519159921661186
Chapter II Neoplasms,Melanoma in situ,SERPINI1,Neuroserpin,34808,138,0.74 [0.42-1.30],0.2943987240718463
Chapter II Neoplasms,Melanoma in situ,SERPINI2,Serpin I2,35486,140,1.04 [0.78-1.39],0.7785838400629508
Chapter II Neoplasms,Melanoma in situ,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,40031,160,1.04 [0.84-1.29],0.7350866816064329
Chapter II Neoplasms,Melanoma in situ,SETMAR,Histone-lysine N-methyltransferase SETMAR,40552,156,1.03 [0.64-1.67],0.9040525852789192
Chapter II Neoplasms,Melanoma in situ,SEZ6,Seizure protein 6 homolog,34686,135,0.81 [0.46-1.42],0.4574078213881817
Chapter II Neoplasms,Melanoma in situ,SEZ6L,Seizure 6-like protein,41097,164,0.56 [0.34-0.94],0.0266941769078522
Chapter II Neoplasms,Melanoma in situ,SEZ6L2,Seizure 6-like protein 2,40789,160,0.79 [0.43-1.45],0.4456903775934523
Chapter II Neoplasms,Melanoma in situ,SF3B4,Splicing factor 3B subunit 4,40789,160,1.03 [0.85-1.24],0.7590307533188358
Chapter II Neoplasms,Melanoma in situ,SFRP1,Secreted frizzled-related protein 1,40549,156,1.26 [0.92-1.73],0.1465729666070084
Chapter II Neoplasms,Melanoma in situ,SFRP4,Secreted frizzled-related protein 4,34878,138,1.23 [0.81-1.85],0.3287507092365201
Chapter II Neoplasms,Melanoma in situ,SFTPA1,Pulmonary surfactant-associated protein A1,40055,159,0.90 [0.69-1.18],0.4388731085216123
Chapter II Neoplasms,Melanoma in situ,SFTPA2,Pulmonary surfactant-associated protein A2,40055,159,0.98 [0.74-1.30],0.9038023555470224
Chapter II Neoplasms,Melanoma in situ,SFTPD,Pulmonary surfactant-associated protein D,40984,163,0.90 [0.73-1.11],0.3176101502063694
Chapter II Neoplasms,Melanoma in situ,SGSH,N-sulphoglucosamine sulphohydrolase,35040,140,0.77 [0.56-1.04],0.0903079367733086
Chapter II Neoplasms,Melanoma in situ,SH2B3,SH2B adapter protein 3,40055,159,1.10 [0.95-1.27],0.1975522242109018
Chapter II Neoplasms,Melanoma in situ,SH2D1A,SH2 domain-containing protein 1A,40939,163,0.91 [0.71-1.18],0.4778108484269381
Chapter II Neoplasms,Melanoma in situ,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,34549,138,0.79 [0.57-1.10],0.1578086191563858
Chapter II Neoplasms,Melanoma in situ,SH3BP1,SH3 domain-binding protein 1,35486,140,0.98 [0.71-1.35],0.8969044607946678
Chapter II Neoplasms,Melanoma in situ,SH3GL3,Endophilin-A3,34783,138,1.06 [0.88-1.29],0.5290368372897116
Chapter II Neoplasms,Melanoma in situ,SH3GLB2,Endophilin-B2,35570,140,0.97 [0.76-1.23],0.8027255869652441
Chapter II Neoplasms,Melanoma in situ,SHBG,Sex hormone-binding globulin,35663,141,0.90 [0.66-1.24],0.5296058462089372
Chapter II Neoplasms,Melanoma in situ,SHC1,SHC-transforming protein 1,34394,136,0.90 [0.77-1.05],0.171332656164963
Chapter II Neoplasms,Melanoma in situ,SHD,SH2 domain-containing adapter protein D,34451,137,0.87 [0.70-1.10],0.2437077998233146
Chapter II Neoplasms,Melanoma in situ,SHH,Sonic hedgehog protein,34608,134,0.95 [0.64-1.41],0.8013432009675063
Chapter II Neoplasms,Melanoma in situ,SHISA5,Protein shisa-5,35644,141,0.94 [0.49-1.80],0.8456175030497978
Chapter II Neoplasms,Melanoma in situ,SHMT1,"Serine hydroxymethyltransferase, cytosolic",41087,164,1.08 [0.92-1.26],0.3755450121248801
Chapter II Neoplasms,Melanoma in situ,SHPK,Sedoheptulokinase,34984,139,0.91 [0.60-1.38],0.6495570151505364
Chapter II Neoplasms,Melanoma in situ,SIAE,Sialate O-acetylesterase,41032,164,1.11 [0.83-1.50],0.4789094228504907
Chapter II Neoplasms,Melanoma in situ,SIGLEC1,Sialoadhesin,41147,164,0.86 [0.62-1.19],0.3672105672166319
Chapter II Neoplasms,Melanoma in situ,SIGLEC10,Sialic acid-binding Ig-like lectin 10,40939,163,1.31 [0.86-2.00],0.2119067146394285
Chapter II Neoplasms,Melanoma in situ,SIGLEC15,Sialic acid-binding Ig-like lectin 15,40031,160,1.01 [0.84-1.21],0.946646450344784
Chapter II Neoplasms,Melanoma in situ,SIGLEC5,Sialic acid-binding Ig-like lectin 5,40993,164,1.01 [0.90-1.14],0.8504693851991988
Chapter II Neoplasms,Melanoma in situ,SIGLEC6,Sialic acid-binding Ig-like lectin 6,41358,164,1.00 [0.65-1.52],0.9898761916921244
Chapter II Neoplasms,Melanoma in situ,SIGLEC7,Sialic acid-binding Ig-like lectin 7,40984,163,1.22 [0.74-2.01],0.43534878268261
Chapter II Neoplasms,Melanoma in situ,SIGLEC8,Sialic acid-binding Ig-like lectin 8,34695,137,1.37 [0.95-1.98],0.0885841207619689
Chapter II Neoplasms,Melanoma in situ,SIGLEC9,Sialic acid-binding Ig-like lectin 9,41299,164,1.02 [0.64-1.64],0.9331419202352064
Chapter II Neoplasms,Melanoma in situ,SIL1,Nucleotide exchange factor SIL1,34695,137,1.01 [0.60-1.67],0.9845612675923364
Chapter II Neoplasms,Melanoma in situ,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,41084,162,0.92 [0.73-1.17],0.4904746613977163
Chapter II Neoplasms,Melanoma in situ,SIRPB1,Signal-regulatory protein beta-1,40880,163,0.98 [0.73-1.33],0.9069246821249392
Chapter II Neoplasms,Melanoma in situ,SIRT1,NAD-dependent protein deacetylase sirtuin-1,34608,134,1.00 [0.83-1.21],0.9763640651759032
Chapter II Neoplasms,Melanoma in situ,SIRT2,NAD-dependent protein deacetylase sirtuin-2,40789,160,1.10 [0.94-1.29],0.2406685947442711
Chapter II Neoplasms,Melanoma in situ,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",40031,160,1.17 [0.93-1.46],0.1835694183297943
Chapter II Neoplasms,Melanoma in situ,SIT1,Signaling threshold-regulating transmembrane adapter 1,40249,159,0.98 [0.76-1.27],0.8866835269706318
Chapter II Neoplasms,Melanoma in situ,SKAP1,Src kinase-associated phosphoprotein 1,40606,158,1.03 [0.85-1.25],0.7390633456105942
Chapter II Neoplasms,Melanoma in situ,SKAP2,Src kinase-associated phosphoprotein 2,41147,164,1.06 [0.93-1.21],0.3833078868682184
Chapter II Neoplasms,Melanoma in situ,SKIV2L,Helicase SKI2W,34518,137,0.88 [0.57-1.36],0.5620459310329863
Chapter II Neoplasms,Melanoma in situ,SLA2,Src-like-adapter 2,35587,140,1.08 [0.92-1.26],0.3270558312429087
Chapter II Neoplasms,Melanoma in situ,SLAMF1,Signaling lymphocytic activation molecule,40249,159,0.98 [0.77-1.25],0.8945917915387837
Chapter II Neoplasms,Melanoma in situ,SLAMF6,SLAM family member 6,40055,159,0.94 [0.64-1.38],0.7521399000334396
Chapter II Neoplasms,Melanoma in situ,SLAMF7,SLAM family member 7,40939,163,0.90 [0.71-1.15],0.4081712288032835
Chapter II Neoplasms,Melanoma in situ,SLAMF8,SLAM family member 8,40055,159,0.96 [0.74-1.24],0.7426928772936472
Chapter II Neoplasms,Melanoma in situ,SLC12A2,Solute carrier family 12 member 2,34518,137,0.45 [0.23-0.89],0.0215871850634431
Chapter II Neoplasms,Melanoma in situ,SLC13A1,Solute carrier family 13 member 1,35477,140,1.05 [0.81-1.36],0.7021056138571863
Chapter II Neoplasms,Melanoma in situ,SLC16A1,Monocarboxylate transporter 1,40031,160,0.75 [0.56-1.00],0.0509455015854058
Chapter II Neoplasms,Melanoma in situ,SLC1A4,Neutral amino acid transporter A,34686,135,0.63 [0.42-0.95],0.0256855729841423
Chapter II Neoplasms,Melanoma in situ,SLC27A4,Long-chain fatty acid transport protein 4,40031,160,1.08 [0.88-1.32],0.4770963112028459
Chapter II Neoplasms,Melanoma in situ,SLC28A1,Sodium/nucleoside cotransporter 1,34394,136,0.84 [0.61-1.15],0.2757887156088803
Chapter II Neoplasms,Melanoma in situ,SLC34A3,Sodium-dependent phosphate transport protein 2C,34394,136,1.34 [1.04-1.73],0.0224161973091096
Chapter II Neoplasms,Melanoma in situ,SLC39A14,Zinc transporter ZIP14,40031,160,0.80 [0.51-1.24],0.311378228169005
Chapter II Neoplasms,Melanoma in situ,SLC39A5,Zinc transporter ZIP5,40939,163,0.93 [0.71-1.22],0.5822200548543048
Chapter II Neoplasms,Melanoma in situ,SLC44A4,Choline transporter-like protein 4,34686,135,1.00 [0.78-1.27],0.9720251229476696
Chapter II Neoplasms,Melanoma in situ,SLC4A1,Band 3 anion transport protein,35644,141,0.79 [0.56-1.13],0.1968161011984165
Chapter II Neoplasms,Melanoma in situ,SLC51B,Organic solute transporter subunit beta,34518,137,1.20 [0.99-1.46],0.0572966863928493
Chapter II Neoplasms,Melanoma in situ,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,34878,138,1.13 [0.93-1.37],0.2175432718811576
Chapter II Neoplasms,Melanoma in situ,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,35486,140,0.68 [0.45-1.03],0.0673571595395448
Chapter II Neoplasms,Melanoma in situ,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",34394,136,1.00 [0.74-1.33],0.9738511973022856
Chapter II Neoplasms,Melanoma in situ,SLIT2,Slit homolog 2 protein,40031,160,1.08 [0.83-1.40],0.5595027879184886
Chapter II Neoplasms,Melanoma in situ,SLITRK1,SLIT and NTRK-like protein 1,34608,134,1.01 [0.60-1.69],0.9821979066312196
Chapter II Neoplasms,Melanoma in situ,SLITRK2,SLIT and NTRK-like protein 2,41358,164,1.01 [0.71-1.45],0.9398932928139666
Chapter II Neoplasms,Melanoma in situ,SLITRK6,SLIT and NTRK-like protein 6,40258,158,0.96 [0.63-1.45],0.8418727704283302
Chapter II Neoplasms,Melanoma in situ,SLK,STE20-like serine/threonine-protein kinase,34984,139,0.95 [0.76-1.18],0.6160222137394895
Chapter II Neoplasms,Melanoma in situ,SLMAP,Sarcolemmal membrane-associated protein,35486,140,1.15 [0.95-1.39],0.1557809790066985
Chapter II Neoplasms,Melanoma in situ,SLURP1,Secreted Ly-6/uPAR-related protein 1,35378,141,0.79 [0.49-1.28],0.3457669203670751
Chapter II Neoplasms,Melanoma in situ,SMAD1,Mothers against decapentaplegic homolog 1,40055,159,1.10 [0.92-1.30],0.2932829376045452
Chapter II Neoplasms,Melanoma in situ,SMAD2,Mothers against decapentaplegic homolog 2,35477,140,1.15 [0.91-1.44],0.2354866024592052
Chapter II Neoplasms,Melanoma in situ,SMAD3,Mothers against decapentaplegic homolog 3,35477,140,1.12 [0.82-1.53],0.4748620574061483
Chapter II Neoplasms,Melanoma in situ,SMAD5,Mothers against decapentaplegic homolog 5,40789,160,1.58 [0.77-3.23],0.2137722598371026
Chapter II Neoplasms,Melanoma in situ,SMARCA2,Probable global transcription activator SNF2L2,40031,160,0.91 [0.74-1.11],0.3507706550318797
Chapter II Neoplasms,Melanoma in situ,SMC3,Structural maintenance of chromosomes protein 3,34394,136,0.62 [0.43-0.90],0.0125467225142039
Chapter II Neoplasms,Melanoma in situ,SMNDC1,Survival of motor neuron-related-splicing factor 30,35486,140,1.08 [0.85-1.38],0.524387582174831
Chapter II Neoplasms,Melanoma in situ,SMOC1,SPARC-related modular calcium-binding protein 1,41358,164,0.90 [0.59-1.38],0.6439966627587976
Chapter II Neoplasms,Melanoma in situ,SMOC2,SPARC-related modular calcium-binding protein 2,41147,164,0.70 [0.48-1.02],0.0630556432479766
Chapter II Neoplasms,Melanoma in situ,SMPD1,Sphingomyelin phosphodiesterase,41143,165,0.84 [0.63-1.12],0.2296596606149112
Chapter II Neoplasms,Melanoma in situ,SMPD3,Sphingomyelin phosphodiesterase 3,34608,134,1.03 [0.78-1.36],0.8326417752906277
Chapter II Neoplasms,Melanoma in situ,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,41079,163,0.86 [0.70-1.06],0.1609838474247694
Chapter II Neoplasms,Melanoma in situ,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,35477,140,1.04 [0.85-1.27],0.7115443861759148
Chapter II Neoplasms,Melanoma in situ,SMS,Spermine synthase,34549,138,1.05 [0.83-1.35],0.6707218355892833
Chapter II Neoplasms,Melanoma in situ,SMTN,Smoothelin,35506,140,1.21 [1.03-1.42],0.0216844061856406
Chapter II Neoplasms,Melanoma in situ,SNAP23,Synaptosomal-associated protein 23,40984,163,1.10 [0.93-1.29],0.2598128274275935
Chapter II Neoplasms,Melanoma in situ,SNAP25,Synaptosomal-associated protein 25,34549,138,1.23 [0.87-1.73],0.2348441019668989
Chapter II Neoplasms,Melanoma in situ,SNAP29,Synaptosomal-associated protein 29,41097,164,1.11 [0.95-1.29],0.1946715227075632
Chapter II Neoplasms,Melanoma in situ,SNAPIN,SNARE-associated protein Snapin,35587,140,1.13 [0.86-1.49],0.385487155577598
Chapter II Neoplasms,Melanoma in situ,SNCA,Alpha-synuclein,34878,138,1.07 [0.93-1.24],0.339347303365119
Chapter II Neoplasms,Melanoma in situ,SNCG,Gamma-synuclein,40682,158,0.87 [0.70-1.07],0.1792314895808135
Chapter II Neoplasms,Melanoma in situ,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",34695,137,0.64 [0.37-1.11],0.1141169773059382
Chapter II Neoplasms,Melanoma in situ,SNRPB2,U2 small nuclear ribonucleoprotein B'',35570,140,0.95 [0.65-1.38],0.7917177090431162
Chapter II Neoplasms,Melanoma in situ,SNU13,NHP2-like protein 1,34518,137,0.71 [0.51-1.00],0.0469836368197156
Chapter II Neoplasms,Melanoma in situ,SNX15,Sorting nexin-15,34878,138,1.19 [0.88-1.60],0.2497675590312232
Chapter II Neoplasms,Melanoma in situ,SNX18,Sorting nexin-18,35486,140,0.99 [0.68-1.43],0.939852145613361
Chapter II Neoplasms,Melanoma in situ,SNX2,Sorting nexin-2,35477,140,1.04 [0.86-1.26],0.6590068099262788
Chapter II Neoplasms,Melanoma in situ,SNX5,Sorting nexin-5,34695,137,1.22 [0.72-2.06],0.4617520513444781
Chapter II Neoplasms,Melanoma in situ,SNX9,Sorting nexin-9,40984,163,1.09 [0.89-1.34],0.3912928276353804
Chapter II Neoplasms,Melanoma in situ,SOD1,Superoxide dismutase [Cu-Zn],40158,156,0.98 [0.73-1.32],0.8880772310154892
Chapter II Neoplasms,Melanoma in situ,SOD2,"Superoxide dismutase [Mn], mitochondrial",40993,164,0.87 [0.59-1.28],0.4797880668427587
Chapter II Neoplasms,Melanoma in situ,SOD3,Extracellular superoxide dismutase,35663,141,0.70 [0.47-1.03],0.0714582760251785
Chapter II Neoplasms,Melanoma in situ,SORBS1,Sorbin and SH3 domain-containing protein 1,35587,140,1.10 [0.75-1.60],0.6237432118953086
Chapter II Neoplasms,Melanoma in situ,SORCS2,VPS10 domain-containing receptor SorCS2,40055,159,0.89 [0.59-1.34],0.5740686297220752
Chapter II Neoplasms,Melanoma in situ,SORD,Sorbitol dehydrogenase,41167,164,0.93 [0.76-1.14],0.4909952254176041
Chapter II Neoplasms,Melanoma in situ,SORT1,Sortilin,40930,163,1.31 [0.91-1.90],0.151545800493624
Chapter II Neoplasms,Melanoma in situ,SOST,Sclerostin,40930,163,0.82 [0.57-1.17],0.2680734454569371
Chapter II Neoplasms,Melanoma in situ,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,34686,135,1.07 [0.78-1.45],0.6843586976518699
Chapter II Neoplasms,Melanoma in situ,SOX2,Transcription factor SOX-2,35521,139,1.34 [0.70-2.53],0.3759329346171892
Chapter II Neoplasms,Melanoma in situ,SOX9,Transcription factor SOX-9,34686,135,0.47 [0.26-0.87],0.0154169504587335
Chapter II Neoplasms,Melanoma in situ,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,35587,140,0.98 [0.56-1.70],0.931741016642482
Chapter II Neoplasms,Melanoma in situ,SPAG1,Sperm-associated antigen 1,35587,140,0.90 [0.67-1.21],0.4955681448132388
Chapter II Neoplasms,Melanoma in situ,SPARC,SPARC,41097,164,1.01 [0.83-1.22],0.9337996493900032
Chapter II Neoplasms,Melanoma in situ,SPARCL1,SPARC-like protein 1,40998,163,1.25 [0.79-2.00],0.343078063365182
Chapter II Neoplasms,Melanoma in situ,SPART,Spartin,34878,138,1.15 [0.93-1.42],0.1896779867797174
Chapter II Neoplasms,Melanoma in situ,SPESP1,Sperm equatorial segment protein 1,35640,141,0.98 [0.58-1.64],0.9311680077378836
Chapter II Neoplasms,Melanoma in situ,SPINK1,Serine protease inhibitor Kazal-type 1,40993,164,0.96 [0.68-1.35],0.8094957683370891
Chapter II Neoplasms,Melanoma in situ,SPINK2,Serine protease inhibitor Kazal-type 2,34878,138,0.94 [0.59-1.49],0.795320326134971
Chapter II Neoplasms,Melanoma in situ,SPINK4,Serine protease inhibitor Kazal-type 4,40939,163,1.07 [0.86-1.32],0.5427455148876719
Chapter II Neoplasms,Melanoma in situ,SPINK5,Serine protease inhibitor Kazal-type 5,40993,164,0.59 [0.38-0.90],0.0150657077634039
Chapter II Neoplasms,Melanoma in situ,SPINK6,Serine protease inhibitor Kazal-type 6,41358,164,0.80 [0.62-1.04],0.0916115937906515
Chapter II Neoplasms,Melanoma in situ,SPINK8,Serine protease inhibitor Kazal-type 8,34518,137,0.59 [0.34-1.03],0.0629173069315481
Chapter II Neoplasms,Melanoma in situ,SPINT1,Kunitz-type protease inhibitor 1,40862,163,0.92 [0.52-1.65],0.7920609067663089
Chapter II Neoplasms,Melanoma in situ,SPINT2,Kunitz-type protease inhibitor 2,41147,164,1.16 [0.82-1.64],0.4101030548122355
Chapter II Neoplasms,Melanoma in situ,SPINT3,Kunitz-type protease inhibitor 3,35486,140,0.97 [0.87-1.08],0.586638515869468
Chapter II Neoplasms,Melanoma in situ,SPOCK1,Testican-1,40682,158,0.99 [0.57-1.72],0.9690460832690024
Chapter II Neoplasms,Melanoma in situ,SPON1,Spondin-1,41020,164,0.84 [0.54-1.30],0.4317027276063842
Chapter II Neoplasms,Melanoma in situ,SPON2,Spondin-2,40803,163,0.69 [0.45-1.05],0.0800779809022902
Chapter II Neoplasms,Melanoma in situ,SPP1,Osteopontin,41415,162,0.83 [0.61-1.13],0.2308637243730036
Chapter II Neoplasms,Melanoma in situ,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",34608,134,1.13 [0.78-1.64],0.5029074381055001
Chapter II Neoplasms,Melanoma in situ,SPRING1,SREBP regulating gene protein,34394,136,0.97 [0.73-1.27],0.8040444183529806
Chapter II Neoplasms,Melanoma in situ,SPRR1B,Cornifin-B,34984,139,0.92 [0.74-1.14],0.4467463644612399
Chapter II Neoplasms,Melanoma in situ,SPRR3,Small proline-rich protein 3,35570,140,0.88 [0.69-1.11],0.2816453740684849
Chapter II Neoplasms,Melanoma in situ,SPRY2,Protein sprouty homolog 2,40249,159,1.02 [0.87-1.19],0.8111634883479752
Chapter II Neoplasms,Melanoma in situ,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",34549,138,0.90 [0.53-1.51],0.6832807006639039
Chapter II Neoplasms,Melanoma in situ,SPTLC1,Serine palmitoyltransferase 1,35570,140,1.02 [0.67-1.56],0.9233079861332036
Chapter II Neoplasms,Melanoma in situ,SRC,Proto-oncogene tyrosine-protein kinase Src,41028,164,1.09 [0.97-1.22],0.1511032000463679
Chapter II Neoplasms,Melanoma in situ,SRP14,Signal recognition particle 14 kDa protein,40789,160,1.06 [0.85-1.33],0.6126461887373675
Chapter II Neoplasms,Melanoma in situ,SRPK2,SRSF protein kinase 2,40939,163,1.11 [0.95-1.31],0.1851930546512699
Chapter II Neoplasms,Melanoma in situ,SRPX,Sushi repeat-containing protein SRPX,35640,141,0.90 [0.58-1.41],0.6477663365639996
Chapter II Neoplasms,Melanoma in situ,SSB,Lupus La protein,40031,160,1.12 [0.90-1.38],0.3154346733180713
Chapter II Neoplasms,Melanoma in situ,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",34608,134,1.10 [0.71-1.72],0.670737258242885
Chapter II Neoplasms,Melanoma in situ,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,40930,163,0.93 [0.82-1.06],0.2719108229042569
Chapter II Neoplasms,Melanoma in situ,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,41135,163,0.93 [0.67-1.29],0.6662503998630832
Chapter II Neoplasms,Melanoma in situ,SSH3,Protein phosphatase Slingshot homolog 3,34394,136,0.92 [0.51-1.64],0.774382425435328
Chapter II Neoplasms,Melanoma in situ,SSNA1,Sjoegren syndrome nuclear autoantigen 1,35486,140,1.12 [0.82-1.52],0.4859909221163372
Chapter II Neoplasms,Melanoma in situ,ST13,Hsc70-interacting protein,34878,138,1.06 [0.80-1.43],0.6721623366616114
Chapter II Neoplasms,Melanoma in situ,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40789,160,1.15 [0.83-1.58],0.4028558336366764
Chapter II Neoplasms,Melanoma in situ,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",41485,164,1.16 [0.73-1.83],0.536563464615701
Chapter II Neoplasms,Melanoma in situ,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",34608,134,0.97 [0.69-1.38],0.8783192457802251
Chapter II Neoplasms,Melanoma in situ,STAB2,Stabilin-2,35644,141,1.01 [0.57-1.79],0.9735029966923114
Chapter II Neoplasms,Melanoma in situ,STAM,Signal transducing adapter molecule 1,35477,140,0.97 [0.63-1.51],0.8979899086309696
Chapter II Neoplasms,Melanoma in situ,STAMBP,STAM-binding protein,40606,158,1.10 [0.89-1.38],0.3731614761285664
Chapter II Neoplasms,Melanoma in situ,STAT2,Signal transducer and activator of transcription 2,34608,134,1.22 [0.99-1.51],0.0665773827618593
Chapter II Neoplasms,Melanoma in situ,STAT5B,Signal transducer and activator of transcription 5B,40789,160,1.05 [0.95-1.16],0.354599798193063
Chapter II Neoplasms,Melanoma in situ,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,34394,136,1.11 [0.89-1.39],0.3515338312716088
Chapter II Neoplasms,Melanoma in situ,STC1,Stanniocalcin-1,41349,165,0.72 [0.51-1.01],0.0596340671154738
Chapter II Neoplasms,Melanoma in situ,STC2,Stanniocalcin-2,40938,164,2.17 [1.22-3.86],0.0081389933284212
Chapter II Neoplasms,Melanoma in situ,STEAP4,Metalloreductase STEAP4,34549,138,1.13 [0.94-1.37],0.200682640754556
Chapter II Neoplasms,Melanoma in situ,STIP1,Stress-induced-phosphoprotein 1,40927,163,1.07 [0.87-1.33],0.5055804178656249
Chapter II Neoplasms,Melanoma in situ,STK11,Serine/threonine-protein kinase STK11,40258,158,1.00 [0.82-1.21],0.9886903889514908
Chapter II Neoplasms,Melanoma in situ,STK24,Serine/threonine-protein kinase 24,40031,160,1.08 [0.86-1.35],0.525789276591681
Chapter II Neoplasms,Melanoma in situ,STK4,Serine/threonine-protein kinase 4,40984,163,1.10 [0.94-1.29],0.2299873673135215
Chapter II Neoplasms,Melanoma in situ,STOML2,"Stomatin-like protein 2, mitochondrial",34394,136,1.09 [0.93-1.28],0.3043009340311251
Chapter II Neoplasms,Melanoma in situ,STX16,Syntaxin-16,40055,159,1.13 [0.90-1.42],0.3012836862805586
Chapter II Neoplasms,Melanoma in situ,STX1B,Syntaxin-1B,34686,135,0.96 [0.63-1.46],0.8513536803546174
Chapter II Neoplasms,Melanoma in situ,STX3,Syntaxin-3,35570,140,1.05 [0.71-1.55],0.8182742930638053
Chapter II Neoplasms,Melanoma in situ,STX4,Syntaxin-4,40789,160,1.04 [0.83-1.31],0.7331773082002859
Chapter II Neoplasms,Melanoma in situ,STX5,Syntaxin-5,34608,134,0.98 [0.65-1.49],0.9370298754677572
Chapter II Neoplasms,Melanoma in situ,STX6,Syntaxin-6,40055,159,1.16 [0.96-1.41],0.1151920896406176
Chapter II Neoplasms,Melanoma in situ,STX7,Syntaxin-7,34608,134,1.08 [0.77-1.51],0.6473299454547814
Chapter II Neoplasms,Melanoma in situ,STX8,Syntaxin-8,40939,163,1.16 [0.88-1.53],0.301526796588802
Chapter II Neoplasms,Melanoma in situ,STXBP1,Syntaxin-binding protein 1,35587,140,1.08 [0.87-1.33],0.4729838095917674
Chapter II Neoplasms,Melanoma in situ,STXBP3,Syntaxin-binding protein 3,40055,159,1.07 [0.78-1.46],0.6969162149765809
Chapter II Neoplasms,Melanoma in situ,SUGP1,SURP and G-patch domain-containing protein 1,35486,140,1.10 [0.74-1.63],0.6365913913946659
Chapter II Neoplasms,Melanoma in situ,SUGT1,Protein SGT1 homolog,40055,159,1.07 [0.90-1.28],0.4238725893326989
Chapter II Neoplasms,Melanoma in situ,SULT1A1,Sulfotransferase 1A1,41349,165,1.05 [0.94-1.17],0.3985308356117294
Chapter II Neoplasms,Melanoma in situ,SULT2A1,Bile salt sulfotransferase,40939,163,0.89 [0.68-1.17],0.4056501538265794
Chapter II Neoplasms,Melanoma in situ,SUMF1,Formylglycine-generating enzyme,34608,134,1.14 [0.93-1.39],0.2191936682768638
Chapter II Neoplasms,Melanoma in situ,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,41349,165,1.11 [0.85-1.45],0.4356415918125201
Chapter II Neoplasms,Melanoma in situ,SUOX,"Sulfite oxidase, mitochondrial",35587,140,0.81 [0.61-1.07],0.1374474105095369
Chapter II Neoplasms,Melanoma in situ,SUSD1,Sushi domain-containing protein 1,40258,158,1.11 [0.83-1.50],0.4715619692794067
Chapter II Neoplasms,Melanoma in situ,SUSD2,Sushi domain-containing protein 2,40993,164,0.82 [0.50-1.35],0.4398527446216175
Chapter II Neoplasms,Melanoma in situ,SUSD4,Sushi domain-containing protein 4,35477,140,1.08 [0.74-1.58],0.6879882017403947
Chapter II Neoplasms,Melanoma in situ,SUSD5,Sushi domain-containing protein 5,34690,136,0.93 [0.57-1.52],0.7742450313767557
Chapter II Neoplasms,Melanoma in situ,SV2A,Synaptic vesicle glycoprotein 2A,34686,135,1.03 [0.80-1.35],0.7997075639162665
Chapter II Neoplasms,Melanoma in situ,SWAP70,Switch-associated protein 70,35486,140,0.97 [0.61-1.53],0.8834341303046558
Chapter II Neoplasms,Melanoma in situ,SYAP1,Synapse-associated protein 1,34878,138,1.25 [0.95-1.65],0.1140047209092874
Chapter II Neoplasms,Melanoma in situ,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,34549,138,0.81 [0.58-1.13],0.2109147897543476
Chapter II Neoplasms,Melanoma in situ,SYT1,Synaptotagmin-1,35570,140,1.01 [0.67-1.50],0.9736222889640378
Chapter II Neoplasms,Melanoma in situ,SYTL4,Synaptotagmin-like protein 4,35640,141,1.15 [0.93-1.42],0.2042116116614636
Chapter II Neoplasms,Melanoma in situ,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,34984,139,1.13 [0.97-1.32],0.11383789760019
Chapter II Neoplasms,Melanoma in situ,TACC3,Transforming acidic coiled-coil-containing protein 3,40789,160,1.07 [0.95-1.21],0.2660941708947879
Chapter II Neoplasms,Melanoma in situ,TACSTD2,Tumor-associated calcium signal transducer 2,36362,140,0.90 [0.53-1.53],0.7094578171143686
Chapter II Neoplasms,Melanoma in situ,TADA3,Transcriptional adapter 3,35477,140,1.33 [0.90-1.96],0.153387337097121
Chapter II Neoplasms,Melanoma in situ,TAFA5,Chemokine-like protein TAFA-5,40789,160,0.77 [0.51-1.16],0.2152882912158497
Chapter II Neoplasms,Melanoma in situ,TAGLN3,Transgelin-3,34394,136,0.97 [0.73-1.27],0.8134197553222748
Chapter II Neoplasms,Melanoma in situ,TALDO1,Transaldolase,35513,141,1.25 [0.88-1.77],0.2119274987144482
Chapter II Neoplasms,Melanoma in situ,TANK,TRAF family member-associated NF-kappa-B activator,40249,159,1.16 [0.95-1.42],0.1391117402124647
Chapter II Neoplasms,Melanoma in situ,TAP1,Antigen peptide transporter 1,34984,139,0.92 [0.68-1.25],0.5983285246540009
Chapter II Neoplasms,Melanoma in situ,TARBP2,RISC-loading complex subunit TARBP2,40031,160,1.16 [0.97-1.39],0.0931319237573582
Chapter II Neoplasms,Melanoma in situ,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",34686,135,1.08 [0.88-1.32],0.4615293646725886
Chapter II Neoplasms,Melanoma in situ,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",35477,140,0.80 [0.51-1.25],0.3250592807230689
Chapter II Neoplasms,Melanoma in situ,TAX1BP1,Tax1-binding protein 1,35570,140,1.32 [1.04-1.68],0.0208894653526125
Chapter II Neoplasms,Melanoma in situ,TBC1D17,TBC1 domain family member 17,40031,160,1.02 [0.75-1.39],0.9009484891828714
Chapter II Neoplasms,Melanoma in situ,TBC1D23,TBC1 domain family member 23,40789,160,1.10 [0.95-1.29],0.2104413798901795
Chapter II Neoplasms,Melanoma in situ,TBC1D5,TBC1 domain family member 5,40939,163,1.08 [0.91-1.28],0.3715649215734692
Chapter II Neoplasms,Melanoma in situ,TBCA,Tubulin-specific chaperone A,34878,138,1.13 [0.93-1.36],0.2236814897495887
Chapter II Neoplasms,Melanoma in situ,TBCB,Tubulin-folding cofactor B,40682,158,1.09 [0.95-1.26],0.2187795009803597
Chapter II Neoplasms,Melanoma in situ,TBCC,Tubulin-specific chaperone C,40682,158,1.17 [0.98-1.39],0.0852549690611739
Chapter II Neoplasms,Melanoma in situ,TBL1X,F-box-like/WD repeat-containing protein TBL1X,40055,159,1.05 [0.89-1.24],0.5334727625029896
Chapter II Neoplasms,Melanoma in situ,TBR1,T-box brain protein 1,34686,135,0.66 [0.42-1.04],0.0752821724197443
Chapter II Neoplasms,Melanoma in situ,TCL1A,T-cell leukemia/lymphoma protein 1A,40618,156,0.86 [0.74-1.00],0.0492688754519554
Chapter II Neoplasms,Melanoma in situ,TCL1B,T-cell leukemia/lymphoma protein 1B,40258,158,1.07 [0.91-1.25],0.424494278531388
Chapter II Neoplasms,Melanoma in situ,TCN1,Transcobalamin-1,34936,137,1.32 [0.86-2.03],0.1987772786153296
Chapter II Neoplasms,Melanoma in situ,TCN2,Transcobalamin-2,41415,162,0.99 [0.62-1.56],0.9515288766050368
Chapter II Neoplasms,Melanoma in situ,TCOF1,Treacle protein,35640,141,0.76 [0.43-1.33],0.3326638283593268
Chapter II Neoplasms,Melanoma in situ,TCP11,T-complex protein 11 homolog,34984,139,0.97 [0.72-1.31],0.8466859543584072
Chapter II Neoplasms,Melanoma in situ,TCTN3,Tectonic-3,35640,141,0.92 [0.54-1.59],0.7695188804623536
Chapter II Neoplasms,Melanoma in situ,TDGF1,Teratocarcinoma-derived growth factor 1,40031,160,0.95 [0.86-1.05],0.3276704146509713
Chapter II Neoplasms,Melanoma in situ,TDO2,"Tryptophan 2,3-dioxygenase",34686,135,0.58 [0.34-0.99],0.0438643123714056
Chapter II Neoplasms,Melanoma in situ,TDP1,Tyrosyl-DNA phosphodiesterase 1,35477,140,0.84 [0.65-1.09],0.1804368074420147
Chapter II Neoplasms,Melanoma in situ,TDRKH,Tudor and KH domain-containing protein,40031,160,1.17 [1.00-1.37],0.0567913058560353
Chapter II Neoplasms,Melanoma in situ,TEF,Thyrotroph embryonic factor,34518,137,1.00 [0.68-1.47],0.9978693980343188
Chapter II Neoplasms,Melanoma in situ,TEK,Angiopoietin-1 receptor,41097,164,0.88 [0.46-1.66],0.6847362928414732
Chapter II Neoplasms,Melanoma in situ,TERF1,Telomeric repeat-binding factor 1,34608,134,1.18 [0.69-2.02],0.5468896838895805
Chapter II Neoplasms,Melanoma in situ,TET2,Methylcytosine dioxygenase TET2,34919,139,0.94 [0.78-1.12],0.4611510651995185
Chapter II Neoplasms,Melanoma in situ,TEX101,Testis-expressed protein 101,34686,135,1.20 [0.87-1.65],0.2606711641851034
Chapter II Neoplasms,Melanoma in situ,TEX33,Testis-expressed protein 33,34984,139,0.72 [0.44-1.20],0.207459733831381
Chapter II Neoplasms,Melanoma in situ,TF,Serotransferrin,35692,141,1.17 [0.56-2.46],0.679116172948151
Chapter II Neoplasms,Melanoma in situ,TFAP2A,Transcription factor AP-2-alpha,34549,138,0.95 [0.72-1.26],0.7456250880162194
Chapter II Neoplasms,Melanoma in situ,TFF1,Trefoil factor 1,40807,164,1.01 [0.85-1.21],0.8977216331082887
Chapter II Neoplasms,Melanoma in situ,TFF2,Trefoil factor 2,41087,164,0.96 [0.75-1.24],0.7592493624003428
Chapter II Neoplasms,Melanoma in situ,TFF3,Trefoil factor 3,40949,162,0.99 [0.71-1.39],0.9652749587866588
Chapter II Neoplasms,Melanoma in situ,TFPI,Tissue factor pathway inhibitor,40877,163,0.83 [0.52-1.31],0.4222149059447365
Chapter II Neoplasms,Melanoma in situ,TFPI2,Tissue factor pathway inhibitor 2,40971,164,0.92 [0.62-1.37],0.6902437910812695
Chapter II Neoplasms,Melanoma in situ,TFRC,Transferrin receptor protein 1,41147,162,1.05 [0.73-1.52],0.7860745929168288
Chapter II Neoplasms,Melanoma in situ,TG,Thyroglobulin,35477,140,1.00 [0.86-1.15],0.950373756498486
Chapter II Neoplasms,Melanoma in situ,TGFA,Protransforming growth factor alpha,40939,163,1.22 [0.92-1.64],0.1697320996812095
Chapter II Neoplasms,Melanoma in situ,TGFB1,Transforming growth factor beta-1 proprotein,41379,164,1.06 [0.74-1.52],0.744228028823666
Chapter II Neoplasms,Melanoma in situ,TGFB2,Transforming growth factor beta-2 proprotein,35477,140,1.17 [0.88-1.56],0.2739050613054327
Chapter II Neoplasms,Melanoma in situ,TGFBI,Transforming growth factor-beta-induced protein ig-h3,40743,163,1.33 [0.79-2.22],0.2810307990556536
Chapter II Neoplasms,Melanoma in situ,TGFBR1,TGF-beta receptor type-1,34608,134,0.71 [0.32-1.58],0.4031716767056539
Chapter II Neoplasms,Melanoma in situ,TGFBR2,TGF-beta receptor type-2,41097,164,0.82 [0.52-1.29],0.3892115395042226
Chapter II Neoplasms,Melanoma in situ,TGFBR3,Transforming growth factor beta receptor type 3,41485,164,0.83 [0.54-1.28],0.393956252865461
Chapter II Neoplasms,Melanoma in situ,TGM2,Protein-glutamine gamma-glutamyltransferase 2,40922,163,0.97 [0.80-1.16],0.7120510347030411
Chapter II Neoplasms,Melanoma in situ,TGOLN2,Trans-Golgi network integral membrane protein 2,35663,141,0.74 [0.40-1.38],0.3448123098322703
Chapter II Neoplasms,Melanoma in situ,THAP12,52 kDa repressor of the inhibitor of the protein kinase,34328,135,0.96 [0.79-1.17],0.7143260138289436
Chapter II Neoplasms,Melanoma in situ,THBD,Thrombomodulin,40984,163,0.87 [0.53-1.44],0.58988406610165
Chapter II Neoplasms,Melanoma in situ,THBS2,Thrombospondin-2,40993,164,1.04 [0.71-1.52],0.853996384798399
Chapter II Neoplasms,Melanoma in situ,THBS4,Thrombospondin-4,41004,163,0.85 [0.62-1.16],0.2974255290705526
Chapter II Neoplasms,Melanoma in situ,THOP1,Thimet oligopeptidase,40798,163,0.99 [0.63-1.57],0.980445387166098
Chapter II Neoplasms,Melanoma in situ,THPO,Thrombopoietin,40258,158,0.98 [0.68-1.41],0.8959551917372091
Chapter II Neoplasms,Melanoma in situ,THRAP3,Thyroid hormone receptor-associated protein 3,34518,137,1.01 [0.87-1.17],0.9082782500265854
Chapter II Neoplasms,Melanoma in situ,THSD1,Thrombospondin type-1 domain-containing protein 1,34344,131,1.12 [0.69-1.82],0.636687502928617
Chapter II Neoplasms,Melanoma in situ,THTPA,Thiamine-triphosphatase,35411,140,1.14 [0.94-1.37],0.174560828444671
Chapter II Neoplasms,Melanoma in situ,THY1,Thy-1 membrane glycoprotein,41349,165,0.87 [0.53-1.43],0.5787663831786081
Chapter II Neoplasms,Melanoma in situ,TIA1,Nucleolysin TIA-1 isoform p40,39812,155,1.03 [0.92-1.16],0.5908463469877647
Chapter II Neoplasms,Melanoma in situ,TIE1,Tyrosine-protein kinase receptor Tie-1,41485,164,0.82 [0.61-1.11],0.1986362726014092
Chapter II Neoplasms,Melanoma in situ,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39955,160,0.82 [0.60-1.12],0.2136201979710842
Chapter II Neoplasms,Melanoma in situ,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,34984,139,0.90 [0.57-1.42],0.6416988734582394
Chapter II Neoplasms,Melanoma in situ,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,41135,163,0.97 [0.71-1.35],0.8737892499378839
Chapter II Neoplasms,Melanoma in situ,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,35640,141,1.23 [0.84-1.81],0.2899826957810777
Chapter II Neoplasms,Melanoma in situ,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,35570,140,1.16 [0.96-1.39],0.1249692945055048
Chapter II Neoplasms,Melanoma in situ,TIMP1,Metalloproteinase inhibitor 1,40543,160,1.12 [0.68-1.84],0.6682593189349848
Chapter II Neoplasms,Melanoma in situ,TIMP2,Metalloproteinase inhibitor 2,35640,141,0.60 [0.28-1.27],0.182606383178139
Chapter II Neoplasms,Melanoma in situ,TIMP3,Metalloproteinase inhibitor 3,41147,164,0.96 [0.86-1.07],0.4528801695171519
Chapter II Neoplasms,Melanoma in situ,TIMP4,Metalloproteinase inhibitor 4,40993,164,0.79 [0.55-1.13],0.1933501585405541
Chapter II Neoplasms,Melanoma in situ,TINAGL1,Tubulointerstitial nephritis antigen-like,40860,163,0.99 [0.52-1.87],0.9667440601103252
Chapter II Neoplasms,Melanoma in situ,TJAP1,Tight junction-associated protein 1,41097,164,1.17 [0.99-1.38],0.0608542154363722
Chapter II Neoplasms,Melanoma in situ,TJP3,Tight junction protein ZO-3,34549,138,0.74 [0.48-1.15],0.181480600248404
Chapter II Neoplasms,Melanoma in situ,TK1,"Thymidine kinase, cytosolic",34984,139,0.85 [0.57-1.27],0.4320208741690663
Chapter II Neoplasms,Melanoma in situ,TLR1,Toll-like receptor 1,34608,134,1.15 [0.62-2.15],0.6545002442254627
Chapter II Neoplasms,Melanoma in situ,TLR2,Toll-like receptor 2,34984,139,0.44 [0.22-0.88],0.0207552813474901
Chapter II Neoplasms,Melanoma in situ,TLR3,Toll-like receptor 3,41452,164,0.82 [0.66-1.02],0.0702937579758887
Chapter II Neoplasms,Melanoma in situ,TLR4,Toll-like receptor 4,34608,134,0.79 [0.44-1.44],0.4494639676145651
Chapter II Neoplasms,Melanoma in situ,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,34686,135,0.88 [0.64-1.22],0.4555056612030668
Chapter II Neoplasms,Melanoma in situ,TMED1,Transmembrane emp24 domain-containing protein 1,34984,139,0.84 [0.61-1.16],0.2882822878058531
Chapter II Neoplasms,Melanoma in situ,TMED10,Transmembrane emp24 domain-containing protein 10,34518,137,1.07 [0.80-1.45],0.6384734055398037
Chapter II Neoplasms,Melanoma in situ,TMED4,Transmembrane emp24 domain-containing protein 4,34518,137,0.56 [0.37-0.84],0.0051167789513857
Chapter II Neoplasms,Melanoma in situ,TMED8,Protein TMED8,35486,140,1.17 [1.00-1.38],0.0517709267991723
Chapter II Neoplasms,Melanoma in situ,TMEM106A,Transmembrane protein 106A,35477,140,1.16 [0.94-1.44],0.1692488149143002
Chapter II Neoplasms,Melanoma in situ,TMEM132A,Transmembrane protein 132A,34695,137,1.05 [0.81-1.36],0.7241247336053722
Chapter II Neoplasms,Melanoma in situ,TMEM25,Transmembrane protein 25,35587,140,0.93 [0.64-1.34],0.7000144277745384
Chapter II Neoplasms,Melanoma in situ,TMOD4,Tropomodulin-4,34394,136,0.76 [0.50-1.17],0.2153075518195215
Chapter II Neoplasms,Melanoma in situ,TMPRSS11B,Transmembrane protease serine 11B,34549,138,1.07 [0.87-1.30],0.5272604024151191
Chapter II Neoplasms,Melanoma in situ,TMPRSS11D,Transmembrane protease serine 11D,35497,140,0.79 [0.52-1.22],0.2907012831877046
Chapter II Neoplasms,Melanoma in situ,TMPRSS15,Enteropeptidase,40789,160,1.04 [0.89-1.21],0.6393712230043078
Chapter II Neoplasms,Melanoma in situ,TMPRSS5,Transmembrane protease serine 5,40484,154,0.98 [0.67-1.43],0.9211317255736514
Chapter II Neoplasms,Melanoma in situ,TMSB10,Thymosin beta-10,40993,164,1.08 [0.90-1.30],0.4071656135181989
Chapter II Neoplasms,Melanoma in situ,TNC,Tenascin,41135,163,1.02 [0.76-1.36],0.9125416620125611
Chapter II Neoplasms,Melanoma in situ,TNF,Tumor necrosis factor,40192,158,1.04 [0.72-1.51],0.8209497622286657
Chapter II Neoplasms,Melanoma in situ,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,35486,140,1.06 [0.76-1.48],0.7154415932042127
Chapter II Neoplasms,Melanoma in situ,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,40249,159,1.06 [0.73-1.55],0.7522727091007866
Chapter II Neoplasms,Melanoma in situ,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,34878,138,1.11 [0.86-1.44],0.4112209545605864
Chapter II Neoplasms,Melanoma in situ,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40682,158,1.08 [0.70-1.67],0.7432064798833999
Chapter II Neoplasms,Melanoma in situ,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40682,158,0.91 [0.60-1.37],0.6380454614497391
Chapter II Neoplasms,Melanoma in situ,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,41060,161,1.06 [0.80-1.41],0.668200218633471
Chapter II Neoplasms,Melanoma in situ,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,41452,164,1.09 [0.76-1.57],0.6305740837105844
Chapter II Neoplasms,Melanoma in situ,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,40948,164,0.77 [0.47-1.27],0.3066295406973459
Chapter II Neoplasms,Melanoma in situ,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,41097,164,1.06 [0.71-1.58],0.7828730777485616
Chapter II Neoplasms,Melanoma in situ,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,41020,164,0.97 [0.62-1.52],0.9061770707180304
Chapter II Neoplasms,Melanoma in situ,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,40249,159,0.82 [0.58-1.17],0.2835212014705284
Chapter II Neoplasms,Melanoma in situ,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,41020,164,1.17 [0.73-1.85],0.5121822129903794
Chapter II Neoplasms,Melanoma in situ,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,34878,138,0.80 [0.54-1.21],0.2913203808470281
Chapter II Neoplasms,Melanoma in situ,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,41358,164,0.90 [0.57-1.42],0.6465261554078785
Chapter II Neoplasms,Melanoma in situ,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,40993,164,0.90 [0.55-1.47],0.6601209918541255
Chapter II Neoplasms,Melanoma in situ,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,40993,164,1.03 [0.70-1.51],0.8931030981674701
Chapter II Neoplasms,Melanoma in situ,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,41349,165,0.95 [0.57-1.58],0.8384994117485416
Chapter II Neoplasms,Melanoma in situ,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,41379,164,0.75 [0.51-1.12],0.1577562442605902
Chapter II Neoplasms,Melanoma in situ,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40682,158,1.01 [0.78-1.31],0.9459964999941388
Chapter II Neoplasms,Melanoma in situ,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,41349,165,0.88 [0.64-1.21],0.4456212287975708
Chapter II Neoplasms,Melanoma in situ,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40682,158,0.97 [0.67-1.41],0.8836118512870963
Chapter II Neoplasms,Melanoma in situ,TNFSF10,Tumor necrosis factor ligand superfamily member 10,41452,164,1.05 [0.61-1.81],0.8526069535967749
Chapter II Neoplasms,Melanoma in situ,TNFSF11,Tumor necrosis factor ligand superfamily member 11,40939,163,0.82 [0.65-1.03],0.0818489881452354
Chapter II Neoplasms,Melanoma in situ,TNFSF12,Tumor necrosis factor ligand superfamily member 12,41452,164,1.01 [0.62-1.63],0.978529556545946
Chapter II Neoplasms,Melanoma in situ,TNFSF13,Tumor necrosis factor ligand superfamily member 13,41147,164,1.33 [0.79-2.24],0.2909180553807826
Chapter II Neoplasms,Melanoma in situ,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,41415,164,1.12 [0.67-1.88],0.6533142417975375
Chapter II Neoplasms,Melanoma in situ,TNFSF14,Tumor necrosis factor ligand superfamily member 14,40682,158,0.97 [0.76-1.24],0.8312538385601549
Chapter II Neoplasms,Melanoma in situ,TNFSF8,Tumor necrosis factor ligand superfamily member 8,35644,141,0.84 [0.53-1.33],0.4534222052053083
Chapter II Neoplasms,Melanoma in situ,TNIP1,TNFAIP3-interacting protein 1,35570,140,1.12 [0.93-1.33],0.2278822494678829
Chapter II Neoplasms,Melanoma in situ,TNN,Tenascin-N,35644,141,1.15 [0.80-1.66],0.4573189166012883
Chapter II Neoplasms,Melanoma in situ,TNNI3,"Troponin I, cardiac muscle",40258,158,1.03 [0.87-1.22],0.7308551147647817
Chapter II Neoplasms,Melanoma in situ,TNPO1,Transportin-1,34984,139,0.67 [0.41-1.09],0.1041947066949154
Chapter II Neoplasms,Melanoma in situ,TNR,Tenascin-R,40682,158,0.99 [0.71-1.38],0.9400177706504318
Chapter II Neoplasms,Melanoma in situ,TNXB,Tenascin-X,40993,164,0.84 [0.49-1.46],0.5421895480885087
Chapter II Neoplasms,Melanoma in situ,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,35640,141,1.08 [0.88-1.32],0.4706425795956088
Chapter II Neoplasms,Melanoma in situ,TOP1,DNA topoisomerase 1,35486,140,0.94 [0.81-1.08],0.3859927275718832
Chapter II Neoplasms,Melanoma in situ,TOP1MT,"DNA topoisomerase I, mitochondrial",34394,136,1.02 [0.73-1.42],0.91421267156005
Chapter II Neoplasms,Melanoma in situ,TOP2B,DNA topoisomerase 2-beta,34608,134,1.14 [0.93-1.40],0.2013560714179336
Chapter II Neoplasms,Melanoma in situ,TOR1AIP1,Torsin-1A-interacting protein 1,34695,137,1.02 [0.75-1.38],0.8953957672442482
Chapter II Neoplasms,Melanoma in situ,TP53,Cellular tumor antigen p53,40055,159,0.93 [0.66-1.29],0.6475552442553918
Chapter II Neoplasms,Melanoma in situ,TP53BP1,TP53-binding protein 1,34608,134,0.95 [0.78-1.15],0.6003002763673537
Chapter II Neoplasms,Melanoma in situ,TP53I3,Quinone oxidoreductase PIG3,34114,136,1.11 [0.81-1.52],0.5107437149915831
Chapter II Neoplasms,Melanoma in situ,TP53INP1,Tumor protein p53-inducible nuclear protein 1,40258,158,0.82 [0.49-1.37],0.4472636846491555
Chapter II Neoplasms,Melanoma in situ,TP73,Tumor protein p73,34686,135,0.79 [0.49-1.29],0.3506875368891489
Chapter II Neoplasms,Melanoma in situ,TPBGL,Trophoblast glycoprotein-like,34686,135,0.74 [0.47-1.16],0.1866442737601285
Chapter II Neoplasms,Melanoma in situ,TPD52L2,Tumor protein D54,34878,138,1.13 [0.97-1.33],0.1131907783091288
Chapter II Neoplasms,Melanoma in situ,TPK1,Thiamin pyrophosphokinase 1,35640,141,1.01 [0.56-1.82],0.9827501834212132
Chapter II Neoplasms,Melanoma in situ,TPM3,Tropomyosin alpha-3 chain,34518,137,0.78 [0.51-1.17],0.2257148925383054
Chapter II Neoplasms,Melanoma in situ,TPMT,Thiopurine S-methyltransferase,40055,159,1.08 [0.89-1.30],0.4349864668595649
Chapter II Neoplasms,Melanoma in situ,TPP1,Tripeptidyl-peptidase 1,40689,163,0.97 [0.71-1.33],0.8669015829074086
Chapter II Neoplasms,Melanoma in situ,TPPP2,Tubulin polymerization-promoting protein family member 2,34984,139,1.08 [0.90-1.31],0.4089682276342151
Chapter II Neoplasms,Melanoma in situ,TPPP3,Tubulin polymerization-promoting protein family member 3,40031,160,1.01 [0.71-1.44],0.9359571612155028
Chapter II Neoplasms,Melanoma in situ,TPR,Nucleoprotein TPR,34518,137,1.01 [0.74-1.39],0.935643293605192
Chapter II Neoplasms,Melanoma in situ,TPRKB,EKC/KEOPS complex subunit TPRKB,34394,136,0.70 [0.51-0.98],0.034664365305446
Chapter II Neoplasms,Melanoma in situ,TPSAB1,Tryptase alpha/beta-1,41389,164,0.97 [0.74-1.25],0.7903720713488606
Chapter II Neoplasms,Melanoma in situ,TPSD1,Tryptase delta,35587,140,1.23 [0.86-1.76],0.2501712769119972
Chapter II Neoplasms,Melanoma in situ,TPSG1,Tryptase gamma,34608,134,1.29 [0.73-2.28],0.3824811352035956
Chapter II Neoplasms,Melanoma in situ,TPT1,Translationally-controlled tumor protein,40249,159,0.94 [0.75-1.18],0.6043174465241188
Chapter II Neoplasms,Melanoma in situ,TRAF2,TNF receptor-associated factor 2,40939,163,1.17 [0.97-1.42],0.1050277712372382
Chapter II Neoplasms,Melanoma in situ,TRAF3,"TNF receptor-associated factor 3, Isoform 2",34608,134,0.93 [0.59-1.47],0.7658205177238588
Chapter II Neoplasms,Melanoma in situ,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,34518,137,0.83 [0.56-1.23],0.3590630825534492
Chapter II Neoplasms,Melanoma in situ,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,34984,139,1.16 [0.98-1.37],0.0771907201469001
Chapter II Neoplasms,Melanoma in situ,TREH,Trehalase,35644,141,0.96 [0.77-1.19],0.6894657751224413
Chapter II Neoplasms,Melanoma in situ,TREM2,Triggering receptor expressed on myeloid cells 2,40948,164,0.90 [0.69-1.19],0.470681070501536
Chapter II Neoplasms,Melanoma in situ,TREML1,Trem-like transcript 1 protein,35663,141,1.08 [0.80-1.46],0.6206937048490024
Chapter II Neoplasms,Melanoma in situ,TREML2,Trem-like transcript 2 protein,40993,164,0.91 [0.60-1.38],0.6520241148949958
Chapter II Neoplasms,Melanoma in situ,TRIAP1,TP53-regulated inhibitor of apoptosis 1,41358,164,1.13 [0.90-1.40],0.2897436764485448
Chapter II Neoplasms,Melanoma in situ,TRIM21,E3 ubiquitin-protein ligase TRIM21,40939,163,1.16 [0.96-1.39],0.1272660182402507
Chapter II Neoplasms,Melanoma in situ,TRIM24,Transcription intermediary factor 1-alpha,34913,138,1.17 [0.92-1.48],0.1999621326505099
Chapter II Neoplasms,Melanoma in situ,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,35486,140,1.10 [0.95-1.28],0.21635092057201
Chapter II Neoplasms,Melanoma in situ,TRIM26,Tripartite motif-containing protein 26,34394,136,0.98 [0.73-1.31],0.8766859183306752
Chapter II Neoplasms,Melanoma in situ,TRIM40,E3 ubiquitin ligase TRIM40,34686,135,1.15 [0.92-1.44],0.2075698931140882
Chapter II Neoplasms,Melanoma in situ,TRIM5,Tripartite motif-containing protein 5,40939,163,1.15 [0.98-1.35],0.0898094807869334
Chapter II Neoplasms,Melanoma in situ,TRIM58,E3 ubiquitin-protein ligase TRIM58,35477,140,1.09 [0.91-1.31],0.3547242261539871
Chapter II Neoplasms,Melanoma in situ,TRPV3,Transient receptor potential cation channel subfamily V member 3,34518,137,0.88 [0.61-1.26],0.4787574098186629
Chapter II Neoplasms,Melanoma in situ,TSC1,Hamartin,34608,134,0.96 [0.76-1.21],0.7426879359995453
Chapter II Neoplasms,Melanoma in situ,TSC22D1,TSC22 domain family protein 1,35587,140,1.17 [0.93-1.47],0.1810751494828089
Chapter II Neoplasms,Melanoma in situ,TSHB,Thyrotropin subunit beta,40984,163,1.05 [0.89-1.25],0.5538855324593146
Chapter II Neoplasms,Melanoma in situ,TSLP,Thymic stromal lymphopoietin,40258,158,0.82 [0.62-1.07],0.1424513988521371
Chapter II Neoplasms,Melanoma in situ,TSNAX,Translin-associated protein X,34518,137,0.85 [0.56-1.30],0.4567960584956676
Chapter II Neoplasms,Melanoma in situ,TSPAN1,Tetraspanin-1,40258,158,0.89 [0.69-1.15],0.3736319770575127
Chapter II Neoplasms,Melanoma in situ,TSPAN15,Tetraspanin-15,34518,137,0.96 [0.69-1.34],0.8288950325879967
Chapter II Neoplasms,Melanoma in situ,TSPAN7,Tetraspanin-7,34549,138,0.85 [0.69-1.04],0.1114173030871766
Chapter II Neoplasms,Melanoma in situ,TSPAN8,Tetraspanin-8,35486,140,1.03 [0.88-1.21],0.7248711593641732
Chapter II Neoplasms,Melanoma in situ,TSPYL1,Testis-specific Y-encoded-like protein 1,34608,134,1.26 [0.85-1.86],0.2452800516283582
Chapter II Neoplasms,Melanoma in situ,TST,Thiosulfate sulfurtransferase,39963,159,1.05 [0.87-1.26],0.6426834714815607
Chapter II Neoplasms,Melanoma in situ,TTF2,Transcription termination factor 2,34686,135,1.00 [0.71-1.40],0.9881443382613044
Chapter II Neoplasms,Melanoma in situ,TTN,Titin,34518,137,0.94 [0.73-1.22],0.6561674347498583
Chapter II Neoplasms,Melanoma in situ,TTR,Transthyretin,35302,139,1.01 [0.53-1.95],0.9721518674062348
Chapter II Neoplasms,Melanoma in situ,TUBB3,Tubulin beta-3 chain,34549,138,0.63 [0.35-1.15],0.1329378882712545
Chapter II Neoplasms,Melanoma in situ,TWF2,Twinfilin-2,35644,141,1.11 [0.91-1.34],0.3057310838059764
Chapter II Neoplasms,Melanoma in situ,TXK,Tyrosine-protein kinase TXK,34984,139,0.97 [0.78-1.21],0.7776594833897654
Chapter II Neoplasms,Melanoma in situ,TXLNA,Alpha-taxilin,40682,158,1.12 [0.96-1.32],0.1590156516302733
Chapter II Neoplasms,Melanoma in situ,TXN,Thioredoxin,35066,140,0.91 [0.62-1.34],0.6448523110591204
Chapter II Neoplasms,Melanoma in situ,TXNDC15,Thioredoxin domain-containing protein 15,41097,164,0.93 [0.56-1.54],0.7747331575898533
Chapter II Neoplasms,Melanoma in situ,TXNDC5,Thioredoxin domain-containing protein 5,41349,165,1.11 [0.91-1.36],0.3112068494290623
Chapter II Neoplasms,Melanoma in situ,TXNDC9,Thioredoxin domain-containing protein 9,35570,140,1.18 [0.88-1.58],0.2702694970821115
Chapter II Neoplasms,Melanoma in situ,TXNL1,Thioredoxin-like protein 1,34486,137,1.01 [0.86-1.19],0.8866229775311822
Chapter II Neoplasms,Melanoma in situ,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",40993,164,1.12 [0.84-1.51],0.4433758611480203
Chapter II Neoplasms,Melanoma in situ,TYMP,Thymidine phosphorylase,40723,161,1.18 [0.96-1.46],0.1219206250581057
Chapter II Neoplasms,Melanoma in situ,TYRO3,Tyrosine-protein kinase receptor TYRO3,40984,163,1.18 [0.73-1.93],0.4963013326838962
Chapter II Neoplasms,Melanoma in situ,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",34608,134,1.32 [1.00-1.73],0.0491116083738693
Chapter II Neoplasms,Melanoma in situ,UBAC1,Ubiquitin-associated domain-containing protein 1,40789,160,0.92 [0.62-1.38],0.6972193781465115
Chapter II Neoplasms,Melanoma in situ,UBE2B,Ubiquitin-conjugating enzyme E2 B,35477,140,0.85 [0.48-1.49],0.5665280546781992
Chapter II Neoplasms,Melanoma in situ,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,35640,141,1.30 [1.01-1.68],0.0439079594426128
Chapter II Neoplasms,Melanoma in situ,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,34608,134,1.10 [0.84-1.43],0.4988578111787509
Chapter II Neoplasms,Melanoma in situ,UBQLN3,Ubiquilin-3,34518,137,0.93 [0.66-1.31],0.6933810154575442
Chapter II Neoplasms,Melanoma in situ,UBXN1,UBX domain-containing protein 1,34878,138,1.09 [0.86-1.39],0.4639847063746622
Chapter II Neoplasms,Melanoma in situ,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,35486,140,1.13 [1.00-1.27],0.0484524475904008
Chapter II Neoplasms,Melanoma in situ,UGDH,UDP-glucose 6-dehydrogenase,34518,137,0.86 [0.70-1.05],0.1454905806554607
Chapter II Neoplasms,Melanoma in situ,UHRF2,E3 ubiquitin-protein ligase UHRF2,34518,137,0.36 [0.20-0.65],0.0006464508181648
Chapter II Neoplasms,Melanoma in situ,ULBP2,UL16-binding protein 2,40682,158,0.75 [0.50-1.12],0.1550951740697674
Chapter II Neoplasms,Melanoma in situ,UMOD,Uromodulin,41357,164,0.90 [0.70-1.16],0.435059974715598
Chapter II Neoplasms,Melanoma in situ,UNC5D,Netrin receptor UNC5D,34608,134,0.71 [0.37-1.37],0.308466813909157
Chapter II Neoplasms,Melanoma in situ,UNC79,Protein unc-79 homolog,34394,136,1.05 [0.79-1.40],0.7299802558937645
Chapter II Neoplasms,Melanoma in situ,UNG,Uracil-DNA glycosylase,35477,140,0.79 [0.48-1.29],0.3462790742468393
Chapter II Neoplasms,Melanoma in situ,UPB1,Beta-ureidopropionase,35640,141,1.00 [0.83-1.19],0.970258254946136
Chapter II Neoplasms,Melanoma in situ,UPK3A,Uroplakin-3a,34549,138,1.10 [0.80-1.51],0.5547921392240991
Chapter II Neoplasms,Melanoma in situ,UPK3BL1,Uroplakin-3b-like protein 1,34917,138,0.67 [0.44-1.02],0.0613138490120551
Chapter II Neoplasms,Melanoma in situ,UROD,Uroporphyrinogen decarboxylase,34878,138,1.17 [0.92-1.48],0.1973054913131338
Chapter II Neoplasms,Melanoma in situ,UROS,Uroporphyrinogen-III synthase,34686,135,1.06 [0.84-1.33],0.6488267793106242
Chapter II Neoplasms,Melanoma in situ,USO1,General vesicular transport factor p115,40789,160,1.12 [0.96-1.31],0.1608839438579949
Chapter II Neoplasms,Melanoma in situ,USP25,Ubiquitin carboxyl-terminal hydrolase 25,35477,140,1.24 [0.99-1.54],0.0610455491844327
Chapter II Neoplasms,Melanoma in situ,USP28,Ubiquitin carboxyl-terminal hydrolase 28,35570,140,1.18 [0.80-1.75],0.4014956442714852
Chapter II Neoplasms,Melanoma in situ,USP47,Ubiquitin carboxyl-terminal hydrolase 47,34518,137,1.14 [0.96-1.35],0.1366989211591156
Chapter II Neoplasms,Melanoma in situ,USP8,Ubiquitin carboxyl-terminal hydrolase 8,40258,158,1.06 [0.91-1.23],0.4510095211239058
Chapter II Neoplasms,Melanoma in situ,UXS1,UDP-glucuronic acid decarboxylase 1,40055,159,0.99 [0.76-1.30],0.9482774718047388
Chapter II Neoplasms,Melanoma in situ,VAMP5,Vesicle-associated membrane protein 5,40258,158,0.86 [0.64-1.15],0.3039938990772832
Chapter II Neoplasms,Melanoma in situ,VAMP8,Vesicle-associated membrane protein 8,34608,134,1.14 [0.95-1.38],0.1641575439976424
Chapter II Neoplasms,Melanoma in situ,VASH1,Tubulinyl-Tyr carboxypeptidase 1,40939,163,1.11 [0.94-1.31],0.237500100369585
Chapter II Neoplasms,Melanoma in situ,VASN,Vasorin,40329,161,0.92 [0.54-1.54],0.7395817302778094
Chapter II Neoplasms,Melanoma in situ,VASP,Vasodilator-stimulated phosphoprotein,35663,141,1.18 [0.95-1.47],0.1356945456736464
Chapter II Neoplasms,Melanoma in situ,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,40789,160,1.07 [0.53-2.19],0.8429190001639676
Chapter II Neoplasms,Melanoma in situ,VAV3,Guanine nucleotide exchange factor VAV3,34549,138,1.10 [0.93-1.30],0.2555191308789687
Chapter II Neoplasms,Melanoma in situ,VCAM1,Vascular cell adhesion protein 1,41076,163,1.10 [0.65-1.85],0.7223486357831457
Chapter II Neoplasms,Melanoma in situ,VCAN,Versican core protein,41349,165,0.98 [0.62-1.56],0.934240119443274
Chapter II Neoplasms,Melanoma in situ,VCPKMT,Protein-lysine methyltransferase METTL21D,34394,136,1.12 [0.95-1.32],0.1756827912787615
Chapter II Neoplasms,Melanoma in situ,VEGFA,Vascular endothelial growth factor A,41327,163,1.06 [0.84-1.35],0.6169925635243216
Chapter II Neoplasms,Melanoma in situ,VEGFB,Vascular endothelial growth factor B,34608,134,1.07 [0.59-1.91],0.8312642016486014
Chapter II Neoplasms,Melanoma in situ,VEGFC,Vascular endothelial growth factor C,41097,164,1.00 [0.79-1.28],0.9724846888887184
Chapter II Neoplasms,Melanoma in situ,VEGFD,Vascular endothelial growth factor D,41384,163,1.08 [0.73-1.60],0.6878168322377586
Chapter II Neoplasms,Melanoma in situ,VGF,Neurosecretory protein VGF,35587,140,0.91 [0.53-1.55],0.7199005080765697
Chapter II Neoplasms,Melanoma in situ,VIM,Vimentin,40258,158,0.92 [0.83-1.03],0.1662971524521537
Chapter II Neoplasms,Melanoma in situ,VIPR1,Vasoactive intestinal polypeptide receptor 1,34695,137,1.06 [0.55-2.05],0.8591509728568782
Chapter II Neoplasms,Melanoma in situ,VIT,Vitrin,35640,141,0.77 [0.50-1.19],0.2451930087600018
Chapter II Neoplasms,Melanoma in situ,VMO1,Vitelline membrane outer layer protein 1 homolog,40789,160,1.30 [1.04-1.62],0.0218776833718002
Chapter II Neoplasms,Melanoma in situ,VNN1,Pantetheinase,35663,141,0.89 [0.72-1.10],0.2797474566716122
Chapter II Neoplasms,Melanoma in situ,VNN2,Vascular non-inflammatory molecule 2,40789,160,0.88 [0.65-1.18],0.3866526635014968
Chapter II Neoplasms,Melanoma in situ,VPS28,Vacuolar protein sorting-associated protein 28 homolog,34984,139,1.27 [1.01-1.59],0.0419106562644004
Chapter II Neoplasms,Melanoma in situ,VPS37A,Vacuolar protein sorting-associated protein 37A,40789,160,1.15 [0.97-1.37],0.1109615242756058
Chapter II Neoplasms,Melanoma in situ,VPS4B,Vacuolar protein sorting-associated protein 4B,35477,140,1.10 [0.93-1.30],0.2765728498387887
Chapter II Neoplasms,Melanoma in situ,VPS53,Vacuolar protein sorting-associated protein 53 homolog,40789,160,1.11 [0.93-1.33],0.2435238508839947
Chapter II Neoplasms,Melanoma in situ,VSIG10,V-set and immunoglobulin domain-containing protein 10,35477,140,0.74 [0.44-1.25],0.2602513711360165
Chapter II Neoplasms,Melanoma in situ,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,34518,137,0.69 [0.41-1.19],0.1824943083766529
Chapter II Neoplasms,Melanoma in situ,VSIG2,V-set and immunoglobulin domain-containing protein 2,35477,140,1.02 [0.78-1.32],0.905350125459138
Chapter II Neoplasms,Melanoma in situ,VSIG4,V-set and immunoglobulin domain-containing protein 4,40938,164,1.08 [0.76-1.52],0.6751858037556653
Chapter II Neoplasms,Melanoma in situ,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,40920,163,1.16 [0.93-1.44],0.1884528965706927
Chapter II Neoplasms,Melanoma in situ,VSNL1,Visinin-like protein 1,35570,140,0.83 [0.53-1.30],0.4183815186021088
Chapter II Neoplasms,Melanoma in situ,VSTM1,V-set and transmembrane domain-containing protein 1,40031,160,0.91 [0.68-1.21],0.5203064062238901
Chapter II Neoplasms,Melanoma in situ,VSTM2B,V-set and transmembrane domain-containing protein 2B,34984,139,0.87 [0.57-1.32],0.5070441235080401
Chapter II Neoplasms,Melanoma in situ,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,40258,158,1.07 [0.85-1.35],0.5828937726299066
Chapter II Neoplasms,Melanoma in situ,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,41349,165,1.06 [0.87-1.28],0.5619961091489082
Chapter II Neoplasms,Melanoma in situ,VTCN1,V-set domain-containing T-cell activation inhibitor 1,40055,159,0.80 [0.50-1.28],0.3514124735556193
Chapter II Neoplasms,Melanoma in situ,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,34878,138,1.19 [0.91-1.57],0.2013723748044498
Chapter II Neoplasms,Melanoma in situ,VWA1,von Willebrand factor A domain-containing protein 1,41296,164,0.85 [0.61-1.18],0.3248400761537066
Chapter II Neoplasms,Melanoma in situ,VWA5A,von Willebrand factor A domain-containing protein 5A,34394,136,1.05 [0.86-1.27],0.6514821300052911
Chapter II Neoplasms,Melanoma in situ,VWC2,Brorin,40537,157,0.90 [0.62-1.29],0.5620298476938321
Chapter II Neoplasms,Melanoma in situ,VWC2L,von Willebrand factor C domain-containing protein 2-like,35587,140,1.01 [0.72-1.43],0.9474615582710048
Chapter II Neoplasms,Melanoma in situ,VWF,von Willebrand factor,41485,164,0.85 [0.70-1.03],0.0889703560824085
Chapter II Neoplasms,Melanoma in situ,WARS,"Tryptophan--tRNA ligase, cytoplasmic",40993,164,1.17 [0.81-1.69],0.3957656016488761
Chapter II Neoplasms,Melanoma in situ,WAS,Wiskott-Aldrich syndrome protein,40249,159,0.86 [0.69-1.08],0.2003509537603392
Chapter II Neoplasms,Melanoma in situ,WASF1,Wiskott-Aldrich syndrome protein family member 1,40258,158,1.08 [0.93-1.26],0.317741047461915
Chapter II Neoplasms,Melanoma in situ,WASF3,Wiskott-Aldrich syndrome protein family member 3,40031,160,1.02 [0.86-1.20],0.8508502168681167
Chapter II Neoplasms,Melanoma in situ,WASHC3,WASH complex subunit 3,35570,140,1.09 [0.89-1.34],0.4007324033690376
Chapter II Neoplasms,Melanoma in situ,WASL,Neural Wiskott-Aldrich syndrome protein,34608,134,0.91 [0.68-1.21],0.5092800917700024
Chapter II Neoplasms,Melanoma in situ,WDR46,WD repeat-containing protein 46,35477,140,0.83 [0.51-1.34],0.4369193289243891
Chapter II Neoplasms,Melanoma in situ,WFDC1,WAP four-disulfide core domain protein 1,34755,137,0.79 [0.55-1.13],0.198894237946874
Chapter II Neoplasms,Melanoma in situ,WFDC12,WAP four-disulfide core domain protein 12,41294,163,1.09 [0.88-1.35],0.4429790264108234
Chapter II Neoplasms,Melanoma in situ,WFDC2,WAP four-disulfide core domain protein 2,38889,153,1.26 [0.87-1.83],0.2158966868968568
Chapter II Neoplasms,Melanoma in situ,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40552,156,1.02 [0.72-1.45],0.8927002529762357
Chapter II Neoplasms,Melanoma in situ,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",41020,164,0.76 [0.51-1.15],0.1939759348546792
Chapter II Neoplasms,Melanoma in situ,WIF1,Wnt inhibitory factor 1,41358,164,0.93 [0.62-1.40],0.7448209343927541
Chapter II Neoplasms,Melanoma in situ,WNT9A,Protein Wnt-9a,40249,159,1.01 [0.61-1.66],0.976871337344306
Chapter II Neoplasms,Melanoma in situ,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,40682,158,1.16 [0.89-1.50],0.2709794111206677
Chapter II Neoplasms,Melanoma in situ,XCL1,Lymphotactin,41358,164,1.08 [0.85-1.36],0.5404929701225352
Chapter II Neoplasms,Melanoma in situ,XG,Glycoprotein Xg,41282,162,0.88 [0.57-1.35],0.5477238113127274
Chapter II Neoplasms,Melanoma in situ,XIAP,E3 ubiquitin-protein ligase XIAP,34608,134,1.17 [0.88-1.56],0.2687232915717907
Chapter II Neoplasms,Melanoma in situ,XPNPEP2,Xaa-Pro aminopeptidase 2,41097,164,0.94 [0.82-1.08],0.4056746467759226
Chapter II Neoplasms,Melanoma in situ,XRCC4,DNA repair protein XRCC4,40031,160,0.98 [0.66-1.43],0.897873375567251
Chapter II Neoplasms,Melanoma in situ,YAP1,Transcriptional coactivator YAP1,35570,140,0.73 [0.39-1.37],0.327357785453982
Chapter II Neoplasms,Melanoma in situ,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",35486,140,1.10 [0.98-1.23],0.1025266786481139
Chapter II Neoplasms,Melanoma in situ,YES1,Tyrosine-protein kinase Yes,40789,160,1.08 [0.96-1.22],0.2014642247829189
Chapter II Neoplasms,Melanoma in situ,YJU2,Splicing factor YJU2,35477,140,0.84 [0.50-1.41],0.5052513704884067
Chapter II Neoplasms,Melanoma in situ,YOD1,Ubiquitin thioesterase OTU1,34518,137,0.91 [0.70-1.18],0.4852371799625841
Chapter II Neoplasms,Melanoma in situ,YTHDF3,YTH domain-containing family protein 3,40249,159,1.08 [0.91-1.27],0.3750761467655703
Chapter II Neoplasms,Melanoma in situ,YWHAQ,14-3-3 protein theta,34878,138,1.15 [0.92-1.43],0.2283085065886708
Chapter II Neoplasms,Melanoma in situ,YY1,Transcriptional repressor protein YY1,34608,134,0.62 [0.33-1.15],0.1302744970629571
Chapter II Neoplasms,Melanoma in situ,ZBP1,Z-DNA-binding protein 1,34608,134,1.03 [0.69-1.55],0.8855678617934689
Chapter II Neoplasms,Melanoma in situ,ZBTB16,Zinc finger and BTB domain-containing protein 16,40055,159,1.24 [1.03-1.50],0.023513766106841
Chapter II Neoplasms,Melanoma in situ,ZBTB17,Zinc finger and BTB domain-containing protein 17,40258,158,0.85 [0.59-1.23],0.3919843472134703
Chapter II Neoplasms,Melanoma in situ,ZCCHC8,Zinc finger CCHC domain-containing protein 8,34518,137,0.72 [0.52-1.01],0.0579424729922724
Chapter II Neoplasms,Melanoma in situ,ZFYVE19,Abscission/NoCut checkpoint regulator,35486,140,1.06 [0.89-1.27],0.525085876413125
Chapter II Neoplasms,Melanoma in situ,ZHX2,Zinc fingers and homeoboxes protein 2,35570,140,1.01 [0.63-1.63],0.958220079459362
Chapter II Neoplasms,Melanoma in situ,ZNF174,Zinc finger protein 174,34608,134,0.91 [0.57-1.45],0.7019837557216382
Chapter II Neoplasms,Melanoma in situ,ZNF75D,Zinc finger protein 75D,34984,139,0.95 [0.72-1.25],0.7243062915639185
Chapter II Neoplasms,Melanoma in situ,ZNF830,Zinc finger protein 830,35477,140,0.87 [0.69-1.10],0.2383186885499248
Chapter II Neoplasms,Melanoma in situ,ZNRD2,Protein ZNRD2,35486,140,1.03 [0.81-1.30],0.8101785514739717
Chapter II Neoplasms,Melanoma in situ,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,35477,140,0.94 [0.69-1.28],0.6899943089549238
Chapter II Neoplasms,Melanoma in situ,ZP3,Zona pellucida sperm-binding protein 3,34695,137,1.04 [0.97-1.11],0.2579407810225652
Chapter II Neoplasms,Melanoma in situ,ZP4,Zona pellucida sperm-binding protein 4,34394,136,0.99 [0.60-1.64],0.979103865075432
Chapter II Neoplasms,Melanoma in situ,ZPR1,Zinc finger protein ZPR1,34549,138,1.05 [0.90-1.23],0.5161436430082365
